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ABSTRACT
Terminal dehydration, a condition that may affect dying cancer patients, may contribute 
significantly to symptom distress. This in turn may affect the quality of life and suffering 
experienced by the dying person.
A survey was carried out to investigate the attitudes of doctors and nurses towards terminal 
dehydration and its treatment with artificial hydration therapies. Differing perceptions 
towards terminal dehydration were found. These were attributed to differing philosophical 
approaches, whereby specialist palliative care clinicians support the belief that greater 
benefit for dying patients is gained by treating the symptoms of terminal dehydration, in 
contrast, to other clinicians who perceive that there is more benefit from preventing or 
correcting the state of terminal dehydration.
An empirical investigation of symptom distress, with particular reference to symptoms 
related to terminal dehydration, led to the development of a Physical Symptom Distress 
Scale (PSDS) and in conjunction with the established Rotterdam Symptom Checklist 
(RSCL), a clinimetric framework was used to evaluate it. It was found to be valid, reliable 
and feasible for both clinical and research use and, although a quantitative tool, the 
researcher argues that it may be used as a starting point for meaning-centred assessment of 
symptoms thus contributing to more holistic patient care.
Severe fatigue, presence of other distressing symptoms, and impaired cognitive 
functioning frequently precluded the use of self-assessment scales. Consequently, a study 
investigating nurses’ use of behavioural indicators of distress as an alternative to self- 
assessment was carried out. Although this failed to yield a reliable and valid instrument it 
provides a useful foundation for further developmental work in this important area.
The development of the PSDS has provided an instrument that may be used in future 
studies to evaluate what interventions comprise optimal care for dehydrated dying patients. 
Suggestions for further research are offered.
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11 Introduction
Dehydration is a condition that may affect people in the end stages of the cancer disease 
trajectory. Causes include a decrease in fluid intake that may accompany anorexia and 
decreasing level of consciousness, and an increase in lethargy and sleepiness in the 
presence of continued or accentuated loss of body fluids. This state, occurring in the last 
few days of life, is known as terminal dehydration.
Terminal dehydration has been associated with different forms of treatment ranging 
from the use of artificial hydration therapies (AHT) (e.g. the administration of artificial 
fluids via an intravenous infusion (IVI), or a subcutaneous (SC) or nasogastric (NG) 
route) to supportive care (involving oral care to relieve dry mouth and drug treatment 
for control of symptoms). The treatment of terminal dehydration has been a source of 
considerable debate, both in clinical practice and in the palliative care and mainstream 
health-related literature.
In the light of the literature reviewed and the empirical studies detailed here, this thesis 
argues that patients dying of malignant disease may suffer distress, either from 
symptoms arising as a consequence of the dehydration or symptoms arising from 
treatment with AHT. However, this symptom distress may not always be recognised 
because, as yet, there is no suitable method of assessing its extent or degree. The lack of 
suitable measurement instruments has also impeded the conduct of clinical research 
designed to investigate this condition or to identify appropriate treatment modalities. 
Thus, it is argued that research into suitable methods of assessment of symptom distress 
is urgently required.
1.1 Outline of thesis content
Chapter 2 reviews the literature pertaining to dehydration in the dying patient, including 
its pathophysiological basis, and describes the current extent of knowledge and the 
evidence base for practice. Evidence is presented demonstrating that different 
approaches to clinical management are adopted, with non-palliative care specialists 
supporting the use of AHT in the dehydrated dying patient and the palliative care 
specialists generally advocating management by local less invasive measures. The 
discussion highlights the need for greater understanding both of the condition and the 
reasons for differences in practice that were observed.
2Chapter 3 describes a survey carried out to investigate the attitudes of doctors and 
nurses towards terminal dehydration and its treatment with AHT. The survey instrument 
contained statements pertaining to distressing symptoms and supported the findings of 
the literature review regarding the differences in practice observed. This chapter argues 
that the differences seen in clinical practice regarding what constitutes most appropriate 
management may be dependent on the clinician’s perception of whether there is more 
benefit to the patient from treating the state of dehydration or from treating symptoms 
that may arise as a consequence of the condition. It is proposed that the unifying 
dimension to these philosophically different approaches can be found in the common 
concern regarding symptom occurrence. It is recognised by clinicians that the presence 
of symptoms attributable to terminal dehydration, or its treatment with AHT, may be a 
source of significant distress and may impact on the quality of life. This illustrates the 
need for further work investigating the significant area symptom distress, related to 
terminal dehydration, in the dying patient.
Chapter 4 involves an analysis of the literature concerning symptom distress and the 
interrelated concepts of quality of life and suffering. This highlights a lack of conceptual 
clarity in definitions pertaining to these concepts. Existing methods used to assess 
symptom distress are explored; the critique concludes that no symptom distress scale 
had been developed to date that was validated for use in a population of patients dying 
from malignant disease. Consequently, it is argued that an exploratory study is required 
to elucidate which symptoms are sources of distress in such a population. This is 
described in Chapter 5 which first describes an empirical investigation of symptom 
distress, with particular reference to symptoms related to terminal dehydration, and then 
discusses issues surrounding the development of a Physical Symptom Distress Scale 
(PSDS). Chapter 6 continues this theme and describes a study designed to test the 
PSDS, using a clinimetric framework to evaluate its reliability, validity and sensibility.
It is argued that, as symptom distress is a subjective experience, self-assessment is the 
most appropriate form of measurement. However, whilst undertaking the empirical 
studies described in Chapters 5 and 6, it became apparent that instruments relying on 
self-assessment were often not feasible in the target population (i.e. cancer patients in 
the last stages of the dying trajectory). Severe fatigue, presence of other distressing 
symptoms, impaired cognitive status and reduced levels of consciousness frequently
3precluded their use. Consequently, an alternative approach, in the form of assessment of 
symptom distress by proxy, was examined. Chapter 7 describes a study investigating 
nurses’ use of behavioural indicators of distress as an alternative to self-assessment.
Ethical dilemmas are inherent in any research involving human subjects. However, the 
investigations using participants who are close to death, and their bereaved relatives, 
raised significant ethical issues during the course of this work. Chapter 8 explores these 
issues and relates them to methodological decisions made and their possible effects on 
the confidence that can be placed in the study findings. The final chapter, (Chapter 9) 
concludes with a discussion and integration of the studies described.
An underlying premise, central to the development of this thesis, is that a prerequisite 
for research is the establishment of reliable, valid, sensitive and feasible outcome 
measures. Whilst the identification of a clinical problem involving distressing 
symptoms related to terminal dehydration, and/or its treatment, provided the stimulus 
for the research endeavour, the main focus of the work remained at the level of scale 
development and testing. This has provided a strong foundation for the future 
investigations that are required to address the clinical problem of terminal dehydration 
that actuated this work.
42 Dehydration in the dying
2.1 Introduction/Overview
There are many possible sources for the suffering that the dying may experience 
(Cassell, 1982). The contributory role of dehydration in adding to or reducing this 
suffering is poorly understood (Viola et al, 1997). Patients dying of cancer often 
experience dehydration in the terminal stages of illness; as death approaches anorexia is 
often profound and patients’ desire to eat and drink is diminished (Musgrave, 1990; 
Dunlop et al, 1995). Prior to the technological advancement of intravenous infusions 
(IVIs), subcutaneous infusions and feeding via nasogastric and parenteral routes, dying 
persons unable to take fluid orally were likely to experience dehydration. Dehydration 
can now be treated with artificial hydration therapies (AHT) (e.g. infusions via 
intravenous, subcutaneous, nasogastric, or rectal routes). It is not clear if these therapies 
benefit the imminently dying and there has been considerable discussion in the literature 
regarding the appropriateness of withdrawing or withholding AHT.
Dehydration, as a sequel to a gradual deterioration associated with advancing malignant 
disease (with increasing weakness, fatigue, drowsiness, anorexia and weight loss), can 
be seen as a normal part of the dying process. However, the ready availability of 
invasive techniques to maintain hydration when patients are no longer able to take 
adequate amounts orally means that AHT is often used. The main reason for this 
appears to be the perception that dehydration causes distressing symptoms (e.g. 
Micetech et al, 1983; Collaud and Rapin, 1991). Health care professionals in palliative 
care settings have challenged this assumption and the often routine practice of 
administering AHT to dying patients seen in hospitals. It is suggested that, in some 
instances, dehydration may be beneficial and that the use of AHT may contribute to 
distressing symptoms itself (e.g. Zerwekh, 1983; Printz, 1989). However, more recently, 
some palliative care clinicians have questioned whether the use of AHT may in fact 
reduce problems associated with dehydration and opioid toxicity and cognitive 
impairment (e.g. Fainsinger and Bruera, 1994).
Discussion about appropriate treatment concerns the discomfort of being dehydrated or 
of receiving AHT. This chapter first reviews the pathophysiology of dehydration and 
patterns of symptomatology that may occur. The advantages and disadvantages of
5dehydration and electrolyte imbalance are then considered. Attitudes and perceptions 
towards terminal dehydration in health care professionals and family caregivers are 
explored and the review concludes with an examination of studies pertaining to 
symptoms and dehydration.
2.2 Physiology of dehydration
In contrast to the rapidly increasing literature regarding the management and ethical 
debates surrounding terminal dehydration, there is little pertaining to the 
pathophysiology of dehydration in the dying patient. Dehydration is defined as "the 
reduction or complete loss of water content" (Churchill's Medical Dictionary, 1989). 
However, this term is often used imprecisely to describe various conditions with 
different causes, symptoms, biochemical abnormalities, which may require different 
management. Dehydration is a complex fluid and electrolyte imbalance and discussions 
of dehydration are usually subdivided according to sodium balance: normo- hypo- or 
hypernatraemic dehydration (normal sodium concentrations, low sodium concentrations 
or high sodium concentrations respectively).
2.2.1 Normonatraemic dehydration
This is a common disturbance of fluid balance and is usually not severe. It occurs when 
fluid loss and sodium losses occur in equal proportions, such as in mild vomiting and 
diarrhoea (Kumar and Clark, 1990).
2.2.2 Hyponatraemic dehydration
Hyponatraemic dehydration results from depletion of both water and sodium but salt 
loss predominates, or when salt and water are lost together but only water is replaced. 
Losses like this may arise from the gut (e.g. vomiting and diarrhoea), or from the 
kidneys (e.g. overuse of loop diuretics, diuresis caused by glucose osmosis or severe 
uraemia, or adrenal insufficiency) (Anderson et al, 1985).
Clinical manifestations are often associated with volume depletion and include signs of 
circulatory insufficiency (such as reduced blood pressure, postural hypotension, cold 
peripheries, decreased cerebral perfusion), uraemia, hyponatraemia, and haemo- 
concentration. Patients may experience dryness of the mouth and mucous membranes, 
diminished sweat, decreased skin turgor (Silver, 1990), and neurological consequences
6such as weakness, apathy, lethargy, restlessness, confusion, coma and seizures (Billings,
1985). Billings (1985) notes that nausea, vomiting, anorexia and taste loss are noted in 
experimental subjects with hyponatraemic dehydration but suggests that these may be 
contributing causes rather than a result of the condition. Thirst is often absent in 
hyponatraemic dehydration as this symptom is primarily provoked by a raised sodium 
concentration.
2.2.3 Hypernatraemic dehydration
Hypernatraemic dehydration develops when water loss is greater than the loss of 
sodium and may occur when fluid intake is insufficient (e.g. unconscious patients with 
no fluid intake, confusional states which reduce the normal response to thirst) and rarely 
with loss of normal thirst. It also results from increased fluid loss, such as that 
associated with vomiting and diarrhoea, from the skin and lungs in febrile patients or 
the fluid loss causes by burns. Losses of water from renal causes in sufficient amounts 
to cause hypernatraemia only occur in diabetes insipidus or osmotic diuresis as in 
hyperglycaemia (Kumar and Clark, 1990). Clinical manifestations include intense thirst 
and diminished mental status, ranging from mild confusion to coma. Weakness, fatigue 
and low-grade fever have been noted also (Billings, 1985).
2.2.4 Terminal dehydration
Most cancer patients experience decreased oral intake prior to death; contributory 
causes include severe anorexia, chronic nausea, dysphagia and cognitive failure (Coyle 
et al, 1990; Bruera et al, 1992; Bruera et al, 1996). Billings (1985) suggests that 
dehydration in the terminally ill patient may present as a mixed disorder of salt and 
water loss and may be caused by normal water losses from the lungs, skin and kidneys, 
with failure to replace those losses, or abnormal gastrointestinal or renal losses. 
Normonatraemic (or isotonic) dehydration may also occur and the symptoms associated 
with hypo- or hypernatraemia may not be manifest in this form of the condition 
(Billings, 1985). Dunlop et al (1995) suggest that the dehydration observed in terminal 
cancer patients is not equivalent to that seen in acute conditions and that the 
distinguishing features are systemic symptoms such as fatigue and drowsiness which 
precede the reduction and then cessation of fluid intake by days or weeks.
7It is not clear which forms of dehydration occur in the dying and to what degree they 
manifest the signs and symptoms described above. Beauchamp and Childress (1994) 
suggest that evidence indicates that patients allowed to die without artificial hydration 
sometimes die more comfortably than patients who receive hydration and that “it is 
often misleading to project the common experience of hunger and thirst on a dying 
patient who is malnourished and dehydrated” (p.205). This supports the earlier 
observation that the experience of dehydration in the final stages of life may be different 
from that experienced in acute illness episodes or under experimental conditions. 
Consequently, the following questions arise: does dehydration or treatment with AHT 
cause distressing symptoms in the dying? Can these distressing symptoms be 
measured/assessed? What treatment is required to relieve such problems?
2.3 Advantages and disadvantages of dehydration
Clinicians with a special interest in terminal care (e.g. Lamerton, 1980; Baines, 1990) 
suggest that dry mouth and occasional thirst are the only symptoms which can be 
attributed to dehydration in the dying; additionally, they do not report other symptoms 
such as headache, nausea, vomiting and cramps which are cited in reviews of the effects 
of water deprivation (e.g. Billings, 1985). Some workers go further suggesting that 
dehydration may be beneficial to the dying patient, giving examples of possible 
mechanisms of benefit. For instance, Zerwekh (1983) suggests that dehydration may 
reduce distressing symptoms, such as a decline in urine output, which reduces the need 
for 'toileting', lessens the likelihood of incontinence and reduces the need for 
catheterisation. She also suggests that a decrease in gastrointestinal fluids will reduce 
episodes of vomiting, whilst a reduction in pulmonary secretions will lessen coughing 
and congestion; decreased pharyngeal secretions may relieve the sensation of coughing 
and 'drowning'. Dehydration may also decrease both peripheral and pulmonary oedema 
and so reduce pressure symptoms around the tumour. However, the author cites no 
empirical evidence to support her claims but relies solely on her experience and 
observations.
Dolan (1983) found a higher incidence of tracheal suctioning in terminally ill patients in 
hospitals compared to hospices. It was hypothesised that this was due to the IV fluid 
support given to hospital patients, in whom the renal shutdown prior to death, combined 
with the additional IV fluids, caused pulmonary oedema. However, no attempt was
8made to assess other contributing factors. For example, drug treatment of pulmonary 
symptoms may have differed in the two groups, as specialists in palliative care advocate 
the use of anticholinergic drugs for control of excess oropharynx and tracheal secretions 
in the terminal phase (e.g. Twycross and Lichter, 1998).
Norberg et al (1980) suggest that, when terminal geriatric patients are unable to 
maintain adequate food and fluid intake, they become somnolent and die peacefully, 
'apparently without thirst, hunger or pain'. However, Hamdy (1980), in a reply to this, 
states that “dehydration is an unpleasant condition and there is no reason to believe that 
elderly patients do not feel thirst” (p. 717). This is not clear though, as Phillips et al 
(1984) have demonstrated thirst deficits in the elderly; thus, the elderly patient dying of 
malignant disease may not experience as much thirst as the younger patient. There is no 
conclusive evidence to support either of these arguments.
Dehydration itself has been associated with apathy, depression, dysphagia and 
oesophageal dysfunction (Judge, 1978). Hamdy (1980) also suggests that the “'well 
established” consequences of dehydration (e.g. nausea, hypotension, decreased renal 
perfusion with oliguria, uraemia and cerebral hypoperfusion) lead to impaired mental 
functioning and confusion, and concludes that death cannot, therefore, be as painless 
and peaceful as others claim.
Turner and Turner (1988) state that dehydration with significant volume depletion 
(although they do not specify what is considered to be 'significant' in this context) often 
leads to postural hypotension, falls, decreased skin perfusion and, therefore, increased 
risk of pressure sore development. Dehydration and the resultant rise in blood viscosity 
will also increase the risk of deep vein thrombosis and the formation of pulmonary 
emboli. However, it may be suggested that these potential complications may not be as 
significant for the imminently dying patient.
The consequences of dehydration in the dying are unclear; the review of the literature 
suggests advantages and disadvantages, most of which are not supported by empirical 
evidence. There is a clear need to assess the proposed benefits and ill effects of artificial 
hydration in this patient population.
92.4 Electrolyte Imbalance
It is not clear if electrolyte imbalance necessarily follows dehydration in the terminal 
stages of illness. Musgrave (1990) reports that there is often a decrease in fluid volume 
and electrolyte imbalance in the dying but does not provide any evidence for this 
assertion. Dresser and Boisaubin (1985) claim that dehydration leads to death through 
hyperosmolality, with hypernatraemia and hypercalcaemia, although this is not 
supported by clinical research. Zerwekh (1983) suggests that dehydration may lead to 
electrolyte imbalance and an associated neuromuscular irritability and 'twitching', and 
on occasions, disorientation and nausea, whilst the electrolyte imbalance may serve as a 
natural anaesthetic and may facilitate a reduction in pain medication. Printz (1989) also 
uses her experience in terminal care to suggest that dying patients are more comfortable 
with less hydration although this conclusion is not empirically supported. In extreme 
states of acidosis, hypernatraemia, hypercalcaemia and hypovolaemia leading to 
cerebral anoxia, some degree of analgesia may be anticipated since the neurological 
sequelae of these states range from lethargy to coma (Arieff and Defranzo, 1985). 
However, there may still be positive effects even if the dehydrated patient does not have 
marked electrolyte imbalance. Calorie deprivation (often concurrent with terminal 
dehydration) results in the production of ketones which may cause a partial loss of 
sensation since ketones have been found to exert anaesthetic effects on the squid axon 
(Elliot et al, 1984). Furthermore, opioid peptides may be produced in larger quantities in 
advanced states of malnutrition or dehydration (Majeed et al, 1986; Takahashi et al,
1986), contributing to pain relief.
Oliver (1984), in the course of a study of hypercalcaemia, found that, in 22 patients 
dying without AHT, 12 had essentially normal biochemistry with only mildly raised 
urea concentration, five were markedly uraemic and five were both uraemic and 
hypercalcaemic. This suggests that, even without hydration, patients may die with 
normal blood biochemistry. However, although this work is often cited as evidence for 
not hydrating the dying, the sample size is too small to enable valid conclusions to be 
drawn. Furthermore, this study cannot contribute towards the discussion of electrolyte 
imbalance as possible sequelae to dehydration as no definition of dehydration is 
discussed with respect to the subjects. Thus, those patients with normal blood chemistry 
may have passed quickly into the dying phase and, in fact, be well hydrated.
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Waller et al (1994) studied 68 patients in a palliative care setting 48 hours or less before 
death; 13 of these patients received artificial hydration via an IVI. Routine biochemical 
tests and urinalyses were correlated with a level of consciousness scale. Dehydration 
('substantial') was defined as serum urea concentration of 12 mmol/1 or more and 59 of 
the 63 patients fulfilled this criterion. There was no significant difference between the 
urea concentrations of the treated and non-treated group; serum sodium concentration 
was significantly higher in the group not receiving IV fluids (p<0.02). A significant 
correlation was shown between serum sodium and level of consciousness. The 
disproportionate size of the study groups, and the small sample treated with IVI, may 
have affected the outcome. The fact that the mean urea concentration for this group was
50.9 mmol/1, indicating (by the authors' own definition) a substantially dehydrated state, 
suggests that the treatment was not adequate (or that their definition of dehydration is 
inadequate), or that dehydration in this dying population cannot be corrected by AHT. 
The two groups were not randomised for treatment with IVIs, thus bias may have been 
introduced and the results must be interpreted with caution. It can be concluded from 
this patient series that, whatever the treatment, those patients approaching death had 
electrolyte imbalance, in contrast to the results presented by Oliver (1984).
This discussion reveals a controversy regarding electrolyte imbalance; the physiological 
effects of giving or withholding AHT in the dying are not well established.
2.5 Cause of death
Brooker (1992) raises the question of whether it may be more difficult to withdraw IV 
therapy once it has been started in the dying patient, implying that the withdrawal of 
fluids will lead to the patient's death. Surely the patient will die of his underlying 
malignant disease whether or not he is artificially hydrated, for if this were life saving 
treatment, the discussion about withdrawal would not have been raised in the first 
place? Studies of patients with inoperable gastrointestinal obstruction have indicated 
that there is no significantly longer survival in patients treated with IVIs compared to 
those who are not (Baines et al, 1985). Saunders (1986) suggests that patients do not die 
from dehydration but from a general 'running down' of all body systems. Such 
arguments are raised in the ethical discussions surrounding withholding or withdrawing 
artificial hydration and are beyond the scope of this literature review. The question
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under consideration here is whether the use of artificial hydration will facilitate a more 
comfortable death.
2.6 Attitudes towards terminal dehydration
As highlighted earlier, there appears to be a division of opinion regarding the correct 
treatment for the dehydrated dying patient. Although artificial hydration therapies have 
proven benefits in the acute situation, it is less clear whether they benefit the 
imminently dying patient. Hydration is a prerequisite for life; its cessation will allow or 
hasten death. Thus, the literature reveals continuing debate on the ethical, moral and 
emotional issues surrounding the provision of artificial hydration in the end stages of 
life.
2.6.1 Perceptions of health care professionals
It appears that people dying from malignant diseases in general hospitals are more likely 
to receive fluid replacement than those dying at home or in the hospice setting. For 
example, Micetech et al (1983) investigated the attitudes of 218 doctors towards 
hydration in the hypothetical case of a comatose dying patient with widespread 
malignant metastases. Of the 96 respondents, 73% would order an intravenous infusion 
(IVI) at a 'physiologically rehydrating rate1 (Group 1), 27% would replace fluid at a rate 
insufficient to rehydrate the patient (Group 2). If required, 84% of Group 1 and 28% of 
Group 2 would replace the infusion and 40% of Group 1 would insert a central line, or 
perform an IV cutdown, if a peripheral site was not available (c.f. 5% of Group 2); 71% 
of Group 1 would not discontinue the IVI after 3 days even in the absence of clinical 
improvement. Of all the respondents 50% regarded intravenous fluids as a central part 
of the standard of care provided for the terminally ill, comatose patient.
Marin et al (1989) surveyed 833 doctors with a similar hypothetical case. Of the 488 
respondents, 53% would administer IV fluids, with 83% of these resiting the cannula as 
required and 26% resorting to the use of a central venous line if no other route was 
available. Increasing age and seniority of doctor had a significant effect on the treatment 
decision made, with 63% of house officers and senior house officers administering 
fluids compared with 45% of registrars and consultants (p<0.01). 85% of those who 
would use IV fluids in this case stated that 'ensuring the patients' comfort’ was the 
reason for their decision. The authors note that few respondents (4%) mentioned the
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feelings of relatives as influencing their decision; however, the question asked focused 
on the single most important factor influencing the decision and perhaps there are a 
number of inter-related factors that this question was not sensitive enough to 
investigate. Of those using IV fluids only 27% would 'monitor the patient's condition to 
ensure good hydration and electrolyte balance' compared with 68% giving 'sufficient 
only to maintain adequate fluid balance'. The differences between good and adequate 
fluid and electrolyte balance are not discussed and one could postulate that "adequate" 
fluid balance is good. The question asked actually limited the answer to either of these 
statements, thus failing to elicit responses which could further explore the issues 
surrounding the regimes of hydration therapy and reasons for particular decisions. Thus 
comparison cannot be made with the study of Micetech et al (1983), which found some 
doctors suggesting hydration but not at a 'physiological' rate.
Collaud and Rapin (1991) surveyed 978 doctors in French-speaking Switzerland. Of the 
397 respondents, 28% indicated the use of artificial hydration for conscious dying 
patients and 44% for the comatose patient. Doctors were asked for their assessment of 
discomfort due to dehydration and the treatment that they would propose to correct this 
situation. Results indicated a diversity of opinion, with 42% suggesting that dying 
patients suffer significantly from dehydration and 33% that patients scarcely suffer. 
Further differences were highlighted in the reasons accounting for the discomfort, 29% 
assessed the discomfort due to thirst as slight and 33% as serious. Sixty percent of 
respondents felt that the presence of an IVI provided no extra source of discomfort.
There were significant differences between hospital physicians and general practitioners 
who assessed overall discomfort, thirst, dry mouth and hunger in dehydration as 
significantly lower than surgeons (Collaud and Rapin, 1991). Doctors who chose 
artificial hydration were significantly more prone to considering thirst and suffering as 
'serious' than those preferring hydration by mouth. This suggested that two thirds of the 
doctors studied thought that AHT was not the best way to respond to dehydration in the 
dying and that the choice appears to be partly dependent on the doctor's subjective 
assessment of suffering and thirst resulting from dehydration. Other factors contributing 
to this decision process were not investigated and may be very important. A common 
problem in the methodology of hypothetical case reports is the difference between 
practice and theory. The number of doctors stating that they actually use IVIs in such
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patients was twice as high as the number of doctors who selected treatment with IVIs in 
the hypothetical case reports. The external context of treatment therefore appears to be 
an important consideration and a limitation to this type of study.
Burge et al (1990), in a retrospective study of patients dying in a tertiary care facility, 
noted that 81% received IV fluids within the last 30 days of life and 69% died with 
fluids running. The use of fluid replacement appeared to be independent of age, gender, 
site of primary tumour, presence of metastases and duration of illness. Similarly, 
rehydration was independent of the presence of family members, the language spoken 
by the patient and the presence of "do not resuscitate" orders. The choice of factors that 
were examined for their influence on decision making was not explained; the effects of 
dementia or confusion were not included and, when medications were investigated, the 
possibility of an alternative route of medication did not appear to be considered. The 
content validity of the method of investigation can, therefore, be questioned. There are 
also limitations on a retrospective audit, as written documents may not accurately reflect 
the thinking and reasoning of clinicians at the time of decision making or the actual 
action taken. Incomplete records were evident and 30% of all notes had no information 
regarding whether or not IV therapy was employed.
A study by Andrews and Levine (1989) suggests that perceptions of terminal 
dehydration may be influenced by experience of observing this condition. Their 
findings indicated that hospice nurses experienced in observing dehydration have a 
more positive perception of this state than those who have not, such that artificial 
hydration therapy is not generally advocated (Andrews and Levine, 1989). Enck (1989) 
cites the study by Andrews and Levine (1989) as providing good evidence to suggest 
that dehydration is not painful and that symptoms may be lessened by this state; 
however, this work concerns the perceptions of nurses regarding dehydration and does 
not provide clinical evidence to support the claims made.
Although it can be suggested that the differences in perceptions of dehydration, and 
attitudes towards its treatment, may be related to the experience of the health care 
worker involved, the reasons underlying these merit further investigation. In particular, 
the accumulation of detailed clinical evidence is required to establish whether 
dehydration or the use of artificial hydration therapies can benefit the dying patient or 
whether they can be a source of distress.
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These studies suggest that in the USA, UK, Canada, and Switzerland many health care 
professionals perceive artificial hydration as a useful and necessary part of the care of 
the dying patient. However, opinion is divided and others contend that AHT is not the 
form of treatment to confer the most benefit to patients in this situation. The debate 
seems to centre on the perception of the amount of distress caused by symptoms of 
dehydration or caused by treatment with AHT.
2.6.2 Family/caregivers perceptions
Musgrave et al (1996) reported a pilot study investigating attitudes of Israeli terminally 
ill patients, their families and health care professionals towards intravenous hydration. 
A convenience sample of thirty-three patients considered having a prognosis of ten days 
or less was interviewed using a semi-structured approach. All patients were treated with 
IV therapy. Findings revealed that patient, family and nurse involvement in decisions to 
commence IV therapy was low (5% patients, 19% family and 36% nurses). Only seven 
of the patients were able to express their attitudes towards the IV therapy and these were 
positive. The authors, however, suggest caution in interpreting this, citing findings from 
De Stoutz et al (1995) that up to 80-90 % of terminally ill patients may be delirious. 
However, work from proponents of the use of AHT in the terminal stages suggest that 
using AHT may reduce the incidence of delirium (Bruera et al, 1995) and the sample of 
patients in the Musgrave et al (1996) study were all artificially hydrated.
Eighty-one percent of the families and seventy-one percent of nurses were positive 
regarding the use of the IV therapy. The prime reason offered for use of IV fluids was 
for the administration of medication; this supports the findings of Burge (1990). The 
second most frequent reason was for the giving of fluids, with different explanations 
such as relief of suffering and prolonging life. Musgrave et al (1996) suggest that the 
overall positive attitude towards IV hydration could be attributable to the Jewish culture 
prioritising the principle of the sanctity of life and cites her earlier work (Musgrave,
1987) suggesting that, within this context, “every effort must be made to prolong life” 
(p.50). Multinational research by Norberg and colleagues (1994) found Israeli nurses 
placing high emphasis on this principle, in contrast to trends in other countries, giving 
priority to the principles of beneficence and autonomy. Norberg et al’s work (1994) 
concerned feeding, nevertheless, nutrition and hydration are often considered together in 
ethical discussions (e.g. Musgrave et al, 1996; Holmes, 1998). Although AHT is being
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frequently used in this context there is little evidence to support the use of AHT to 
prolong lifespan. Limitations of the Musgrave et al (1996) study include the small 
sample size and convenience sampling which may have introduced bias. Additionally, 
the setting in Israel with its particular ethical culture may limit its generalisability. 
However, what this research emphasises is the importance of investigating cultural 
differences in ethical principles and attitudes towards terminal dehydration and AHT.
Parkash and Burge (1997) investigated the perspectives of family caregivers concerning 
terminal dehydration using semi-structured qualitative interviews with seven family 
members of patients in a palliative care programme. The participants had dealt with or 
would soon deal with issues concerning terminal dehydration. Results suggested that 
factors influencing caregivers included: concerns about symptom distress (both positive 
and negative towards artificial hydration, e.g. weakness, dry skin, frequent urination, 
sickness, pain, sooner death, prolonging life); ethical (e.g. relief of suffering, some 
positive comments and some negative towards artificial hydration); emotional 
considerations (e.g. caring and giving up); information exchange between health 
professionals and family; culture (e.g. feeding as sign of caring, IV therapy as basic 
standard care). Interestingly, the importance of sanctity of life as a prime consideration, 
as found by Musgrave et al (1996), was not supported in this study. This underlines the 
importance of cultural difference in considering the issues around terminal dehydration 
and use of AHT. Limitations of this work are recognised by the authors as mainly due to 
the limited diversity of culture represented in the sample. The cultural pool consisted of 
white, middle-class, predominantly Christian (and faith important to them) Canadians.
Additionally, the authors note that the sample is mainly representative of relatives 
caring for patients at home. This may have affected the experience of the subjects, as 
those under home care were not exposed to the more interventionist culture seen in 
hospitals. Further limitations of the study include the non-random sample selection and 
small sample size, thus introducing the potential for bias and limiting generalisability. 
Some of the family caregivers were actually facing the issues surrounding terminal 
dehydration as the patient died within days of the interview, however others died within 4- 
6 weeks of the interview. Thus some were considering the issues in the abstract as opposed 
to considering them at the time they were happening and this may have affected the results. 
Finally, there was no consideration of the validity and reliability of the coding and
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interpretations given to the interview transcripts, thus bias could have been introduced 
here.
Despite their methodological limitations these studies indicate that the issues surrounding 
dehydration in the dying patient for family caregivers are similar to those of health care 
professionals; namely concern regarding the potential distressing symptoms arising from 
the dehydration or from treatment with AHT.
2.7 Symp toms rela ting to dehydra tion
If the main symptoms attributable to dehydration in the dying are dry mouth and thirst, 
as postulated by some clinicians (e.g. Lamerton, 1980; Baines, 1990), then 
consideration of the prevalence of such symptoms and other possible causes is required. 
Dunlop (1989) studied the incidence of symptoms in 50 patients with far advanced 
cancer and asked them to rank the five most distressing; dry mouth was the second most 
distressing symptom (weakness was the first). Although the artificial imposition of a 
distress score to a subjective report of a symptom may be criticised with respect to 
validity, this small sample may reflect the importance and frequency of this symptom in 
the terminal patient. Reuben et al (1988), investigating clinical symptoms and length of 
survival in patients with cancer, found that 73.5% of 1592 patients reported a dry mouth 
on their first interview. However, subjects had an estimated life expectancy of less than 
six months and there is no indication of how many of these were in the last few days of 
life.
Hanks (1983) reported the most common symptoms of patients on admission to a 
hospice finding that 45% of patients in 1978 and 41% of patients in 1981 recorded a dry 
mouth. Again, it is not known how many of these patients were close to death. A study 
of the quality of life of patients with advanced cancer found 30% of patients describing 
dry mouth as “a lot” and “awful” on entry to a palliative care programme (Ventafridda 
et al, 1990a). Such findings suggest that dry mouth is a common symptom in cancer 
patients generally and not just related to dehydration. Causes of a dry mouth other than 
dehydration include the use of drugs with anticholinergic side-effects (e.g. morphine, 
phenothiazines, antihistamines), candidiasis, local radiotherapy, mouth breathing, 
malignant involvement of the salivary glands and cancer chemotherapy (Hanks, 1983; 
Holmes, 1990; Ventafridda et al, 1998).
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Although equivocal, it has been suggested that the use of artificial hydration may 
increase pulmonary symptoms (Dolan, 1983) (see Section 2.3). Lichter and Hunt (1990) 
found that 56% of 200 patients in the last 48 hours of life exhibited noisy and moist 
breathing; 25% of patients required medication (hyoscine) and 21% required nursing 
interventions including occasional suctioning, position changes and reassurance.
Inoperable malignant obstruction of the gastrointestinal tract causes nausea and 
vomiting and, depending on the level of obstruction (whether sufficient mucosal surface 
for fluid absorption is maintained), may cause dehydration. Baines et al (1985) studied 
40 patients with obstruction, of whom 38 were unsuitable for surgery and were 
managed medically without IV fluids and nasogastric (NG) suction. Dehydration was 
not reported as a problem in any of the patients, although the way in which this was 
assessed was not explained. A more detailed study assessed 22 patients with inoperable 
intestinal obstruction (Ventafridda et al, 1990b). Dry mouth and thirst were assessed 
daily by the patient on a Likert scale (or by the carer/relative if he was not able). The 
degree of symptoms was compared before treatment with drug therapy, 2 days after 
commencement of conservative drug therapy and 2 days before death. An upward trend 
of dry mouth (P<0.05) was observed throughout the study period although this was 
successfully treated by the administration of liquids by mouth or sucking ice cubes. It is 
not clear how the efficacy of treatment was assessed if the mouth observations were of 
increasing dryness. A knowledge of the time span of assessment would be useful (i.e. 
whether the respondent was asked to assess the state of his mouth and thirst generally 
over the last 24 hours or at the particular time of assessment) and then if the assessment 
times were standardised. Sixteen of the patients reported thirst; 8 scoring 2 or 3 (2 = 
moderate, 3 = strong) and 8 scoring 1. One patient required IV therapy for the treatment 
of his thirst. Although it is concluded that the use of IV therapy was not necessary for 
the treatment of dry mouth, no attempt was made to define the hydration status of the 
patients and therefore it is difficult to attribute the source of dry mouth (and thus 
treatment needs) to dehydration, drug therapy or another cause.
Thirst is a symptom that can be difficult to assess. Levy and Catalano (1985) suggest 
that, in advanced disease, thirst is more often a symptom of poor oral hygiene than of 
actual dehydration but do not support this with clinical evidence. Thirst and dry mouth 
are sometimes assessed together (e.g. McCann et al, 1994) and this lack of clarity makes
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interpretation difficult. A thirst deficit in the elderly has been demonstrated (Phillips et 
al, 1984), which may have implications for the discussion surrounding terminal 
dehydration. For example, the elderly patient dying of malignant disease may not 
experience as much thirst as the younger patient. Further investigation of the 
interrelationships between the symptoms of thirst and dry mouth is required.
Burge (1993) in a cross-sectional survey of 52 palliative care unit in-patients, with a 
prognosis of 6 weeks or less, assessed the nature and severity of symptoms possibly 
associated with dehydration, their association with biochemical measures of 
dehydration, and nurse assessment of fluid intake. No subjects received artificial 
hydration. Subjects assessed their symptoms using visual analogue scales (VAS). 
Fatigue was the highest scoring symptom (mean VAS 61.8mm), followed by dry mouth 
(mean 60mm), thirst (53.8mm) and bad taste (mean 46.6mm). No association was found 
between thirst and the fluid status variables or confounding variables (age, medication, 
oral disease, and mouth care regimen). The generalisability of the study can be 
questioned due to the small sample size (52) and the nature of the excluded group (58% 
of all patients considered) who were sicker, had a shorter survival time, less fluid intake 
and required more mouth care than the study participants.
McCann et al (1994) attempted to determine the frequency of symptoms of hunger and 
thirst in a group of terminally ill patients and assess whether these symptoms could be 
alleviated without the use of artificial hydration or nutrition. Thirty-two patients able to 
communicate their needs consistently to caregivers were included; 16 patients who 
expressed needs inconsistently or were in various stages of coma or delirium were 
excluded. Subjects assessed their hunger and thirst on dichotomous scales and the effect 
of food and fluid on these. When they became unable to communicate the family and 
team used a 0-10 discomfort score. Results showed a low incidence of hunger and thirst 
-  20 (63%) never experienced hunger, 11 (34%) experienced no thirst/diy mouth and 9 
(29%) experienced thirst /dry mouth during the first 25% of their stay only. Twelve 
patients had thirst/dry mouth, which continued until death. All symptoms were relieved 
with oral food/fluid, ice chips or mouth care. Only four of the sample had “some 
discomfort” during their admission. These results suggest that thirst and hunger can be 
alleviated by local measures and that artificial fluids and feeding have a limited role. 
However, since the sample size is very small, and fluid status was not actually assessed,
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and the validity and reliability of the team/family assessments in the later stages was not 
described, caution is needed when interpreting the findings. Additionally, the authors 
note that they assessed thirst and dry mouth together (they did not consider concurrent 
drug use) and these may need separating, as previously described.
Musgrave et al (1995) investigated the effects of IV fluids on thirst in patients with a 
life expectancy of less than ten days. Nineteen patients on an adult oncology unit, dying 
with IV fluids (500 -  3000 mL/day), were asked to rate their thirst as “none”, “mild”, 
“moderate” or “severe”. Nurses caring for the patients were asked to record the presence 
or absence of leg oedema and ascites. Recordings were taken on the day the patient died 
(9 patients) or the day preceding death (10 patients). Ninety-five percent experienced 
varying degrees of thirst (32% experienced mild thirst, 42% moderate thirst, 21% severe 
thirst and 5% (1 patient) no thirst). This percentage is higher than that reported by 
McCann et al (1994) in which 37.5% experienced thirst prior to death and no IV fluids 
were used. However, the findings of Musgrave et al (1995) are similar to those of 
Ellershaw et al (1995), although the latter sample did not receive AHT. Musgrave et al 
(1995) postulate that the variation in results seen in their study and that of McCann et al 
(1994) may be due to differences in mouth care -  supporting the link that has been 
made by others between the experience of thirst and dry mouth (e.g. Ellershaw et al,
1995). An interesting finding was that, despite the small sample size and wide age range 
for the thirst groups, thirst increased as the average age decreased. This supports the 
need for further investigations into the effect of age on thirst experience as referred to 
earlier (Phillipps et al, 1984). This study did not record any of the drugs the patients 
were taking, although many drugs used in palliative care have side effects of dry mouth 
(e.g. opiates, anticholinergics) so that these may have contributed to the experience of 
thirst.
Seventy-eight percent of patients had oedema or ascites. Musgrave et al (1995) found no 
pattern when descriptive comparisons were made (e.g. thirst levels compared with 
respect to IV fluid volume, fluid output volume, oral fluid intake, serum sodium, serum 
urea, and presence of ascites or oedema). IV fluid volume did not appear to affect the 
presence of oedema or ascites. However, this was a pilot study and, as such, the sample 
size was small, emphasising the effect of the missing data (only 12/19 had laboratory 
data) and indicating a need for caution when interpreting the results. As nurses assessed
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thirst and knew the IV fluid volumes, assessment of ascites or oedema may have been 
biased; there was also potential for selection/exclusion bias as half of the original 
sample were excluded (Viola et al, 1997). Although nurses were trained in the data 
collection procedures there was no indication of any inter-reliability testing. Finally, the 
population from which the sample were drawn was described as mainly receiving or 
being evaluated for active treatment -  this acute oncology setting may not be 
particularly generalisable to palliative care populations dying in non-acute areas.
Ellershaw and colleagues (1995) studied 82 patients dying of malignant disease without 
AHT. Subjects were included when they became unable to take oral fluids. The 
symptoms of thirst, dry mouth (self-report by subject -  present/absent) and respiratory 
tract secretions (assessed by two researchers -  present/absent) were investigated with 
respect to level of hydration as defined by biochemical parameters. The findings 
showed no statistically significant relationship between level of hydration and 
respiratory tract secretions, thirst or diy mouth. The incidence of thirst and dry mouth 
was high with 20 of the 23 able to respond verbally reporting a dry mouth (87%) and 19 
of the 23 reporting thirst (83%). The authors note that a high proportion of the study 
population, dying without AHT, had essentially normal biochemistry -  “the results 
reflecting a degree of normality not usually thought to be associated with patients dying 
without artificial hydration therapy” (Ellershaw et al, 1995 p. 195). The study’s main 
weaknesses were its lack of reporting regarding excluded patients, its lack of data 
regarding validity and reliability of respiratory tract secretion outcomes and its low 
response rate to thirst and dry mouth questions. Additionally, the authors do not report 
the relationship between the frequency of mouth care and last mouth care given before 
assessment of thirst and dry mouth was carried out. Viola et al (1997) suggest that the 
two cohorts (those identified as biochemically dehydrated and those biochemically 
hydrated) become more similar with respect to hydration status between study entry 
(when blood tests were taken) and death. However, as the mean and median time from 
study entry until death was only two days, this may not have had a significant impact on 
the findings.
Bruera et al (1995) studied the effect of regular cognitive monitoring, opioid rotation 
and artificial hydration using subcutaneous fluids on impaired mental status. This was a 
retrospective “natural” experiment looking at two samples of patients on a palliative
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care unit during two different 1-year time periods. The first sample comprised 117 
patients (during 1988-1989) and the second sample, taken after the introduction of the 
three measures (regular cognitive monitoring, opioid rotation and AHT using 
subcutaneous fluids), comprised 162 patients (during 1991-1992). The mean volume of 
subcutaneous fluids administered was 1083 - 1159 ml per day. Review of patients charts 
suggested that there was no significant change in impaired mental status (32% and 41%) 
over the two periods, but a significant decrease in agitated impaired mental status (26% 
and 10%, p < 0.001) was associated with the administration of fluids. They also found a 
significant reduction in the use of haloperidol and other psychoactive drugs. Whilst this 
study is used by the authors to advocate the use of subcutaneous fluids for treatment in 
the imminently dying (“relatively low volumes of water per day may help prevent the 
development of agitated delirium” (Bruera et al, 1995, p. 291)), the design of the study 
makes it difficult to establish the relative contribution of the effect of opioid rotation 
and artificial hydration to the significant findings. Additionally, retrospective chart 
review raises limitations concerning adequacy and accuracy of recordings and the 
potential for misinterpretation of the documents. Further, there was a change in the 
definition of impaired mental status between the two study periods. Other limitations 
include the potential for unmeasured changes to have impacted between the study 
periods (e.g. referral patterns, other treatments) and the potential bias due to a lack of 
blinding to which time period the case notes came from (Viola et al, 1997).
Vullo-Navich et al (1998) studied 31 dying patients not receiving AHT. Patient 
symptoms (thirst, dry mouth, nausea and vomiting, abdominal cramps, diarrhoea, 
constipation, incontinence, pulmonary/pharyngeal secretions, shortness of 
breath/coughing, choking/drowning sensations, oedema, ascites, death rattle and use of 
suctioning) were assessed using a Likert-type scale; level of comfort (0-4 range) was 
assessed 8 hourly by nurses trained to use the data collection tools. Where possible, the 
nurse carried out the assessment with the help of the patient and family. The authors 
note that validity and reliability checks were not carried out but suggest that the 
advantages of high nurse to patient ratio, small numbers of nurses carrying out 
assessments and opportunities for nurses to collaborate due to overlapping shifts helped 
to maintain consistency.
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However, difficulties with nurse assessment of patient symptoms have been well 
documented (e.g. Holmes and Eburn, 1989; Tanghe et al, 1998) and reliability cannot be 
assumed. Dehydration was defined as an oral intake <500 ml per day for two 
consecutive days or as an average over three days. Nineteen patients met the 
dehydration criteria; 15 of these consented to blood sampling. The results showed no 
statistically significant difference in comfort scores between pre-dehydration and 
dehydration phases and 85% of the sample had optimum comfort scores. A statistically 
significant difference was found between mean daily comfort scores of normonatraemic 
and hypernatraemic subjects, with normonatraemic subjects displaying higher comfort 
scores. However, the authors note that those with abnormal serum sodium still had 
comfort scores in the top third comfort levels.
The most commonly occurring symptom was dry mouth (but this was relieved by local 
measures); shortness of breath and dyspnoea were second (occurring in less than 10% of 
cases). Despite the increased degree of symptom occurrence in the last three days of life 
the degree of distress caused was noted as low. The authors did not report associations 
between level of hydration and symptom occurrence. Fifty-six percent of patients in this 
study had a serum sodium level within the normal range and the median and mode of 
the whole sample was also within the normal range -  lending support to the hypothesis 
of Billings (1985) that normonatraemic dehydration may occur in the terminal phase of 
life. No evaluation was made of the drugs administered to patients in this study but the 
authors note that the symptoms reported may have been influenced by the 
anticholinergic drugs given to relieve pulmonary symptoms (Vullo-Navich et al, 1998).
2.7.1 Comment
Since the original review of the literature carried out at the beginning of 1992 and this 
update (1998/9) the number of papers discussing terminal dehydration has increased 
rapidly, indicating the importance of this clinical area. Although more research studies 
have considered the effect of dehydration/artificial hydration in the terminally ill, their 
limitations have been discussed.
When considering the seven main studies (Burge et al 1993; McCann et al, 1994; 
Waller et al, 1994; Bruera et al, 1995; Ellershaw et al, 1995; Musgrave et al, 1995; 
Vullo-Navich et al, 1998) comparisons are difficult as different outcome measures were
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employed. For example, thirst was of interest to most of the studies but assessed 
variously by visual analogues scale (Burge, 1993), dichotomous answers (McCann et al, 
1994; Ellershaw et al, 1995), four point verbal rating (Musgrave et al, 1995), or Likert- 
type ratings (Vullo-Navich et al, 1998).
Other outcomes included discomfort, alertness, respiratory tract secretions, impaired 
mental status, ascites and leg oedema but these represent only some of the potential 
outcomes revealed in the literature reviewed earlier. Lack of consensus regarding the 
priority that should be given to studying such variables hampers progress in a search for 
an evidence-base to practice. Additionally, the lack of consideration of issues 
concerning reliability and validity of the assessment of symptoms identified is of 
concern. This compromises the confidence that can be placed in the findings.
Sample sizes were generally small and lacking randomisation, limiting their 
generalisability, and increasing the chances of sampling error, thereby reducing the 
reliability and validity of the results. Viola et al (1997) note that no agreement seems to 
exist regarding the population of palliative care patients for whom this uncertainty 
regarding artificial hydration and dehydration is most important, and the works 
described demonstrate this through the varied prognosis at time of study entry. This, 
again, makes comparisons between studies difficult.
Acknowledging their limitations, the findings of these studies are summarised. The 
studies which examined thirst did not find a relationship between fluid status or fluid 
therapy and thirst (Burge et al 1993; McCann et al, 1994; Ellershaw et al, 1995; 
Musgrave et al, 1995; Vullo-Navich et al, 1998) neither was a relationship between 
thirst and serum sodium levels demonstrated (Burge et al, 1993; Musgrave et al, 1995). 
These studies also show that dry mouth and thirst were highly prevalent symptoms 
(McCann et al, 1994; Ellershaw et al, 1995; Musgrave et al, 1995) in the populations 
investigated. Bruera et al (1995) concluded that AHT might help prevent agitated 
delirium from occurring. Musgrave et al (1995) found a high prevalence of thirst in the 
presence of IV fluids and demonstrated no relationship between the presence of IV 
fluids and oedema or ascites. Ellershaw et al (1995) found no association between fluid 
status and the presence or absence of respiratory tract secretions and Vullo-Navitch et al 
(1998) found no association between levels of comfort or symptom occurrence and fluid 
status.
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2.8 Conclusions
The literature reviewed is not conclusive. What is known is that dehydration is a 
complex disorder with different forms, and may be associated with electrolyte 
imbalance (although this is not an automatic corollary to dehydration in the terminal 
stages of life). Dehydration in the patient with end-stage cancer is probably not 
equivalent to that seen in acute or experimental situations and the pathophysiological 
response to dehydration in the dying may cause less symptomatology than other forms 
of dehydration (Dunphy et al, 1995). The use of AHT in dying patients appears 
common in hospitals but palliative care practitioners generally contend that AHT is 
unnecessary. It is known that clinical practice varies according to the health care 
practitioner’s perceptions of the effects of dehydration and AHT on the dying patient. 
Cultural and moral values may also affect such perceptions. Symptoms such as thirst 
and dry mouth are frequently seen at the end stages of disease but these have multiple 
causes and are not solely related to dehydration.
Unequivocal evidence does not exist. Claims regarding benefits of dehydration (e.g. 
increased pain relief, decrease in pulmonary secretions and choking and drowning 
sensations, reduction in vomiting) and adverse effects of AHT (e.g. increased 
pulmonary oedema, increased incontinence, increased pain) are largely anecdotal. 
Likewise, there is no empirical data to support the claim that dehydration increases the 
incidence of postural hypotension and falls, pressure sore development and thrombosis 
occurrence. It is unclear whether dehydration and electrolyte imbalance are distressing 
events in the dying patient or if they are beneficial and can enhance the quality of dying. 
Similarly, it is unclear whether artificial hydration therapies benefit or burden the dying 
patient.
What emerges from this discussion is that this is an important area for investigation as 
dehydration and/or AHT in the dying patient is perceived by health care professionals as 
having the potential to contribute significantly to distressing symptoms experienced. 
One of the goals of palliative care is to decrease suffering and promote a comfortable 
death. This is for the benefit of the dying individual and the family/friends of the dying, 
as the way someone dies may linger in the memories of those who live on (Saunders, 
1989) and this may have an impact on their responses to bereavement.
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The studies reviewed indicate both a lack of consensus regarding what constitutes 
appropriate outcome measures for this population and the absence of reliable and valid 
instruments for such measurement. This will be explored further in Chapter 4. First 
though, the next chapter describes a survey to investigate health care professionals’ 
attitudes to terminal dehydration in more detail.
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3 Terminal dehydration survey
3.1 Background
The previous chapter demonstrated that dehydration may present as a clinical problem 
for dying patients. Distressing symptoms may result from dehydration or its treatment 
with artificial hydration therapies (AHT). The literature revealed differing approaches to 
the management of this condition. Some clinicians advocate the use of AHT to relieve 
symptoms thought to be caused by terminal dehydration while others argue that 
terminal dehydration need not be treated with AHT, as AHT may itself cause distressing 
symptoms and dehydration may reduce symptom distress (e.g. Billings, 1985; Zerwekh, 
1983; Burge et al, 1990).
Evidence from Andrews and Levine (1989) suggested that hospice nurses who had 
observed dehydration in dying patients not treated with AHT, have a more positive 
perception of this state than nurses who had not observed this condition. This positive 
perception was attributed to the appreciation of the possibility that dehydration may be 
beneficial to the patient who is close to death. The Andrews and Levine study was 
based on a sample of nurses from 127 hospices in New Jersey and Pennsylvania. The 
study groups consisted of 85 nurses defined as ‘experienced’ if they had observed 
patients in whom no form of fluid or food was given for at least three days before death 
and eight ‘inexperienced’ nurses who had not observed such patients. Both groups 
completed a questionnaire that included a series of statements about dehydration.
The results supported the hypothesis that hospice nurses who have observed dying 
patients in a dehydrated state have a more positive perception than those who have not 
observed this state. However, the sample of nurses selected were all hospice nurses and, 
by definition, accustomed to working with large numbers of dying patients; 
consequently a more useful comparison group may have been a group of nurses not 
working in a hospice/palliative care setting. Additionally, no consideration was given to 
the seniority of the respondents which may be anticipated to affect attitudes towards 
terminal dehydration (House, 1992). Importantly, Andrews and Levine (1989) omitted to 
include views of doctors. Although understanding nurses’ attitudes is important as they 
contribute to decision making in care, they are not always involved in this (Musgrave et al,
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1996), and doctors hold a more powerful position; thus there is a need also to elicit 
doctors’ views.
The study reported here attempted to replicate the Andrews and Levine (1989) study in 
the UK, as the literature review suggested that geographical variations in attitudes 
towards terminal dehydration exist. It is important to explore attitudes related to 
dehydration as health care practitioners’ views may strongly influence the care that 
patients receive. Additionally, further investigation into variations in attitudes towards 
terminal dehydration will assist an understanding of the complexities of this condition 
and increase the development of management strategies that will improve the symptom 
experience of the dying patient. The limitations described above were taken into 
account and attempts were made to overcome them. The views of doctors were also 
included because, as discussed earlier, doctors are an important part of the 
multidisciplinary team considering treatment options at the end of life, and ultimately 
take responsibility for prescribing medical treatment.
3.2 Method
A cross-sectional survey was designed to assess attitudes to terminal dehydration in a 
sample of health care professionals (doctors and nurses). The purpose was to compare 
attitudes towards terminal dehydration in health care professionals who had experience 
in palliative care with those who had not and also to enable comparison of attitudes in 
those who had experience of observing terminal dehydration with those who had not. 
Exploration of the effect of other variables, such as level of seniority and speciality, on 
perceptions towards terminal dehydration were also considered.
3.2.1 Sample
The survey was conducted in a convenience sample of doctors and nurses drawn from 8 
hospices and 5 general hospitals. All doctors and nurses were approached in the 
hospices involved (due to small numbers of staff in these smaller institutions). Lists of 
doctors were obtained from the general hospitals and a stratified random sample (to 
include junior and senior doctors and a range of specialities) were sent questionnaires. 
Nurses were approached through the Directors of Nursing for the hospitals that 
consented to various wards being approached. Using these methods initial groups of 250 
health care professionals in general hospitals and 180 health care professionals in
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hospices/palliative care units were identified and sent/given the questionnaire and a 
prepaid envelope for its postal return.
3.2.1.1 Appropriate number o f subjects and sites
Due to limited information from the previous study it was not possible to carry out 
meaningful power analysis to test for appropriate sample size. Thus this initial number 
was selected in the hope of obtaining group sizes of 100 in each location (i.e. general 
hospital or hospice); it was important to allow for a reduced response rate due to the 
postal questionnaire method. More hospice sites were selected as they had a smaller 
pool of staff on which to draw.
3.2.2 Instrumentation
The questionnaire used was based on that developed by Andrews and Levine (1989) 
(Appendix 1). The first section concerned the independent variable of experience. 
Respondents were asked if they had observed any patient in whom no form of food or 
fluid was given or taken for at least three days before death. This patient was 
operationally defined as dehydrated at the time of death (Andrews and Levine, 1989). 
The questionnaire was adapted for this study by the addition of a question asking 
respondents to indicate an approximate number of people they had seen in this state if 
they had answered ‘yes’. This was used to subdivide the two primary groups into 
‘experienced’ and ‘inexperienced’ subgroups (with respect to terminal dehydration). 
‘Experienced’ staff were defined as those who had observed more than ten imminently 
dying patients in a dehydrated state (untreated with AHT) and ‘inexperienced’ as those 
who had observed ten or fewer such patients. Andrews and Levine (1989) did not use 
any quantification in their definition. The operational definition was altered, as it was 
felt important to ensure that people ‘experienced’ in observing a particular state had 
done so on more than one occasion. However, it is recognised that the figure of ten 
represents an arbitrary cut-off point. It could be argued that this use of an arbitrary 
figure reduces the validity of comparisons between the groups; however, more 
confidence can be placed in this definition, as practitioners viewing a number of 
instances of this state can be deemed to have experience in comparison to those only 
observing one or two cases.
The second section comprised ten statements concerning dehydration to which 
respondents indicated their level of agreement using a five-point Likert scale. Both
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positive and negative statements about terminal dehydration were included (Figure 3-1). 
Negative statements were reverse scored (statements 2, 5 and 6). Responses to the ten 
individual statements were summed to give a total score for perception of dehydration. 
Possible scores ranged from 10 (least positive perception) to 50 (most positive 
perception). A higher score indicates greater agreement with statements about benefits 
of dehydration and disadvantages of AHT in the imminently dying patient (Andrews 
and Levine, 1989). Additional demographic data was asked at the end of the 
questionnaire such as information regarding clinical specialism, professional group and 
seniority, previous hospice experience and the duration of such experience.
Figure 3-1: Statements regarding perceptions of dehydration and scoring system
1. As fluid intake is reduced there is reduction in bouts of 
vomiting
2. Dehydration causes apathy and depression
3. Dying patients who are dehydrated rarely complain of thirst
4. There is relief from choking and drowning sensations when 
fluids are discontinued
5. Dehydration is painful
6. Dry mouth caused by lack of fluid necessitates the use of IV 
and/or tube feeding
7. Coughing and pulmonary congestion are decreased with 
dehydration
8. Tracheal and nasogastric suctioning are unnecessary for 
patients who are not given IV fluids
9. Patients who are dehydrated experience relief from distressing 
symptoms
10. Dehydration can be beneficial for the dying
5 point Likert scale 
5 4 3 2 1
Definitely Probably Neither Probably Definitely
agree agree agree nor don’t agree don’t agree
disagree
Attitudes towards terminal dehydration have not been studied in any published work 
prior to the study cited. Research tools are required to be appropriate and reflect the 
conceptualisation of the phenomenon under investigation (Rudestam and Newton, 
1992). When considering the questionnaire designed by Andrews and Levine (1989) 
this was developed from literature pertaining to terminal dehydration and so has face 
validity. It did not, however, appear to have been subjected to any formal reliability or
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validity testing. Replication of this study methodology, including use of this instrument, 
was considered appropriate as items included appeared to be consistent with the relevant 
literature and areas of debate within the researcher’s own clinical experience. 
Discussion of the instrument’s reliability and validity performance following this study 
is included below.
3.2.3 Procedures
Ethics Committee approval was required for six of the twelve study sites. In the other 
sites, permission for access was granted through the Directors of Nursing or Head of 
Medical Staff or Director of the Hospice. Following granting of access, an information 
sheet and questionnaire were sent to individual doctors or nurses or given to a link 
person on an individual ward or hospice for administration to medical and nursing staff. 
A stamped addressed envelope was enclosed for the reply.
3.2.4 Data analysis
Data were analysed using the statistical package SPSS®. It was considered an a priori 
assumption that the factors most likely to influence sums of scores in the sample 
population were the experience of observing untreated terminal dehydration, the location 
of the respondent (hospice or general hospital), professional group (nursing or medical), 
seniority within that group and specialism of the respondent. Analysis of variance was 
the method of statistical analysis chosen to explore the effects of these variables on the 
sums of scores. Internal consistency, a measure of reliability of the scale, was assessed 
by estimation of Cronbach’s coefficient alpha. Kendall’s tau was used as a non- 
parametric test of association between variables. (A summary of statistical tests used in 
throughout this work can be found in Appendix 2.)
3.3 Results
3.3.1 Demographic characteristics of sample
Of the 430 questionnaires issued to potential respondents 197 were completed and 
returned giving a 46% response rate. The response rate in the hospice subgroup was 
higher than1 in the general hospital subgroup (62% and 31% respectively). This needs to 
be considered when interpreting the results as such a discrepancy may reduce the 
generalisability of the findings.
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Data from the returned questionnaires showed that respondents were from eight 
hospices and five general hospitals and they were aggregated into two groups ‘hospice’ 
and ‘non-hospice’. The two groups comprised 113 and 84 respondents respectively, 
constituting 57.4% and 42.6% of the sample population. Of the 190 respondents giving 
information of their professional status, 139 (73.2%) were nursing staff and 51 (26.8%) 
were medical staff.
Thirty-two respondents (16.2%) indicated that they had never observed someone in the 
state of terminal dehydration (as operationally defined above) and 162 (82.2%) stated 
that they had. Responses to the second question, asking respondents to approximate the 
number of patients they had observed in terminal dehydration, were used to subdivide 
the two primary groups into ‘experienced’ and ‘inexperienced’ subgroups (with respect 
to terminal dehydration). ‘Experienced’ were defined as those who had observed more 
than ten imminently dying patients in a dehydrated state (untreated with AHT) and 
‘inexperienced’ as those who had observed ten or fewer such patients. Using this 
criteria, 74 respondents were ‘experienced’ in observing terminal dehydration (37.6%) 
and 88 (44.7%) were inexperienced; 35 respondents (17.8%) failed to give information 
regarding the number of patients seen in this state and were therefore classed as missing 
data.
Fourteen (8.9%) of the medical staff and 57 (36.1%) of the nurses were experienced 
caring for patients with terminal dehydration (Figure 3-2).
Figure 3-2: Proportions of medical and nursing staff, with experience in
observing terminal dehydration
□  Experienced  
medical staff
□  Inexperienced  
medical staff
□  Experienced  
nursing staff
□  Inexperienced  
nursing staff
□ 36%
□
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Thirty-five (22.2%) of the medical staff and 52 (33%) of the nurses were inexperienced 
in caring for patients with this condition.
A further breakdown of experience in terminal dehydration by profession and grade is 
given in Table 3-1.
Table 3-1: Distribution of respondents by profession, grade and experience.
Experienced (%) Inexperienced (%)
Medical staff
House Officer/ Senior 
House Officer
2(1.3) 16(10.1)
Registrar/Senior Registrar 5 (3.2) 9 (5.7)
Consultant 5 (3.2) 9 (5.7)
General Practitioner 2(1.3) 1 (0.6)
Nursing staff
Staff nurse or equivalent 40 (25.3) 48 (30.4)
Sister or charge nurse 17(10.8) 4 (2.5)
N = 158 (missing data = 39 (20%))
In view of the wide dispersal of respondents among staff, grade and experience, 
regrouping was carried out to facilitate reliable analysis of the data. Thus data from the 
three general practitioners were discarded as they formed too small a group for 
meaningful analysis. The remaining groups were divided into medical and nursing 
subgroups with two levels in each. The medical group was formed into Junior (house 
officers) and Senior (registrars and consultants) levels; similarly the nursing group was 
formed into Junior (staff nurse and equivalent) and Senior (sister and charge nurse) 
levels. Wh^re necessary, account was also taken of experience as defined above, within 
each grade (Table 3-2).
Table 3-2: Distribution of respondents by seniority and experience following
regrouping
Experienced (%) Inexperienced (%)
Medical staff
Junior 3 (1.9) 16(10.1)
Senior 11 (7.0) 19 (12.0)
Nursing staff
Junior 40 (25.3) 48 (30.4)
Senior 17(10.8) 4 (2.5)
N = 158 (missing data = 39 (20%))
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The association of respondents with level of experience of observing terminal 
dehydration and place of work is illustrated in Figure 3-3. Analysis of this data, using 
Kendall’s tau as a measure of association, indicated a highly significant association of 
experience of observing terminal dehydration with hospice staff (tau = -0.539;
p<0.0001).
Figure 3-3: Distribution of experienced and inexperienced health care staff by 
place of work (with respect to observing terminal dehydration)
□  General Hospital 
Experienced
□  General Hospital 
Inexperienced
□  Hospice 
Experienced
□  Hospice  
Inexperienced
□  15% q 8%
Respondents were asked to indicate the specialist area in which they worked, as it could 
be hypothesised that some areas would be more likely to be associated with more 
positive perceptions of dehydration in the imminently dying, for example oncology 
specialists may have been exposed to palliative care experience and/or literature 
concerning terminal dehydration. Of the 190 respondents giving this information 106 
(53.8%) worked in palliative care, 29 (14.7%) in oncology, 24 (12.2%) in surgery, 30 
(15.2%) in medicine and 1 (0.5%) in psychiatry. In subsequent data analysis, the single 
representative from psychiatry was excluded due to the small sample size.
3.3.2 Distribution of data;
The Likert scale responses were analysed after scoring each statement from 1 (least 
positive perception) to 5 (most positive perception) with reverse scoring of the negative 
statements (2, 5, and 6). The responses to each question are at the ordinal level and, as 
such, would not necessarily be expected to be normally distributed. The sums of scores 
(i.e. the total of the score for each of the ten questions), with a maximum score of 50,
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are, however, aggregates of ordinal variables and as such a normal distribution may be 
anticipated (Nunnally and Bernstein, 1994; Pett, 1997).
Data distributions were assessed using the Kolmogorov-Smirnov goodness of fit test, an 
estimation of the deviation of the cumulative frequency distribution from that predicted 
for a normally distributed population (Norusis, 1993). As the sample was non-random, 
it was important to assess the distribution of responses, to see how representative they 
were of the population being studied. Examination of the sums of scores for the whole 
sample using the Kolmogorov-Smirnov goodness of fit test indicated that the sample 
data were normally distributed (Kolmogorov-Smirnov Z = 0.99, p = 0.28).
The two principal groups to be compared on the basis of experience of observing 
terminal dehydration were subdivided and assessed for the distribution characteristics of 
the sums of scores for each subgroup. For the ‘experienced’ subgroup Kolmogorov- 
Smirnov Z = 1.01 (p = 0.26). For the ‘inexperienced’ subgroup Kolmogorov-Smirnov Z 
= 0.99 (p = 0.28). Therefore normal distributions of sums of scores were demonstrated 
in both groups. These tests indicate the suitability of parametric statistical analysis.
3.3.3 Descriptive statistics
Responses to the ten statements for the total sample are shown in Table 3-3. There was 
a good distribution of responses across categories, illustrating diversity in reaction to the 
statements. Reliability of the scale was assessed using Cronbach’s coefficient alpha, a 
measure of internal consistency, which yielded an alpha of 0.76, indicating an 
acceptable level of reliability (Nunnally and Bernstein, 1994).
The total score mean for the whole sample was 30.94 (SD 8.44); the median score was 
30, and the range was 12-49 (theoretical possible range 10-50).
Table 3-4 demonstrates the comparison of responses to statements between the current 
sample (and experienced sub-group) and the sample of Andrews and Levine (1989).
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Table 3-3: Frequency distribution for statements (N = 193)
Statement
No. 1
Response* 
frequency (Percent) 
2 3 4 5
Missing Median Mean
1
As fluid intake is reduced 
there is reduction in bouts 
of vomiting
18
(9.3)
50
(25.9)
39
(20.2)
64
(33.2)
22
(11.4)
0 3.0 3.11
2
Dehydration causes apathy 
and depression
31
(16.1)
42
(21.8)
39
(20.2)
56
(29)
25
(13)
0 3.0 2.99
3
Dying patient who are dehydrated 
rarely complain of thirst
27
(14.0)
37
(19.2)
25
(13.0)
77
(39.9)
27
(14.0)
0 4.0 3.21
4
There is relief from choking and 
drowning sensations when fluids 
are discontinued
36
(18.7)
46
(23.8)
43
(22.3)
45
(23.3)
23
(11.9)
0 3.0 2.86
5
Dehydration is painful
61
(31.6)
54
(28.0)
39
(20.2)
24
(12.4)
15
(7.8)
0 4.0 3.63
6
Dry mouth caused by lack of fluid 
intake necessitates the use of Ivs 
and/or tube feeding
132
(68.4)
35
(18.1)
10
(5.2)
11
(5.7)
5
(2.6)
0 5.0 4.44
7
Coughing and pulmonary 
congestion are decreased 
with dehydration
34
(17.6)
53
(27.5)
35
(18.1)
51
(26.4)
17
(8.8)
3
(1.6)
3.0 2.81
8
Tracheal and nasogastric suction 
are unecessary for patients who 
are not given IV fuids
52
(26.9)
49
(25.4)
28
(14.5)
36
(18.7)
28
(14.5)
0 2.0 2.68
9
Patients who are dehydrated 
experience relief from distressing 
symptoms
63
(32.6)
46
(23.8)
38
(19.7)
36
(18.7)
10
(5.2)
0 2.0 2.4
10
Dehydration can be beneficial 
for the dying patient
41
(21.2)
37
(19.2)
53
(27.5)
35
(18.1)
27
(14.0)
0 3.0 2.84
Response* *fl = Definitely don't agree; 2 = Probably don't agree; 3 = Neither agree nor disagree; 
4 = Probably agree; 5 -  Definitely agree ________________________
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Table 3-4: Comparison of responses to statements between current study and
Andrews and Levine (1989)
Statement % respondents who definitely agree or 
probably agree with statement
Andrews & 
Levine 
(1989)
Current total 
sample
Current
Experienced
sub-group
1. As fluid intake is reduced there is 
reduction in bouts of vomiting
71% 45% 62%
2. Dehydration causes apathy and 
depression
51% disagree or 
probably 
disagree
38% disagree or 
probably 
disagree
57% disagree or 
probably 
disagree
3. Dying patients who are dehydrated 
rarely complain of thirst
73% 54% 66%
4. There is relief from choking and 
drowning sensations when fluids are 
discontinued
51% 35% 54%
5. Dehydration is painful 82% disagree or 
probably 
disagree
58% disagree or 
probably 
disagree
83% disagree or 
probably 
disagree
6. Dry mouth caused by lack of fluid 
necessitates the use of IV and/or tube 
feeding
85% disagree or 
probably 
disagree
86% disagree or 
probably 
disagree
94% disagree or 
probably 
disagree
7. Coughing and pulmonary congestion 
are decreased with dehydration
49% 35% 49%
8. Tracheal and nasogastric suctioning 
are unnecessary for patients who are 
not given IV fluids
40% 33% 49%
9. Patients who are dehydrated 
experience relief from distressing 
symptoms
37% 24% 43%
10. Dehydration can be beneficial for the 
dying
53% 32% 55%
3.3.4 Inferential statistics
As previously stated, it was considered that the factors most likely to influence sums of 
scores in the sample population were the experience of observing untreated terminal 
dehydration, the location of the respondent (hospice or general hospital), professional 
group (nursing or medical), seniority within that group, and specialism of the 
respondent. Analysis of variance (ANOVA) was used to examine the effects of these 
variables upon the sums of scores.
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3.3.4.1 Single factor effects
3.3.4.1.1 Location of respondent
It was suggested that the location of the respondent may affect the perception of 
terminal dehydration. The following null and alternative hypotheses were posed:
• Null hypothesis
There is no difference in mean total scores between health care professionals 
working in a hospice or general hospital environment
• Alternative hypothesis
Health care professionals working in a hospice environment will have greater mean 
total scores than those working in a general hospital environment
One-way analysis of variance demonstrated that the mean total score for the general 
hospital staff (26.5, SD 7.0) was significantly lower than that of hospice staff (34.3, SD 
7.85); F (d f 1,191) = 52.3, pO.OOOl. Confidence intervals for the mean scores, at the 
95% level, were 25.2 - 28.4 for the general hospital staff and 32.3 - 35.3 for the hospice 
staff. Thus the null hypothesis can be rejected.
The Levene test for homogeneity of variance yielded a Levene statistic of 5.29, p =
0.02. At this level of significance the null hypothesis that the variances of the two 
groups are equal has to be rejected and the assumption that the two groups demonstrate 
equal variances cannot be upheld. Homogeneity of variance is one of the assumptions 
required for ANOVA. As a consequence a non-parametric test, the Mann-Whitney U, 
was carried out. This yielded a score of 1323.5, pO.OOOl. Thus the alternative 
hypothesis can still be accepted.
3.3.4.1.2 Experience of observing terminal dehydration
It was suggested that the experience of observing terminal dehydration might affect the 
perception of the condition. The following null and alternative hypotheses were posed:
• Null hypothesis
There is no difference in mean total scores between health care professionals with 
experience of observing terminal dehydration and those without such experience
• Alternative hypothesis
Health care professionals with experience of observing terminal dehydration will 
have greater mean total scores than those defined as inexperienced in observing 
terminal dehydration
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One-way analysis of variance indicated that the mean total score for the experienced 
group (35.5, SD 8.4) was significantly higher than that of the inexperienced group 
(26.8, SD 6.8); F {df\,\56) = 51.77, p<0.0001. Confidence intervals for the mean total 
scores were 33.5-37.5 for the experienced group and 25.4-28.3 for the inexperienced 
group. Thus the null hypothesis can be rejected.
Responses to the ten statements were broken down into the two groups and tested for 
individual difference (Table 3-5) using the Mann-Whitney U test.
Table 3-5: Frequency responses to ten statements broken down by experience in 
observing terminal dehydration ((Experienced N = 72, Inexperienced N = 86)
Statement
No.
Experience in 
observing TD 1
Response* 
frequency (Percent) 
2 3 4 5
Missing Mean Median Mann- 
Whitney U
P
1 Experienced 5 10 12 30 15 0 3.6 4.0 1847.5 <0.0001
(6.9) (13.9) (16.7) (41.7) (20.8)
Inexperienced 9 31 22 22 2 0 2.7 3.0
(10.5) (36.0) (25.6) (25.6) (2.3)
2 Experienced 16 25 13 12 6 0 2.6 2.0 1736.5 <0.0001
(22.2) (34.7) (18.1) (16.7) (8.3)
Inexperienced 7 10 15 36 18 0 3.6 4.0
(8.1) (11.6) (17.4) (41.9) (20.9)
3 Experienced 7 6 11 34 14 0 3.6 4.0 2131.5 <0.0001
(9.7) (8.3) (15.3) (47.2) (19.4)
Inexperienced 15 22 12 32 5 0 2.9 3.0
(17.4) (25.6) (14.0) (37.2) (5.8)
4 Experienced 9 13 11 25 14 0 3.3 4.0 1992.5 <0.0001
(12.5) (18.1) (15.3) (34.7) (19.4)
Inexperienced 19 25 25 14 3 0 2.5 2.0
(22.1) (29.1) (29-1) (16.3) (3.5)
5 Experienced • 38 22 9 2 1 0 1.7 1 1328.0 <0.0001
(52.8) (30.6) (12.5) (2.8) (1.4)
Inexperienced 12 21 22 19 12 0 3 3.0
(14.0) (24.4) (25.6) (22.1) (14.0)
Response* I = Definitely don't agree; 2 = 
4 = Probably agree; 5 = Definitely agree
Probably don't agree; 3 = Neither agree nor disagree;
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Table 3-5: continuec
Statemenl
No.
Experience in 
observing TD 1
Response* 
frequency (Percent) 
2 3 4 5
hissing Mean Median Mann- 
Whitney I
P
6 Experienced 62 6 2 1 1 0 1.2 1.0 1959.0 <0.0001
(86.1) (8.3) (2.8) (1.4) (1.4)
Inexperienced 43 23 6 10 4 0 1.9 1.5
(50) (26.7) (7.0) (11.6) (4.7)
7 Experienced 10 11 14 26 9 2 3.2 3.0 2223.0 0.005
(13.9) (15.3) (19.4) (36.1) (12.5) (2.8)
Inexperienced 14 32 16 17 6 1 2.6 2.0
(16.3) (37.2) (18.6) (19.8) (7.0) (1.2)
8 Experienced 16 13 8 17 18 0 3.1 3.0 2151.0 0.001
(22.2) (18.1) (11.1) (23.6) (25.0)
Inexperienced 29 24 14 16 3 0 2.3 2.0
(33.7) (27.9) (16.3) (18.6) (3.5)
9 Experienced 16 12 13 23 8 0 2.9 3.0 1892.0 <.0001
(22.2) (16.7) (18.1) (31.9) (11.1)
Inexperienced 33 29 15 9 0 0 2 2.0
(38.4) (33.7) (17.4) (10.5) (0)
10 Experienced 9 9 16 19 19 0 3.4 4.0 1594.0 <.0001
(12.5) (12.5) (22.2) (26.4) (26.4)
Inexperienced 25 24 28 7 2 0 2.3 2.0
(29.1) (27.9) (32.6) (8.1) (2.3)
Response* I = Definitely don't agree; 2 = Probably don't agree; 3 = Neither agree nor disagree; 
4 = Probably agree; 5 = Definitely agree
Significant differences were found for all of the statements, with the experienced group 
agreeing more with statements regarding benefits of dehydration and problems 
associated with AHT and disagreeing more with negative statements (p<0.005).
3.3.4.1.3 Professional status
It was suggested that the professional background of the respondent may have an affect 
on perception of terminal dehydration and so the following hypotheses were posed:
• Null hypothesis
There is no difference in mean total scores between doctors and nurses
• Alternative hypothesis
Doctors and nurses will have different mean total scores
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One-way analysis of variance indicated that the mean total score for nurses (31.7, SD 
8.19) was significantly higher than that of the doctors (28.4, SD 8.56); F (d f 1, 184) 
= 5.31, p<0.02. The confidence intervals for the mean total scores in the two groups 
were 30.3 - 33.0 for nurses and 25.9 - 30.9 for the doctors. Thus the null hypothesis can 
be rejected.
3.3.4.1.4 Specialism of respondent
It was suggested that the clinical specialism of the respondent may have an effect on 
perceptions of terminal dehydration and so the following hypotheses were posed:
• Null hypothesis
There is no difference in mean total scores between different specialities
• Alternative hypothesis
Health care professionals from different specialities will have different mean total 
scores
One-way analysis of variance indicates significant differences in the perception of 
terminal dehydration between the four principal specialities represented in the sample 
population; F (df 3, 182) = 20.03, p<0.0001 (summary results presented in Table 3-6). 
Thus the null hypothesis can be rejected.
Table 3-6: Summary of ANOVA results for total score by experience of observing
terminal dehydration
Clinical
Speciality
Mean total score SD 95% Confidence 
Interval
palliative care 
n=  106
34.5 7.8 33.0-36.0
oncology 
n = 29
30.2 7.1 27.5-32.9
surgery 
n = 24
25.5 6.25 22.9-28.1
medicine 
n = 30
24.6 6.8 22.1-27.2
F = 20.03
p<  0.0001
A multiple comparison procedure (Fisher’s least significant difference (LSD) test) was 
performed to ascertain the relationships between the group means. Results indicated that 
those specialising in palliative care had significantly greater mean total scores than all
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other specialities. Those specialising in oncology also had a significantly greater mean 
total score than those specialising in medicine.
3.3.4.2 Interaction effects
Significant interaction terms for effects on the total scores were indicated between 
professional group (medical or nursing), seniority within that group and experience of 
observing terminal dehydration. Professional group and seniority were collapsed into a 
single variable (profession by seniority) with four groups (medical senior, medical 
junior and nursing senior and nursing junior) and a two-way ANOVA performed with 
this new variable and experience of observing terminal dehydration. The following 
hypotheses were proposed:
• Null hypotheses
1. The mean total score for the experienced group is the same as the inexperienced 
group -  see section 4.3.4.1.2
2. The mean total score is the same for the different professional groups by 
seniority
3. Interaction hypothesis: the mean scores for each combination of factors are 
equal
Results of the two-way ANOVA are shown in Table 3-7 and demonstrate that the 
experience of observing terminal dehydration significantly affected mean total scores (as 
in section 3.3.4.1.2). The factor of profession/seniority by itself had no effect on the 
total mean score. However, there was a significant experience by profession/seniority 
effect, F {df 1,3) = 2.77, p = 0.04. Thus null hypothesis 1 and 3 can be rejected but null 
hypothesis 2 cannot.
Table 3-7: ANOVA summary for total score by experience of observing terminal 
dehydration and profession/seniority of respondent
Source of variation Sum of 
squares
d f mean
square
F P power
Experience of 
terminal dehydration
1327.10 1 1327.10 23.72 <0.0001 0.99
Profession/ seniority 129.91 3 43.30 0.78 0.51 0.21
2-way interactions 
Experience by 
Profession/seniority
464.38 3 154.79 2.77 0.04 0.66
The experience and profession/seniority factors were combined into a new variable and 
analysed using a one-way ANOVA. This showed that highly significant effects were
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attributable to this new factor, F (<d f l , 146) = 8.76, p<0.0001. Tamahane’s multiple 
comparison test was carried out. This post hoc procedure is suitable for use when the 
Levene test demonstrates unequal variances among the groups (Levene test of 
homogeneity yielded a test statistic of 3.10, p = .003, indicating that equal variances 
among the groups could not be assumed). This demonstrated that the senior medical 
group who were experienced in terminal dehydration (37.1, SD 5.88) and the junior 
nursing staff with experience in terminal dehydration (35.4, SD 9.24) had significantly 
higher mean total scores than junior medical staff with low experience in terminal 
dehydration (26.1, SD 7.88), senior medical staff inexperienced in observing terminal 
dehydration (23.7, SD 5.56) and junior nursing staff with low experience (27.4, SD 
6.03).
The senior nursing staff with experience in terminal dehydration (33.7, SD 7.94) also 
had significantly higher scores than the senior medical staff inexperienced in terminal 
dehydration (23.7, SD 5.56). Although the highest scoring group was the junior medical 
staff experienced in observing terminal dehydration (42.0, SD 5.66) there were only two 
in this group; this probably accounted for the lack of significance in this analysis. 
Confidence intervals at the 95% level are shown in Table 3-8 and support the 
unreliability of the data in this last group due to the small sub-sample size.
Table 3-8: Confidence intervals for mean total score for 
Profession/Seniority and Experience
Group Mean
Total
Score
95%
Confidence
Interval
N
Experienced
Junior medical 42.0 -8.8 to 92.8 2
Senior medical 37.1 32.9 to 41.3 10
Junior nursing 35.4 32.5 to 38.4 40
Senior nursing 33.7 29.6 to 37.8 17
Inexperienced
Junior medical 26.1 21.9 to 30.3 16
Senior medical 23.7 20.8 to 26.5 17
Junior nursing 27.4 25.6 to 29.2 48
Senior nursing 33.3 16.1 to 50.4 4
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3.4 Discussion
3.4.1 Reliability and validity of the questionnaire
Confidence in the reliability and validity of a measure is essential if a study’s findings 
are to be interpreted with meaning. Consequently consideration of the reliability and 
validity of the questionnaire scale used to assess perceptions of terminal dehydration in 
this study is important. Reliability has been defined as the degree of constancy with 
which an instrument measures the attribute under investigation (Polit and Hungler, 
1991). Scale reliability is reflected in the internal consistency of the items included in 
the scale. If items are highly inter-correlated, it is implied that they are measuring the 
same underlying attribute or latent variable (DeVellis, 1991). Cronbach’s coefficient 
alpha (Cronbach, 1951) is a commonly used measure of internal consistency. Nunnally 
and Bernstein (1994) suggest that an alpha of 0.70 is acceptable as a lower bound for 
alpha. In this study alpha was 0.76 indicating an acceptable level of internal 
consistency.
Internal consistency is not the only measure of reliability. The stability of an instrument 
is a measure of its constancy over time -  how much scores vary from one test 
administration to another. The assessment of stability by a test-retest procedure with the 
same group of subjects can demonstrate reliability. However, this was not possible in 
this study as respondents replied anonymously in order to attempt to increase uptake of 
the survey. Establishing inter-rater reliability is important when two or more people are 
judging others and this was not an issue in this self-administered questionnaire. 
Consequently, for the purpose of this study assessment of internal consistency was 
considered to be the most appropriate indicator of reliability.
Validity is the degree to which an instrument measures what it is supposed to be 
measuring (Polit and Hungler, 1991). Establishing validity, like reliability, is not a one- 
off event. Content validity concerns the extent to which the content in a measure is 
representative. The original scale items were derived from the literature surrounding 
terminal dehydration, but no information is given in the source paper (Andrews and 
Levine, 1989) regarding any validity checks that were made (e.g. discussion with 
experts). When choosing to replicate this study the questionnaire was considered in the
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light of the existing literature, clinical expertise and professional expertise and appeared 
to have a reasonable level of content validity.
Criterion-related validity correlates a measure with an external criterion; however, no 
measurement instrument to examine attitudes towards terminal dehydration existed to 
enable such a comparison to be made. Construct validity considers the extent to which 
an instrument measures the construct under investigation. A method for assessing this is 
the known groups technique (DeVellis, 1991) where different groups would be expected 
to differ on the attribute under investigation and differences would be shown in the 
scores obtained. In this study it was hypothesised a priori that experience of observing 
terminal dehydration would be associated with a more positive perception of this state. 
Thus the differences observed in the two groups (experienced and inexperienced with 
respect to observing terminal dehydration) support the construct validity of the 
questionnaire.
This consideration of issues regarding the reliability and validity of the questionnaire 
increases the confidence that can be placed in the findings.
3.4.2 General discussion of findings
The results of this study are consistent with those of Andrews and Levine (1989), 
indicating that health care professionals who have experience of observing terminal 
dehydration (untreated with AHT) have a different perception of this state than those 
who are not experienced in observing this condition. Responses to the statements, which 
concerned distressing symptoms associated with terminal dehydration or its treatment 
with AHT, support the diversity in opinion regarding the sequelae to dehydration and its 
treatment in the dying population (e.g. Hamdy, 1980; Zerwekh, 1983).
The higher response rate from health care professionals working in hospices compared 
with general hospitals, and the difference in general reaction to the study and ease of 
access to potential respondents (more positive in hospice environments), may indicate a 
higher level of interest and awareness of this clinical area. This is also reflected in the 
increasing quantity of debate observed in the palliative care literature (Chapter 2).
Only 16% of respondents had never observed terminal dehydration (as operationally 
defined for the study). This finding was surprising, as previous research had indicated
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that treatment of terminal dehydration with artificial fluids until the time of death was 
quite commonplace in the UK (e.g. Marin et al 1989). However, the subdivision into the 
experienced and inexperienced subgroups (with respect to observing terminal 
dehydration) gave figures of 38% experienced and 44% inexperienced (18% missing data). 
Although the cut-off point of more than ten observations equating with ‘experienced’ was 
an arbitrary figure this did confer greater confidence on the suggestion that respondents 
defined as experienced had multiple exposures to this condition and were not being 
influenced by a one-off observation.
The highly significant association between the level of experience in observing terminal 
dehydration and working in a hospice was anticipated and probably reflected the dominant 
practice of palliative care at the time of the study (i.e. AHT was not routinely used at the 
end of life).
Results from the analysis of variance supported the factors hypothesised to influence 
perceptions of terminal dehydration. Working in a palliative care (hospice) environment 
and experience of observing terminal dehydration were associated with significantly 
higher mean total scores. As experience of observing terminal dehydration and location in 
a hospice environment were closely associated the significant findings in these two groups 
are difficult to disassociate.
The finding that nurses had significantly greater mean total scores than doctors, indicating 
a difference in attitudes towards terminal dehydration, may reflect the levels of experience 
of observing terminal dehydration. However, other factors may be contributing to this and 
further investigation is required. This finding suggests a possible source of tension within a 
multidisciplinary team regarding the appropriate palliative treatment of dying patients.
The effect of speciality on total score, whilst not surprising, indicates a need for a 
consistent approach to this clinical situation and the importance of this topic as an area of 
study. The higher levels of disagreement with positive statements regarding terminal 
dehydration in the surgery and medicine sub-groups may reflect an underlying difference 
in philosophy of care or a lack of awareness or knowledge regarding the situation, between 
these groups and those in oncology or palliative care specialities.
The interaction effects seen between professional group, seniority within that group and 
experience in observing terminal dehydration needs to be interpreted with caution due to
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the small size of some of the sub-groups. Indeed, contributory factors, such as location of 
respondent, speciality and professional group, were shown to be strongly associated with 
experience of observing terminal dehydration; as such, their independence cannot be 
assured.
Comparing the current findings with those of Andrews and Levine’s (1989) is hampered 
by the lack of data given in their publication. Overall mean total scores were not available. 
However, it is interesting to note that with the exception of statements 5 and 6 fewer 
respondents from the total sample in the current study agreed or probably agreed with 
statements than did in Andrews and Levine (1989) study (see Table 3-4). This may be 
attributable to geographical and cultural differences (see Chapter 2) or to changes in 
attitudes over time. Alternatively, this finding may be accounted for by the presence of 
greater numbers of practitioners defined as inexperienced compared with Andrew and 
Levine’s sample, as responses from the experienced sub-group in the current study were 
more similar overall to those of Andrews and Levine (Table 3-4).
The questionnaire contained seven positive statements about terminal dehydration and 
three negative statements, pertaining to symptoms and the distress caused by them, in 
relation to dehydration and the use of AHT therapies. It is interesting to note the high 
disagreement, across all groups, with the use of intravenous infusions (IVIs) for 
treatment of dry mouth due to dehydration. In studies, such as those of Marin et al 
(1989) and Collaud and Rapin (1991) using hypothetical cases, the use of IVIs for the 
treatment of terminal dehydration was advocated more frequently. However, this finding 
may be a reflection of the increasing use of less invasive forms of AHT (such as 
subcutaneous infusions). It may be that adding further questions or altering this question 
to be more discriminatory could be appropriate for investigating the use of different 
methods of fluid administration for the correction of dehydration, electrolyte imbalance 
and possible symptoms occurring as a consequence. Alternatively, the results may 
reflect the dilemma of using hypothetical case reports that may not reflect real world 
situations (see Chapter 2). Limitations of quantitative survey instruments such as this 
are highlighted here, as it would have been useful to elicit data that would increase 
understanding regarding the reasoning behind the perceptions observed.
Thirty-seven percent of Andrew and Levine’s (1989) sample agreed or probably agreed 
that dying patients who are dehydrated experience relief from distressing symptoms.
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Similar levels of agreement were seen in the experienced sub-group in the current study 
whereas only 24% of the whole sample supported this statement. This figure appears 
quite low considering that four of the items on the questionnaire would appear to relate 
to this statement and they receive greater agreement (i.e. 1, 4, 7 & 8: reduction/relief 
from vomiting, choking and drowning sensations, pulmonary congestion and the need 
for suctioning). More respondents (53% in Andrews and Levine (1989) and 55% in 
current experienced group) felt that dehydration was beneficial for the dying. Further 
research explaining possible mechanisms of perceived benefit may be helpful, as it 
would appear from these findings that perceived benefit may not be associated solely 
with relief or prevention of distressing symptoms.
This survey has demonstrated that health care professionals working in hospices, who 
are generally more experienced in observing terminal dehydration untreated with AHT, 
appear to perceive symptoms as consequences of dehydration in a different manner to
i/i
those working in general hospital settings (particularly those in surgical or medical 
specialities). They disagree more with statements pertaining to distressing symptoms 
that can be attributed to dehydration and agree more with statements pertaining to the 
contribution of dehydration to relief of distressing symptoms. Additionally, they also 
agree more with statements indicating the role of AHT in increasing symptom distress.
It is suggested that a key feature of this debate may lay in a fundamental difference in 
approach. Those supporting terminal dehydration may be addressing the issue through 
the management of symptoms and the distress caused by them, and their opponents 
(those advocating the use of AHT for treating dehydration in the dying) may be 
attempting to reduce the state/condition of dehydration and thus prevent the occurrence 
of distressing symptoms. Thus the issue becomes less one of debating assumptions 
regarding whether more symptoms occur as a result of dehydration or AHT and more 
one of how practitioners conceptualise the role of their interventions.
It can now be seen that differences in practice described in the literature (Chapter 2), 
and supported through the findings of this survey, could be explained by the palliative 
care approach accepting a state (terminal dehydration) that departs from normal 
homeostasis and which concentrates on improving comfort, through relief of distressing 
symptoms. In contrast, the approach of the general hospital may concentrate on altering, 
or correcting, the deranged state, in order to remove a source of potentially distressing
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symptoms. Thus the apparent discrepancy in practice may be because the groups are 
attempting to deal with different elements of the problem. Significantly, these differing 
conceptualisations (managing symptoms or altering the underlying condition) have a 
unifying theme, namely that of distressing symptoms. Dehydration and/or its treatment 
with AHT, may significantly impact on the symptom experience, and hence quality of 
life and dying, of the individual. The clinical problem becomes, then, one of an issue of 
perspectives on how to manage the symptoms, and distress that they cause, which may 
arise from the state or its treatment.
3.5 Conclusions
This study tested the primary hypothesis that experience of observing terminal 
dehydration is associated with different perceptions of this state. Andrews and Levine 
(1989) recommended that their study be replicated in other states and nations, using 
larger sample sizes including larger groups of professionals not experienced in terminal 
dehydration, and using other professional groups than nurses. This has been attempted here 
and the results have indicated that working in a palliative care setting, which is strongly 
associated with observing terminal dehydration, is associated with a different perception 
compared to those working in more generalist settings. This work reveals the continued 
diversity in opinion regarding the consequences of terminal dehydration and treatment 
with AHT and proposes that this may be due to different approaches to management (i.e. 
prevention of a state or management of a condition). The study highlights the notion that 
symptom distress is the unifying factor, and concern, in both approaches. If this area is to 
be addressed adequately, in order to provide an evidence-base for best practice, then 
attention must be given to the empirical investigation of symptom distress in this 
population. The next chapter explores the literature related to this concept.
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4 Symptom distress in the dying
4.1 Introduction
One of the goals of palliative care is the achievement of the best quality of life for 
patients and their families: “control of pain, of other symptoms, and of psychological, 
social and spiritual problems, is paramount” (Cohen et al, 1997, p.4). Symptoms arise 
from both the advancing disease and its treatment and are often seen as indicators of 
pathophysiology or as inevitable side effects of treatment (Rhodes and Watson, 1987). 
The previous two chapters have highlighted potential problems associated with terminal 
dehydration. Dehydration or the treatment of dehydration with artificial hydration 
therapies (AHT) may contribute to distressing symptoms in the dying patient.
Traditionally, the impact of cancer, and its treatment, on the lives of patients has been 
studied in terms of length of survival and tumour response rates but there has been 
increasing research interest into the definitions and measurement of the effects of illness 
and its related symptoms on quality of life (e.g. Priestman, 1984). However, as the later 
discussion will demonstrate, quality of life is a complex construct and open to different 
definitions. A consistent feature of quality of life assessment is the effect of symptom 
experience (e.g. Holmes and Dickerson, 1987; Aaronson et al, 1988; Ferrel, 1989a), and 
as such demonstrates the importance of controlling symptoms. Kaye (1992) emphasised 
that symptom control is the foundation of good palliative care.
Before one can study the effectiveness of treatment interventions it is essential to have a 
means of assessing the outcomes that may be affected by that treatment. The physical 
consequences of dehydration/AHT may be reflected in symptoms experienced by the 
patient and thus the following section discusses the concept of symptom distress and its 
measurement. This chapter considers the terminology around symptom distress and 
explores the concepts of quality of life, suffering and symptom distress. It will then look 
at existing measures of symptom distress within the cancer population and particularly 
within the palliative care population.
4.2 Symptoms
‘Symptom’ is a term that is often used without definition or clarification of what its’ 
meaning is, assuming a common understanding. Rhodes and Watson (1987)
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characterised symptoms as subjective phenomena regarded as indicators of a condition 
departing from normal function, sensation or appearance. Whilst the inherently 
subjective nature of physical symptoms and sensations is recognised, some symptoms 
are apparent to someone other than the individual experiencing them (e.g. vomiting or 
sweating). This is supported by the definition given by the Concise Oxford Dictionary 
(Fowler and Fowler, 1964), stating that a symptom is a perceptible change in the body 
or its functions, indicating disease and may be subjective, (i.e. perceptible only to the 
person experiencing it) or objective (i.e. perceptible to others). The private nature of 
symptoms, as defined by Rhodes and Watson (1987), indicates that assessment of 
symptoms and their cause may be difficult for an observer. Symptoms may be analysed 
according to factors such as frequency, duration and severity of occurrence and the 
degree of distress that they may cause. These will be explored in more detail later.
Signs may be differentiated from symptoms in that an observer can ascertain them. Signs 
are the translation of the symptoms into the signs of the disease, often for the purpose of 
diagnosis (e.g. the patient’s chest pain (symptom) becomes angina (a sign of coronary 
artery disease) for the doctor) (Kleinman, 1988).
4.2.1 The meaning of symptoms
Symptoms may be understood within a biomedical framework. According to this model 
symptoms are reflections of altered somatic processes achieving meaning in relationship 
to distinct (biochemical or physiological states (Good and Delvecchio Good, 1981; 
Kleinman, 1988). In contrast to this disease-orientated approach, interpretative medical 
anthropology offers a meaning-centred approach, proposing a view of symptom 
experience as the result of multidimensional processes (e.g. physiological, 
psychological and cultural) occurring within the context of social transactions 
(Woodgate and McClement, 1998). This is not to say that symptoms only occur in a 
social context but suggests that symptom experience is wider than an individual 
response to a bodily sensation. This approach emphasises the view of symptoms as an 
expression of the person’s reality and represents the meanings that the illness may have 
for the person.
Kleinman (1988) makes a distinction between disease (alteration in the structure or 
functioning of the body), illness (“the human experience of symptoms and suffering”
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and “how the sick person and their family perceive, live with, and respond to symptoms 
and disability” p.3.) and sickness (the understanding of a disorder in relation to wider 
economic, political and social forces). This has relevance to the discussion of symptoms 
in palliative care populations, as viewing symptoms from a purely biomedical model, 
where they are seen as a reflection of pathophysiological processes, may detract from 
understanding the meaning that symptoms and the illness have for the individual. This 
emphasises the importance of understanding, not only the frequency and severity of 
symptom occurrence, but the distress that such symptoms have.
4.3 Quality of life and suffering in the palliative care population
4.3.1 Quality of life
The concept of symptom distress is frequently referred to as part of the wider concept of 
quality of life. The concept of quality of life itself remains open to multiple definitions 
and interpretations vary greatly in their frames of reference/theoretical frameworks. 
General consensus seems to exist regarding the multidimensional nature of quality of 
life and, in particular, health-related quality of life within a population of people with 
cancer. Domains reported include: physical (including symptoms), psychological, 
social, financial. Grant et al (1990) and Maguire and Selby (1989) identify further 
elements such as life appraisal, sexual functioning and body image. More recently 
Molassiotis (1997) notes the dimension of spirituality as an important component of 
quality of life. However, the importance of the contribution of physical comfort to 
quality of life is reflected in the fact that 17 of 20 scales reviewed included the physical 
domain in their operationalisation of quality of life (de Haes and van Knippenberg, 
1985).
There appears to be a lack of clarity in definitions of quality of life and symptom 
distress. For example, Peruselli et al (1993) carried out a study entitled “Quality of life 
assessment in a Home Care program for advanced cancer patients: a study using the 
Symptom Distress Scale”. In this study they discuss the importance of assessment of 
multiple domains of quality of life and include symptom distress within that. After 
defining symptom distress they utilise the McCorkle and Young Symptom Distress 
Scale (1978) to evaluate a Home Care Programme and claim that the reduction in 
symptom distress scores confirms the validity of a quality-of-life monitoring system
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using a patient-rated symptom assessment instrument. In this study Peruselli et al 
(1993), whilst acknowledging the need for multidimensional assessment, appear to be 
using symptom distress as the operationalisation of quality of life. It could be argued 
that this is inadequate and what they are assessing is not quality of life but simply a 
component of it. The reduction of symptom distress has not been proven to affect 
quality of life as only symptom distress has been explored.
The frequently used McCorkle and Young Symptom Distress Scale (1978) contains 
items reflecting three of the quality of life domains (i.e. physical, functional and 
emotional well being) (McClement and Woodgate, 1997). This highlights further the 
apparent confusion of the concept definitions and perhaps indicates an overlapping of 
boundaries. The accuracy of measurement of a concept is directly related to the clarity 
with which it is defined (Knafl and Deatrick, 1993). Quality of life measures that 
include a physical domain vary in the number of symptoms that they include. For 
example, the McGill Quality of Life Questionnaire (Cohen, et al 1995; Cohen et al, 
1997) assesses 3 symptoms whereas the McCorkle and Young’s (1978) assesses 13. 
Scales also differ in what aspects of symptoms they measure (e.g. some measure 
symptom frequency and not the distress caused by the symptom (Hollen et al 1993)). 
Variability in these aspects of measuring symptom distress within quality of life 
instruments inhibits exploration of the relationship between symptom distress and 
quality of life across studies. Additionally, these may affect the essence of what is being 
measured by the physical domain within the quality of life assessments. Such lack of 
consistency and conceptual clarity may threaten the progress of research.
Ferrel et al (1991) devised a conceptual model based on their previous work in cancer 
patients (e.g. Ferrel et al, 1989a; Ferrel et al, 1989b; Padilla et al, 1990). Figure 4-1 
demonstrates possible relationships between pain and quality of life. From this model it 
can be seen that just one symptom, pain, is a complex phenomena in itself, impacting on 
the four dimensions of quality of life, including the physical well-being domain and its 
associated symptoms.
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Figure 4-1: Impact of pain on the dimensions of quality of life 
(from Ferrell et al, 1991)
Physical well-being and Psychological well-being
associated svmptoms
Functional ability Anxiety
Strength/fatigue Depression
Sleep and rest Enj oyment/leisure
Nausea Pain/distress
Appetite Happiness
Constipation Fear
Social concerns Spiritual well-being
Caregiver burden Suffering
Roles and relationships Meaning of pain
Affection/sexual function Religiosity
Appearance
Cowan et al (1992) critique the use of symptom distress as a definition of quality of life 
instead of as a factor influencing it. They propose a theoretical basis of the concept of 
quality of life as the perceived sense of satisfaction with one’s current life influenced by 
functional alterations, symptom distress, and severity of disease (although others argue 
that quality of life must be distinguished from related but different concepts such as life 
satisfaction (King et al, 1997)). Their theoretical framework (Figure 4-2) places 
manifest symptom distress as a mediating variable along with functional alterations and 
cognitive adaptation (Cowan et al, 1992). Antecedent variables such as severity of 
disease, aggressiveness of treatment and socio-economic level are included.
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Figure 4-2: Conceptual framework of factors affecting quality of life
(from Cowan et al, 1992)
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A pilot study was carried out to gain empirical data to support this theoretical model and 
to ascertain if the model of quality of life could be generalised to chronic disease, and 
not be disease specific, by comparing subjects who had experienced malignant 
melanoma and myocardial infarction (Cowan et al, 1992). A strength in the study lay in 
the utilisation of more than one measure for each variable in order to ascertain the 
sensitivity, reliability and validity of the measures used. The small sample sizes (30 
with melanoma and 27 with myocardial infarction) reduced the statistical power of the 
testing, making comparisons between the groups difficult. In addition, the lack of 
subjects at more advanced levels of the disease reduces the representativeness of the 
sample. Despite these limitations the data supported some of the relationships proposed; 
of particular interest to this discussion was the finding that, in the sample taken as a 
whole, and in the malignant melanoma sub-group, perceived quality of life and manifest 
symptom distress were inversely related (p < 0.01). This demonstrates the importance of 
separating symptom distress as a distinct component from quality of life.
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4.3.1.1 Suffering
Relief of suffering is one of the central tenets of palliative care (Saunders, 1989). This 
aim shares one of the inherent difficulties discussed in the previous sub-section -  that of 
little agreement in definition (Cherny et al, 1994). Chapman and Gavrin (1993) identify 
three common features present in most discussions: 1) suffering usually involves a 
perceived threat to the integrity of the self; 2) it is by definition an unpleasant and 
psychologically complex experience; 3) it represents an enduring psychological state 
rather than a transient experience. They identify two other important features: that 
suffering reflects perceived helplessness in the face of threat and that may involve 
perceived loss (of a physical, psychological or social resource). The loss of an 
existential resource is missing from their list.
Kuppelomaki and Lauri in a recent paper (1998) describe the nature of the suffering 
experienced by 32 patients with incurable cancer. Data was collected mainly by 
interviews and supplemented with a questionnaire. Three different dimensions were 
identified: physical, psychological and social. The physical components of suffering 
were divided into those caused by the illness itself and those by the treatment. The 
sample included some patients quite close to death (63% of patients died between five 
days and nine months after the study) and symptoms were a frequent component 
contributing to suffering.
Thus suffering may have multiple origins. Jacobsen and Breitbart (1996) view suffering 
as a subjective phenomenon influenced by biological, psychological and social 
processes. They suggest that control of physical symptoms is a central part of any effort 
to relieve suffering in the palliative care patient. It can be seen that the dimensions of 
suffering have areas of overlap with dimensions of quality of life (discussed above).
4.3.1.2 Symptom distress, suffering and effect on caregivers
Palliative care is not confined to the patient but rather the patient is seen in the context 
of their significant relationships so that the family is seen as the unit of care. Suffering 
is not limited to the patient; family members also suffer (Hinds, 1992) which, in turn, 
may exacerbate the patient’s suffering (Wellisch et al, 1989; Cherny et al, 1994). 
Research into family needs when caring for people with terminal illness has revealed 
patient comfort and adequacy of pain control as primary concerns (McGinnis, 1986; 
Skorupka and Bohnet, 1982). Hull (1990), in a longitudinal qualitative study combining
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semi-structured interviews and participant observation with 14 family members of 10 
patients, found that for many families, the most distressing symptoms were those related 
to mental changes: the inability to communicate, confusion and seizures. In addition, 
physical deterioration and the associated increased dependence were sources of distress. 
Concerns about pain as a source of distress to caregivers were not supported in this 
study in contrast to other care-giving literature and the authors suggest that this may be 
due to the hospice controlling pain well in the population sampled. Due to the small 
sample size and qualitative nature of this study the findings are not meant to be 
generalised but to give greater understanding into the experience of the sample.
In a larger, more quantitative study, the importance of control of symptoms is 
emphasised, as Kurtz et al (1995) in a longitudinal study of 150 cancer patients and 
their care-givers found that patient symptoms were a predictor of patient depression 
which, in turn, predicted care-giver depression. The study sample consisted of patients 
at diagnosis or recurrence and, therefore, the findings are not necessarily generalisable 
to a terminal population. However, the general literature on psychosocial disruption in 
cancer patients and families finds symptom distress to be an important predictor of 
emotional distress in families (e.g. McCorkle and Quint-Benoliel, 1983).
4.3.1.3 Comment
This discussion has demonstrated that quality of life and suffering have overlapping 
dimensions. Importantly, it has highlighted that symptom experience may contribute to 
these broader concepts. However, symptom distress requires conceptualising in its own 
right and the next section will explore this further.
4.4 Determinants of symptom distress
Symptom distress appears to be a multidimensional phenomenon and more than a direct 
reflection of pathophysiological disturbance. Some symptoms occurring with malignant 
disease and its treatment (e.g. nausea, tiredness and pain) are not immediately apparent 
to an observer (Holmes and Ebum, 1989). In addition, the degree of distress 
experienced when a symptom is present is not absolute or standard across individuals. 
Factors have been identified which may affect the perception of symptom distress. For 
example, Abrams (1966) found that different individuals had different symptoms and 
concerns at different stages of their disease and other studies have found that disease
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state influences the symptom distress experienced by patients (e.g. McCorkle and 
Quint-Benoliel, 1983; Silverfarb et al, 1980; Munkres et al, 1992). Tishelman et al 
(1991) explored the relationship between symptom distress and a variety of possible 
explanatory variables, in a heterogeneous group of cancer patients. They found in 
contrast to the works cited above that disease state was not statistically related to reports 
of symptom distress in this patient group. However, over 67% of variance in symptom 
distress scores were accounted for by the variables sense of coherence, marital status, 
oncologic treatment, diagnosis, social support and assessment of individual need. This 
discrepancy in findings regarding disease stage and the experience of symptom distress 
may be due to limitations in the studies and lack of comparability due to the use of 
heterogeneous samples. Tishelman et al’s (1991) study sample was biased with respect 
to age (respondents had a significantly lower age than non-respondents) and mortality 
rates (non-respondents had a significantly higher mortality rate) -  thus the sample were 
less unwell and those in the later stages of disease were underrepresented (only 20% 
died in the 18 months following the study).
The complexity of the situation is raised in Germino and McCorkles’s (1985) study of 
acknowledged awareness of life-threatening disease and the experience of symptom 
distress. They postulate that the increased symptom distress experienced may act as a 
reminder of their life-limiting disease, which may lead to increased awareness. 
However, the knowledge of a disease as life threatening may lead to an increased 
experience of symptom distress (Tishelman et al, 1991).
Rhodes and Watson (1987) also suggest that factors such as thoughts related to 
symptoms, degree of attention given to symptoms and mood and mental outlook may 
amplify symptom distress. Other researchers have implicated other determinants such as 
type of home nursing treatment. For example, McCorkle et al (1989) found that patients 
with inoperable lung cancer receiving home nursing care experienced less symptom 
distress than those not receiving such care. Other factors may have modifying or 
determining effects on symptom distress such as socio-economic status, race, culture, 
role, educational level, health knowledge, values and past experiences (McClement and 
Woodgate, 1997). However, relationships are not clearly defined. Factors such as social 
support are usually considered to be positive or buffering factors (Tishelman et al, 
1991). However, studies such as those by Gil et al (1987) and Flor et al (1987) suggest
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that a supportive social environment may lead to increased reports of symptoms such as 
pain. Tishelman et al (1991) suggest that the increased reports of symptom distress 
associated with increased social support may be explained intuitively by the social 
support increasing in response to distress expressed. However it is possible that the 
increased distress is reported as a result of reinforcement from a supportive 
environment, indicating a legitimisation of symptom distress.
Thus it appears that the distress experienced by a person is individual and is broader 
than the simple constituents of physical symptoms (MacAdam and Smith, 1987); the 
complex phenomenon reflects both ‘illness’ and ‘sickness’ perceptions (Tishelman et al, 
1991).
Lenz et al (1995; 1997) have proposed a theory of unpleasant symptoms (Fig.4-3) 
generated from their studies concerning fatigue and dyspnoea (this is not specifically 
cancer related but a middle range theory not meant to be disease specific).
Figure 4-3: Middle range theory of unpleasant symptoms (from Lenz et al, 1995)
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The theory has three main components: the symptoms that the individual is 
experiencing, the influencing factors and the consequences of the symptom experience. 
In the original 1995 model one symptom was depicted but further development in the
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1997 version demonstrates the often concurrent nature of multiple symptoms (Fig. 4-4). 
Symptoms are conceptualised to be measured separately or in combination with other 
symptoms. The occurrence of multiple symptoms is suggested to be multiplicative 
rather than additive. Thus two or more symptom occurring simultaneously are likely to 
be synergistic.
Figure 4-4: Middle range theory of unpleasant symptoms (from Lenz et al (1997)
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Dimensions affecting symptoms are considered to be intensity, referring to strength, 
amount or severity of the symptom experienced; timing, which refers to the duration or 
frequency of its occurrence; quality, which refers to the way they are manifested, often 
reflected in the vocabulary used to describe what it feels like; and distress, referring to 
the degree to which a person is bothered by the symptom.
Thus, what appears to be missing from this theory is the relationship between 
unpleasant symptoms and quality of life. Although Lenz et al (1997) suggest that it is 
the distress dimension which contributes most to quality of life (but do not indicate 
what empirical evidence they have for such a claim), they do not highlight quality of life 
in their theory per se. It may be that, as well as the effect on performance, quality of life 
should be considered here.
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This theory may be useful to guide clinical research as theoretically-derived measurement 
instruments require conceptual mapping (that is developing a scheme in which to organise 
the meaning of the concepts under consideration) (Waltz et al, 1991). This theory places 
the various components of the symptom experience in a usable framework and aids 
identification of the dimensions that may be important to measure.
4.5 Comment
This review so far, has highlighted issues regarding the lack of consensus regarding 
definitions used by researchers when studying symptom distress, lack of clarity between 
the terms symptom and symptom distress and the blurring of the constructs of quality of 
life, suffering and symptom distress.
Distress implies mental or physical suffering and can be caused by pain, other 
symptoms, trouble, worry or other stressors (Concise Oxford Dictionary (Fowler and 
Fowler, 1964)). It has been defined by Leventhal et al (1979) as the amount of upset the 
sensations cause and Nightingale (1946) suggested distress was suffering and upset. 
Symptom distress is, then, a concept concerning the degree of discomfort or suffering 
(both physical and mental) resulting from the occurrence of the symptom (McCorkle 
and Young, 1978; Rhodes and Watson, 1987). It can be seen as contributing to the 
wider constructs of quality of life and, indeed, as part of a theory of unpleasant 
symptoms (Lenz et al, 1997). Symptom frequency or intensity is often equated with 
symptom distress but it has been demonstrated that those symptoms that are most 
intense or most frequent are not necessarily the most distressing to individuals (Rhodes 
and Watson, 1987; Lough et al, 1987) and, as Lenz et al’s (1997) theory illustrates, the 
distress caused by a symptom is a separate issue from its frequency and intensity. 
Nonetheless, attempts have been made to measure the degree of distress caused by 
individual symptoms.
If the assessment and control of symptoms is one of the major aims of palliative care 
then the identification of an appropriate assessment tool is a prerequisite to effective 
care. In 1963, Hinton suggested that there was a need to attempt to analyse more exactly 
the degree and nature of distress in the dying and that this may aid its relief. The next 
section explores the literature relating to this issue.
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4.6 Measurement of symptom distress
Attempts to measure symptom distress in the cancer patient have been widely reported. 
Hinton (1963) measured physical and mental distress through interviews with dying 
patients. Physical distress was defined as "physical discomfort of such a degree that it 
distressed the patient and was severe enough to warrant treatment directed towards its 
relief'. Four levels of distress were identified: “absent”, “relieved”, “unrelieved and 
inconsistent” and “unrelieved and constant”. Distress was measured as it related to pain, 
dyspnoea, nausea and vomiting, malaise and persistent cough; other less common 
symptoms were omitted. This early attempt at measuring symptom distress yielded 
results of clinical value but, as assessment was made through undirected interviews with 
no specific or standard questioning, there may have been inconsistent assessment of 
distress and there was no possibility of establishing the reliability of the assessments. 
Thus bias, introduced through non-standardised interviews, may have been present. 
There was no indication of how frequently a symptom had to be mentioned to be 
included in the assessment so that the validity of this approach may also be questioned.
Twycross (1972) developed a scale to assess the symptoms of pain, mood, nausea, 
vomiting, appetite, anxiety, dyspnoea, coughing and constipation for use in a study 
assessing the efficacy of two analgesics (morphine and diamorphine). More recently, 
McCorkle and Young (1978) have developed a symptom distress scale for use in 
patients with malignant disease. Items included here were based on an earlier study of 
26 patients receiving active cancer treatment (either chemotherapy or radiotherapy) 
(Schneider, 1976). Open-ended interviews regarding areas of concern to patients 
revealed symptoms that agreed with those reported by others. The validity of the items 
selected cannot be assured as the sample size was small and the report does not present 
any raw data to indicate the frequency of symptoms identified by the subjects. In 
addition, the authors do not state which studies these findings were compared with. 
However, further studies by Holmes (1989a) confirmed the validity of items in a 
heterogeneous population of patients with malignant disease.
The 10 symptoms included in the scale were nausea, mood, appetite, insomnia, pain, 
mobility, fatigue, bowel pattern, concentration and appearance (McCorkle and Young, 
1978). Responses to each symptom were scored on a five point (Likert-type) scale with 
a statement at each end representing the extremes of response to each item. A study of
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45 cancer patients demonstrated that the scale had internal reliability as assessed by 
Cronbach coefficient a  = 0.82. The scale was never intended to cover all possible 
symptoms but to assess those considered to be of most concern to patients. No attempt 
was made at this stage of testing to ask respondents if there were other symptoms that 
distressed them or which were of more concern and, therefore, further analysis of 
content validity (other than in the development) was not considered. In addition, it is 
unclear if the assessments made by each patient were considering the same time span, as 
the instructions stated that the subject was to "put a circle around the number that most 
closely measures how they perceive their distress at that moment or that day"; this lack 
of consistency in data collection may have affected the reliability of the scale.
The Symptom Distress Scale (SDS) developed by McCorkle and Young (1978) has 
been used since in a study of patients receiving chemotherapy for initial and recurrent 
cancer (Munkres et al, 1992). A revised scale, with the additional items of strength and 
bodily discomfort, proved to have high reliability (as assessed by Cronbach’s a  = 
0.85). Larson et al (1993) also used a modified version of this scale to compare bone 
marrow transplant patients' and their nurses' perceptions of symptoms. The modification 
added symptoms common to patients undergoing bone marrow transplantation and, 
again, the scale yielded high reliability scores. The repeated use of a scale is important 
in terms of validation (Nunnally and Bernstein, 1994) but these studies sampled patients 
undergoing active treatment and, as such, do not add evidence for their use in the dying.
The use of this scale in its most recent version has been tested in a population of 
patients with advanced cancer receiving palliative home care (Peruselli et al, 1993). 
Forty-three patients were included in a longitudinal study, completing the scale at 
weekly intervals for as long as their physical condition would permit. Internal 
consistency of the scale was high (Cronbach's a  = 0.78). Factor analysis identified four 
factors, accounting for 67.4% of the variance in the scores. The first factor related to 
psychological symptoms and appetite and fatigue, the three others related to pain, 
nausea and breathing. The authors conclude that such a test, which explores a small 
number of all possible symptoms, is a valid instrument for the measurement of 
symptom distress in terminal patients in a home care setting.
However, criteria for sample selection were not discussed so that it is difficult to know 
how representative this sample was of a dying population. Also of note is the fact that
63
the data only refers to those patients who were capable of completing a minimum of 2 
questionnaires. This highlights an important area for consideration when assessing 
symptoms at the end stages of illness: that is the ability of the patient to complete 
questionnaires unaided. The study demonstrated that the scale had discriminant ability 
over time as a significant reduction in symptom distress was seen in some areas and a 
significant increase in others. A major criticism of this study is that no attempt appeared 
to be made to assess the content validity of the scale or the reliability in the patient 
sample; considering the dearth of studies using a population of patients close to death 
the appropriateness of the tool cannot be assumed.
Although McCorkle and Young (1978, p.374) define symptom distress as “the degree of 
discomfort from the specific symptom being experienced as perceived by the patient”, 
the actual scale, and later modifications (e.g. McCorkle and Quint-Benoliel, 1983), 
appear more to measure frequency and intensity, and not explicitly rate the distress of 
each symptom included. For example, for nausea, patients score on a five-point Likert 
scale between “I feel as sick as I could possibly be” and “I do not feel sick at all”. Thus 
although the authors state that this measures the amount of distress caused by the 
symptom, the wording seems to be reflecting intensity of the symptom occurrence.
A modification of the McCorkle and Young SDS, using the same items but scaling with 
Linear Analogue Self Assessment techniques, has been developed by Holmes and 
Dickerson (1987) and evaluated in a large heterogeneous sample of 120 cancer patients 
undergoing active treatment (Holmes, 1989a). The scale proved to be acceptable to 
patients and appeared to be quick and easy to use. Reliability of the modified scale 
exceeded that of the original (Cronbach's a  = 0.97). Content validity was assessed by 
comparison with previous literature and appeared to be consistent; subject's opinions 
were elicited and no omissions were apparent. Further validation of the scale was 
evaluated through the use of multiple regression analysis (Holmes, 1989b), which was 
able to explain the majority of the variance in scores observed. Possible differences in 
symptom distress in patients with widespread or advanced disease were investigated but 
no significant differences were found. However, only 25% of the sample had 
widespread disease and it may be that the sample was too small to detect differences or 
that the incidence of symptom distress is not necessarily dependent on the extent of the 
disease. It may also be argued that, as the items for inclusion in the scale were not
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developed and tested in a population with advanced disease, their distress was not being 
measured in these items.
The original symptom distress scale includes items developed in patients from an 
outpatient setting undergoing active treatment with either radiotherapy or chemotherapy 
(McCorkle and Young, 1978) and has been tested in a similar populations (Holmes and 
Dickerson, 1987; Holmes, 1989a; Sutcliffe and Holmes, 1991). Although some of the 
patients studied had 'advanced disease' it is not apparent at what stage in their illness 
trajectory they were and they were still undergoing active treatment. Therefore it can be 
suggested that the content validity of the scale for use in a population of dying patients 
not undergoing active radiotherapy or chemotherapy cannot and should not be assumed.
Other systems for measuring symptoms have been developed for use in clinical research 
trials, often in conjunction with quality of life scales (e.g. Functional Living Index for 
Cancer, Schipper et al, 1984; European Organisation of Research on Treatment of 
Cancer, Aaronson et al, 1986; Rotterdam Symptom Checklist, de Haes et al, 1986). A 
major strength of some of these scales is their extensive testing and validation in large 
multi-centre settings. However, despite their validation, their transfer for use in a patient 
population not undergoing active treatment, where goals of therapy are palliation, may 
be inappropriate. For example, some of the items included in the scale may be less 
appropriate in the patient close to death (e.g. symptoms such as hair loss, included in the 
well established Rotterdam Symptom Checklist) and their validity cannot be assumed 
(Ahmedzai, 1991).
A quality of life scale developed for use in dying patients (MacAdam and Smith, 1987) 
includes ratings of six symptoms (appetite, nausea, pain, breathing, constipation and 
diarrhoea). These six items were part of a 20-item questionnaire, reduced from an 
original 43-item tool containing 12 items regarding physical symptoms. Items were 
discarded after the initial scale assessment if they duplicated each other or were 
relatively rare (less than 10% response rate). This scale, like other quality of life 
measures, includes physical symptoms alongside other dimensions of assessment such 
as social support, knowledge of, and involvement in, illness and psychological 
symptoms. Thus symptom distress is part of a wider construct being measured. The 
extraction of the symptom distress component cannot confer the same reliability and 
validity estimates and these would need to be examined before a scale could be used in
65
a different population. Additionally, as the scales need to be of manageable length (so 
that a very ill population can complete them), only the major items contributing to the 
subscale can be included; further testing of this measure would be required if using a 
subscale alone, as this may reduce the sensitivity of the subscale in assessing that 
construct.
A modular approach to quality of life scores is proposed by some researchers (e.g. 
Aaronson et al, 1989), whereby subsections of the scales (modules) could be used 
independently. An analysis of the use of the Rotterdam Symptom Checklist in 3 studies 
revealed that, although both the psychological and the physical dimensions are essential 
in the symptom experience of the cancer patient, it was possible to distinguish the 
dimensions empirically with good reliability and validity (de Haes et al, 1990).
Bruera et al (1991) describe an assessment system based on a visual analogue scale for 
daily symptom assessment. This Edmonton Symptom Assessment System (ESAS) 
contains 9 scales for pain, activity, nausea, depression, anxiety, drowsiness, appetite, 
sensation of well-being and shortness of breath; an extra empty scale is included for a 
symptom of particular importance to an individual. Patients are assessed twice daily 
either by the patient alone, the patient with the assistance of the nurse or the nurse or a 
relative. If a symptom cannot be assessed it is left blank. The authors suggest that this 
tool is a simple and useful method of monitoring palliative care patients and for 
repeated use in a very ill population. However, these conclusions are not supported by 
research evidence. There is no attempt to investigate or discuss the reliability or validity 
of the tool. Content validity appears to be assumed, with no explanation of the basis for 
item selection. Despite the use of multiple assessors (patient and/or nurse and patient 
and/or relative) inter-rater reliability is not considered. Therefore, despite the large 
sample size (101), the scale cannot be said to be reliable or valid at this stage of its 
development.
Limitations of the instruments discussed include lack of clarity of conceptualisation. As 
previously discussed, it has been demonstrated that symptom frequency and intensity 
does not necessarily equate with symptom distress and these are probably separate but 
related dimensions of the symptom experience. Additionally, many of these measures 
have been tested in heterogeneous samples of patients with malignancy and very few
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studies have considered the type and staging of the cancer where different symptoms 
may have more relevance.
4.7 Symptoms in dying patients
As existing scales which attempt to measure symptom distress have been derived and 
tested mainly in population of cancer patients still undergoing active treatment 
(radiotherapy and chemotherapy) it may be useful to consider studies investigating 
symptoms in the dying cancer patient receiving palliative treatment only.
Hinton’s work (1963), utilising unstructured interviews with 121 patients, with a 
prognosis of less than six months, measured physical distress from pain, dyspnoea, 
nausea or vomiting, malaise and cough. Limitations of the assessment were discussed in 
Section 4.6 and, because the symptoms were not measured consistently, its applicability 
is limited. Large scale surveys of dying cancer patients examined symptom occurrence 
in 215 and 168 patients respectively (Cartwright et al, 1973; Cartwright, 1991). Such 
studies provide useful data regarding which symptoms occur most frequently. However, 
it is important to note that these studies examined the last year of the patients' life and so 
give a global impression of symptom occurrence. They do not address questions such as 
whether symptoms remained constant over this time or whether some were associated 
with an earlier phase of illness and others at a stage closer to death. Also, these studies 
relied on retrospective interviews with bereaved carers as the only data source. It may 
not be certain that symptom occurrence was being truly accounted for, as this technique 
is dependent on the accuracy of subjects' memories; also, memories may have been 
distorted by the distress of the bereaved subject's perceptions of the dying person. 
Whilst the important contribution of such large scale surveys is not denied, such work 
may not be recording actual events but those perceived by the carer and, therefore, 
reflect their memory and emotional state of bereavement rather than providing a 'true' 
picture of the patient's distress.
Studies of patients closer to death have been carried out. For example, Hockley et al 
(1988) surveyed patients who were thought to have "less than three months to live" by 
their hospital doctor. The incidence of 16 symptoms was recorded following interviews 
with patients. The most frequently reported symptoms were anorexia, insomnia, 
immobility, malaise and sore mouth. It is unclear how the 16 symptoms were chosen
67
and there is no indication of whether the sample met the criteria of being in the last 3 
months of their lives. However, such studies do indicate which symptoms are of 
concern to practitioners in palliative care and common in their patients, but they may 
then reflect practitioners’ concerns rather than patients.
Further sources of information regarding symptoms in dying patients are reports of 
symptoms on admission to hospice units (e.g. Hanks, 1983; Curtis, 1991). Curtis 
(1991) aimed to identify the presenting symptoms of patients on referral to a palliative 
care team by using a 38-symptom checklist following a review of the body systems. The 
interviewer assessed the severity of any identified symptoms (mild, moderate or severe). 
A weakness of this study is the subjectivity of the severity measurements together with 
the absence of any attempt to assess reliability between the raters (up to 5 different 
raters). The lack of reliability evaluation questions the validity of the findings, as 
reliability is a prerequisite for validity (Oppenheim, 1992). Despite this, the study 
approach is important as it attempts to assess a wide range of symptoms (38) in a 
consistent manner. This contrasts with other studies (e.g. Cartwright et al, 1973) 
whereby information related to symptoms is based on a preselected number of 
symptoms or is gathered post hoc (e.g. Hanks, 1983).
These studies pertain to symptoms present on admission to a hospice and so may not 
cover all the symptoms that occur at a later time, closer to death. However, it may be 
that symptoms that occur in dying patients are stable with respect to time in the dying 
trajectory and are established at an early stage of terminal disease. The National 
Hospice Survey (Wachtel et al, 1988) followed 1,119 dying patients in the U.S.A. One 
of the measures was of symptoms concerning nausea and/or vomiting, constipation, 
fever and shortness of breath (derived from interviews with patients) and the symptoms 
of pain, diarrhoea, problems with eating/anorexia and weight loss (derived from 
interviews with the principal care person - non-professional). The prevalence of 
symptoms was high in the 4-6 week period before death (e.g. pain affected 55% of 
patients, shortness of breath 50%, nausea and/or vomiting 44%) and did not increase 
much as death approached. Assessments were made at two-weekly intervals and it may 
be that changes in symptom occurrence at the end stage of disease would be missed. 
However, another consideration is that it is the prevalence of symptoms that is being
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measured by such studies rather than a change in their severity or intensity; it may be 
that it is the latter that change.
A small number of studies report symptoms up to the time of death. For example, Coyle 
et al (1990) carried out a retrospective review of the case notes of 90 consecutive 
patients involved in a palliative care programme. Although this was retrospective, the 
data was recorded prospectively through daily contact with the patient. For the purposes 
of this work symptoms were recorded at weekly intervals and included those that the 
patient recorded; the nurses did not document symptoms that were not spontaneously 
raised by the patient. Forty-four different symptoms were identified. It may be argued 
that the assessment of symptoms only volunteered by the patient may underestimate 
symptoms present as patients may only volunteer symptoms that they feel are 
acceptable to mention, or that they feel the nurse wants to hear. However, the fact that 
44 different symptoms were recorded indicates the diversity of symptoms that may 
affect a dying patient, and is the largest number reported in the literature reviewed.
4.8 Conclusions
This literature review started from the premise that terminal dehydration or its treatment 
with AHT may contribute to the symptoms experienced by the dying cancer patient. 
Control of symptoms is one of the fundamental goals of palliative care, as symptoms 
have been demonstrated to be factors affecting the constructs of quality of life and 
suffering, for both the patient and the family. The discussion argued that symptoms 
should not just be seen in terms of a pathophysiological response to disease processes, 
or its treatment; there may be gains from drawing on the ‘meaning-centred’ approach of 
the medical anthropologists, whereby symptoms are also seen as representing the 
meanings that the illness may have for the individual. This supported the assessment of 
distress caused by symptoms, as a distinct entity from symptom occurrence and 
severity.
The concepts of quality of life and suffering were explored in relation to symptom 
distress and the blurring of boundaries and overlapping of the dimensions described in 
these constructs was highlighted. Symptom distress was observed to be an important 
component of these wider constructs, but it was emphasised that symptom distress 
required consideration as a concept in its own right. Further understanding of symptom
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distress is required if the interrelationships between these constructs are to be 
understood.
Consequently, multiple determinants of symptom distress were identified, reflecting the 
importance of considering symptoms in the wider context of illness and sickness, as 
well as bodily manifestations of disease processes. Lenz et al’s theory of unpleasant 
symptoms (Lenz et al 1995; Lenz et al, 1997) was introduced and this also supported 
the argument for viewing symptom distress as a separate issue from symptom frequency 
and intensity.
Finally, methods used to assess symptom distress were explored. This discussion 
highlighted the fact that no symptom distress scale has been developed and validated for 
use in a population of patients dying from malignant disease. Although scales 
measuring symptom distress have been used in some patients who have advanced 
disease, little confidence can be placed in their reliability and validity with respect to a 
population of patients close to death. It was, therefore, necessary to design an 
exploratory study to elucidate which symptoms are sources of distress to such patients. 
The results of such a study could then be used to consider the suitability of existing 
methods of symptom distress assessment or assist in the development a new measure. 
Without reliable and valid measurement instruments, it is impossible to investigate 
meaningfully the impact of symptoms related to dehydration and/or artificial hydration 
therapies on quality of life and suffering in the dying cancer patient.
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5 Development of a symptom distress scale
5.1 Background
The previous two chapters have argued that dehydration in the dying cancer patient 
and/or its treatment with artificial hydration therapies (AHT) may significantly 
contribute to the symptom distress experienced, and consequently affect the quality of 
life and suffering of the individual. Before further investigations into terminal 
dehydration can occur methods of assessing symptom distress need to be established. 
Chapter 4 highlighted the fact that, to date, no symptom distress scale had been 
developed and validated for use in a population of patients dying from malignant 
disease. Although a variety of scales measuring symptom occurrence and symptom 
distress have been used in some patients who have advanced disease, limited confidence 
can be placed in their reliability and validity with respect to a population of patients 
close to death. It was, therefore, necessary to design an exploratory study to elucidate 
which symptoms are sources of distress to such patients and which symptoms are 
thought to relate to dehydration and artificial hydration therapies. Symptoms identified 
could then be compared with existing measurement instruments. If none of the currently 
available instruments include the identified symptoms, the modification of an existing 
scale or the development of a new one will be considered.
This chapter discusses a study designed to identify distressing symptoms in the dying 
cancer patient, with particular reference to those symptoms that may be related to 
terminal dehydration or its treatment; it goes on to describe the design of an instrument 
to measure physical symptom distress.
5.2 Part 1: Study to identify distressing symptoms in patients dying of 
cancer
5.2.1 Aims
The aim of the study was to explore the symptom experience of people dying of 
malignant disease in order to inform decision making regarding the suitability of 
existing methods of assessment of symptom distress in this population and to generate 
further understanding/insight concerning the concepts of symptom distress and terminal 
dehydration.
71
5.2.2 Method
5.2.2.1 Design
The study was a descriptive cross-sectional investigation that was designed to identify 
symptoms causing distress in dying cancer patients and to help clarify the concept of 
symptom distress. As such, this was an exploratory work, to which qualitative methods 
are particularly suited (Polit and Hungler, 1991). The interview is a predominant 
method used in qualitative research and semi-structured interviews were used at this 
stage of the work in order to allow the subjects to speak freely about their experience.
5.2.2.2 Sample
A non-probability (convenience) sample of 49 patients and 60 professional carers from 
three in-patient hospice units and two general hospital oncology units was obtained; in 
addition, a random sample of 30 bereaved carers was taken from one hospice unit. This 
sample was selected for the preliminary investigation to provide a heterogeneous cross- 
section of informants. The aim of multi-centre sampling was to reduce the potential of 
institutional bias.
Using health care professionals as a data source was deemed appropriate as the earlier 
work, described in Chapter 3, demonstrated that health care professionals have attitudes 
towards terminal dehydration (and its treatment with AHT) that may significantly affect 
clinical care and thus the symptoms experienced. Bereaved carers were included as 
opinions of family caregivers may highlight important areas of symptom distress from a 
different perspective of the patient or professional carer. The use of three data sources 
(patient, professional carer and bereaved carer) employed the strategy of data source 
triangulation, in an attempt to maximise the range of data obtained (Knafl and 
Breitmayer, 1991).
The sampling method adopted may have a direct effect on the reliability, validity and 
replicability of a study and there are differing opinions as to which method is the most 
appropriate. Some qualitative researchers use the process of randomisation (e.g. 
Leininger, 1985). However, others suggest that this may not always be appropriate, as a 
small randomly selected sample violates both the quantitative principle requiring a 
sample to be large enough to ensure representativeness and the qualitative principle that
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a sample is appropriate (i.e. involving the selection of subjects who are best able to 
supply the information required for the study) (Morse, 1991a).
When sampling issues were considered, it was thought that purposeful (theoretical) 
sampling, according to the needs of the study, would be inappropriate because of the 
exploratory nature of the research question, requiring the understanding of the range of 
symptoms distressing to the dying patient. It would be difficult to select informants and 
then be confident that a complete picture was obtained. Therefore, randomisation of 
subjects with an adequate sample size was the preferred procedure. However, there were 
pragmatic considerations for the patient and professional carer samples, i.e. the patient 
selection required the veto of ward staff (a prerequisite condition from the units granting 
access) and the professional carer sample had to be obtained when their time schedule 
permitted; these made randomisation an unachievable target. Convenience sampling 
was thus adopted for the patient and professional carer samples. Although the weakest 
form of sampling, examination for sources of bias took place. Extraneous variables 
which may have biased the sample, such as length of time since qualification and years 
of palliative care experience (for professional carers) and demographic variables, such 
as age and gender, site of malignancy, for the patient sample were recorded. For the 
bereaved carer data source, a random sample was obtained, through one palliative care 
service.
Decisions regarding sample size were based on qualitative demands of saturation of data 
emerging from the interviews. It was anticipated that the sample size of around 50 in 
each sub-group would provide saturation, a sampling concept in qualitative research 
whereby data collection ceases when no new material or themes are being generated 
(Polit and Hungler, 1991; Morse, 1991a).
All subjects were required to give informed written consent and be over the age of 18 
years. Eligible patients were those with malignant disease, who were considered by the 
medical staff to have a life expectancy of less that 3-4 weeks and who were not 
receiving active, curative treatment but palliative care. Patients were excluded if they 
could not co-operate because of physical or mental impairment or who were, in the 
opinion of the nursing staff, unsuitable to participate for any reason (this screening of 
potential respondents was a requirement of senior staff granting access to data collection
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sites; it could be considered a form of gatekeeping and the implications are discussed in 
Chapter 8).
Professional carers were included if they were caring for patients dying of malignant 
disease. The professional carer sample were not necessarily those caring for the patients 
included in the study as the aim was not to compare assessment/reporting of symptoms 
in the data sources but to provide data regarding dying patients in general.
Bereaved persons were eligible if they had been carers of a person who had died of 
malignant disease at a minimum of six months (maximum of eight months) before the 
interview. Following discussion with bereavement experts, the time frame was selected 
reflecting the need avoid the initial acute reaction to the bereavement but not to allow a 
long gap after the event when memory effects may influence the data collected1. 
Subjects who, in the opinion of the bereavement service, were unsuitable for any reason 
were excluded.
5.2.2.3 Access and ethical considerations
Access to subjects was negotiated through individual institutions. Approval was 
obtained from each Unit's Consultant and Senior Nurse Manager.
Protocols were submitted to five Health Authority Ethics Committees for approval 
before commencing the study. Two Committees required that General Practitioners of 
patients who agreed to be involved were informed, despite the fact that they were in­
patients in a hospice or oncology unit and involved in a one-off interview study. 
Consent to inclusion in the study was sought after explanation of the aims of the project; 
an information sheet was given and informed written consent was obtained after 
allowing time for reflection and questions (Appendices 3 to 6). Subjects were able to 
withdraw at any time during the interview. Confidentiality and anonymity in any report 
were assured. A numbered participant list was kept separate from the data collected. 
Participants could not be identified on the tapes or on the transcripts.
1 It was recognised that reactions to bereavement are individual and subject to much variation. In the 
absence of empirical evidence regarding the most appropriate and reliable data collection time expert 
opinion was used.
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5.2.2A Instruments and procedure
The interview method was employed for data collection and the same researcher 
conducted all interviews. A semi-structured interview was used in all three groups to 
include the areas shown in Table 5-1. Qualitative studies do not usually employ 
structured interviews but are unstructured or semi-structured in order to reduce the 
potential bias and introduction of preconceived ideas about content (Morse, 1991b).
Table 5-1: Content guide for semi-structured interviews
PATIENT PROFESSIONAL CARER BEREAVED CARERS
How subject is feeling today
Follow up on any symptoms/ 
problems mentioned
Symptoms which are troubling 
them
Symptoms which they have had 
in the past which have been 
distressing
If there is a main/worst 
symptom
Length of time qualified
Past palliative care experience
Symptoms felt to be distressing 
to the dying in the last few days 
of life
Symptoms felt to be distressing 
to the dying in the unconscious 
phase before death
Show list o f symptoms and ask 
for comment on importance o f 
these symptoms in the dying 
patient
Symptoms felt to be distressing 
to relatives and professional 
carers at this end stage
How to care for the dying 
person who can no longer 
maintain an adequate oral fluid 
intake
Discomfort or symptoms which 
may arise from 1  oral intake 
and dehydration
Discomfort or symptoms which 
may arise from artificial 
hydration therapies
How dehydration should be 
treated in the dying
How fluid and electrolyte 
balance should be monitored in 
the dying
General introduction to the
person who
died
Nature and length o f the illness
At what stage and why the 
hospice became involved in 
care
Symptoms and problems o f the 
dying person in the last few 
weeks o f life
Symptoms and problems o f the 
dying person in the last few 
days o f life
If there was a main or worst 
symptom for the dying person
If there was a main or worst 
symptom for the bereaved 
carer (and why)
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The topic guide was developed from the need to identify symptoms causing distress to 
dying patients and those that may be caused by dehydration or artificial hydration 
therapies. Open-ended questions were used to introduce the topic and then more specific 
questions followed when the subjects identified symptoms. This approach was used in 
order to increase the comprehensiveness of the data collected and to produce a 
systematic procedure enabling some replication. However, a weakness of the semi­
structured approach lies in the possibility of omission of topics and the flexibility and 
variability in the sequence and wording of questions which may influence the responses 
obtained and decrease comparability (Patton, 1990).
The use of standardised questions was considered but this may reduce the naturalness of 
the interview and impose constraints, particularly in the patient and bereaved carer 
settings where the establishment of rapport and trust are essential; this may reduce the 
quality of data obtained. Therefore, an attempt was made to keep the sequence of 
questioning as similar as possible, to try to reduce any bias introduced in this manner.
Pilot studies were conducted with the three groups to standardise the introduction and 
consenting procedure, to test the recording equipment and to check the interview 
schedules for ambiguity and difficult questions. Three professional carers were 
interviewed and it was noted that subjects experienced difficulty in recalling symptoms 
which they felt were significant and stated that they would be able to think of many 
more after the interview. As a result, the interview schedule was revised to include a list 
of symptoms frequently used in other studies; subjects were initially asked about 
symptoms affecting the dying patient and were then given the list to comment on. No 
other difficulties were observed. Three patient and two bereaved carer interviews were 
included in the pilot study and these did not reveal any difficulties with the procedures.
Patient interviews took place on the wards, at the bedside or in side rooms as the 
patient’s condition and preference determined. It was important that patients determined 
as far as possible where the interview took place for their comfort and relaxation to be 
maximised. Although confidentiality was assured with respect to the handling of the 
data, privacy of the interviews carried out on the wards could not be assured and this is 
a limitation of the data collection procedure. Informed written consent was obtained 
after patients had time to consider their involvement and discuss this with their family if
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they wished. If participants agreed then the interview was recorded on audio-cassettes; 
if they objected to audio-recording then notes were taken during the interview. 
Additional information was recorded from the patients’ medical notes regarding 
demographic details of age, gender, disease site, and past treatments. Field notes were 
also taken immediately after the interviews to record contextual issues and observations 
made during the research encounters.
The researcher approached professional carers for written consent to an interview. 
Interviews took place away from the ward, in a side room or office. Interviews were 
recorded by audiotape and demographic details were recorded on a data sheet.
A random sample of bereaved carers (six-eight months post bereavement) was obtained 
from records of deaths over a two month period at one of the hospice units. 
Identification of potential subjects by bereavement service personnel may have 
introduced bias so a random selection was made (using random number tables) and then 
the list shown to a senior bereavement worker to exclude any thought to be unsuitable 
(for example, persons known to be suffering severe emotional distress or who were 
suicidal). No potential subjects were excluded at this stage. A letter of introduction was 
sent to potential subjects, explaining the nature of the study and informing them that a 
researcher would be telephoning them after a given time, and also offering them an 
opportunity to give written refusal with no further contact (Appendix 5). Bereaved 
carers who did not give written refusal were then contacted by telephone and visits were 
arranged if consent was given. This process was adopted in order to minimise the 
likelihood of distress caused by ‘cold’ calling at the door of a bereaved person (a 
technique used in a large national survey of the last year of life by Cartwright and Seale 
(1990)). However, Addington-Hall and McCarthy’s (1995) Regional Study of the Care 
for the Dying (RSCD) (based on the survey methods used by Cartwright et al (1973) 
and Cartwright and Seale (1990)), noted that the introduction of the letter into the 
methodology may have contributed to the reduced response rates obtained (80% 
obtained by Cartwiright and Seal (1990) compared with 69% in the RSCD). Addington- 
Hall and McCarthy (1995) reported anecdotal evidence from interviewers who worked 
on both surveys suggesting that receiving a letter caused more distress for some than a 
visit from an interviewer, as there was no opportunity to express anxiety immediately or 
for the interviewer to discuss concerns that they may have had about the research
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straight away. However, in this study a telephone number was given so that people 
could telephone if they wished to discuss concerns immediately and difficult ethical 
decisions, such as a trade-off between high response rates and possible minimisation of 
distress, sometimes have to be made.
Subjects were seen in their own home and written informed consent was obtained on 
arrival. A semi-structured interview was carried out in the subject’s home, with no other 
family members present where possible. Data was collected by audiotape of the 
interviews or hand-written notes, as previously discussed. Demographic details were 
recorded on a data collection sheet.
5.2.3 Data analysis
Data obtained from the recorded interviews were transcribed onto word-processor and 
then subjected to content analysis, a process for analysing the content and making 
inferences from the data (Weber, 1990). The computer package Ethnograph® was used 
in data handling to facilitate storage and handling of textual data.
5.2.3.1 Scheme for content analysis:
A process of content analysis as outlined by Krippendorff (1980) was employed.
1. Unitising: delineation of the portions of the transcripts to be coded. In this instance, 
the unit chosen was that of themes. A theme could be a phrase, sentence or 
paragraph containing material relating to symptom topics.
2. Categorising: development of a category system for classifying units of content. 
Categories should reflect the purpose of the research, be exhaustive, and be mutually 
exclusive and independent (Holsti, 1969 p.95). The main aim of the interviews was 
to investigate the symptoms that were believed to be of concern to dying patients. 
Therefore, transcripts were read to gain an overall picture of what subjects were 
describing in response to the question concerning which symptoms they considered 
distressing. The second reading was accompanied by annotation of the text, giving 
headings to symptoms that were identified. These headings were then developed and 
given category definitions (Appendix 7) and then applied to all transcripts. 
Categories were considered to be mutually exclusive (i.e. a unit of text could only 
be placed in one category).
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3. Quantification: the presence of categories in each interview transcript was recorded. 
Tables were then drawn concerning the frequency of category occurrence.
4. Reliability assessment of the coding scheme. If the reliability assessment is 
unsatisfactory then redefinition of categories and further testing of the scheme is 
necessary.
Descriptive statistics were used to explore and present the data.
5.2.3.2 Reliability o f coding
As with all research, consideration of reliability and validity is essential in order to 
allow confidence in the results obtained. Three types of reliability relate to content 
analysis: stability, accuracy, and reproducibility (Krippendorff, 1980). Stability refers to 
the extent to which the results of the content analysis vary over time and is tested when 
one coder repeats the analysis and the results are compared. This is a form of intra-rater 
reliability. For the purposes of this study assessment of stability was not considered 
appropriate as the coder may remember items previously coded and, as Weber (1990) 
suggests, this is the weakest form of reliability testing as only one person is coding. 
Accuracy refers to the extent to which the classification of text compares to a standard 
or norm (Weber, 1990); however, standard codings are infrequently available for texts 
and were not suitable for this analysis.
Reproducibility (referred to as inter-rater or inter-coder reliability) refers to the extent to 
which the coding schedule produces the same results when more than one coder codes 
the same text. High reproducibility is considered a minimum standard for content 
analysis (Weber, 1990). In this analysis inter-rater reliability was assessed by two raters 
(the researcher and an independent person (a nurse experienced in palliative care ) 
independently coding a random sample of 20 transcripts (15% of total sample) using the 
coding categories developed by the researcher. Consistency between the raters was then 
assessed.
5.2.3.2.1 Percentage agreements
Percentage agreement gives an estimate of inter-rater agreement by showing the 
proportion of occurrences when both judges make the same rating (Everitt and Hay, 
1992), however it is limited by the fact that it does not allow for the fact that some
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agreement between the two raters could be expected to occur by chance and as such 
may give an inflated estimate of agreement (Bakeman and Gottman, 1986; Brennan and 
Hays, 1992).
5.2.3.2.2 Cohen’s kappa
A further test of reliability, was established by computation of Cohen's kappa (Cohen, 
1960), a statistic which calculates the level of agreement which would have occurred 
excluding that by chance.
The critical assumptions for the kappa coefficient are (Pett, 1997):
1. That nominally scaled data are paired observations of the same phenomena (e.g. 
Observer 1 vs. Observer 2)
2. Observations are assigned to categories that are mutually exclusive and may or may 
not have order to them
3. The resulting agreement matrix is symmetric (equal number of rows and columns)
4. The judges operate independently (Cohen, 1960)
These criteria were fulfilled in this study. Kappa gives a ratio of the agreement adjusted 
for chance agreement (Cohen, 1960). Total agreement between the two raters would 
give a value for Kappa (K) of 1.0. If the proportion of agreement is equal to that 
expected by chance alone the value of K returned would be 0. There are two approaches 
to assessing the kappa statistic: testing its level of significance (Bakeman and Gottman, 
1986) and evaluating its magnitude (e.g. Fleiss, 1971). As Pett (1997) suggests, 
although a significant test would indicate that the agreement between observers is 
significantly greater than would be expected by chance, the statistic does not indicate 
strength of agreement; however, there are no strict guidelines for the assessment of 
magnitude of kappa. Fleiss (1971) indicates that kappas of 0.40 to 0.60 are fair, 0.60 to 
0.75 are good and values greater than 0.75 indicate excellent agreement between raters.
5.2.3.2.3 Reliability assessments
Percentage agreement between the researcher and the independent rater were 96%. The 
kappa scores showed excellent agreement with a coefficient of agreement: K = 0.97. 
The substantial levels of agreement as assessed by percentage agreements and kappa 
scores suggest that the coding scheme could be considered reliable.
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5.2.3.3 Validity o f coding
Weber (1990) distinguishes between the validity of the classification system and the 
validity of the interpretation of the content variables. As the data collected were being 
analysed for distressing symptoms experienced by the dying cancer patient, 
consideration of the validity of the classification system is discussed.
Face validity concerns the correspondence between definitions of concepts measured 
and definitions of the categories that measure them (Weber, 1990). This was assessed 
by giving two expert palliative care clinicians the coding definitions and checking 
whether they felt this was representative of the symptoms occurring in the patient 
population. The independent raters considered the coding representative.
5.2.4 Results
Data was obtained from three data sources, 49 patients, 60 professional carers and 30 
bereaved relatives. The results will be presented for each sample.
5.2.4.1 Patient sample characteristics
Forty-nine patients from three hospice units and two general hospital oncology units 
agreed to participate in the study giving a 65% response rate. The majority of refusals 
were because patients felt too unwell (17); some stated that they did not want to be 
involved in research (2) or that visitors were expected (2) and refused the invitation for 
the researcher to return at a more convenient time. The mean age of the sample was 65 
years; 25 were male and 24 were female. All patients had diagnoses of malignancies, 
the commonest being lung cancer and gastro-intestinal cancer; 69% of the sample had 
metastatic disease.
Accrual into the study was time-consuming due to the seriously ill nature of the sample. 
The inclusion criteria of a life-expectancy, as assessed by medical staff, of less than four 
weeks was not easy. Although this was accurate in nearly three-quarters of the sample 
some patients were missed. Additionally, as many were so weak and close to death it 
was often difficult to find a suitable time to interview them (e.g. when they had enough 
energy, not being visited by friends/family or being attended to by staff). This increased 
the time required for the completion of the data collection.
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The length of time from admission to time of interview ranged from 1 to 56 days. Time 
elapsing between interview and the patients' death ranged from 1 to 124 days with a 
mean time span of 15 days (SD 22.3). Seventy-two percent of the sample died within 
one month of the interviews. Twenty patients were from the two oncology units, within 
general hospitals, and 29 patients from the three hospice units. As the results from this 
sample were to be pooled, a comparison of demographic details was made to check for 
any major differences between the groups (Table 5-2); the sample from the general 
hospitals had a significantly lower mean age than the hospice group (p = 0.015) and the 
hospice group had more subjects with lung and gastro-intestinal primary cancers.
Table 5-2: Demographic and medical characteristics of patient sample
Hospice Hospital
Oncology
Total
Sample size 29 20 49
Age: range (years) 42-90 36-81 36-90
mean (years) 69 59 65
standard deviation 13.3 14.9 14.7
Sex: male 16 9 25
female 13 11 24
Site of primary malignancy:
lung 10 3 13
gastro-intestinal 10 6 16
genito-urinary 4 5 9
breast 1 4 5
unknown primary 2 2 4
other 2 0 2
Metastatic disease 19 15 34
Time from admission to interview:
range (days) 1-56 1-27 1-56
mean (days) 13 11 12
Time from interview to death:
range (days) 1-124 1-80 1-124
mean (days) 14 15 15
standard deviation 24.0 20.2 22.4
< 4 weeks 20 13 33
> 4 weeks 7 6 13
missing data 1 2 3
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Thirty-six respondents consented to the tape recording of interviews. Those not willing 
to be taped gave reasons such as not being able to think quickly enough (1), not liking 
to be recorded (4) or just refusing to be taped (2). Five patients were unable to be 
recorded because of symptoms (e.g. too painful to talk (1), severe shortness of breath 
(2), voice too weak because of deterioration (2)). Notes were taken from these patients 
at the time of interview.
Interviews took between five and forty-five minutes; the average interview time was 
twenty-five minutes. No respondents chose to withdraw once the interviews 
commenced. Some subjects used the opportunity to talk about issues other than those 
covered in the interview, and shared considerably more of their experiences than 
required. Interviewing dying patients about their symptom experience was at times 
emotional for both the respondent and researcher as it appeared, for some, to elicit 
feelings of loss and coping with advancing disease and approaching death. This was 
acknowledged by the researcher allowing time for the expression of emotion, crying and 
changing topics of discussion for a while if the participant wished. Consent to continue 
with the interview was always sought if participants became upset. This form of process 
consent as opposed to one-off consent at the beginning was considered ethically 
important. On the whole respondents commented on the value of being able to discuss 
their situation.
Interview transcripts were analysed for the symptoms reported by patients as distressing 
to them. Pain, fatigue and anorexia were reported by over 40% of patients. Table 5-3 
indicates the main symptoms described by patients.
Subjects were asked if there was one symptom that was worse than the others were or 
which was the main cause of distress. Of the 37 who reported a main distressing 
symptom, 7 (19%) reported fatigue, 5 (14%) reported pain and 5 (14%) weakness.
In the literature relating to cancer, fatigue (also known as asthenia) is known to be one 
of the main distressing symptoms (World Health Organisation, 1990). However, a 
common difficulty encountered is that there are no clear unequivocal definitions of 
fatigue (Piper, 1993; Glaus, 1996; Neuenschwander and Bruera, 1998).
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Table 5-3: Frequency of symptoms reported by patients to cause them distress
Symptom Frequency (n = 49) %
Pain 34 69.4
Fatigue 24 48.9
Anorexia 20 40.8
Nausea 18 36.7
Vomiting 16 32.7
Dry mouth 16 32.7
Difficulty with breathing 16 32.7
Drowsiness 13 26.5
Weakness 13 26.5
Fear 11 22.4
Constipation 10 20.4
Concentration 8 16.3
Low mood 8 16.3
Lack of mobility 7 14.3
Mouth: infection 6 12.2
sore 6 12.2
Dysphagia 6 12.2
Anxiety 6 12.2
Diarrhoea 5 10.2
Loss o f interest 5 10.2
Bleeding 5 10.2
Thirst 4 8.2
Sleeplessness 3 6.1
Body image 3 6.1
Loss o f independence 3 6.1
Taste changes 3 6.1
Incontinence 2 4.1
Cough 2 4.1
Dizziness 2 4.1
Swollen abdomen 2 4.1
Swelling of limbs 2 4.1
Itch 2 4.1
Tremor 1 2.0
Numbness 1 2.0
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The concept of fatigue may include phenomena such as tiredness, drowsiness, and poor 
concentration and these could be seen as indicators or consequences of fatigue. Fatigue 
is often defined as “extreme tiredness” (Glaus, 1996). However, related phenomena 
such as weakness and lack of energy are sometimes incorporated into definitions (e.g. 
Neuenschwander and Bruera, 1998), and, indeed, in this study patients appeared to be 
using different terms, such as tiredness, weakness and lack of energy to describe related 
sensations.
5.2.4.2 Professional carers sample characteristics
Sixty professional carers consented to participate giving a response rate of 80%. Lack of 
time (in 11 cases) accounted for most of the refusals. Twenty-seven (45%) were 
working on 2 oncology units in general hospitals and 33 (55%) were working in the 3 
hospice units. Table 5-4 shows more detailed characteristics of this sample.
Table 5-4: Characteristics of professional carer sample
Hospices General hospital oncology 
units
Nurses (n) Ward sister 4 Ward sister 3
Staff nurse 25 Staff nurse 18
Doctors (n) Registrar 2 SHO* 4
Consultant 2 HO* 2
Total sample (n) 33 27
Years qualified:
range 3-38 1-15
mean 12 4
*SHO = Senior House Officer 
*HO = House Officer
Fifty-eight interviews were recorded by audiotape. One person refused to be taped and 
recording equipment failure accounted for the other written transcript. Interview length 
ranged from 15-50 minutes (with a mean duration of 30 minutes).
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The content of the professional carer transcripts was initially analysed for symptoms felt 
to be distressing to patients in the last few days of life and then particularly in the 
unconscious phase. Additionally, symptoms thought to be attributable to dehydration or 
artificial hydration therapies in the dying were noted.
Table 5-5: Frequency of symptoms thought to be distressing to patients in their last 
days of life as reported by professional carers
Symptoms Frequency (n = 60) %
Pain 56 93.3
Nausea 28 46.6
Vomiting 23 38.3
Difficulty with breathing 16 26.7
Fear 15 25
Dry mouth 11 18.3
Constipation 10 16.7
Restlessness 10 16.7
Confusion 10 16.7
Anxiety 9 15.0
Anorexia 8 13.3
Chestiness 6 10.0
Weakness 5 8.3
Fatigue 5 8.3
Incontinence 5 8.3
Dehydration 5 8.3
Changes in body image 4 6.6
Diarrhoea 4 6.6
Pressure sores 4 6.6
Agitation 4 6.6
Cough 3 5.0
Dysphagia 3 5.0
Stiffness 2 3.3
Loss of independence 2 3.3
Low mood 2 3.3
Odour 2 3.3
Twitching 1 1.6
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Table 5-5 shows that professional carers most frequently cited pain, nausea, vomiting 
and difficulty with breathing. A comparison of symptoms actually reported by patients 
and those thought to be distressing by professional carers (Table 5-6, p.87) indicates 
some differences. For example, fatigue was not a symptom commonly proposed by 
professional carers as causing distress (8.3%) whereas nearly half of the patient sample 
(48.9%) reported fatigue and this was most frequently cited as the main source of 
distress (14%). Similarly, anorexia was reported less frequently by professional carers.
It must be remembered when making such comparisons that the professional carers 
were not reporting symptoms present in the patient sample itself, but were considering 
dying patients in general.
Professional carers were shown a list of commonly reported symptoms taken from 
studies of cancer patients and asked if they felt that any were less important to the dying 
patient in the last few days of life. Table 5-7 (p.88) shows that over one third of the 
sample felt that anorexia was less important to the dying patient, although interestingly 
many commented that they felt that this was more distressing to the family than to the 
patient. More than one fifth of the sample felt that weakness, odour, poor concentration, 
and decreased mobility were less important. Data is reported for 51 of the professional 
carers in this section as, in nine cases, the interviews were terminated prematurely as 
respondents had to attend to telephone calls, bleeps or ward situations and could not 
return to interview situation.
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Table 5-6: Frequency of symptoms reported by patients and 
professional carers to cause distress.
Sym ptom Patients 
(n =  49) %
Professional 
carers (n = 60) %
Pain 34 69.4 56 93.3
Fatigue 24 48.9 5 8.8
Anorexia 20 40.8 8 13.3
Nausea 18 36.7 28 46.6
Vomiting 16 32.7 23 38.3
Dry mouth 16 32.7 11 18.3
Difficulty with breathing 16 32.7 16 26.7
Drowsiness 13 26.5 0 0
Weakness 13 26.5 5 8.3
Fear 11 22.4 15 25.0
Constipation 10 20.4 10 16.7
Concentration 8 16.3 0 0
Low mood 8 16.3 2 3.3
Lack of mobility 7 14.3 0 0
Mouth: infection 6 12.2 0 0
sore 6 12.2 0 0
Dysphagia 6 12.2 0 0
Anxiety 6 12.2 9 15.0
Diarrhoea 5 10.2 4 6.6
Loss of interest 5 10.2 0 0
Bleeding 5 10.2 0 0
Thirst 4 8.2 0 0
Sleeplessness 3 6.1 0 0
Body image 3 6.1 4 6.6
Loss of independence 3 6.1 2 3.3
Taste changes 3 6.1 0 0
Incontinence 2 4.1 5 8.3
Cough 2 4.1 3 5.0
Dizziness 2 4.1 0 0
Swollen abdomen 2 4.1 0 0
Swelling o f limbs 2 4.1 1 1.7
Itch 2 4.1 0 0
Tremor 1 2.0 0 0
Numbness 1 2.0 0 0
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Table 5-7: Symptoms which professional carers feel are less important to dying 
patients in the last few days of their life.
Symptom Frequency(n = 51) %
Anorexia 18 35.3
X mobility 12 23.1
Pressure sores 11 21.2
Odour 11 21.2
Weakness 10 19.2
Concentration 10 19.2
Sleeplessness 9 17.3
Drowsiness 9 17.3
Constipation 8 15.4
Tiredness 7 13.5
Twitching 7 13.5
Restlessness 6 11.5
Incontinence: bladder 6 11.5
bowel 5 9.8
Depression 4 9.6
Tables 5-8 and 5-9 indicate symptoms thought to be attributable to dehydration and 
artificial hydration therapies by the professional carers. It can be seen that dry mouth 
and dry skin were the most frequently symptoms associated with dehydration. Dry 
mouth was mentioned by over eighty percent of the sample, whereas only 22% felt that 
thirst was a distressing symptom attributable to dehydration. Symptoms associated with 
fluid overload were most commonly attributed to the use of AHT.
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Table 5-8: Symptoms causing distress that may be attributable to dehydration,
reported by professional carers.
Symptom
Frequency 
(n =  58) %
Dry mouth 47 81
Dry skin 21 36.2
Thirst 13 22.4
Sore mouth 9 15.5
Itching 7 12.1
Infection of mouth 5 8.6
Confusion 3 5.2
Urine infection 3 5.2
Catheter blocking 3 5.2
Restlessness 3 5.2
Twitching 3 5.2
Pyrexia 3 5.2
Fatigue 2 3.5
Table 5-9: Symptoms causing distress that may be attributable to artificial 
hydration therapies, reported by professional carers.
Symptom Frequency (n =  59) %
Fluid overload: 22 37.3
pulmonary oedema 19 32.2
peripheral oedema 13 22.0
incontinence 16 27.1
T catheterisation 7 11.9
Chestiness 8 13.6
Cannulation:
pain 22 37.3
^ mobility 7 11.9
inflammation 7 11.9
Vomiting 4 6.8
Restlessness 2 3.4
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5.2.4.3 Bereaved carers sample characteristics
Thirty bereaved carers of patients dying under the care of one hospice unit consented to 
be included in this study. Sixty were approached by letter (following random selection 
from records of deaths) but 17 could not be contacted by telephone; of the 43 contacted 
personally 13 refused, giving a response rate of 69%. Reasons for refusal were mainly 
because the person felt too upset to talk about the death (7). Three respondents refused 
to allow the interview to be taped and notes were taken.
Twenty-two of the respondents were female and eight were male. Fifteen (50%) of the 
respondents were spouses of the deceased, 8 were children and 2 were siblings. The 
time between the death of the patient and the interview with the bereaved carer ranged 
between 6 and 8 months.
Interview length ranged from % hour to 3% hours with an average length of 1 Vz hours. 
The early part of the interaction was spent in attempts to gain rapport with the subject 
before commencing on a potentially upsetting interview. Emotional distress was 
provoked in the majority of interviews but many of the subjects expressed relief and 
satisfaction about being able to talk about the death of their loved one.
Interview transcripts were analysed for symptoms felt to be distressing to the patient in 
the last few days of life and distressing for the carer. Table 5-10 shows that over 50% of 
bereaved carers reported pain, anorexia and drowsiness as being a major source of 
distress to the dying patients. It is difficult to know how much this figure represents real 
distress to patients or how much it is influenced by the bereaved persons’ memory of 
what they found most distressing.
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Table 5-10: Symptoms reported by bereaved carers to be distressing
to dying patients
Symptom Frequency (n = 30) %
Pain 26 86
Anorexia 20 67
Drowsiness 15 50
Weakness 13 43
Difficulty with breathing 12 40
Confusion 12 40
Dry mouth 11 37
Constipation 7 23
Fatigue 5 17
Oedema 4 13
Nausea 3 10
Vomiting 3 10
Anxiety 3 10
Dysphagia 3 10
Thirst 2 7
Low mood 2 7
Loss of independence 2 7
Mouth: infection 1 3
sore 1 3
Diarrhoea 1 3
Sleeplessness 1 3
Body image 1 3
Odour 1 3
5.2.5 Discussion
The aim of this study was to identify symptoms distressing to the dying cancer patient. 
This information could then be used to consider measurement of symptom distress and 
issues related to management strategies for terminal dehydration. As such, multiple data 
sources were used in order to increase the understanding of symptom distress in the 
dying patient as experienced by the patient, and perceived by the professional carer and 
non-professional carer/family member. Professional carers were used to examine 
symptoms thought to be related to dehydration in the dying.
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The results of the patient interviews indicated a diversity in symptoms experienced and 
those reported to cause distress by bereaved and professional carers; this is supported by 
work such as Coyle et al (1990) which identified 44 different symptoms affecting the 
dying. The presence of a symptom did not always mean that the patient reported it as 
causing concern or difficulty. For example, a forty-five year old lady with three leaking 
abdominal fistulae and ascites stated that she had no problems causing her distress or 
difficulty and expressed a very positive attitude towards life and the hospital she was in, 
despite appearing to have severe symptoms. Whilst acknowledging disruption and 
altered body function and sensation, this patient did not describe these as symptoms 
when asked about her symptom experience. This emphasises the highly individual 
nature of the experience of symptoms and concurs with Rhodes and Watson (1987) and 
Lenz et al (1995, 1997) who suggest that symptoms need to be assessed separately for 
occurrence and the amount of physical or emotional upset or suffering the person 
experiences as a result of that symptom. In addition, this strongly supports the argument 
that assessment of symptom distress should be subjective and that symptoms need to be 
understood within the context of what meaning the symptoms have for the individual 
experiencing them (Good and Delvecchio Good, 1981; Kleinman, 1988).
Much information was obtained during the patient interviews which was in excess of 
the requirements of the study. Patients appeared to welcome the opportunity to discuss 
areas concerning their illness and life events. Many patients were able to articulate their 
perceived source of difficulties and worries (such as fear of the future, fear of dying, 
concerns about family members, loss of independence). At this stage it has been 
important to limit analysis of the transcripts to areas pertinent to the research objectives, 
despite the temptation to explore the rich data obtained in other areas. However, future 
analysis of the data may provide additional information about other areas that may 
prove to be of interest in understanding the patients’ experience.
The sample of patients involved may not be truly representative of the total population, 
as many patients were not accessible to the researcher. Reasons for this included ward 
nurses protecting certain patients (e.g. because they felt that an interview would be too 
distressing) or because symptoms actually prevented the subject being approached (e.g. 
severe dyspnoea, vomiting). The sample then can be said to be representative only of 
patients believed to be suitable for interview so that certain symptoms may have been
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missed or under-represented. This indicated the need for consideration of other findings, 
as well as these results, in the scale development.
The sample of professional carers was able to identify symptoms that they felt caused 
distress to the dying patient but frequently stated that they were concerned that they 
were forgetting important symptoms because of the constraints of the interview. Only 5 
symptoms were reported by more than 25% of the sample, perhaps supporting this 
concern. The results from this sample need then to be interpreted with caution and again 
certain symptoms may be under-represented because of memory effects and the 
interview itself. The introduction of the list of symptoms, in an attempt to increase 
recall, may have introduced bias; however this was given after the main body of the 
interview and therefore should not affect the data obtained during the earlier stages.
It was interesting that some professional carers (4) felt that pressure sores were a 
distress to patients and cited them as a symptom rather than the pain or discomfort they 
caused. Similarly, five professional carers stated that dehydration was a distressing 
symptom and did not elaborate further. As these terms had been introduced by 
respondents they were included on the checklist, however, it is recognised that they are 
not symptoms as defined in the previous discussion (Chapter 2). Such individuals 
appear to be describing conditions or problems that may contribute to distressing 
symptoms (or as in the case of reduced mobility describing a functional consequence of 
a symptom) rather than the symptoms themselves. It may be that some professionals do 
not have a clear concept of what a symptom is. Rhodes et al (1998) suggest that 
objective signs and subjective symptom assessment can be confused by clinicians.
Ninety-six percent of professional carers reported pain as a distressing event to dying 
patients and this extremely high figure may be disproportionate to the actual occurrence 
of the symptom. For example, Twycross (1972) suggests that most patients with cancer 
do not suffer pain. Similarly, Saunders (1989) noted that pain was adequately relieved 
in the majority of dying patients. Of course it may be that, when pain is present, it is 
extremely distressing in the majority of patients and the respondents were responding to 
a perception of the possibility of pain rather than to its actual occurrence or incidence. 
Obviously professional carers were asked about symptoms causing distress and not how 
frequently they felt that they occurred; perhaps if this question had been added the 
results could be interpreted in a more meaningful manner. This point is raised to express
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caution in interpreting the symptoms noted by professional carers, in this part of the 
study, as indicative of the actual symptom experience of the patients included.
Comparison of symptoms reported by patients as causes of distress and those suggested 
by professional and bereaved carers revealed differences. Fatigue was a source of 
distress in half of the patient sample whereas only 8% of professional carers felt that it 
was important and 17% of bereaved carers identified it as a source of distress to the 
patient. Similarly, over a third of professional carers felt that anorexia was less 
important in the dying patient whereas 40% of patients cited it as a source of distress. It 
may be suggested that the less tangible symptoms cannot be accurately interpreted or 
recognised by outsiders and that only the patient can be the judge (Neugarten et al, 
1961; Rhodes and Watson, 1987). This stresses the importance of investigating the 
symptom experience of the patient and not relying on studies which use a predetermined 
set of symptoms (e.g. Hinton, 1963; Cartwright and Seale, 1990) and of comparing 
carers’ and patients’ perceptions.
Three quarters of the patient sample died within one month of the interview, indicating 
that staff were able to identify patients in the end stages of their disease with some 
accuracy. However, the mean length of time from interview to death was 15 days and it 
may be that comparison of symptoms reported by patients and professional carers is not 
particularly accurate since professional carers were asked to consider the last few days 
of life. So it may be that the point in the dying trajectory described by professional 
carers was not the same as that experienced by the patients. As it was not possible to 
follow patients longitudinally it can only be speculated whether the symptoms described 
by the patients would continue to be the main sources of distress or whether they would 
change with time. This highlights the need for careful validation of any scale developed 
for use in dying patients.
Symptoms identified by bereaved carers did not differ significantly from those 
identified by patients and professional carers. Again, the most frequently noted 
symptom was pain (86%), and this is reflected in the survey of bereaved carers by 
Cartwright (1991) who cited pain most often. The results presented here also broadly 
concur with the findings of Addington-Hall et al (1991). In interviews with 80 bereaved 
carers, anorexia, breathlessness, constipation, and pain were the most commonly 
reported symptoms in the patient’s last week of life.
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It may be suggested that the bereaved carer accounts, 6 to 8 months after the event, are 
subject to unreliability due to memory loss or that the person is accounting their own 
distress and not the actual experience of the patient. Twenty-two symptoms were noted 
in total from the bereaved carers indicating, perhaps, that they were able to remember in 
some detail. The importance of the memory of symptom distress in the minds of the 
bereaved is an area for further investigation.
Concern regarding the quality of data collected using the retrospective approach for care 
of the dying has been raised as little is known about how the data diverges from the 
actual events that took place or effects of bereavement on what the respondent 
remembers and judges (Higginson et al, 1994). Hinton (1996), in a longitudinal study of 
71 dying patients and their carers, found that bereaved relatives retrospective views of 
symptoms (particularly pain, anorexia and depression) had less congruency when 
compared with patient assessments or relative assessments made while the patient was 
alive. Additionally, differences may be found in relation to the nature of the respondent 
to the deceased (e.g. a respondent who did not have close contact with the deceased may 
have less knowledge about their symptoms and there is some evidence that children of 
the deceased may take a more negative view than other respondents (Cartwright and 
Seale, 1990 ).
However, with regard to the aim of the study (i.e. that of generating knowledge to be 
used in developing a measure of symptom distress for use in the dying), the inclusion of 
the bereaved as a data source is supported by the knowledge that the way a person dies 
lives on in the memory of the deceased (Saunders, 1989); it is, therefore, important to 
consider symptoms that are significant to them as well as to the patient. After all, the 
discrepancies seen may both be reflecting different aspects of the patient’s dying.
The symptoms described by professional carers that were felt to pertain to dehydration 
in the dying patient support the prevalent attitudes towards this state found in the survey 
in Chapter 3. For example, in the survey, nearly two thirds of clinicians experienced in 
observing terminal dehydration untreated with artificial hydration therapies (AHT), 
mainly from hospice or oncology settings, disagreed that dehydration causes apathy and 
depression and 83% disagreed with the statement that dehydration causes pain. In the 
current study no clinicians reported these symptoms as arising as a consequence of 
terminal dehydration. Similarly, only 22% of clinicians reported thirst as a distressing
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symptom associated with terminal dehydration in the current work and more than two 
thirds of the survey sample supported the attitude that dehydrated dying patients rarely 
complain of thirst.
With respect to attitudes towards the consequences of using AHT in dehydrated dying 
patients, the two studies concurred again thus supporting the validity of the findings. 
Consequently, clinicians in the current study recognised that AHT could contribute to 
symptoms of fluid overload (e.g. incontinence, chestiness and breathing difficulties) and 
many of those from hospice and oncology settings in the survey supported statements 
that demonstrated attitudes indicative of this.
These findings support the argument that in order to address meaningfully the 
management issues associated with terminal dehydration, assessment of symptom 
distress is prerequisite. The knowledge generated from this work, both including and 
emphasising symptoms related to terminal dehydration and its treatment with AHT, 
serve as a basis to confirm the utility of existing tools or to develop a new one.
5.2.5.1 Reliability and validity issues
The initial design of the study included the patient's primary carer (non-professional) as 
a data source. However, early pilot interviews with three carers indicated that the 
impending death of the patient was such a distressing event that the carer found it 
difficult to consider symptom distress as a separate issue from the whole dying 
experience; the interviews were causing distress to both the subject and researcher. In 
response to this the research design was altered to include bereaved carers.
The interview as a data collection method is based on the assumptions that the 
perspective of others is both meaningful and accessible (i.e. it can be made explicit). 
The accessibility of the information is dependent both on the interviewer and the 
interviewee. Issues surrounding the reliability and validity of the data gained through 
these interviews are considered as there are many potential sources of error in this 
process.
Reliability is concerned with the consistency and reproducibility of the subjects' 
(informants) accounts (Selltiz et al, 1976) and of the researcher's ability to collect and 
record the information accurately. Audiotaping of the interviews was carried out in
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order to overcome unreliability introduced through reliance on the researcher’s memory, 
to permit independent examination of the transcripts and to reduce the loss of detail that 
may occur if reliant on hand-written notes at the time of the interview. This process 
contributes to the notion of credibility or confidence in the truth of the data (Lincoln and 
Guba, 1985). However, in 13 patient interviews, 2 professional carer and 3 bereaved 
carer interviews, audiotaping was not possible. In these cases, where note taking was 
unavoidable, the researcher attempted to note as much information as possible but it is 
recognised that some data may have been missed or that misinterpretation or 
misrepresentation of symptoms may have occurred through the note taking process.
A further consideration of reliability or dependability (Lincoln and Guba, 1985) 
concerns the stability of the findings over time. Brink (1991) suggests that interviewers 
could ask equivalent/alternate forms of the same question to see if respondents give the 
same information, or use repeated interviews and compare responses given. The latter 
technique could only be used if one was investigating constructs that do not change over 
time. The use of equivalent forms of questions was thought to increase interview length 
beyond the limits of some subjects and therefore verification of the truth or accuracy of 
the data was not possible. A form of methodological triangulation using, for example, 
patient's notes to verify symptoms present could have been employed. However, it 
would be difficult to know if differences occurred because of patient's incomplete 
reporting or the inaccuracy of medical/nursing records as authors such as Jacox et al 
(1994) and Kookier (1995) suggest that patients frequently do not report symptoms 
spontaneously and Coyle et al (1991) that a symptom checklist may increase reporting 
when compared with spontaneous patient reporting. Similarly, Ng and van Gunten 
(1998), in a survey of 100 patients admitted to a palliative care unit, found a difference 
in the symptoms reported in charts as opposed to the frequency reported by patients 
during a structured interview. With the exception of pain and confusion/mental changes 
other symptoms were reported more frequently during the structured interview than 
were found on patient charts. An alternative strategy could have been to compare patient 
reports with nurse/doctor reports. However, there is considerable evidence indicating a 
lack of consistency of symptom assessment between patient and professional carer (e.g. 
Camp, 1988; Holmes and Ebum, 1989; Peruselli et al, 1992; Larson et al, 1993; Rhodes 
et al, 1998). In addition, the objective was to identify symptoms of distress to the patient 
and not actual symptoms occurring so that verification may not be essential.
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Identification of potential sources of bias that may have affected subject responses was 
carried out. A reflective approach was adopted, whereby interview tapes were replayed 
after the interview to note methodological problems such as missed cues, ambiguous 
and leading questions. The introduction of the researcher to subjects as a nurse may 
have been a source of bias. It was felt that it was important for patients and bereaved 
carers to know the background of the researcher as this might aid the establishment of 
trust and give permission to talk about 'personal' and medical/nursing problems. This 
was thought to be particularly valuable in the situation of a one-off interview, where 
there is little time for the researcher and subject to become acquainted. However, this 
may have had the effect of reducing honesty in responses because of social desirability - 
the subject may have felt obliged to say what he/she thought the researcher wanted to 
hear, as a member of the nursing profession. It may have been interesting to use a non­
nurse interviewer and compare results but time and financial constraints did not allow 
this.
Another consideration concerns three interviews with bereaved carers, where other 
relatives requested to be present at the interviews. The presence of another family 
member during an interview may have affected the information given by the primary 
informant (e.g. the informant may have omitted certain details for fear of upsetting the 
other). Where the second family member intervened and expressed disagreement with 
the account from the first, the 'key' subject was used. The decision was taken to include 
these interviews in the data set, as exclusion may have introduced bias in itself, and 
Bradbum and Sudman (1978), in a large survey of factors affecting interview data, 
found that the presence of others at the interview did not have a significant effect on the 
findings obtained.
A final methodological consideration is that of the effect of the researcher on the 
subject's responses. Although in both the patient and bereaved carer interviews it was 
made explicit that the interview was for research purposes, and not a therapeutic 
intervention, the effect of being listened to may have influenced the responses given. 
Other techniques would, perhaps, have different weaknesses. Interaction bias may be an 
inevitable part of the interview process as it is not a sterile question and answer session 
but a complex human interaction (Patton, 1990). This highlights the importance of not 
relying on interview data as the only research method. The results obtained will be used
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in conjunction with the literature; further research is then required to validate these 
findings.
Transferability, a concept equating with the generalisability of the quantitative approach 
(Polit and Hungler, 1991), is gained through data collection from a sample 
representative of the whole population. However, as discussed earlier, two of the 
samples were limited by non-random selection and this may have introduced bias in the 
selection. The results need to be interpreted with caution. Qualitative methods function 
to explore and identify concepts and thus the results require validation through further 
testing.
5.2.6 Comment
This qualitative study has identified symptoms causing distress in patients with 
malignancy at the end of life. This work has not elicited information regarding the cause 
of the symptoms or the nature of factors contributing to distress. Rather, it was explicit 
in its aims to identify symptoms experienced at the end of life, in order to consider the 
suitability of existing measurement scales for the assessment of symptom distress with 
particular reference to symptoms concerning terminal dehydration. This study has 
demonstrated the unique symptom experience of individuals and, due to the subjectivity 
of symptom distress, supports the need for a self-reporting measurement approach. The 
next section will discuss scale development.
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5.3 Part 2: Development of a measurement instrument
5.3.1 Frame of reference
A frame of reference is an abstract conceptualisation that places a study within a context 
of meaning and forms a way of viewing and interpreting the phenomena under 
investigation (Bums and Grove, 1987). This work now concerned investigating methods 
to measure symptoms and the distress they cause in order that the appropriate care may 
be given to the dying patient.
Measurement is a fundamental activity of science. The variables with which science is 
concerned must be adequately measured before the relationships between them can be 
studied in detail (Nunnally and Bernstein, 1994). Measurement scales are collections of 
items intended to reveal levels of a theoretical variable not readily observable by direct 
means (DeVellis, 1991). The underlying construct that a scale is intended to reflect has 
been termed the latent variable (DeVellis, 1991). The latent variable being considered 
here is that of symptom distress. Thus the research endeavour needs to focus, for the 
present, on measurement issues.
The determination of the scientific usefulness of a measure is a major factor in scale 
development and evaluation. The discipline of psychometrics has developed in the 
fields of psychology and sociology, in response to the challenge of creating raw data 
from observations that mostly are expressed in words rather than the dimensional data 
often used in laboratory tests (Feinstein, 1983). A frequent goal is the construction of 
rating scales or indexes that resemble dimensional scales used in other forms of 
scientific measurement.
Traditionally, there are two main goals involved in developing indexes for 
psychological and social testing (addressed in the discipline of psychometrics). These 
are establishing the “reliability” of a scale (i.e. the repeatability or generalisability of a 
measure) and the estimation of measurement error, and establishing “validity” 
(Nunnally and Bernstein, 1994). Reliability is necessary but not, in itself, sufficient for a 
measure to have validity. Validity is the other main measurement issue; this is a multi­
faceted concept concerning the assessment of an instrument's ability to do what it is 
intended to do (Nunnally and Bernstein, 1994). Both reliability and validity contribute 
to the generalisability of a scale, that is the extent to which an instrument can be used
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with confidence in populations it is designed for. It is suggested that the rigorous 
statistical testing applied to psychometric measures in order to validate them is aimed at 
standardisation as a goal in science.
Feinstein (1987) challenges the use of the pure psychometric approach in health and 
illness measures. He suggests that the basic scientific goal in clinical measurement is 
sensibility, what he terms ‘enlightened common sense’ (Feinstein, 1987 pl44), which 
combines qualitative assessments with the quantitative measures of reliability and 
validity. The importance of establishing reliability and validity for measurement 
instruments is not undermined by this argument. Rather the contribution of a further 
dimension on which to judge the usefulness of rating scales is proposed. Thus, when 
considering the development and testing of a measure to assess symptom distress, it is 
argued that it will be important to balance the, often statistical, assessment of the 
attributes of reliability and validity with more intuitive, qualitative and diverse 
assessments of how sensible the measure is, in the clinical and research arena for which 
it is intended.
A framework for the measurement issues concerning symptom distress is outlined in 
Figure 5-1.
Feinstein’s clinimetric theory starts from the premise that every measurement 
instrument has a purpose, demonstrated by its clinical function and by the justification 
of its existence (Feinstein, 1987). The literature review (Chapters 2 & 4) has shown that 
no measurement instruments have been developed or validated for use in a population 
of dying cancer patients, or which match the intended purpose of investigating symptom 
distress related to issues of terminal dehydration. Existing instruments are either 
validated for populations earlier in their cancer disease trajectory or measure symptom 
occurrence and severity rather than distress, which has been identified as a distinct 
concept (e.g. Rhodes and Watson, 1987; Lenz et al, 1997). This serves as a justification 
for the need to develop a measuring tool for the purpose of measuring symptom distress, 
in clinical practice and research settings, related to terminal dehydration. The next 
sections deal with steps in this process and have been informed by guidelines for scale 
development (Feinstein, 1987; Streiner and Norman, 1989; DeVellis, 1991).
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Figure 5-1: Outline of Measurement Issues Concerning Symptom Distress
LATENT VARIABLE
Independent variables [symptom distress]
which may affect 
latent variable e.g.
terminal dehydration ▼
SYMPTOM DISTRESS SCALE
scientific  Usefulness
II
RELIABILITY >  VALIDITY
i
GENERALISABILITY
5.3.1.1 Generation o f item pool
The process of scale development requires the selection of items to be included. The 
construct of symptom distress has been discussed (Chapter 4) and the literature, theory 
and current empirical data were used to inform the choice of component variables. A 
pool of possible symptoms to be used was generated from the results of 3 data sources 
(patients, bereaved and professional carers). The next stage was to select the most 
frequently endorsed symptoms (Table 5-1 la and 5-1 lb), in order to generate an item 
pool.
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Table 5-1 la: Symptoms most frequently endorsed by subject groups:
Patient Professional carer Bereaved carer
Pain ✓ ✓ S
Fatigue ✓ ✓ S
Nausea ✓ ✓
Vomiting ✓ ✓ ✓
Anorexia V ✓
Breathing S v' y
Dry mouth S V S
Drowsiness S V
Weakness S S S
Fear S s
Constipation V s S
Low mood S s
Confusion s S
Restlessness s
Anxiety s S
[* anorexia thought by 35% of professiona carers to be less important to dying patients
in the last few days of life]
Table 5-1 lb: Symptoms most frequently endorsed that may be attributable to 
dehydration or artificial hydration
Professional carer Patient Bereaved carer
Dry mouth ✓ ✓ S
Sore mouth ✓ ✓ V
Thirst ✓ V ✓
Dry skin ✓
Itchy skin ✓
Confusion V ✓
Restlessness S ✓
Twitching S
Pyrexia S
Catheter blockage S
Fatigue S S
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5.3.1.2 Reduction o f redundant items
Items in a measuring instrument are required to reflect the essence of the construct 
being measured and assist in the operationalising of the latent variable. The purpose of 
the scale was to measure symptom distress and thus items are required that reflect this. 
As the study demonstrated, the symptom experience of the dying cancer patient is 
complex and there are a very large number of symptoms that can cause distress. It 
would not be feasible to include the whole universe of possible symptoms in such a 
scale; such an instrument would result in unmanageable length. Hence the most 
common symptoms causing distress in this population were selected.
As previously discussed, although the overall symptom experience of the patient is 
multi-dimensional, it has been demonstrated by de Haes et al (1990) that physical and 
psychological symptoms can be distinguished empirically. As the main focus of this 
instrument was the measurement of symptoms related to the state of terminal 
dehydration, and the evidence gathered suggested that physical symptoms were of most 
importance, it seems reasonable to exclude psychological symptoms (e.g. fear, anxiety, 
low mood). The physical symptoms included those thought to pertain particularly to 
dehydration and artificial hydration therapies. Of the 21 remaining symptoms 
restlessness and twitching were discarded as it was felt they pertained mainly to the 
imminently dying phase (when the patient is unconscious) and, were not, therefore, 
amenable to self-assessment. Further items considered to be redundant were catheter 
blockage and pyrexia; these were removed as the scale was still felt to be too long and 
these would be amenable to clinical assessment. Confusion was also omitted at this time 
as a self-assessment could not be reliably carried out if the subject was confused (and 
one would not be using the scale in this instance).
The use of items generated from the empirical investigation of symptoms in dying 
patients supports their validity. It is recognised that, in making decisions about the 
exclusion of symptoms, some symptoms of importance and validity to some patients 
will be missed. However, the length of the questionnaire has to be considered. The 
shorter the scale the less burden it places on respondents and, given the very ill nature of 
the population intended to use the scale, this is highly relevant. Despite this, it is 
recognised that a consequence of brevity is a possible reduction in reliability and
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validity; some trade-off between acceptability and reliability and validity has to be 
accepted (Streiner and Norman, 1989; DeVellis, 1991).
5.3.1.3 Comparison o f items selected with reviewed literature
As studies of symptoms in dying patients have frequently concerned symptom 
occurrence rather than symptom distress (e.g. Hanks, 1983; Hockley et al, 1988) direct 
comparison with the present study may not be appropriate. However, consideration of 
frequently reported symptoms in dying populations is used alongside the empirical data 
collected here for item selection. This item pool was then compared with the literature 
reviewed in Chapter 3 concerning symptom distress studies in general cancer patients 
and symptom prevalence studies in terminal cancer patients. The items surrounding 
terminal dehydration were supported by authors such as Zerwekh (1983) and Billings 
(1985) (see Chapter 2).
Items for inclusion in a physical symptom distress scale were then selected by including 
those that were most frequently endorsed in the current investigation, and supported by 
other studies. Items included are: pain, nausea, vomiting, tiredness, lack of appetite, 
shortness of breath, drowsiness, weakness, constipation, poor concentration, dry mouth, 
sore mouth, thirst, dry skin and itchy skin. Although, decreased concentration was not 
frequently endorsed by any of the samples, the item was included as it has been noted to 
be a problem in other studies (e.g. McCorkle and Young, 1978; Holmes and Dickerson, 
1987) and has been reported as a good marker of a subject's ability to complete the scale 
meaningfully (Dunlop, 1993, personal communication). The terminology selected to 
describe the items included was influenced by words used by patient and bereaved 
samples in the empirical study. For example, although fatigue was used to describe the 
symptom after the content analysis had been carried out, the word tiredness was 
selected, as this was the most commonly used term in the lay populations. Fatigue was 
not used in common parlance in these groups, whereas the professional carer 
populations frequently referred to this. Likewise, shortness of breath was selected in 
favour of dyspnoea (the term most frequently used by clinicians).
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5.3.1.4 Scaling selection
The measurement of symptom distress requires more than simple presence or absence of 
the symptom. A scale needs to have variability and to be able to discriminate 
differences in the underlying attribute. Additional considerations, when selecting choice 
of scaling, included the advanced nature of patients’ illness requiring the scale to be 
simple, quick, discriminatory, and easily understandable.
It is suggested that increasing the number of items in a scale, and increasing the number 
of response options within each item, will increase the variability of a scale (DeVellis, 
1991). However, variability was also expected to be measured by summing the test 
items, as well as demonstrating individual variability in each variable included.
The question that needs to be asked is what is the ability of respondents to discriminate 
meaningfully on the scale? Vague quantity descriptors may cause problems of 
interpretation and it is suggested that visual analogue scales (VAS) (a continuous line 
anchored by descriptors representing opposite ends of the continuum) may increase the 
sensitivity of responses (Mayer, 1978). Nevertheless, there is no guarantee that marks in 
the same place on the continuum for two different respondents may be considered 
identical and Streiner and Norman (1989) suggest that the advantages may be more 
perceived than real, the VAS providing an illusion of accuracy because it may be scored 
to the decimal place. Additionally, studies have proven that there are high correlations 
between scores obtained in Likert-type scales and VAS (Downie et al, 1978; Holmes 
and Dickerson, 1987). VAS scaling has been found to be more difficult to complete 
than graphic scaling (Huskisson, 1974), especially within an elderly population. 
Therefore, the decision was taken to use a Likert-type scaling as it is simple to 
understand and fulfilled the other requirements.
The Likert-type scaling used in the often used Rotterdam Symptom Checklist (de Haes 
et al, 1990) (“Have you been bothered by...”, “not at all”, “a little”, “quite a bit”, “very 
much” -  scoring 1-4) appeared to fulfil the requirements. However, it was felt that the 
addition of a category for subjects to mark the presence of a symptom but the absence of 
distress may help to clarify the important point that symptoms may be present but not 
actually causing concern to the patient. The response category format selected for the 
Physical Symptom Distress Scale was: “not at all”, “yes but not distressing”, “a little 
distressing”, “quite a bit distressing”, and “very distressing”.
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5.3.1.5 Selection o f time span
Symptom distress has been defined as a dynamic construct and can vary from one 
moment to the next (e.g. Rhodes and Watson, 1987. See Chapter 4.). As such, the 
question of which time period should be reported (e.g. now, last four hours, today, 
yesterday, last week, last month, etc.), needs to be addressed. During the end stages of 
malignant disease, when body systems are beginning to fail (Saunders, 1986), symptom 
experience may fluctuate quite rapidly. A new distressing symptom may arise in 
response to things such as organ failure and tumour activity, or distress caused by 
existing symptoms may be modified by external and internal factors in short time 
frames (e.g. medication, psychological factors, social engagement (Tishelman, 1991)). 
The issue of time span has received relatively little attention in the literature related to 
symptom distress. For the purposes of this work the time frame “since yesterday” was 
selected as it takes into account changes over short periods, without being so short that 
completion too frequently would burden the subject. It also recognises that memory 
may be important and remembering the symptom experience of the last two days is 
more likely to be accurate compared with reflecting on the last two weeks or month.
5.4 Conclusions
This exploratory study has identified symptoms causing distress to a heterogeneous 
population of dying cancer patients and those thought to be important by samples of 
professional and bereaved carers. These have been considered alongside studies of 
symptom occurrence in dying patients and studies of symptoms in populations of cancer 
patients who are not necessarily dying. A clinimetric framework (Feinstein, 1987) was 
used to provide a theoretical background to scale development and testing. From the 
empirical work, an item pool of symptoms contributing to symptom distress, related to 
terminal dehydration in the dying patient, was generated and then items were selected 
for inclusion in a physical symptom distress scale. The time span “since yesterday” was 
selected and five-point, Likert-type, response categories were chosen. The Physical 
Symptom Distress Scale (PSDS) is presented in Figure 5-2 (page 108).
Confidence in research using this instrument can only be attained if further work is 
undertaken to establish the properties of reliability, validity and, equally as important, 
the sensibility of the measurement tool. Consequently the next chapter describes a study 
to test the newly developed PSDS.
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Figure 5-2: The Physical Symptom Distress Scale 
SCALE FOR ASSESSMENT OF PHYSICAL SYMPTOM DISTRESS 
Would you please, for all symptoms mentioned, say to what extent you have been 
bothered or distressed by them, by ticking the box which describes best how you feel.
Since yesterday have you been bothered by:
1 2 3 4 5
Not Yes but not A little Quite a bit Very
s t all distressing distressing distressing distressing
PAIN □ □ □ □ □
TIREDNESS □ □ □ □ □
NAUSEA □ □ □ □ □
VOMITING □ □ □ □ □
SHORTNESS OF 
BREATH
□ □ □ □ □
LACK OF 
APPETITE
□ □ □ □ □
DROWSINESS □ □ □ □ □
WEAKNESS □ □ □ □ □
CONSTIPATION □ □ □ □ □
POOR □  
CONCENTRATION
□ □ □ □
DRY MOUTH □ □ □ □ □
SORE MOUTH □ □ □ □ □
THIRST □ □ □ □ □
DRY SKIN □ □ □ □ □
ITCHY SKIN 
INCONTINENCE
□ □ □ □ □
OF BLADDER
Other:
□ □ □ □ □
□ □ □ □ □
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6 Testing the Physical Symptom Distress Scale
6.1 Background
Symptom distress is an important concept within palliative care, particularly towards the 
end of life (see Chapter 4). Chapters 2 and 3 demonstrated that symptom distress may 
arise as a sequel to terminal dehydration, or its treatment with artificial hydration 
therapies. If strategies are to be devised and evaluated for the management and 
reduction of symptom distress related to this area, then assessment of symptom distress 
is vital, for both clinical and research purposes. The review of currently available 
measures of symptom distress for use in palliative care patients (Chapter 3) concluded 
that evidence of a reliable and valid tool for such purposes was not available. Following 
an exploratory study to identify symptoms causing distress to dying cancer patients 
(Chapter 5), a scale for the assessment of physical symptom distress (PSDS) has been 
developed. Construction of this scale was described in Chapter 5. Measurement 
instruments can only be used with confidence if they have been subjected to testing of 
their reliability and validity; consequently testing of the PSDS is now required.
6.2 Aim
The aim of the study was to examine the properties and performance of the new 
Physical Symptom Distress Scale (PSDS) and to compare it with the Rotterdam 
Symptom Checklist (RSCL) in relation to reliability, validity, acceptability, feasibility 
and sensitivity. The RSCL is a frequently used instrument within cancer care but has not 
been validated for use in palliative care populations. A subsidiary aim was to add to the 
body of knowledge regarding the concept of symptom distress in patients with terminal 
malignant disease.
6.3 Method
The study utilised a non-randomised, explorative, cross-sectional design to test the 
questionnaires in a heterogeneous sample of patients dying of malignant disease. The 
cross-sectional design captures phenomena at the period of data collection and allows 
this to be related to external variables (Polit and Hungler, 1991). A descriptive and 
correlational approach was used to investigate the variables of interest.
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6.3.1 Study setting and sample
The study setting was a palliative care in-patient unit. Subjects were recruited into the 
study during the time period February-April 1994 and December 1995 to June 1996. 
The study population consisted of 98 patients with cancer, admitted to the in-patient 
palliative care unit for terminal care and/or symptom control.
6.3.1.1 Selection/entry criteria
The target population eligible for inclusion was initially defined as adult patients with 
malignant disease, considered by the medical/nursing staff to have a life expectancy of 
less than 3-4 weeks, who were not receiving active, curative treatment but palliative 
care. However, during the pilot testing of the first 20 subjects possible over- or under­
estimation of prognosis by different staff members meant that this definition was felt to 
be unreliable and carried the potential to introduce selection bias. Consequently it was 
decided to remove the prognosis factor from the inclusion criteria. It was anticipated 
that a cross-section of patients in the hospice would then be obtained which could be 
broken down into subsets, according to time from death, for analysis. Subjects were 
required to give informed written consent.
The criteria for exclusion from the study were a diagnosis of a non-malignant condition, 
inability to understand or speak English, inability to co-operate because of physical or 
cognitive impairment, or if patients were, in the opinion of the staff, unsuitable to 
participate for any reason.
6.3.1.2 Appropriate sample size
Estimating sample sizes for field-testing when developing measuring instruments is 
difficult. In test reliability studies the larger the sample size the more accurate is the 
estimation of reliability; Guildford (1956) and Kline (1986) recommend 200 subjects. 
With regard to sample sizes required for factor analysis however, Kline (1994) suggests 
that with a clear factor structure samples of a 100 are adequate. (Unless previous 
research indicates the presence of a clear factor structure Kline’s observations (1994) 
are only useful as a post hoc guide). There is general agreement that there should be 
more subjects than variables and Gorsuch (1983) proposed a minimum of 5 subjects per 
variable and not less than 100 individuals per analysis. Thus, ideally, sample sizes in 
excess of 200 subjects are recommended. However, recruitment of subjects who have
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advanced disease is difficult and in the time available for the study a realistic target of 
100 subjects was set which would allow some confidence in the statistical measures 
employed.
6.3.2 Instrumentation
6.3.2.1 The Physical Symptom Distress Scale (PSDS)
As has been shown in Chapter 5, the Physical Symptom Distress Scale (PSDS) 
(Appendix 8) is a self-assessment instrument designed to assess the occurrence and 
severity of distress of some of the physical symptoms associated with terminal 
malignant disease, including factors related to terminal dehydration. The questionnaire 
measures 16 symptoms on a Likert-type scale, measured at an ordinal level. The 
questionnaire considers the time span of the last two days (Figure 6-1).
Figure 6-1: Symptoms included in PSDS and method of scaling
Pain Constipation
Tiredness Poor concentration
Nausea Dry mouth
Vomiting Sore mouth
Shortness of breath Thirst
Lack of appetite Dry skin
Drowsiness Itchy skin
Weakness Incontinence of bladder
Scaling response
1 2 3 4 5
None Yes but not A little Quite a bit Very
distressing distressing distressing distressing
6.3.2.2 The Rotterdam Symptom Checklist
This scale was developed primarily as a tool to measure symptoms reported by cancer 
patients participating in clinical research (de Haes et al, 1990). It has been used in many 
studies as a measure of health-related quality of life and the Medical Research Council 
(MRC) Working party on quality of life assessments (Maguire and Selby, 1989), 
Saunders and Baum (1992) and Fallowfield (1990) recommend its use for eliciting 
important dimensions of quality of life. It was constructed on the basis of analyses of 
data from three studies undertaken with different checklists (Pruyn, et al 1980): (1) the
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Hopkins Symptom Checklist (Luteijn et al, 1979); (2) a symptom checklist used in a 
study on the symptoms of 150 breast cancer patients (Linssen et al, 1979); (3) a Dutch 
version of the Symptom Distress Scale (McCorkle and Young, 1978), applied to a group 
of 49 hospitalised cancer patients (Leendertse et al, 1979). Selection of items from the 
checklists was based on factor analysis, judgement by a group of expert oncologists and 
the distribution of responses (de Haes et al, 1990).
Initial testing was carried out on a 34-item scale comprising physical and psychological 
symptoms and eight items were added referring to functional status. The scale also 
includes a final item relating to a global quality of life question (“all things considered, 
how would you describe your quality of life during the past week?”) and this is scored 
on a seven point scale ranging from “extremely poor” to “excellent”. Patients are asked 
to indicate the degree to which they had been bothered by the symptoms during the past 
three days, on a Likert-type rating scale (categories: not at all, a little, quite a bit, very 
much). Early reliability and validity testing of the scale was carried out by de Haes et al 
(1983) and it has since been used in a variety of further studies (e.g. Hopwood, 1984; de 
Haes and Welvaart, 1985; Fallowfield et al, 1986; Morris and Royle, 1988). Further 
testing, by de Haes et al (1990), using principal components analysis in three different 
studies provided further confirmation of the instrument’s reliability and confirmed its 
ability to distinguish between the physical and psychological dimensions. Internal 
consistency has been shown to be good for both the physical and psychological sub­
scales (Cronbach’s a  = 0.71-0.88 and 0.88-0.94 respectively) (de Haes et al, 1990).
Further testing of the instrument has been addressed through studies such as Greer et al 
(1992) who found it to be sensitive to different treatments in a study of 174 adult cancer 
patients, and Hopwood et al (1991) who reported that it correctly identified 75% of 
patients suffering from an affective disorder, as judged by a psychiatric clinical 
interview. However, these studies do not support the tool’s validity in a palliative care 
setting. Bowling (1995) suggested that further validity testing was required. The final 
version includes 30 symptoms, a global quality of life item and eight items concerning 
activities of daily living.
The RSCL can be used without the functional status sub-section (de Haes et al, 1990) 
and it was felt that the items included in this section were too insensitive to the 
population under investigation. Items regarding ability to care for oneself, walk about
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the house, housekeeping, climbing stairs, odd jobs, walk out of doors, shopping, and 
going to work were felt to be potentially distressing to the proposed in-patient hospice 
sample, many of whom would be in the last days and weeks of life; additionally the 
responses would be greatly skewed towards the categories unable to do or able to do 
with help. Thus this section was omitted from the questionnaire (see Appendix 9 for 
version of RSCL used). The scale was used to assess the items within the same time 
span as the PSDS.
This instrument was chosen for use in this study as it has been frequently used in cancer 
populations and is increasingly being used in the palliative care setting. Consequently, it 
is appropriate to compare the new Physical Symptom Distress Scale with this 
established checklist, but also to consider the performance of the RSCL in this patient 
population, as it has been validated for use in cancer populations at an earlier stage in 
their disease trajectory but has not been adequately validated for use in this population.
6.3.2.3 Patient characteristics: demographic and other medical related data 
Additional information was obtained from medical/nursing sources including: 
demographic details, diagnosis, treatment therapies, medication, date of patient's death. 
This data was expected to be useful in the exploration of external variables and 
symptom distress in the patient population under study.
6.3.2.4 The use o f other measures
The complex nature of the construct under consideration (symptom distress) was 
discussed in Chapter 3. Consideration was given as to whether to use other measures 
concurrently. An index such as the Hospital Anxiety and Depression Scale (HADS) 
(Zigmond and Snaith, 1983), could be used as an indicator of anxiety and depression to 
examine these as separate concepts in relation to symptom distress. Similarly, measures 
of social support and functional ability could have been included in order to consider 
their relationship with symptom distress. However, in very ill populations, one has to 
consider ethical and methodological issues which may arise with the use of multiple 
scales. These include: the research burden they may cause and the possible interference 
with the quality of data; asking questions about the usefulness of scales involving 
activities which are usually inappropriate at this stage of disease (see Chapter 8 for 
further discussion). It was decided that the use of two questionnaires and a debriefing
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interview would be sufficient and feasible; although use of concurrent measures may be 
desirable this would not be practical for the sample.
6.3.3 Procedure
6.3.3.1 Ethical approval and access
The Ethics Committee used by the palliative care unit involved in this study was 
approached for approval to collect data from patients in the in-patient unit. The proposal 
was accepted and approval obtained. Permission was obtained from the developers of 
the Rotterdam Symptom Checklist to adapt and use their instrument. Permission for 
access to the research site was sought through the Director of Nursing and Medical 
Director of the palliative care unit. This was obtained, with the proviso that the nursing 
staff on duty at the time of data collection gave permission before any subjects were 
approached.
6.3.3.2 Process o f consent and data collection
Before the start of data collection, the investigator trained a part-time research assistant 
in the study procedures. Since the investigator and the research assistant both collected 
data, careful briefing was carried out in order to standardise the approach and avoid the 
introduction of bias or confounding sources of error. As the instrumentation involved 
self-assessment the likelihood of bias was felt to be minimal but, as assistance was 
required by some subjects, this was important.
The investigator or research assistant obtained a list of current admissions in the 
palliative care unit on each data collection day. They then asked the nurse in charge to 
identify which patients could be approached, using the inclusion and exclusion criteria 
outlined above. Potential participants were approached by the investigators at their 
bedside, and asked if they would like to hear about the study and if they were willing to 
consider being involved. Oral consent for this was obtained and then the aims and 
methods of the study were explained and confidentiality assured. They were given a 
written information sheet (Appendix 10) and the opportunity to ask questions or be left 
to think over their consent/discuss with family members; a time to return was 
negotiated.
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Once patients had agreed to participate, written consent was obtained and instructions 
were given as to how to complete the questionnaires. The order in which questionnaires 
were completed was determined randomly. Participants completed the scales, separated 
by a 15-20 minutes gap. Any event occurring in the intervening time (e.g. bath, severe 
pain necessitating analgesia etc.) was noted.
Following completion, subjects were asked short questions regarding the acceptability 
of the instruments, any difficulties experienced in completion, the level of help required 
for completion, and the content (e.g. any symptoms which were distressing them which 
were not included in the scales or any items that they felt were irrelevant). Finally, 
socio-demographic data and other medical data were collected from the patient and 
medical/nursing notes after the questionnaires had been completed.
Oppenheim (1992) suggests that the ordering of information/questionnaire is very 
important and that asking respondents about socio-demographic data may appear 
intrusive and lack relevance at the beginning of a questionnaire/interview. Additionally, 
with a population of participants so ill it was important to reduce the research burden as 
far as possible, so that opportunities to obtain information from other sources were 
sought. Oppenheim (1992) advises that respondents be left alone for completion of self­
administered questionnaires once explanations have been given. He suggests that this 
approach “ensures a high response rate, accurate sampling and a minimum of 
interviewer bias, while permitting interviewer assessments, providing necessary 
explanations (but not interpretation of questions) and giving the benefit of a degree of 
personal contact” (p. 103). This was not felt to be appropriate in this study as some 
participants were quite unwell and needed assistance with reading the questions or 
recording the responses. Additionally, it was felt that some questions may be upsetting 
and that the investigator should be on hand to talk with respondents if necessary.
6.3.4 Data analysis
Data was coded and transferred from the written documents to a data base and statistical 
program (SPSS®). Statistical analysis was performed using the SPSS® programme. 
Descriptive statistics were used to identify characteristics of the sample and to classify 
the data.
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For each symptom an ordinal scale was used (PSDS 0-4; RSCL 0-3). A score was given 
for each individual symptom and a total score for the scales was obtained by summing 
individual symptom scores. Higher scores indicate more discomfort. The RSCL 
includes a global quality of life question which respondents scored from 1-7 (excellent 
to extremely poor).
6.3.4.1 Assumptions for statistical testing
Normality plots were undertaken to study the distribution of the data and to check if the 
underlying assumptions for the statistical procedures would be met. This is necessary so 
as to ensure appropriate statistical tests are carried out (Polit, 1996). Some individual 
items did not show normal distribution. As the responses to these items are at the 
ordinal level they would not necessarily be expected to be normally distributed (Altman, 
1991). However, the sums of scores for each scale are aggregates of ordinal variables 
and, as such, a normal distribution may be anticipated (Nunnally and Bernstein, 1994; 
Pett, 1997). Data distributions for the sums of scores for both the PSDS and the RSCL 
were tested using the Kolmogorov-Smimov goodness of fit test which indicated that the 
sample data were normally distributed (Kolmogorov-Smimov Z = 0.71, p = 0.70 for 
PSDS; Kolmogorov-Smimov Z = 1.04, p = 0.21 for RSCL). Regression plots were 
analysed and a fair approximation to linear relationship between variables was obtained. 
Thus it was appropriate that parametric statistics be used for analysis where indicated.
6.3.4.2 Strategy for instrument testing
Table 6-1 summarises the assessment strategies employed. Acceptability of the 
questionnaires was assessed by consideration of frequency of patients agreeing to 
participate, numbers withdrawing from the study and comments made during the 
debriefing questions. Feasibility of the instruments for use in the clinical setting was 
determined by evaluating time taken for completion and the level of help required.
Before the performance of the instruments can be assessed as a whole, analysis of 
responses to rating scales begins with item analysis and then progresses to analysis of 
item composites (Aiken, 1996). Item analysis was considered qualitatively in the first 
instance, through observing respondents whilst completing the scales and then by 
analysing the frequency of item endorsement.
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Table 6-1: Summary of assessments used to evaluate the scales
Property Evaluated Method Statistical Technique
Feasibility Completion time Not applicable (N/A)
Acceptability Response rates 
Attrition rates
Post-questionnaire interviews
N/A
Reliability Internal consistency Cronbach’s alpha
Validity (content) Patient/Family carer/Professional 
carer/ Literature (pre-test)
N/A
Validity (content) Patient interviews (post test) 
Relationships between scores for 
different items
N/A
Inter-item correlations 
Multiple regression 
analysis
Validity
(concurrent)
Comparison between the scales Selective item 
correlation
Validity (construct) Relationship between total scores 
and independent variables
Analysis of variance 
(ANOVA)
Validity (construct) Relationship between scale items Factor analysis
Correlation matrices were constructed for the 2 questionnaires. Reliability of the scales 
was estimated by the determination of internal consistency (Cronbach's coefficient 
alpha). As discussed in Chapter 5, the assessment of validity depends on the extent to 
which an instrument measures what it is intended to measure. However, as there is no 
universally accepted ‘gold standard’ measure of symptom distress, validity was 
evaluated indirectly. Correlation analyses of individual symptom scores between the 
two scales was performed to assess criterion-related validity; content validity of the 
scales was assessed through open-ended questions to subjects (in addition to the 
previous assessment utilising prior studies and professional opinion (see Chapter 5).
Further investigation of the validity of the instrument was examined through factor 
analysis to identify potentially problematic variables in the scale and groups of related 
symptoms; multiple regression analysis was employed to explain variation in the total 
scores obtained.
Independent variables that it was believed may influence variations in symptom distress 
(identified through the literature reviewed in Chapter 4) were examined using one-way 
analysis of variance (ANOVA) (independent variables: disease status, age of subjects, 
gender, site of disease, quality of life assessment). These studies contribute to construct 
validation; a process whereby hypothesised links between variables are tested
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empirically, in order to validate further both the scale and the construct of symptom 
distress and factors affecting it (Streiner and Norman, 1989).
6.4 Results
6.4.1 Characteristics of the study sample
122 patients were asked to participate in the study; 24 refused; a response rate of 80% 
was therefore obtained. The most common reasons for refusal were severe tiredness (n 
= 9), feeling too anxious (n = 3), too unwell (n = 2); other reasons such as disliking 
questionnaires, being involved in too much research in the past, not wanting to read 
anything, feeling that there was too much going on for the individual were also given.
The 122 patients eligible for approach represented only 27% of the total population of 
patients over the data collection time. Nurses did not deem other patients suitable for 
reasons such as: patient too ill or dying (27%); decreased cognitive ability/confusion 
(25%); deafness or communication difficulties (9%); non-malignant diagnosis (6%); 
patient already included in study (16%); patient already refused (4%) and other reasons 
(13%) such as patient deemed too emotionally fragile, too fearful, too depressed, 
uncooperative, too angry, involved in other research projects or patients with learning 
difficulties deemed unable to give informed consent.
Ninety-eight patients participated in the study. Table 6-2 presents the sample 
characteristics. Forty-four percent were male and fifty-six percent female. Ages ranged 
from 33-89 years with a mean age of 67 years (median 68 years). The main sites of 
disease were colorectal, lung, genito-urinary, and breast. Sixty-five percent had 
metastatic disease.
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Table 6-2: Characteristics of the sample (N = 98)
Number %
Gender male 43 44
female 55 56
Age < 40 years 5 5
41-60 years 17 17
61-80 years 64 65
> 80 years
mean = 67 years (SD 13.2) 
median = 68 years 
range = 33-89 years
12 12
Site of cancer colorectal 25 26
lung 17 17
breast 15 15
genito-urinary 16 16
other 25 26
State of primary tumour 21 22
disease regional metastases 13 13
distant metastases 64 65
Reason for symptom control 64 65
admission to palliative terminal care 18 18
care unit (as entered 
on nursing notes)
respite 12 12
The average time from admission until entry into the study was 17 days (median 8, SD 
23). The mean time from study inclusion until death was 68 days (median 41 days, SD 
77.9); this mean was raised by the inclusion of some extreme outliers. Fifty percent of 
the sample died within a month. Table 6-3 shows a breakdown of the time from study 
inclusion until death. If the outliers surviving more than 100 days are excluded then the 
mean time is reduced to 37.4 days (median = 30, SD = 29.7, N = 74). As the scale was 
designed primarily for use in patients in the last few weeks of life there was concern that 
the outliers may skew the results. Consequently, in subsequent analyses where relevant, 
tests were run including the whole sample, excluding the outliers (those who survived 
more than 100 days) and for the subgroup of those dying within 30 days. Any reported 
differences in the findings between these groups are noted.
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Table 6-3: Sample characteristics with respect to time from 
study inclusion until death
Number of days from study 
inclusion until death
Frequency (%) Cumulative percent
0-7 12 (12.9) 12.9
8-14 9(9.7) 22.6
15-21 16 (17.2) 39.8
22-28 6 (6.4) 46.2
29-35 8 (8.6) 54.8
36-56 11 (11.8) 66.7
57-84 7 (7.5) 74.2
85-112 11 (11.8) 86
113-200 4 (4.3) 90.3
200-300 4 (4.3) 94.6
300-390 5(5.4) 100
Total = 93 
Missing data = 5
The median time taken to complete the questionnaires was 4 minutes for the PSDS 
(range 1-15 minutes) and 8 minutes for the RSCL (range 3-20 minutes). However, use 
of the questionnaires frequently led to subjects wanting to talk after completion and 
raised some emotional and psychological concerns. These included subjects wanting to 
discuss their deteriorating condition and quality of life; issues surrounding the impact of 
their symptoms on their family; the unpredictable course of their disease and what the 
future might have in store, and relationships within the family. In particular, the
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question regarding sexual function on the RSCL led some patients to discuss their 
relationship with their partner and the impact of their illness. Thirty-five percent of 
subjects declined to answer the question regarding sexual dysfunction; 25% omitted to 
answer and 10% left it out but spoke about this with the researchers. Additionally the 
question focusing on desperate feelings about the future led to some further discussion 
and expression of emotion at times.
The administration of the two questionnaires and post-questionnaire interviews took 
between 20 minutes and one hour. Forty-five percent of the sample required help in 
completing the scales - 38% with writing and 7% with both reading and writing. No 
subjects withdrew once they had agreed to take part in the study.
6.4.2 Instrument performance
The first stage of analysis in instrument testing is item endorsement, so as to estimate 
both the uptake of the variables and distribution among the response categories. Tables 
6-4 and 6-5 show frequency of item endorsement for both of the scales.
Table 6-4: Item distribution for Physical Symptom Distress Scale (N= 98)
None
(%)
Yes but not 
distressing 
(%)
A little 
distressing 
(%)
Quite a bit 
distressing 
(%)
Very
distressing
(%)
Missing 
data (%)
Pain 30.6 20.4 26.5 16.3 6.1 0.0
Tiredness 15.3 .33.7 22.4 17.3 10.2 1.0
Nausea 62.2 11.2 7.1 12.2 7.1 0.0
Vomiting 79.6 4.1 3.1 8.2 5.1 0.0
Shortness of 
breath
44.9 17.3 18.4 10.2 8.2 1.0
Appetite 44.9 21.4 16.3 7.1 10.2 0.0
Drowsiness 27.6 41.8 14.3 11.2 5.1 0.0
Weakness 16.3 16.3 27.6 21.4 17.3 1.0
Constipation 51.0 13.3 13.3 13.3 8.2 1.0
Concentration 36.7 26.5 14.3 16.3 6.1 0.0
Dry mouth 25.5 29.6 18.4 20.4 6.1 0.0
Sore mouth 77.6 8.2 10.2 3.1 1.0 0.0
Thirst 40.8 35.7 12.2 6.1 4.1 1.0
Dry skin 38.8 36.7 13.3 7.1 3.1 1.0
Itchy skin 82.7 6.1 4.1 5.1 2.0 0.0
Incontinence 77.6 9.2 3.1 2.0 3.1 5=catheter
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For the PSDS, four of the 16 items were infrequently present, with over 70% of subjects 
scoring none. These were vomiting, sore mouth, itchy skin, and incontinence. 
Symptoms appearing to cause the most distress (scoring quite a bit distressing or very 
distressing) were weakness (39%), tiredness (28%), dry mouth (27%), poor 
concentration (22%) and pain (22%).
None of the sample reported the complete absence of symptoms and over half the 
sample reported the occurrence of nine or more symptoms on the PSDS.
Table 6-5: Item distribution for Rotterdam Symptom Checklist (N= 98)
None
(%)
A  little 
(%)
Quite a 
bit (%)
Very
much
(%)
M issing  
data (%)
Appetite 44.9 25.5 18.4 11.2 0.0
Irritability 64.3 24.5 9.2 2.0 0.0
Tiredness 9.2 37.8 33.7 17.3 2.0
Worrying 44.9 19.4 28.6 7.1 0.0
Sore muscles 48.0 29.6 14.3 8.2 0.0
Depressed 39.8 38.8 15.3 5.1 1.0
Lacking energy 11.2 30.6 33.7 22.4 2.0
Back pain 43.9 25.5 21.4 9.2 0.0
Nervousness 65.3 20.4 8.2 3.1 3.0
Nausea 56.1 20.4 13.3 7.1 3.1
Desperate feelings 
about future
46.9 22.4 18.4 6.1 6.1
Difficulty sleeping 43.9 31.6 19.4 5.1 0.0
Headaches 80.6 14.3 1.0 4.1 0.0
Vomiting 72.4 11.2 10.2 3.1 3.1
Dizziness 63.3 24.5 9.2 3.1 0.0
Decreased sexual 
interest
48.0 4.1 2.0 9.2 26.5% + 
10% - left out 
with comment
Tension 45.9 36.7 13.3 4.1 0.0
Abdominal aches 49.0 27.6 20.4 3.1 0.0
Anxiety 38.8 31.6 22.4 4.1 3.1
Constipation 43.9 26.5 16.3 11.2 2.0
Diarrhoea 77.6 10.2 4.1 6.1 2.0
Heartburn 58.2 25.5 15.3 1.0 0.0
Shivering 83.7 9.2 5.1 1.0 1.0
Tingling hands & feet 70.4 18.4 8.2 3.1 0.0
Concentration 38.8 31.6 23.5 5.1 1.0
Sore mouth/ pain 
swallowing
70.4 17.3 10.2 2.0 0.0
Hair loss 78.6 7.1 6.1 4.1 4.1
Burning/ sore eyes 72.4 21.4 4.1 1.0 1.0
Shortness o f breath 39.8 25.5 20.4 12.2 2.0
Dry mouth 20.4 36.7 26.5 15.3 1.0
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For the RSCL, eight of the 30 items were infrequently scored (>70%); these were 
headaches, vomiting, diarrhoea, shivering, tingling, sore mouth, hair loss and sore eyes.
Examination of frequency tables for all variables indicated that for 13 of the 16 
variables on the PSDS the category 4 (“very distressing”) was scored in less than 10% 
of cases; in the RSCL 24 of the 30 items scored 3 (“very much”) in less than 10% of 
cases, indicating a lack of severe distress present in the majority of the sample. 
Symptoms appearing to cause the most “bother” (scoring quite a bit or very much) were 
lack of energy (56%), tiredness (51%), dry mouth (42%), worry (36%), shortness of 
breath (33%), back pain (30%), poor appetite (29%) and lack of concentration (29%).
Item 16, decreased sexual interest, appeared to be problematic; the item was heavily 
skewed towards “none” (48%); over one quarter of the sample declined to answer and a 
further 10% omitted to respond on the questionnaire but commented to the researchers 
on the unsuitability of this question because of their age or the extent of their illness.
Total scores for each scale were obtained by summing individual items (Table 6-6). The 
mean score for the PSDS was 17 (SD 9.3, range = 0 -43 ,  potential maximum score = 
64). The RSCL had a mean score of 22 (SD 12.1, range = 2 -6 7 ,  potential maximum 
possible = 90). The RSCL quality of life score ranging from 1 “excellent” to 7 
“extremely poor” had a mean value of 4 -  “neither good nor bad”.
Table 6-6: Descriptive statistics for scale total scores (PSDS and RSCL) and 
global quality of life score (RSCL)
mean SD median actual
range
theoretical
range
total score PSDS 17.48 9.3 16 0-43 0-64
RSCL 21.95 12.1 21 2-67 0-90
quality of 
life score
RSCL 4 1.6 3 1-7 1-7
The possible effect of the order in which questionnaires were completed having an 
effect on the responses was investigated by using t-tests on the mean scores on the
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RSCL and the PSDS. No significant differences were found so that it can be concluded 
that this exerted no influence on the responses obtained.
6.4.3 Comparison of item endorsement on PSDS and RSCL 
Comparison of item endorsement between identical items on the two scales was carried 
out to test the reliability of subjects’ responses. Both parametric and non-parametric 
(distribution free) methods of analysis yielded high correlation coefficients, with all 8 
items reaching statistical significance when tested with either methods of analysis 
(Table 6-7), indicating that patients were able to assess their level of symptom distress 
in a reliable manner.
Table 6-7: Correlation coefficients for similar items on the PSDS and RSCL
(N = 98)
Symptom Pearson’s R Kendall’s Tau- 
b
tiredness 0.55 0.47
nausea 0.76* 0.69*
vomiting 0.86* 0.83*
shortness of breath 0.79* 0.85*
appetite 0.71* 0.62*
constipation 0.73* 0.66*
dry mouth 0.72 0.66*
sore mouth 0.73* 0.67*
p<0.0001
It was not anticipated that the correlations would be perfect for the responses to the 
same items as the scaling was different between the measures. The PSDS includes the 
response category of “yes, but not distressing” allowing respondents to indicate the 
presence of a symptom which, despite its occurrence, is not causing distress. Table 6-8 
compares the frequency of the responses obtained using each of the scales.
Significance testing was not carried out on this data, as multiple significance testing on 
this large number of variables would carry a risk of spurious findings and false positive 
and false negative errors (Polit, 1996).
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However, it is useful to visually inspect the categories and see the effect that the altered 
scoring may have. The addition of the category ‘yes but not distressing’ appeared to be 
useful: in 7 of the 8 identical symptoms over half of respondents scoring a little on the 
RSCL scored yes but not distressing on the PSDS, suggesting that this is a meaningful 
category to include. The items tiredness and shortness of breath behaved differently: 
scoring in the categories quite a bit and very much were lower on the PSDS compared 
with the RSCL score for the same items.
6.4.4 Internal consistency
Correlation matrices were derived for each of the scales (Figures 6.2 & 6.3) from which 
it can be seen that the total score obtained using the PSDS correlates significantly with 
all variables except PI (pain) and P16 (incontinence). The total score obtained using the 
RSCL correlated significantly with all variables but less strongly with R16, R21, R26, 
R27, R29 (sexual interest, diarrhoea, sore mouth/pain on swallowing, hair loss, 
shortness of breath). There were many significant correlations between items; these 
were further explored using multiple regression analysis and factor analysis (see 
sections 6.4.5 and 6.4.6).
Figure 6-2: Correlation matrix derived from the Physical Symptom Distress Scale
PI Significance of correlations
P2 0.04
P3 0.11 0.31 r>.205 p<0.05
P4 0.03 0.25 0.70 r>.267 p<0.01
P5 -0.11 0.23 0.01 0.19 r >.338 p<0.001
P6 0.00 0.31 0.51 0.47 0.15
P7 -0.02 0.49 0.26 0.31 0.08 0.32
P8 -0.01 0.52 0.31 0.32 0.33 0.38 0.32
P9 -0.01 0.21 0.25 0.23 0.03 0.28 0.22 0.25
P10 -0.02 0.44 0.43 0.42 0.22 0.27 0.39 0.43 0.28
P ll .23 0.15 0.19 0.10 0.11 0.03 0.21 0.21 0.04 0.29
P12 -0.05 0.17 -0.02 -0.08 0.19 -0.06 0.07 0.01 0.00 0.18 0.32
P13 0.12 0.14 0.25 0.31 0.14 0.33 0.39 0.23 0.21 0.26 0.47 0.18
P14 -0.01 0.17 0.28 0.15 -0.02 0.17 urn 0.10 0.02 0.14 0.28 0.32 0.34
P15
P16
0.10
-0.08
0.15
-0.05
0.13
0.08
0.01
0.04
-0.01
-0.06
-0.01
0.24
0.00
0.03
0.04
0.02
-0.19
0.23
0.17 0.16 0.37 0.04 
-0.08 0.10 0.04 0.23
0.44 
0.21 -0.02
Total 0.17 0.60 0.61 0.62 0.36 0.60 0.55 0.61 0.38 0.63 0.45 0.29 0.57 0.45 0.27 0.19
PI P2 P3 P4 P5 P6 P7 P8 P9 P10 P ll P12 P13 P14 P15 P16 Total
Key:
P i = Pain. P2 = Tiredness. P3 = Nausea. P4 = Vomiting. P5 = Shortness of breath. P6 = Appetite. 
P 7 = Drowsiness. P8 = Weakness. P9 = Constipation. P10 = Concentration. P ll  = Dry mouth. 
P12 = Sore mouth. P13 = Thirst. P14 = Dry skin. P15 = Itchy skin. P16 = Incontinence of bladder. 
Total = Total score.
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One aspect of reliability was assessed using Cronbach’s coefficient alpha (a), a measure 
of internal consistency. The PSDS demonstrated a Coefficient a  of 0.77 and a 
standardised a  of 0.77. The standardised alpha is obtained when all items are 
standardised to have a variance of 1. Since items on this scale have comparable 
variances there is minimal difference between the two values. There was no significant 
increase in a  if any of the items were removed from the scale.
When the reliability analysis was carried out using data provided by the sub-group of 
the sample who died within 100 days of completing the scales, Cronbach’s a  = 0.74 
(Standardised a = 0.74) (n = 70). Similarly, there was a small reduction in the values of 
alpha obtained in the sub-group who died within one month of the study: Coefficient a 
= 0.70 and the standardised a = 0.71 (n = 34).
The Cronbach’s a  of 0.86 (standardised a  = 0.89) is higher for the RSCL; there was no 
significant increase in a  if any of the items were removed from the scale. Results of the 
analysis for the sub-group dying within 100 days of the study yielded an identical a of 
0.86 (standardised a  = 0.89, n = 52) and for the sub-group who died within 30 days of 
the study Cronbach’s a = 0.87 (standardised a = 0.91, n = 24).
As, in previous studies, the RSCL has been shown to consist of 2 subscales (de Haes,
1990), the physical and psychological variables were separated and the alpha computed 
for them separately. The psychological scale (containing the items irritability, worrying, 
depressed mood, nervousness, desperate feelings about the future, tension, anxiety, and 
difficulty concentrating) yielded an a of 0.80 (standardised a = 0.81) and the physical 
(containing the items appetite, tiredness, sore muscles, energy, low back pain, nausea, 
sleeping, headaches, vomiting, dizziness, sexual interest, abdominal ache, constipation, 
diarrhoea, heartburn/belching, shivering, tingling, sore mouth/pain when swallowing, 
hair loss, burning/sore eyes, shortness of breath, and dry mouth) an a  of 0.78 
(standardised a  = 0.83). Again, for the subscales, neither scale alpha could be 
significantly improved by eliminating any particular item. Analyses of the sub-groups 
yielded very similar findings.
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6.4.5 Multiple regression analysis
Multiple regression analysis was carried out to investigate relationships between 
individual scale items and the total scale scores. As the scale totals are aggregate scores 
of individual scale items it was to be expected that they would account for the variance 
seen in the total scores. However, multiple regression is useful in scale development to 
detect possible redundant items. Barker Bausell (1986) maintains that three or four 
variables can often explain almost as much variation in the dependent variable as can be 
explained by a larger number of variables and, as such, this analysis may give 
information regarding possible simplification of the scales. For this analysis, the total 
score of symptom distress from the PSDS was the dependent variable and the 
independent variables were those listed in Table 6-9.
Table 6-9: Independent variables for the Physical Symptom Distress Scale
PI Pain P9 Constipation
P2 Tiredness P10 Concentration
P3 Nausea P ll  Dry mouth
P4 Vomiting P12 Sore mouth
P5 Shortness of breath P13 Thirst
P6 Appetite P14 Dry skin
P7 Drowsiness P15 Itchy skin
P8 Weakness P16 Incontinence
Concentration was the best predictor of the level of symptom distress, explaining 39.2% 
of the variance amongst this sample. This was highly statistically significant (p<0.0001) 
(Table 6-10). Appetite explained a further 19.6% of the variance, followed by thirst 
(9.8%) and tiredness (7.8%). These factors together accounted for 76.5% of the total 
variance. The remaining items contributed minor amounts to the total; nausea did not 
enter into the equation at a statistically significant level.
Multiple regression analysis is a powerful statistical procedure and attention was given 
to the following areas. Multicollinearity can occur if the independent variables are too 
highly intercorrelated. Examination of the correlation matrices for the independent 
variable indicated that none of the intercorrelations exceeded 0.85, since tolerance 
levels all exceeded 0.6 this indicated that multicollinearity was avoided (Polit, 1996).
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Table 6-10: Multiple regression analysis for Physical Symptom Distress Scale
Symptom Variance
(%)
Cumulative
variance
(%)
‘t ’ P
Concentration 39.2 39.2 10.26 <0.0001
Appetite 19.6 58.8 6.54 <0.0001
Thirst 9.8 68.7 5.28 <0.0001
Tiredness 7.8 76.5 5.41 <0.0001
Dry skin 3.9 80.3 4.13 <0.0001
Vomiting 3.5 83.8 4.29 <0.0001
Dry mouth 2.2 85.9 3.62 <0.001
Weakness 1.7 87.7 3.45 <0.001
Sore mouth 1.4 89.1 3.24 <0.002
Pain 1.6 90.6 3.69 <0.0001
Shortness of 
breath
0.9 91.6 3.00 <0.004
Drowsiness 1.0 92.6 3.37 <0.001
Constipation 1.0 93.6 3.42 <0.001
Itchy skin 0.6 94.2 2.88 <0.005
Incontinence 0.4 94.6 2.40 <0.019
N.B. Nausea not entered into equation at statistically significant level
Additionally, suppression can occur, when an independent variable contributes 
significantly to the variance even though it is not correlated with the dependent variable. 
This is due to the independent variable suppressing some of the variability that is 
irrelevant in other independent variables. The bivariate correlation coefficients and the 
beta weights obtained for each independent variable were examined to look for 
suppression effects. No evidence of suppression effects was found.
A major consideration in the use of multiple regression analysis is sample size. 
Inadequate sample sizes can raise the risk of Type I and Type II errors, particularly if 
large numbers of independent variables are included in the analysis (Polit, 1996). 
Tabachnick and Fidell (1989) suggest that the minimum requirement is five times more 
cases than predictors but recommend that, for stepwise regression, a ratio of 40:1 is 
desirable. In this analysis the sample size was 98, thus just reaching the minimum 
number recommended. However, due to the relatively large number of independent 
variables used in the analysis, the stability of the results is not assured with this sample 
size and requires validation in other studies.
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Multiple regression analysis was not carried out for the Rotterdam Symptom Checklist 
as the number of independent variables was 30 and, as such, the sample size was 
considered too small for the results to be interpreted with meaning.
6.4.6 Factor analysis
Factor analysis was used to determine how many latent variables (or constructs) 
underlie the sets of items included in the scales and to help to define the context or 
meaning of the factors. This is useful when assessing the validity of instruments.
Consideration was given to whether the data was suitable for factor analysis. Factor 
analysis utilises the correlation matrix therefore the assumptions underlying correlations 
need to be considered. First, the correlations should be linearly related and, as reported 
earlier, regression plots showed a fair approximation to linear relationships. Polit (1996) 
notes that the factor analytic solution may be enhanced by variables being normally 
distributed, but that the factor solution may be worthwhile even when normality is not 
attained for all variables; as discussed previously, normal distribution was not attained 
for all of the individual variables. Visual inspection of the correlation matrices for both 
scales shows that many of the variables are correlated with each other at a statistically 
significant level. Bartlett’s test of sphericity was used to test the hypothesis that the 
correlation matrix was an identity matrix (i.e. all the diagonal terms are 1 and all off- 
diagonal terms are 0 (that is no inter-item correlations) (Norusis, 1994)); for the PSDS 
correlation matrix it yielded a value of 405.6343, p< 0.001 and for the RSCL Bartlett’s 
test of sphericity = 1002.1942, p < 0.001; thus the hypothesis that the matrices are an 
identity can be rejected. Norusis (1994) states that use of factor analysis be reconsidered 
if it appears that the correlation matrix is close to identity, as the variables must be 
related to each other for the factor model to be appropriate.
The Kaiser-Meyer-Olkin (KMO) measure of sampling adequacy is another a priori 
factor analysis test (an index comparing the magnitude of the observed correlation 
coefficients and the partial correlation coefficients); small values for KMO indicate that 
factor analysis of variables may not be useful (Norusis, 1994). Kaiser (1974) 
characterises KMO measures below 0.5 as unacceptable. For the PSDS the KMO = 0.73 
and for the RSCL KMO = 0.71. Thus the use of a factor model for further exploration of 
the data appeared appropriate.
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6.4.6.1 Factor analysis o f the PSDS
The sixteen items of the PSDS were factor analysed using the principal components 
method of factor extraction. Two competing goals influence decisions regarding the 
number of factors to extract and rotate: maximising the variance explained by the factor 
model and maximising the parsimony (or simplest explanation) of the factor solution 
(Kline, 1994; Polit, 1996). Five factors, accounting for 63% of the variance, were 
extracted using the criterion of a minimum eigenvalue of 1 (since factors with 
eigenvalues less than 1 are no better than a single variable as each variable has a 
variance of 1 (Polit, 1996)). Cattell (1978) and Hammond (1995) caution that this 
method may overestimate the number of factors, particularly in large matrices. 
However, it has value in identifying an upper bound. A second approach is to use 
Cattell’s scree test, which plots successive eigenvalues for the factors. It is suggested 
that the cut-off point for selecting factors to extract and rotate is where the line changes 
slope (Kline, 1994; Polit, 1996). The plot (Figure 6-4) shows a discontinuity in the steep 
slope between factor two and the remaining factors.
Figure 6-4: Scree plot for PSDS factor analysis
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Hammond (1995) recommends the use of interpretability as the criterion for selecting 
the number of factors, with the solution which makes the most theoretical sense being 
the most appropriate. Hence, the first five factors were rotated for this exploratory stage 
of the analysis as they have eigenvalues greater than 1 and each accounts for at least 5% 
of the variance.
The factors were orthogonally rotated using the varimax procedure in an attempt to 
maximise the variance of the loading within factors, across variables, in order to 
facilitate interpretation of the factors (Polit, 1996); these are demonstrated in Table 6- 
11. The items are ordered and shown by size of loading to facilitate interpretation of the 
factor matrix.
Each factor is determined by the items that load most heavily on it. In this case, items 
loading strongly on Factor 1 are tiredness, weakness, poor concentration, drowsiness 
and shortness of breath. These seem to relate closely together and perhaps describe the 
syndrome asthenia seen in the fatigue literature (Ingham and Portney, 1998). The 
second factor seems to concern gastrointestinal symptoms: nausea, vomiting and poor 
appetite. The third pertains to three factors related to skin and mouth and factor 4 relates 
to bowel function and thirst. The fifth factor loads the items dry mouth, thirst and pain.
6.4.6.2 Factor analysis o f the RSCL
Similar procedures were carried out for the RSCL using the principal components 
method of factor extraction followed by varimax rotation. Using the eigenvalue > 1 
criterion, ten factors were extracted. Cattell’s scree test was carried out (see explanation 
above). The plot (Figure 6.5, p. 135) shows a discontinuity in the steep slope between 
factor two and the remaining factors, suggesting that these two factors be rotated. 
However, the first four factors were included at this exploratory stage of the analysis as 
they accounted for at least 5% of the variance.
Table 6-11: Rotated factor analysis solution for the PSDS
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Variable
FI
Factor Loadings 
F2 F3 F4 F5
Communalities
P2 Tiredness .68 .29 .14 -.08 .04 .57
P8 Weakness .68 .31 -.02 .07 .04 .56
P5 Shortness of breath .67 -.15 .01 .03 -.08 .48
P10 concentration .62 .38 .18 -.05 .11 .58
p7 drowsiness .52 .28 -.04 .07 .25 .44
P3 Nausea .12 .86 .17 .05 .10 .80
P4 Vomiting .24 .78 -.08 .08 .07 .68
P6 Appetite .24 .65 -.03 .35 -.02 .60
P15 Itchy skin -.01 .12 .81 -.26 .02 .74
P14 Dry skin -.03 .24 .75 .25 .11 .69
P12 Sore mouth .30 -.30 .66 .10 .11 .64
P16 Incontinence -.19 .07 .12 .80 -.03 .69
P9 Constipation .26 .25 -.22 .51 .01 .44
PI Pain -.19 .15 -.09 -.30 .75 .71
P ll  Dry mouth .26 -.08 .31 .18 .71 .71
P13 Thirst .23 .17 .16 .51 .56 .68
Eigenvalue 4.1 2.0 1.5 1.3 1.2
% of variance 
explained
25.7 12.2 9.4 8.0 7.4
*Factor-related items are printed in bold
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Figure 6-5: Scree plot for RSCL factor analysis
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9Results from the varimax rotation are demonstrated in Table 6.12. The items are 
ordered and shown by size of loading to facilitate interpretation of the factor matrix. 
Factor 1, explaining 24.5% of the variance, refers to some of the psychological 
symptoms, namely worrying, tension, anxiety, depression and irritability, with poor 
sleep related as well. This factor had six items with loadings (correlations of the 
variables with the factor) above the minimum recognised value of 0.30 (Nunnally and 
Bernstein, 1994; Kline, 1994; Polit, 1996). A variable that correlates highly with a 
factor is called a “salient”. A value greater than 0.60 is considered high (Nunnally and 
Bernstein, 1994; Kline, 1994); worry, anxiety, depression and tension had loadings in 
excess of 0.6 and only one item (irritability) also had high loading on other factors. The 
second factor had 5 items with loadings >0.4: these were the gastrointestinal symptoms 
of nausea, vomiting, and heartburn, with concentration and irritability as well.
2 The communalities for the variables are all reasonably high (> 0.57), indicating that the variance of the 
variables is partially explained by the common factors. Examination of the estimated correlations and 
residuals (the reproduced correlation matrix) shows that 34% of the residuals are greater that 0.05 in 
absolute value -  thus the model appears to fit the data reasonably well (Norusis, 1994).
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This factor accounted for 8.5% of the variance. The third factor comprises the items of 
lacking energy, concentration, sore eyes, appetite and sexual interest, with irritability 
loading onto it as well. The fourth factor had five items with loadings above 0.40. This 
factor contained various physical symptoms.
Table 6-12 : Rotated factor analysis solution for the RSCL
Variable
FI
Factor Loadings 
F2 F3 F4
Communalities
R4 worry .82 .14 .01 .14 .81
R19 anxiety .75 .03 .30 -.02 .72
R6 depressed .68 .23 .13 .12 .78
R17 tense .60 .08 .11 .29 .81
R12 sleep .42 -.20 .03 .01 .68
R14 vomiting .07 .87 .20 .07 .84
RIO nausea .15 .77 .28 .06 .73
R22 heartburn .03 .54 -.24 .07 .67
R2 irritability .41 .42 .42 -.02 .75
R7 energy .28 .07 .76 -.02 .73
R25 concentration .12 .42 .66 .10 .75
R28 sore eyes -.09 .12 .65 .21 .64
R1 appetite .24 .37 .46 .10 .56
R16 sexual interest .25 .07 .45 -.31 .57
R24 tingling hands & feet .04 .01 -.01 .84 .78
R21 diarrhoea -.02 -.11 .14 .68 .73
R8 back pain .30 .29 -.06 .60 .64
R23 shivering .02 .32 .14 .52 .73
R5 sore muscles .28 .20 .21 .45 .58
Eigenvalue 7.36 2.55 2.42 1.80
% of variance explained 24.5 8.5 8.1 6.0
*Factor-related items are printed in bold
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6.4.7 Correlation of total symptom distress scores with quality of life scores 
Pearson correlation coefficients were calculated to examine the relationship between 
total symptom distress scores and the global quality of life ratings (measured on the 
RSCL). Symptom distress as rated on the PSDS correlated significantly with the global 
quality of life score (r = 0.415, P <0.01). Similarly the total score on the RSCL 
correlated significantly with the global quality of life score ( r = 0.464, p <0.01). This 
relationship was explored further using one-way analysis of variance (ANOVA). The 
ANOVA summary table (Table 6-13) indicated that quality of life rating was 
significantly effected by symptom total scores on both the PSDS (F (d f  6,90) = 5.13, p 
<0.0001) and the RSCL (F (#6,90) = 7.19, pO.0001).
Table 6-13: ANOVA results for total scores on PSDS and RSCL 
by quality of life ratings
Global quality of life rating
excellent 
n = 6
good 
n = 24
moderately 
good 
n = 25
neither 
good nor 
bad 
n = 13
rather 
poor 
n =  13
poor 
n = 11
extremely 
poor 
n = 5
M SD M SD M SD M SD M SD M SD M SD F P
PSDS 6.7 4.4 14.5 9.9 15.1 7.7 21.5 7.3 21.4 8.6 17.6 8.0 292 9.3 5.13 <Q0001
RSCL 92 3.8 20.3 10.1 16.4 9.7 24.9 8.4 29.6 92 24.4 12.0 40.8 19.5 7.19 <aoooi
Fisher’s LSD multiple comparison procedure was carried out to determine which group 
differences contributed to the significant F statistic. The post hoc tests showed that those 
rating their quality of life as excellent had significantly lower total scores on the PSDS 
than all the other groups (p < 0.05). Those rating their quality of life as good had 
significantly lower scores that those rating quality of life as neither good nor bad, rather 
poor and extremely poor (p < 0.03).
6.4.8 Association of age with symptom distress scores
Pearson correlation coefficients were calculated to examine the relationship between 
total symptom distress scores and age of subjects as age has been shown to affect 
symptom experience (Addington-Hall et al, 1998). No statistically significant
138
relationship was found between age and symptom distress as rated on either scale (r = 
-0.05, P = 0.61 for PSDS; r = -0.14, p = 0.16 for RSCL). However, when one-way 
analysis of variance was undertaken associations between age and total scores were 
demonstrated. The ANOVA summary table (Table 6-14) indicated that age group had a 
significant impact on total scores on both the PSDS (F (d/3,94) = 3.18, p =0.03) and the 
RSCL (F (#3,94) = 2.67, p = 0.05).
Table 6-14: ANOVA summary for total scores on PSDS and RSCL by age group
Age grou is (years)
<40 
n = 5
41-60 
n =  17
61-80 
n = 64
>80 
n = 12
M SD M SD M SD M SD F P
PSDS 28.8 8.8 15.4 6.9 16.4 9.4 18.0 9.9 3.18 0.03
RSCL 33.6 12.8 24.2 10.4 19.9 10.9 24.6 16.9 2.67 0.05
Addington-Hall et al (1998) used different age groupings when investigating 
relationships between age and symptom experience. When the age bands were altered to 
be the same (<65 years, 65-74 years, 75-84 years, >85 years) the ANOVA yielded a 
non-significant result for the PSDS (F (dj3,94) = 0.74, p =0.53), but significant result 
for the RSCL (F ( #  3,94) = 2.8, p = 0.04). Post hoc multiple comparison procedure 
(LSD) indicated that the lowest age group (<65 years) had significantly greater mean 
score on the RSCL than the 65-74 age group.
A multiple comparison procedure (Fisher’s LSD test) was carried out to determine 
which means were significantly different from each other. Results indicated that 
younger subjects (less than 40 years old) had significantly greater mean total scores for 
the PSDS than all other age groups (P <0.03). Subjects in the lowest age group had 
significantly greater mean scores on the RSCL than the 61-80 year age group, but no 
significant differences were found between other age groups. The finding that the 
Pearson correlations were not significant although the ANOVA results indicated a 
relationship between age and total scores suggests that the relationship between age and 
symptom distress is not linear.
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6.4.9 Association of gender with symptom distress scores
One-way analysis of variance demonstrated that gender was not related to total 
symptom distress scores as measured on the PSDS or the RSCL. For the PSDS the 
analysis yielded an F statistic {df 1,95) = 0.19, p = 0.66; and for the RSCL F {df 1,95) = 
0.86, p = 0.36.
6.4.10 Association of disease status with symptom distress scores
One-way analysis of variance was used to examine the effect of disease status (primary 
cancer only with no metastases, local spread, distant metastases) on total scores for the 
PSDS (F {df 2,95) = 0.24, p=0.79) and RSCL (F {df 2,95) = 0.79, p=0.46). No 
significant differences in the group means were found indicating that disease status was 
unrelated to total symptom distress scores.
6.4.11 Association of site of disease with symptom distress scores
One-way analysis of variance was used to examine the effect of site of primary disease 
(lung, breast, gastrointestinal, genitourinary, other) on total scores for the PSDS (F {df 
4,93) = 1.8, p=0.14) and RSCL (F {df 4,93) = 1.06, p=0.38). No significant differences 
in the group means were found suggesting that there was no relationship between the 
site of disease and total symptom distress scores.
6.4.12 Association of closeness to death at time of assessment with symptom 
distress scores
Pearson correlation coefficients were calculated to examine the relationship between 
total symptom distress scores and closeness to death at time of assessment, as it was 
hypothesised that patients with more advanced disease may experience greater distress 
from symptoms. A statistically significant relationship was found between closeness to 
death and symptom distress as rated on the PSDS (r = -0.28, P = 0.006) but no 
relationship was found with respect to total score on the RSCL (r = -0.13, p = 0.21). 
One-way analysis of variance was undertaken for the RSCL (F {df5,85) = 1.20, p=0.32) 
(Table 6-15). No significant differences in the group means were found supporting the 
findings of the correlation, that closeness to death was unrelated to total symptom 
distress score on the RSCL.
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Table 6-15: ANOVA summary for total scores on PSDS and RSCL
by time until death
Time until death (days)
0-14 
n = 19
15-30 
n = 19
31-60 
n = 19
61-90 
n = 9
91-120 
n =  13
>120 
n =  12
M SD M SD M SD M SD M SD M SD F P
PSDS 22.1 9.3 19.4 6.7 15.0 10.0 15.9 7.5 12.1 5.9 12.8 9.6 3.41 0.007
RSCL 27.5 15.7 21.2 9.2 22.6 13.0 18.0 10.5 18.6 7.5 19.7 12.0 120 0.32
One-way analysis of variance for the PSDS (F {df 5,85) = 3.41, p= 0.007) demonstrated 
an association between closeness to death and total scores (Table 6-15). A post hoc 
multiple comparison procedure (Fisher’s LSD test) indicated that the group of patients 
within 14 days of death had significantly greater mean total scores for the PSDS than 
those dying after one month or more (P <0.01). Subjects in the group dying between 15 
and 30 days of the study had significantly greater mean scores on the PSDS than those 
dying after three months or more.
6.4.13 Acceptability, content, assistance required - debriefing 
For the PSDS less than 2% of subjects had comments regarding the nature of any items. 
However, with the RSCL the main item causing upset was “decrease in sexual interest”, 
with 7% finding it upsetting and 25% feeling that it was irrelevant; importantly, 25% of 
subjects declined to answer altogether. Hair loss was another item felt to be less relevant 
thus supporting the poor endorsement seen in the frequency analysis.
Forty-five percent of the sample required help to complete the scales - 38% with writing 
and 7% with both reading and writing. When asked regarding any preference for either 
of the scales, 50% felt there was no real difference, 27% preferred the RSCL as they felt 
it was ‘more complete’ and 23% preferred the PSDS as they found it simpler and 
shorter. In addition 24% preferred the scaling of the PSDS with the extra division for 
symptom presence without distress.
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6.5 Discussion
6.5.1 Introduction
The purpose of this study was to test a new instrument developed to measure symptom 
distress in dying cancer patients suitable for clinical and research purposes. The clinical 
problem of symptom distress arising as a consequence of terminal dehydration, or its 
treatment with artificial hydration therapies, justified the need for research tools to 
enable the assessment of symptom distress and the evaluation of treatment strategies. 
There was no instrument available that had demonstrable reliability and validity in 
palliative care populations (Chapter 4). Furthermore, previous research into the 
symptom experience of dying cancer patients has tended to focus on symptoms present 
on admission to palliative care units and as such provides no evidence for symptom 
experience at different stages of the disease trajectory. Therefore, the first stage was to 
identify, using qualitative methods, symptoms causing distress to dying cancer patients 
(Chapter 5). It is suggested that the quality of data obtained from qualitative interviews 
is dependent on the skills and experience of the researcher (Guba and Lincoln, 1981); 
however, the results of this study (Chapter 5) were used in conjunction with existing 
literature as a foundation for the instrument developed, thus increasing the confidence 
that can be placed in its validity. Nevertheless, there was a need for testing of the 
instrument in order to establish further confidence in its properties of reliability, validity 
and its usefulness, before it could be used in studies related to terminal dehydration.
6.5.2 Representativeness of sample
The sample obtained in this study represented only 27% of the total population of 
patients in the palliative care unit over the data collection period. Although accrual of 
patients approached by the researchers was high (80% response rate) the substantial 
proportion of patients who were unable to be approached for consent is problematic. 
Approximately half the population were deemed by nurses as either too ill/dying or as 
having confusion/reduced cognitive ability to give meaningful informed consent. This 
emphasises the importance of developing alternative strategies of assessment of 
symptom distress (i.e. by proxy) in the palliative care population (see Chapter 7). 
Nurses appeared to act as ‘gatekeepers’ to many patients whom they felt were not well 
enough or whom they deemed too emotionally vulnerable. Interestingly, a person whom 
one nurse suggested was not appropriate to approach for consent on a particular
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occasion was sometimes considered appropriate by a different nurse on the following 
day (for the same reasons). One can only speculate as to why this may have occurred; 
perhaps some nurses are more reluctant to support research using dying patients, taking 
a paternalistic and protective role. This issue of gatekeeping is considered in more detail 
in Chapter 8.
The implications of such gatekeeping for this study lie in the consideration of how 
representative the sample can be said to be. It did appear that less unwell patients were 
included in the sample, reflected by the mean length of time from interview until death. 
It could be argued that this represents the proportion of people who are able to complete 
self-assessment scales, and as such is suitable. Results from analysing the data in the 
whole sample and in the sub-samples who died in a shorter time did not reveal any 
notable differences, allowing confidence to be placed in the results. However, a matter 
of concern is the proportion of subjects who may have been able to complete the 
instruments but whom the nurses were protecting from the demands of a research 
project. Thus the results need to be interpreted with caution and further testing is 
required; particular attention needs to be given to methods of accessing patients in this 
vulnerable group.
An additional consideration of the representativeness of the sample is that of the 
selection of a palliative care in-patient unit for recruitment. It could be suggested that 
that the poor item endorsement seen in some of the items on the PSDS reflected a high 
level of symptom control, attributable to specialist palliative care services, and that 
different levels of symptom distress would be seen in populations of cancer patients 
dying in different settings (e.g. general hospital wards, home). Some of the symptoms 
included in the PSDS relate particularly to terminal dehydration and it would not be 
expected to see this condition in patients who were not close to death; this may offer an 
alternative explanation. Further testing of the scale with a larger sample of patients 
closer to death and in samples of patients not under specialist palliative care is 
recommended.
6.5.3 Missing items
There is debate in the literature as to how to manage missing items in data. In this study, 
question 16 in the RSCL concerning decreased sexual interest was missing in 36% of
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the sample. Data from the Medical Research Council (MRC) and the European 
Organisation for Research and Treatment of Cancer (EORTC) trial experience suggest 
that, for most items, between 0.5-2.0% of values will be missing from returned forms 
(Curran et al, 1998). Review of 7000 forms in six MRC trials indicated that 92% of 
forms contained complete information for 29 of the 30 questions on the symptom 
section of the RSCL. Decreased sexual interest on the RSCL has posed a problem for 
patient compliance, approximately 19% left this question blank in previous studies (9- 
25% missing for this item across trials including lung, bronchus, bladder, renal and head 
and neck cancers). Interestingly, similar problems have been reported for questions of 
this nature on the EORTC quality of life questionnaire, QLQ C-30, addressing issues of 
sexuality (Curran et al, 1998). Some questions manifested age or gender differences 
with older patients being more likely to leave questions unanswered and females being 
far more likely to avoid this question than males (Fayers et al, 1998). Associations with 
gender and age suggest that ‘missing’ data may be informative, with patients 
experiencing problems being less likely to admit them (Curran et al, 1998).
Missing items are important as they concern central statistical issues of bias and power. 
Consideration of whether the characteristics of patients with missing data differ from 
those for whom the data is available is important as the results may reach biased 
conclusions if, for example, sicker patients were less able to complete the questionnaires 
satisfactorily (Fayers et al, 1998). Additionally, if patients are excluded by statistical 
analyses, because of their missing data, the sample size is reduced and statistical power 
may be lost.
When the age and gender of respondents leaving this question unanswered were 
compared with those completing the question in this study no statistically significant 
differences were found although more women (40%) avoided this question than men 
(30%) supporting the observations of the MRC trials (Fayers et al, 1998). When 
response to this item was analysed with respect to patients’ nearness to death no 
significant differences were found. Similarly, mean total scores of symptom distress 
(scored on the PSDS and RSCL) did not differ significantly between responders and 
non-responders. This suggests that there is not significant bias in the group that 
responded to the items.
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However, it is still important to consider the reasons why this data may be missing. 
Some items may be missing completely at random; more likely, in this case, is that the 
patient was too ill or too distressed to answer the question or that they did not feel that 
the question was applicable. This latter interpretation is supported by the fact that ten 
patients commented on this item (and left it blank), stating that it was inappropriate 
given their age, their single/widowed status or as they were so unwell. The findings in 
this study and those reported by the MRC indicate that the use of this item requires 
further validation.
Methods for dealing with missing items were considered when calculating values for the 
summated scale (total score) and the option of treating the scale scores as missing for 
the statistical analyses when a constituent item was missing was adopted. Although this 
resulted in overall loss of data, it seemed more appropriate than estimating the scale 
score from the mean of the items which are available (simple mean imputation) (Fayers 
et al, 1998) which, although a simple solution, in situations where censoring of an 
answer is likely (as in this case) can lead to misleading results (Fayers et al, 1998).
6.5.4 Scale evaluation
Clinimetrics is a term used to describe the “domain concerned with indexes, rating 
scales, and other expressions that are used to describe or measure symptoms, physical 
signs, and other distinctly clinical phenomena in clinical medicine” (Feinstein, 1987 
p.5). The three areas suggested by Feinstein (1987) for the evaluation of measurement 
instruments, consistency (often referred to as reliability), validity (or accuracy) and 
sensibility, will be considered here.
6.5.5 Reliability
Reliability concerns the degree of consistency of a measure and evidence is required 
that the scale measures in a reproducible manner (Polit and Hungler, 1991; DeVellis,
1991). Reliability is not a unitary concept but constitutes various components requiring 
consideration (Barker Bausell, 1986). The reliability of a scale is the proportion of true 
variance attributable to the true score of the variable being measured (Barker Bausell, 
1986 p.178). Thus it can be represented as:
Reliability = true variance 
total variance
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Reliability is dependent on the extent that the scale includes reliable items which share a 
common construct. Therefore it is important that all the items included in a scale are 
measuring the same construct at the same time as having reliability in themselves 
(DeVellis, 1991).
Internal consistency assesses the extent to which individual items on a scale are 
measuring the same phenomenon (i.e. the homogeneity of the scale). If the items are 
strongly related to the latent variable (the construct being measured) then there will be 
high inter-item correlation (DeVellis, 1991). Cronbach's coefficient alpha (a) 
(Cronbach, 1951) is one means of estimating the proportion of a scale's variance that is 
attributable to the true score of the latent variable. Alpha estimates divide the variation 
in a set of scores into that which is due to true variation in the construct being measured 
and that which is caused by measurement error. Coefficient alpha estimations are based 
on a single administration of the measure.
Both the PSDS and the RSCL demonstrated satisfactory internal consistency (PSDS a  = 
0.77; RSCL a  = 0.86). The assessment of what constitutes a satisfactory level of 
reliability depends on the use of the measure and Nunnally and Bernstein (1994) 
suggest that, in early stages of instrument development, modest reliability coefficients 
(e.g. 0.70) are acceptable. Barker Bausell (1986) suggests that coefficient a  has a 
tendency to give a slight overestimation of a measure’s true reliability. However, the 
author does not justify this observation and the generally accepted view is that a  yields 
a conservative estimate (Nunnally and Bernstein, 1994). Novick and Lewis (1967) have 
shown that, in general, a  is the lower boundary of the reliability of an unweighted scale.
Coefficient alpha measurement assesses the degree to which items are measuring the 
underlying construct but it has been noted that, as it is derived from a single assessment, 
it does not take into account other sources of variation such as day-to-day variations in 
measurements or inter-observer variations and therefore it may not be sufficient to rely 
entirely on such testing (Streiner and Norman, 1989). Nunnally and Bernstein (1994) 
advocate the use of at least two types of reliability coefficient for any instrument that is 
to be used widely.
Alternate forms of reliability assesses whether the same group of respondents would 
score similarly on two equivalent forms of the measure. This form of assessment is
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considered to be unwieldy and impractical in the majority of research studies (Barker 
Bausell, 1986) and was not considered here as an alternative or parallel form of the 
scale was not developed.
Inter-rater and intra-rater reliability assess the extent of agreement between different 
observers rating the same subjects (inter) and the same observer rating the same subjects 
on different occasions (intra). Since these scales relied on self-assessment these aspects 
of reliability were not appropriate.
Test-retest reliability assesses the stability of the measure over time. DeVellis (1991) 
suggests that, if the construct being measured is meaningful, then the measure should 
assess the construct comparably on separate occasions. This form of testing poses 
difficulties in deciding upon the appropriate time interval between testing, particularly 
in palliative care. There needs to be sufficient time to prevent respondents from 
remembering their first test and yet be short enough to assume that the underlying 
construct has remained constant. Kelly and McGrath (1988, p.62) identify three 
assumptions of the test-retest method: (1) that the true score measured is either constant 
or changes uniformly with time; (2) that there are no systematic variations in the 
construct being measured (e.g. variations in mood around a constant, such as time of 
day); (3) that instrument changes are constant or uniform. The degree of correlation 
between the first and second administration of the test reflects the reliability of the 
measure of the variable.
Symptom distress is the construct being measured by this scale and it may be argued 
that, as symptoms may change from minute to minute depending on many factors, 
temporal stability cannot be assumed and reliability estimates derived from such studies 
may be very difficult to interpret. A low reliability score may indicate that the measure 
contains a large amount of error or that the construct being measured (i.e. symptom 
distress) is very unstable with respect to time. Alternatively, it may reflect a change in 
the patient’s condition rather than instability. It may be argued that the additional 
burden placed upon dying subjects by completing additional questionnaires, when the 
results may be difficult to interpret, is unjustifiable at this stage in the scale's 
development.
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It follows from this section of the discussion that, at this stage of instrument testing and 
with the design of the instrument, estimation of internal consistency using coefficient a  
was the only available method and demonstrated acceptable values.
6.5.6 Validity
This concerns the degree to which an instrument measures the attribute it purports to 
measure (Polit and Hungler, 1991). Like reliability, validity has different components 
and assessment approaches. Reliability and validity are not independent qualities as a 
scale that is not reliable cannot be valid; reliability places an upper limit on validity and 
the higher the reliability, the higher is the maximum possible validity. Validity is 
generally considered under the facets of criterion and construct validity (content and 
face validity will be considered under the subsection of sensibility (6.5.7 ).
6.5.6.1 Criterion validity
Criterion validity has traditionally been viewed as the correlation of the scale with some 
other measure of the concept being studied, ideally with a 'gold standard’ that has been 
used and accepted in the field. It is divided into concurrent and predictive validity. 
Concurrent validity concerns the correlation of the new scale with the criterion measure 
given at the same time (Rust and Golombok, 1989). In the absence of a well-established 
criterion (if there were one then the need for this study would be greatly reduced), the 
Rotterdam Symptom Checklist (RSCL) represented a frequently used measure of 
symptom experience in cancer patients (although developed as a quality of life measure 
the physical and psychological components of the scale could be considered to be 
assessing symptom experience) and the PSDS correlated highly with it (r = 0.71, P < 
0.001). Nevertheless, the empirical testing of criterion validity assumes that the criterion 
is reliable and valid and it may be suggested that, as the RSCL had not been validated 
previously in a population of dying cancer patients, the interpretation of such a 
comparison must be cautious. Reliability coefficients for the RSCL in this population 
were within acceptable limits (see previous section).
Predictive validity deals with the correlation between the new scale and the criterion 
predicted by the researcher. It deals with the adequacy of the scale to differentiate 
between individuals on some future criterion (Ghiselli et al, 1981; Rust and Golombok,
1989). This is important if a measure has been designed for use as a predictor of future
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behaviour. The current scale has been designed for use to explain current situations and 
not as a predictor and, therefore, this concept was not considered at this stage.
6.5.6.2 Construct validity
Construct validity is the examination of the extent to which an instrument measures the 
construct under investigation (Ghiselli et al, 1981). It is not assessed through a single 
study but, as Barker Bausell (1986 p.217) describes, "it is the evaluation of a gestalt of 
evidence, of a body of research". Construct validity is then, an on-going process 
concerning the assessment of both the measurement instrument and the constructs and 
hypotheses under consideration. As there are many possible hypotheses concerning the 
construct under scrutiny each study adds to a matrix of supportive studies. There are 
different approaches to the assessment of construct validity but the emphasis is on the 
testing of relationships predicted on the basis of the theoretical framework underpinning 
the study.
6.5.6.2.1 Age, gender and disease characteristics
It has been suggested that age and gender may contribute to variance seen in symptoms 
(e.g. Nerenz et al, 1982; Gaston-Johansson et al, 1990) although, Tishelman et al (1991) 
only found statistically significant relationships between age and gender and symptom 
distress in a subscale of symptom distress regarding frequency and intensity of nausea 
and appetite. However, the use of multiple regression analysis in a sample of 41 limits 
the confidence that can be placed in these findings (Tabachnick and Fidell, 1989; 
Hammond, 1995). Seale and Cartwright (1994) concluded that there was no effect of 
age on symptom occurrence in a retrospective study of the last year of life, although 
symptoms were reported to have been more long-lasting in elderly patients and were 
less likely to have been interpreted as ‘very distressing’. They suggest that this finding 
may be due to “a more stoical attitude among older people, to an adjustment to long- 
lasting symptoms or to a real difference in the intensity of symptoms and the resulting 
level of distress”. The study sample comprised both cancer and non-cancer deaths and it 
has been suggested that these findings may be an artefact resulting from the larger 
proportion of non-cancer deaths in the older age group (Addington-Hall et al, 1998).
Addington-Hall et al (1998) found that in a retrospective survey of the last year of the 
lives of 2061 cancer patients, nine symptoms showed a statistically significant decrease
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in prevalence with age, five were not statistically significant and only urinary and faecal 
incontinence increased significantly with age. This retrospective survey data, similar to 
the Cartwright and Seale (1994) study, was sought from family members’ views of the 
last year of the patients’ lives, and, to date, there is no conclusive evidence to support or 
refute the validity of such retrospective accounts. This current study demonstrates 
prospectively, a relationship between symptom distress and age, with younger patients 
experiencing greater symptom distress. It must be noted that the Addington-Hall et al 
(1998) study examined symptom prevalence, as well as, symptom distress, and the 
findings of these studies add to the evidence of an association between age and 
symptom experience. It appears that the effect of the age variable on symptom distress 
may be consistent across the cancer disease trajectory as Degner and Sloan (1995) 
reported newly diagnosed older cancer patients as experiencing less symptom distress 
than younger patients.
In this study gender was not found to contribute to differences in symptom distress 
scores. The effect size (a measure of the strength of the relationship between two 
variables in the population) was extremely small (0.09 for the PSDS and 0.19 for the 
RSCL), supporting the lack of relationship seen between the variables.
Disease characteristics were also analysed for their possible relationship with symptom 
distress. The lack of a statistically significant association between site of disease and 
mean symptom distress scores is difficult to interpret as statistical power for the 
ANOVA test was found to be 0.5 for the PSDS and 0.4 for the RSCL, which is well 
below the accepted standard of 0.8 (Polit, 1996). It is recognised that these results need 
replicating with a larger sample. When considering the extent of disease on symptom 
distress scores (no metastatic spread, regional spread, distant metastases), no 
relationship was demonstrated. This supports the findings of Tishelman et al (1991), 
although direct comparison cannot be made as their sample was biased to the less 
unwell and only 20% of the sample died within 18 months of the study.
The closeness to death of the patients was analysed with respect to its relationship with 
total symptom distress scores. Symptom distress, as rated on the PSDS, was 
significantly higher in those in the last two weeks of life. However, the relationship was 
not demonstrated with respect to symptom distress as measured on the RSCL. This may 
indicate that physical symptom distress is more of a problem in this group (reflected in
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the PSDS) than symptom distress assessed by measures that include psychological 
variables. These findings have relevance in supporting the construct validity of the 
scale; the PSDS was developed with the population of patients very close to death in 
mind, such that distress related to terminal dehydration and its treatment could be 
investigated.
6.5.6.3 Multiple regression analysis
Results from the multiple regression analysis indicate that poor concentration was the 
best predictor of the level of symptom distress, accounting for 39% of variance amongst 
this sample. Concentration correlated highly with the total symptom distress score (r = 
0.63) and also correlated significantly with 10 of the other variables (those not 
correlated significantly were pain, dry mouth, thirst, dry skin, itchy skin and 
incontinence); this supports its use as a predictor variable and can perhaps be 
understood as, clinically, other symptoms may impact upon the ability to concentrate 
but poor concentration may also be reflecting the underlying severity of illness.
Appetite, thirst and tiredness also made significant contributions to the variance seen in 
the total score on the PSDS. These findings are consistent with the interview study 
(Chapter 5), where fatigue and anorexia were the second and third most frequently 
reported distressing symptoms. Interestingly, poor concentration was only reported as 
causing distress in 16% of the patient sample in the interview study compared with 37% 
in this sample; a further 27% reported the presence of the symptom but that it was not 
causing distress. It may be that when patients are asked to report symptoms 
spontaneously, without the aid of a checklist, concentration is not immediately reported, 
particularly if it is being affected; it has been demonstrated that the use of checklists 
results in greater numbers of symptoms reported compared with open discussion 
(Kookier, 1995). The findings of the analysis also support the findings of Holmes 
(1990) where tiredness was found to be a major predictor of variance in symptom 
distress, followed by mood and appetite, in a heterogeneous sample of 120 cancer 
patients. These findings appear to support the validity of the PSDS.
Multiple regression analysis can facilitate the reduction in the number of scale items as 
a significant prediction of the degree of symptom distress can be obtained by 
consideration of just four variables (concentration, appetite, thirst, and tiredness).
151
However, simplification of the scale to include only these factors would significantly 
reduce its value in both the clinical and research setting, as it would fail to identify the 
range of symptoms concerning individuals.
Stepwise regression is regarded by some as a controversial procedure, as there is no 
underlying theoretical or logical rationale to the entry or exclusion of variables in the 
equation. Decisions regarding entry into the analysis are based on statistical criteria. It 
may be useful in exploratory work but caution is required and replication with a second 
sample recommended (Polit, 1996). Additionally, a major consideration in the use of 
multiple regression analysis is sample size. Inadequate sample sizes can raise the risk of 
Type I and Type II errors, particularly if large numbers of independent variables are 
included in the analysis (Polit, 1996). Tabachnick and Fidell (1989) suggest that the 
minimum requirement is five times more cases than predictors but recommend that, for 
stepwise regression, a ratio of 40:1 is desirable. In this analysis the sample size was 98, 
thus just reaching the minimum number recommended. However, due to the relatively 
large number of independent variables used in the analysis the stability of the results is 
not assured and requires validation in future studies.
6.5.6.4 Factor analysis
Exploratory factor analysis was carried out as an aid to construct validation and to 
identify what dimensions underlie the correlations seen between items in the 
instruments. For the PSDS, factor 1 (Table 6-11) comprised items relating to the 
syndrome of asthenia (described in the fatigue literature as a syndrome characterising 
debility and weakness (Ingham and Portenoy, 1998). This suggests that this cluster of 
symptoms is a major contributor to changes in symptom distress and emphasises the 
importance of the need for self-assessment instruments as these symptoms cannot easily 
be identified and assessed by others. The second factor concerns gastrointestinal 
symptoms (nausea, vomiting and appetite). The third relates to skin complaints and sore 
mouth; interpretation of this factor may be confounded by the low endorsement of these 
items, which may account for their close correlations. From the pattern emerging from 
this study it appears that sub-scales could be constructed. However, when reliability 
analyses were carried out only the first two factors yielded acceptable reliability 
coefficients (Table 6-16).
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The results of this factor analysis when compared with that carried out on a symptom 
distress scale by Holmes (1990b) are interesting. Holmes (1990b) found that all 
symptoms, with the exception of diarrhoea, contributed equally to the variance in 
responses.
Table 6-16: Reliability coefficients for sub-scales identified from principal
components analysis of PSDS
Subscale: Cronbach’s 
coefficient a
Factor 1: 0.72
tiredness, weakness, shortness of breath, concentration,
drowsiness
Factor 2: 0.79
nausea, vomiting, appetite
Factor 3: 0.60
itchy skin, dry skin, sore mouth
Factor 4: 0.36
incontinence, constipation
Factor 5: 0.55
pain, dry mouth, thirst
In contrast, de Haes et al (1990) found in two studies, three factors tapping into different 
symptom areas: pain, fatigue and gastrointestinal complaints, whereas this distinction 
was not evident in a third study which yielded a physical factor comprising nearly all 
the physical items on the checklist. They suggest that the difference may be explained 
by the homogeneity of the populations studied as, in the first two studies, most subjects 
were undergoing chemotherapy and this may contribute to a distinct pattern in symptom 
experience leading to a defined dimensional structure; in comparison, the third study 
population was more heterogeneous. However, this explanation cannot be applied to the 
current work as a mixed factor pattern was obtained using a heterogeneous study 
population.
It may be that the pattern underlying physical distress is less stable as other researchers 
have found different dimensional structures associated with physical symptom distress 
(e.g. Schipper et al, 1984; Selby et al, 1984). The diverse findings of such studies, 
together with the inherent difficulties of comparing studies with heterogeneous 
populations or more homogeneous populations, at different stages of disease 
trajectories, prevents the formulation of a general model for the experience of physical
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symptom distress in cancer patients at this time. General theories such as the Theory of 
Unpleasant Symptoms, proposed by Lenz et al (1995, 1997), may make it easier to 
unify concepts across groups as they are considering more global determinants of the 
symptom experience.
Factor analysis of the RSCL yielded a factor structure showing four factors. Using 
Hammond’s (1995) criterion of interpretability, the first two factors appear to make the 
most theoretical sense. The first factor comprises five items relating to a psychological 
dimension (worry, anxiety, depressed, tense, irritability) and the variable sleep; and the 
second factor items relate to gastrointestinal symptoms and irritability. This 
gastrointestinal factor supports the findings of this factor in the PSDS factor analysis, 
contributing to the confidence that can be placed in the factor solution. The work of de 
Haes et al (1990), referred to earlier, identified a psychological dimension in the RSCL 
as a clearly discernible and stable dimension in all three of the studies reported. 
Reliability coefficients of the subscales derived from these studies were consistently 
high, as was the reliability in the current study.
Items included in the psychological factor were not, however, always the same in the 
three studies (de Haes et al, 1990). Irritability loaded onto the gastrointestinal factor in 
their first study, a finding replicated here. This can be explained on intuitive grounds in 
that gastrointestinal symptoms may lead to increased irritability. However, in the 
present work, irritability loaded onto the first three factors, suggesting that it is a less 
discriminating item that correlates with many symptoms. In this study, only five of the 
eight items that de Haes et al (1990) suggest comprise the psychological sub-scale 
loaded onto the first factor; the symptoms desperate feelings about the future, problems 
in concentrating and nervousness had very low item loadings. The different findings 
may be due to the different patient population used in this study from those in the de 
Haes et al studies, thus highlighting the importance of validation studies before 
instruments are used in populations which vary from those originally intended. 
Replication of this study in other palliative care populations is recommended in order to 
see if replication of the factor structure can be attained.
It is recognised that reliability and validity are not just properties of a measuring 
instrument, but also of the population in which they are used (Waltz et al, 1991).
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Thus further testing of reliability coefficients are required each time a measuring 
instrument is used in a different population.
6.5.7 Sensibility
Feinstein (1987) suggests that the basic scientific goal is sensibility, what he terms 
‘enlightened common sense’ (p. 144), which combines qualitative assessments with the 
quantitative measures of reliability and validity. Thus when considering the newly 
developed Physical Symptom Distress Scale (PSDS) and the Rotterdam Symptom 
Checklist (RSCL) as clinimetric measures, it is important to balance the, often 
statistical, assessment of the attributes of reliability and validity with more intuitive, 
qualitative and diverse assessment of how sensible the measure is in the clinical and 
research arena for which they were intended. Indeed, it is argued that if a measure 
cannot be judged to be sensible then expending effort in establishing reliability and 
validity is not warranted. Figure 6-6 (p. 155) illustrates the features that Feinstein (1987) 
suggests require consideration when appraising the sensibility of an index and this will 
provide a framework for the remainder of the discussion.
6.5.7.1 Purpose and framework
It is essential when evaluating a measurement tool to be clear what it is intended to do, 
if one is to determine how well it is serving its purpose. The PSDS was developed 
following the identification of a need for measurement instruments for assessing 
symptom distress in cancer patients at the end stages of life, which would include 
symptoms related to terminal dehydration. Such an instrument could then be used in 
epidemiological and experimental research in this important area of clinical practice 
(see Chapters 1 and 2). Feinstein (1987) suggests that there are different ways of 
classifying the purpose of clinimetric instruments. Those which pertain to the PSDS are:
(1) as a status index, whereby the scale would permit description and rating of clinical 
conditions (acting as both a ‘noun’ indicating the presence or absence of symptoms and 
as an ‘adjective’, denoting the magnitude/degree of distress caused by the symptoms);
(2) potentially as an index of change, whereby ratings pre and post intervention could be 
compared. Thus the PSDS was conceived as a tool for the description and rating of 
symptom distress which could be used as an indicator of change in both clinical and 
research settings.
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Figure 6-6: Features to be considered in appraisal of the sensibility of an index 
(adapted from Feinstein, 1987, p. 166)
- Clinical functions
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Clinical applicability
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Evaluation also involves considering the framework or context of the clinical setting in 
which the instrument is to be employed. In this case the framework was a palliative care 
in-patient setting. This has implications when considering the applicability of the tool in 
other settings. The clinical justification for the tool was provided through the 
discussions in Chapter 3 and 4. Thus it is argued that the PSDS has a framework and 
purpose in its development.
6.5.7.2 Comprehensibility
Comprehensibility concerns the coherence and clarity of a measure. There are no gold 
standards for the assessment of comprehensibility but the PSDS scale and the RSCL 
have a simple scoring system. Feinstein (1987) suggests that a numerical rating scale is 
usually easier to comprehend than an array of adjectives. However, for patient- 
completed questionnaires, it was felt that the descriptors were necessary as an aid to 
respondents whose concentration was known to be problematic (Sutcliffe and Holmes,
1990). Subjects appeared to find the scoring simple and quick to use.
A further method of keeping a scale simple and understandable is to limit the number of 
variables contained in a scale (termed oligiovariability by Feinstein (1987)). The PSDS 
contains 16 variables and the RSCL 31. Respondents found the length of both 
acceptable; some commented that they preferred the shorter PSDS but in contrast others 
reported preferring the RSCL, as it appeared more complete by covering both 
psychological and physical variables.
6.5.7.3 Replicability
According to Feinstein (1987), evaluation of this property concerns the ability of others 
to discern what is required of them in completing the rating scale. Both instruments 
have similar instructions and both researchers felt that subjects, despite being very ill, 
were able to comprehend both scales. In clinimetric evaluation, this property is 
considered to be distinct and different from the principle of consistency (often termed 
reliability or reproducibility) and is a qualitative judgement (Feinstein, 1987). An issue 
arising occasionally was subjects asking the researcher’s what they felt they should 
answer; for example, a patient who had difficulty deciding which category to mark said: 
“what do you think I should say nurse?”. After reiteration that the purpose was self- 
assessment the respondent completed the questionnaire. It is possible that this response
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could be reflecting difficulty in concentrating, a symptom identified in the population 
under study, and not be a reflection on the clarity of the questionnaire.
A further aspect of replicability in patient self-assessment is the role of support provided 
by the interviewer. It was felt that, for many of the patients, it would not have been 
suitable for them to complete the questionnaires unaided as many subjects were too 
unwell to write their own responses, thus training of researchers to administer the 
questionnaires in a consistent manner was important. It was felt that consistency was 
achieved, although it was easy to see how with more ill patients it was tempting to 
intervene on their behalf; this could affect the meaningfulness of results. This, however, 
is a property of the sample and not the instrument itself and would apply whenever the 
instrument is used.
6.5.7.4 Suitability o f scale
This is assessed by two considerations: first, the comprehensiveness of the scale -  thus 
the scale should have an exhaustive scope of categories and be mutually exclusive. Both 
scales fulfilled these criteria. Secondly, the scales should enable discrimination, either 
between people, or between different states in the same person (Feinstein, 1987). If a 
scale fails to discriminate differences in the underlying attribute its usefulness will be 
limited. The results demonstrated that the scales were able to discriminate between 
people of different age groups and between those who were at different points in their 
dying trajectory. Further testing of discriminatory function is required in future studies.
When considering the issue of response categories one has to take into account the 
respondents’ ability to discriminate meaningfully. The four and five point scales did not 
appear to pose difficulties in discrimination for subjects and the item distribution 
analysis supports their utility (Table 6-4).
Selection of the two-day time frame for consideration of symptoms appeared 
meaningful and no patients reported difficulties in this area. The choice of two days was 
based on the underlying premise that symptom distress in a dynamic construct and, as 
such, can be expected to fluctuate (Rhodes and Watson, 1987). DeVellis (1991) 
supports the use of theory to guide time frame selection as arbitrary selection can affect 
the meaningfulness of the results. De Haes et al (1990) found that a time frame of one 
week was meaningful for cancer patients; however, it was reduced for this study as it
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was felt that, in a very ill population with known concentration difficulties, limiting the 
time frame would enable more accurate reflection by participants. The purpose and 
framework of the scale also need to be held in mind when evaluating this facet; 
therefore as the instrument was designed for use in very ill patients, a short time frame 
is desirable as attrition, for whatever cause, in longitudinal studies using palliative care 
populations is a known hazard (McWhinney, 1994). Further validation studies 
considering shorter time frames (e.g. daily or twice daily) are recommended, 
particularly if the tool is also to be used as a clinical index.
6.5.7.5 Face validity
Face validity suggests that the scale appears to measure what it purports to measure. 
Since no one really knows what measures ought to look like the concept has little use 
(Barker Bausell, 1986 p.213). However, Kline (1986) accepts that face validity bears no 
relationship to true validity but suggests that it is important to the extent that subjects 
will not generally co-operate in tests that lack face validity regarding them as lacking 
integrity. Thus achieving face validity increases the acceptability of an instrument to its 
users as the items appear relevant (Streiner and Norman, 1989). However, it is often 
given brief attention in the evaluation of scales as it is a qualitative judgement and 
cannot be assessed with statistical measures. Feinstein’s (1987) framework for appraisal 
of face validity asks first if the focus of evidence is appropriate for the task. The PSDS 
is based on intrinsic evidence -  the direct assessment of symptoms - as opposed to 
extrinsic evidence such as the functional impact of the symptoms on the patient. This 
evidence base can be justified by considering the framework of the scale; the purpose of 
assessing symptom distress and the intrinsic evidence base are in agreement. The RSCL 
in its original format relies on both intrinsic evidence in the psychological and physical 
symptom subscales and extrinsic evidence in the section assessing functional ability; 
again these are supported by the theoretical underpinnings of the scales (de Haes et al, 
1990).
A further element of appraisal with respect to face validity is the biologic coherence of 
the component of the instrument (Feinstein, 1987). This refers to the aggregation of the 
individual items and considers if the total scores have meaning and clinical 
interpretability. For both scales the aggregate scores are based on summation of
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individual symptom scores and do not include other variables that would be difficult to 
interpret. Thus the requirement of biologic coherence is met.
Finally, attention to personal collaboration is required (Feinstein, 1987). The question of 
whether the respondents’ motivation, effort and support might affect the results was 
considered; variations in results would be difficult to interpret if they did. Self­
completion questionnaires should overcome some of the difficulties associated with 
these aspects but consideration of the presence of the researcher and the potential for the 
introduction of bias could not be ruled out.
6.5.7.6 Content validity
Content validity is a concept regarding the adequacy of the item sampling; it is the 
extent to which the instrument includes the relevant content or domains (Nunnally and 
Bernstein, 1994). The assurance of content validity becomes more difficult as the 
degree of abstraction of the measurement increases. When considering symptom 
distress there is a finite but very large range of potential symptoms that may contribute 
to symptom distress. Content validation of the scale may be assessed through the use of 
'experts' (such as experienced health care professionals working with dying patients), 
through the subjects used in the scale testing and from the literature. In this study it was 
ensured by inclusion of items identified in the qualitative study (Chapter 5) and in the 
literature and confirmed by questioning participants after they had been included in the 
study. Results from the PSDS showed that the symptoms causing most distress were 
weakness, tiredness, dry mouth, poor concentration and pain and these are consistent 
with those identified in the earlier study (Chapter 5) thus appearing to support the 
validity of the instrument. The questions asked of participants following their 
completion of the questionnaire asked for any symptoms that were distressing the 
patient but had been omitted. There were no consistently mentioned symptoms. 
Similarly, respondents were asked if they felt any items were distressing, unimportant or 
inappropriate. There were no items on the PSDS that appeared troublesome but sexual 
functioning was mentioned on the RSCL and difficulties in this item were reflected in 
the frequency distribution and number of missing responses.
There was concern from both the researcher and research assistant regarding the ability 
of many of the subjects to comment meaningfully on the content of the scales. The
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exhaustion that many subjects appeared to experience following completion of the two 
scales and any ensuing discussion/emotional release triggered by items, meant that they 
often wanted to stop talking and not go through the debriefing questionnaire. Thus the 
perceived acceptance of the scale content may be due to subjects being too tired to 
reflect; alternatively, it could be attributable to patients feeling unable to be negative 
about the research for fear of being seen to be critical of the care they were receiving 
(see Chapter 8 for further discussion). Thus the absence of comments regarding content 
(accept for the item regarding sexual interest) should be interpreted with caution and 
future studies should continue to address this evaluation area.
At the exploratory stage of scale development the weighting of individual components 
was not considered. However, this is a particularly cogent issue as the importance of 
each component variable may be rated differently by individual patients (Feinstein, 
1987). It could be suggested that the scoring of distress in the PSDS overcomes this 
problem to some extent as the patient is not rating symptom occurrence but how much 
the symptom is distressing them.
There may need to be some trade-off between the content validity of a scale and its 
internal consistency. If the construct being measured is relatively heterogeneous or 
multi-dimensional then it is possible that the scale will have low internal consistency as 
not all the items will correlate well with each other. If items that are not highly inter­
correlated are eliminated to increase internal consistency then the measure may tap only 
one part of the construct and have a much-reduced content validity (Streiner and 
Norman, 1989). It is necessary to be aware of the purpose of the scale and, as such, to 
determine whether high content validity or internal consistency are priorities. Internal 
consistency was acceptable for the PSDS, although it could be increased by methods as 
suggested above. However, there are a wide range of symptoms that can be experienced 
by dying cancer patients and not all will be highly correlated with each other; 
consequently accepting this level of internal consistency is felt to be appropriate.
6.5.7.7 Ease o f usage
Both the PSDS and RSCL were quick and easy to use. However, a further consideration 
is that of the concomitant effort or hazards associated with completing the scales 
(Feinstein, 1987). Many of the subjects were very ill and, as such, found taking part in
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the study quite exhausting. Additionally, completing the scales caused some patients to 
express emotion and distress at their deteriorating condition and focusing on symptoms 
appeared to be a negative experience. Although one could argue that the opportunity to 
openly acknowledge changes in condition and deteriorating condition could be cathartic 
and serve a therapeutic function, it has to be considered that the use of what may appear 
to professionals to be a simple and quick assessment instrument may have a far greater 
impact on the individual being assessed than would be anticipated. This becomes an 
increasingly relevant issue if one is considering the use of the scale in patients up until 
the time of death, or until their cognitive state prevents self-assessment.
6.6 Conclusions and areas for future research
Measurement is a vital aspect of palliative care research and poor measurement or 
inappropriate use of measurement instruments shrouds research findings in ambiguity. 
This study of a newly developed Physical Symptom Distress Scale (PSDS) and the 
Rotterdam Symptom Checklist (RSCL) demonstrates that both scales have acceptable 
reliability and evaluation of sensibility was adequate, supporting their acceptability to, 
and feasibility in, this vulnerable population. The PSDS may have an advantage over 
the RSCL in its scoring, which appears to help distinguish and assess symptom distress 
more than symptom occurrence or severity. Additionally, some items on the RSCL 
appear to be less appropriate for use in very ill populations (e.g. hair loss, sore eyes, 
shivering, tingling hands/feet), supported by their poor item endorsement and 
information from the interviews and debriefing questions. The PSDS includes items felt 
to pertain to terminal dehydration and, as such, could be said to provide a more sensitive 
tool for investigation into this clinical problem. It also has the advantage of being 
shorter and quicker, increasing its acceptability and feasibility in patients near to death. 
Nevertheless, this last point has to be offset with the reduction in information obtained 
(particularly the psychological symptoms). Thus the PSDS is not put forward as a 
replacement for the RSCL but as an alternative with the advantages of providing a more 
appropriate outcome measure for symptoms pertaining to the issue of terminal 
dehydration and a scaling system that reflects symptom distress more than occurrence or 
severity. However, further validation studies are required for both instruments if they 
are to be used in palliative care populations with any confidence.
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The substantial proportion of the population who were unsuitable for inclusion in the 
study, due to cognitive impairment, severe symptoms, decreased level of consciousness 
or who were too unwell, indicates the need for the development of measures to assess 
symptom distress by means other than self-assessment. The following chapter describes 
a study to develop a measurement instrument using behavioural indices of symptom 
distress.
163
7 The development of a scale for nurse assessment of 
symptom distress
7.1 Background
During interviews with dying patients and professional carers it became apparent that, 
towards the final stages of the dying trajectory, there would be many patients who 
would be unable to complete a self-assessment instrument regarding their symptom 
distress (Chapters 5 and 6). Causes of this included decreased level of consciousness, 
severe fatigue, weakness, or other severe symptoms, lack of concentration and mental 
impairment. Within palliative care, the preference is for patient self-assessment of his or 
her condition and symptom experience since, as Neugarten et al (1961) have observed, 
“the individual can be the only proper judge of his well-being”. However, if symptom 
distress is to be assessed in the final stages of life, in order to address important areas 
such as symptoms associated with dehydration or its treatment with artificial hydration 
therapies (Chapter 2), alternative reliable and valid methods of assessment must be 
found.
An alternative to self-assessment is assessment by proxy, where a professional carer (or 
other person) rates a patient for whatever is being measured. This technique has been 
employed, for example, in quality of life measures (e.g. Kamofsky et al, 1948, Spitzer et 
al, 1981) and in the measurement of symptom distress (e.g. Larson et al, 1993). 
However, studies have indicated that such assessment of a patient may not be reliable. 
For example, Camp (1988) found that nurses’ documented assessment of patients’ pain 
did not always agree with the cancer patients’ descriptions of pain, when 30 nurse- 
patient dyads were studied. As patient ratings were compared with nurse documentation 
the findings may reflect an inadequacy in documentation and not incongruity between 
patient and nurse assessments. However, other workers have demonstrated 
disagreements in ratings. For example, Holmes and Ebum (1989) compared nurses' and 
patients' perceptions of symptom distress, using a symptom distress scale based on a 
linear-analogue self-assessment (LASA) scale. Findings indicated that nurses were 
significantly more likely to overestimate the degree of distress caused by some 
symptoms such as pain, nausea, loss of appetite, sleep, concentration, and mood. This 
contrasts with the work of Hunt et al (1977) who found that nurses tended to 
underestimate the level of the patient's pain, and Grossman et al (1991) who
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demonstrated poor agreement between patient and health care professionals (nurses and 
doctors).
Larson et al (1993) compared the perceived symptom distress of patients undergoing 
bone marrow transplants and the nurses caring for them, using the McCorkle and Young 
symptom distress scale (McCorkle and Young, 1978). The results indicated that patients 
perceived significantly more distress from their symptoms within 48 hours of their 
transplant than the nurses did. Similarly, Tanghe et al (1998) studied 189 patients’ 
evaluation of symptom occurrence and distress and 51 nurses who were caring for these 
patients who were undergoing chemotherapy. Again, nurses underestimated the 
majority of symptoms. The highest agreement was for alopecia, nausea and vomiting, 
and the weakest agreement for less observable symptoms such as fatigue. Since patients 
completed their assessment while waiting for their chemotherapy and nurses completed 
theirs at the end of the shift, the difference in the timing of assessments may have 
affected the results obtained, as symptoms may change quite rapidly.
Thus, it cannot be demonstrated that nurse assessments of patient symptom distress are 
reliable. It is suggested that when caring for unconscious dying patients, the nurses’ 
interpretation of the patients’ degree of distress is dependent on the individual 
perceptions of the nurse about the state of unconsciousness and significance of 
individual symptoms. This may contribute to the unreliability of assessments and 
indicates the need to examine alternative methods of measurements.
An alternative to measurement of symptom distress is the use of behavioural 
assessment. It can be argued that assessment of external signs may offer a more 
objective approach than assessment of symptoms, which are recognised as inherently 
subjective (although some are apparent to someone other than the individual 
experiencing them (e.g. vomiting or sweating) (see Chapter 4, Section 4.2)). Research 
using behavioural assessment of symptom distress has not previously been attempted in 
cancer or palliative care populations. There have, however, been studies using 
behavioural approaches to assess pain, a symptom often included in symptom distress 
scales (e.g. Chambers and Price, 1967; Teske et al, 1983; Keefe et al, 1985; McDaniel et 
al, 1986; Coffman et al, 1997). Items in behavioural pain scales include attention, 
anxiety, restlessness, tenseness, frowns, perspiration, cries and groans, and guarded 
movement. Teske et al (1983) found high agreement between nurses when observing
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pain, but low correlations between nurses’ judgements and patients’ self-assessments of 
pain.
Chapko et al (1991) developed a behavioural measure of mouth pain, nausea, and 
wellness for patients receiving radiotherapy and chemotherapy. Although the 
behavioural scale rated by nurses correlated well with self-reports of patients, in 
contrast to the findings of Teske et al (1983), no data is given regarding inter-rater 
reliability of nursing assessment, limiting interpretation. In addition, the sample was 
small (n = 8) limiting the ability to generalise from the findings. The behavioural items 
developed for this scale correspond to behaviours exhibited by patients who are at an 
earlier stage of their disease trajectory. As such, they cannot be directly transferred for 
use in a population much closer to death and with limited activity and conscious 
impairment.
Hurley et al (1992) developed an objective scale to measure discomfort in non- 
communicative patients with advanced Alzheimer’s disease. The nine item scale 
(comprising noisy breathing, negative vocalisation, absence of look of contentment, 
looking sad, looking frightened, frowning, absence of relaxed body posture, looking 
tense and fidgeting) demonstrated content validity, good internal consistency, and high 
inter-rater reliability. The behavioural items used in this scale, again, cannot be directly 
transferred for use in a dying palliative care population. However, these studies suggest 
that the behavioural approach to assessment of distress may be appropriate and possible.
Nurses assess patients using both verbal and non-verbal cues. When caring for the dying 
patient who is unable to verbalise, observable actions (behaviours) and physiological 
signs may give cues regarding the presence or absence of distress. Such behavioural 
indicators may be more reliable than a rating of perceived degree of distress by nurses, 
which may include considerable inferential and subjective processes. This study 
investigated nurses' use of observable indices of distress in the dying patient.
7.2 Method
7.2.1 Design and aims
A non-randomised, cross-sectional design was used to test the reliability and validity of 
an instrument developed for nurses to assess behavioural indicators of symptom distress
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in patients for whom self-assessment is not possible, in a sample of dying cancer 
patients. If the behavioural scale could be demonstrated to be reliable and valid then 
further methods to explore the relationship between behavioural indices of distress and 
the perceived causes of that distress could be developed. These in turn could be used to 
investigate clinical effects of dehydration and the use of AHT in dying patients.
7.2.2 Instrument development
Discussion groups were held with palliative care nurses from two palliative care units 
(varying experience in palliative care from 6 months to 15 years, median time 3 years), 
during which participants were encouraged to discuss the cues used to assess symptom 
distress in patients from whom verbal information cannot be obtained. In particular, 
participants were asked to consider cues used to assess signs of discomfort that could be 
attributed to terminal dehydration or AHT. As it was not possible to record the meetings 
verbatim detailed notes of the main themes arising were recorded. The behaviours and 
signs identified were included as items in a behavioural (observable) assessment scale, 
the Nurse Assessment of Symptom Distress Scale (NASD). The use of a dichotomous 
scale (item present or absent) was considered; however, nurses referred to the frequency 
or intensity of an item as contributing to their assessment of symptom distress. 
Consequently, a scale including elements of magnitude was selected. Scaling intervals 
were selected as “none”, “a little”, “quite a bit” and “very much” to reflect the scoring 
used in many self-assessment scales (e.g. RSCL, see Chapter 6). Figure 7-1 indicates 
the first version of the Nurse Assessment of Symptom Distress Scale (NASD).
7.2.3 Sample
A non-probability sample of qualified nurses caring for patients who were dying of 
malignant disease, considered by professional carers to be in the last week of life, and 
who would be unable to complete a self-assessment due to decreased level of 
consciousness, mental impairment, severe weakness or fatigue, was obtained from two 
palliative care in-patient units. Two units were used for data collection in order to 
reduce the potential for bias to be introduced by the selection of one institution. A 
convenience sample of a minimum of 100 assessments was required for preliminary 
analysis.
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Figure 7-1: The Nurses’ Assessment of Symptom Distress Scale (NASD)
D ate   T im e____  Patient Num ber
Please complete this patient assessment after you have been caring for the patient:
Behaviours observed Frequency
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Frowning
Grimacing
Licking lips
Sucking on mouth sponges
Vocalisation - moan/groan
Movement of legs
Movement of arms
Plucking at air or sheets with hands
Sweating
Tachypnoea - breathing rate fast 
(>20 per minute)
Tachycardia: (pulse >100 per minute)
Twitching
Noisy chest secretions: 
Rattling, congestion,
Startles - eyes suddenly open, body jerks 1-
Other: 1
Please note how long you were with the patient and what you did for the patient: 
Name of nurse assessing:__________________
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7.2.4 Access and ethical considerations
Access to nurses was negotiated through the Senior Nurse Managers of the in-patient 
units. Ethics Committee approval was obtained. The researcher approached ward nurses 
and informed them of the study. It was not possible to ensure that all patients fulfilling 
the entry criteria were assessed, as participation in the study, by nurses, was voluntary.
7.2.5 Instruments and procedure
When patients met the inclusion criteria (see section 7.2.3), two qualified nurses who 
had cared for the patient over the same time period (e.g. carrying out a bed bath 
together, turning a patient, carrying out mouth care) completed the Nurse Assessment of 
Symptom Distress Scale (NASD) forms individually, without conferring. This was 
necessary for testing the inter-rater reliability of the measurement instrument. 
Additional data was collected regarding demographic details of the patient assessed.
7.2.6 Data analysis
Data was coded and transferred to a computer for statistical analysis using the Statistical 
Package for Social Sciences (SPSS®). Descriptive statistics were used to describe the 
sample. Item responses were scored from 0 (none) to 4 (very often). Items were 
summed to give a total score for behaviours of distress (minimum = 0, maximum = 56). 
Reliability of the scale was estimated by the determination of internal consistency 
(Cronbach's coefficient alpha) (Cronbach, 1951). Inter-rater reliability was assessed 
using the kappa correlation coefficient (Cohen, 1960), a non-parametric statistic used 
for data not normally distributed (see Chapter 5, section 5.5.22). Content validity of the 
behavioural indicator scale was assessed by enabling nurses to note on the instrument 
any sign/observable item that they were using to assess the condition of the patient that 
was not included in the scale.
7.3 R esu lts
The original entry criteria indicated assessments were to be made by two qualified 
nurses who had been caring for the same patient over a four-hour period (corresponding 
to natural shift patterns). However, it was quickly evident that, due to the nursing skill 
mix, it was infrequent for two qualified nurses to be caring for the same patient (the 
usual occurrence being a qualified nurse working with a health care assistant). It was
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important to keep assessments to qualified nurses only at this stage of scale 
development in order to reduce possible confounding variables. Additionally, the four- 
hour time period for care was indiscriminate. The two nurses were not necessarily 
seeing the patient at the same time (e.g. one nurse was with a patient for 40 minutes 
carrying out a bed-bath and the second nurse gave assistance with turning, thus only 
observing the patient for 5 minutes). This meant that differences in assessment could not 
be usefully interpreted; they could be attributed to unreliability in the scale or to the fact 
that nurses were observing the patient for different length of times, during which their 
condition had changed. Consequently, the entry criterion was altered to specify 
assessment over any period, as long as the nurses had been present at the same time.
Slow data collection was a difficulty experienced, despite repeated encouragement and 
raising awareness of the study by the researcher, and data collection was terminated 
after 83 pairs of assessments were completed on 42 patients (some patients had multiple 
assessments, carried out at different times). Nineteen of the patients were males and 23 
females; median age of the patients was 72 years. All patients had a diagnosis of 
malignant disease and 65% had metastatic disease. The time that pairs of nurses spent 
with patients, after which they assessed them, ranged from three to sixty minutes, with a 
mean time of 14 minutes (SD 10.2).
7.3.1 Content validity
Nurses using the assessment forms reported that they felt the items included were 
relevant. Exceptions to this were the items tachypnoea and tachycardia, which some felt 
were not regularly assessed unless they were prompted to do so for another reason. The 
use of the option to note “not recorded” aided the interpretability of this. No nurse 
added other items to the scale or stated that they felt a useful behavioural or 
physiological item was missing.
7.3.2 Item analysis
Frequency analysis of the data distribution showed that item endorsement and item 
distribution were poor. Table 7-1 shows that for seven of the fourteen indices (marked 
with *) less than one-third of the items were recorded as present (in any quantity) and, 
for a further two items (sucking sponges and tachycardia), less than 40% were endorsed. 
Items such as licking lips and plucking were virtually never recorded. The items
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Table 7-1: Frequency of endorsement of responses to items on NASD scale 
(scoring one (on movement) or more).
Item Nurse 1 Group 
(%)
Nurse 2 Group 
(%)
Licking lips* 6 2
Moving legs* 18 22
Moving arms* 26 30
Plucking* 4 6
Sweating* 23 28
Twitching* 6 14
Sucking sponges 35 32
Tachypnoea* 34 36
Tachycardia 40 ' 42
Grimacing 49 48
Frowning 47 60
Vocalisation 55 58
Noisy chest 48 46
Startling 40 47
N  = 83 except: 
Sucking sponges n = 71 n = 56
Tachypnoea n = 41 n -  44
Tachycardia n -  34 n = 26
*items endorsed (present at any level) in less than one third o f assessments
tachypnoea and tachycardia were not assessed in all instances as vital signs are not 
recorded routinely in the palliative care units studied. Tachypnoea was assessed in 51% 
of cases and tachycardia in 36% of cases. Mouth care was carried out in 77% of 
instances and hence assessment regarding sucking sponges was made on these 
occasions.
Total scores reflected this poor item endorsement demonstrating a range from 0 - 3 2  
(theoretical range 0 -56), with a mean total score of 6.4 (SD 4.8).
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Five of the items showed greater item endorsement but the distribution was very 
skewed. Figure 7-2 shows the distribution response for grimacing and there was 
clustering of items into none or on movement categories. Frowning (Figure 7-3), 
vocalisation (Figure 7-4) and startling (Figure 7-5) show similar patterns of distribution. 
Noisy chest (Figure 7-6) was the only item to show better distribution. (The histograms 
present distributions from the series of pairs of nurses assessing patients. Nurse 1 is the 
distribution of ratings for the first nurses in the pairs and Nurse 2 represents the group of 
second nurses.)
Figure 7-2: Distribution of responses to frowning
6 0 /
%
□ none
□ on movement
□ occasionally
□ quite often 
B very often
nurse 1 nurse 2
Figure 7-3: Distribution of responses to grimacing
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□ on movement
□  occasionally
□  quite often 
B very often
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Figure 7-4: Distribution of responses to vocalisation
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□ on movement
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Figure 7-5: Distribution of responses to startling
□ none
□ on movement
□ occasionally
□  quite often 
■  very often
nurse 1 nurse 2
Figure 7- 6: Distribution of responses to noisy chest
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7.3.3 Reliability
Inter-rater reliability was assessed using non-parametric correlation coefficients, as the 
scale did not meet the assumptions necessary for parametric testing. Cohen’s kappa 
(Cohen, 1960) was used as a measure of agreement between raters’ assessments, 
excluding that which would have occurred by chance (see p.79). Table 7-2 shows that 
correlation coefficients reached statistical significance for all the items except plucking 
and twitching.
Table 7-2: Correlation coefficients for evaluation of inter-rater reliability for 
nurses9 assessment of behavioural indices.
Indicator Kappa Indicator Kappa
frowning 0.55* moving arms 0.43*
grimacing 0.57* moving legs 0.66*
vocalisation 0.49* plucking -0.02
chestiness 0.66* sweating 0.61*
startling 0.44* tachypnoea 0.33*
licking lips 0.59* tachycardia 0.48*
sucking sponges 0.56* twitching 0.10
*p< 0.001
Statistical significance, although indicating agreement is greater than would be expected 
by chance, does not indicate strength of agreement. Fleiss (1971) suggests an arbitrary 
distinction between Kappa values (Table 7-3) which assess the strength of agreement 
that different kappa values indicate. Thus, the coefficients scoring 0.44 -  0.66 indicate 
fair to good agreement on twelve items but the items twitching and plucking 
demonstrate poor inter-rater reliability. However, the low item endorsement must be 
remembered when interpreting these results.
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Table 7-3: The strength of agreement of Kappa values (from Fleiss, 1971)
Kappa Strength of agreement
<0.00 Very poor (less than chance)
<0.40 Poor
0.40 - 0.60 Fair
0.60 - 0.75 Good
> 0.75 Excellent
Internal consistency of the fourteen items was calculated, using Cronbach’s coefficient 
alpha (a) for each set of observers and for all observers taken together (Table 7-4). The 
reliability coefficients are only moderate.
Table 7-4: Internal reliability of NASD scale
Cronbach’s a
Nurse 1 0.50
Nurse 2 0.64
All observers 0.58
Principal components analysis was used in order to examine the factor structure of the 
scale. Using a minimum eigenvalue of 1.0 for the extraction of factors, varimax rotation 
was used to obtain the final factor structure. Six factors were extracted with a minimum 
eigenvalue of 1.0 but examination of Cattell’s scree plot suggested that four factors be 
retained; these accounted for 50.5% of the variance (Table 7-5).
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Table 7-5: Factor structure of the NASD scale (N = 83)
Factor Loadings
Factor dimension 
and items
FI F2 F3 F4 Communality
Limb movement 
Moving arms .89 -.01 -.02 .07 .78
Moving legs .84 .17 -.03 .10 .79
Facial expression 
Grimacing -.03 .89 .17 -.01 .80
Frowning A l .82 -.13 -.13 .74
Physiological signs 
Tachypnoea -.04 -.02 .86 -.06 .75
Tachycardia .03 -.05 .84 -.08 .74
Factor 4 
Licking lips .16 -.16 -.02 .77 .65
Sucking sponges -.02 .07 -.06 .76 .61
Twitching .05 -.02 -.51 .62 .67
Eigenvalue 2.45 2.20 1.86 1.20
% variance 13.4 12.6 12.6 11.9
explained
Cumulative variance 13.4 26.0 28.6 50.5
The first factor that accounted for 13.4% of the variance concerned movement of limbs. 
The second factor had two items loading highly and concerned facial expression. The 
third factor, accounting for a further 11.9% of the variance, concerned the physiological 
signs of tachypnoea and tachycardia. Three items loaded highly onto the fourth factor
and these were licking lips, sucking sponges, and twitching. A descriptor for this factor 
could not easily by identified. However, the dimensions of the first three factors were 
very interpretable. Again the results of the factor analysis need to be interpreted with 
caution again, as the low item endorsement seen in many of the variables may affect the 
reliability of the analysis.
7.4 Discussion
The purpose of this pilot study was to develop an observer-rated behavioural scale to 
measure symptom distress in dying cancer patients in whom self-assessment is not 
possible. No instrument existed which was suitable for this purpose. If the behavioural 
scale could be demonstrated to be reliable and valid then further methods to explore the 
relationship between behavioural indices of distress and the perceived causes of that 
distress could be developed.
The initial stage of the study used a qualitative approach involving experienced 
palliative care nurses, who had witnessed many deaths, to ensure that the items 
developed had strong face validity. Additionally, the scale was discussed with two 
senior palliative care physicians who were in agreement with the format and content of 
the instrument. It became clear from the discussion groups that there was much 
variation in the interpretation of symptom distress among staff. This supported the 
development of an instrument based on observable signs, an approach utilising 
measures that are more objective. The items included were developed from the 
experience of the clinicians and, as such, were acceptable to nurses participating in the 
study. In addition to the strong face validity, the scale yielded an underlying factor 
structure that made sense to clinicians. This supports the validity of the instrument.
Analysis of item endorsement demonstrated that nine of the fourteen indices selected for 
inclusion in the scale were poorly endorsed. Distribution of responses in four of the 
remaining five indices (frowning, grimacing, vocalisation, and startling) which showed 
better endorsement was poor, with skewed responses towards ‘none’ or ‘on movement’. 
Only the item noisy chest demonstrated fair distribution across the response categories. 
Inter-rater reliability was fair or good for all indices except for plucking and twitching, 
however these results require cautious interpretation due to the high number of items 
scoring zero.
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The poor item endorsement was surprising given that the items selected for inclusion 
were suggested by groups of nurses representative of the nurses actually using the scale. 
Consideration also needs to be given to the question of whether the results are an 
artefact of the sample studied - were the patients assessed representative of the patient 
population?
It was only possible to obtain a convenience sample, with the nurses asked to include as 
many patients fulfilling the entry criteria as possible (it was not possible to ensure all 
dying patients were assessed, due to the voluntary nature of nurse participation which 
was a requirement of access to the units). Therefore, as not all potentially eligible 
patients were included in the study, there was a possibility that the selection of patients 
by the nurses introduced bias. In future studies, it would be beneficial to sample all 
possible patients in the research setting or to select a random sample of that population.
This limitation on the sampling process was difficult. As mentioned previously, getting 
nurses to complete the assessment forms proved difficult. Overt resistance to the study 
was not met. However, nurses needed constant reminding and, despite the researcher 
maintaining the profile of the study in the clinical areas, nurses frequently stated that 
they were too busy to complete the forms or that they forgot until it was too late to 
remember the detail. If a researcher is employed within an organisation it may be less 
difficult to introduce research protocols which entail data collection on all patients (e.g. 
Jones et al, 1998). It was impossible to anticipate the difficulties experienced in 
obtaining assessments.
Patient demographics for the sample not included were analysed to see if any obvious 
bias was apparent. It was only possible to do this at one data collection site (accounting 
for 74% of the sample obtained). In this palliative care unit, 57% of all patients dying 
over a three month period had at least one assessment carried out. There were no 
significant differences between age, gender, or diagnosis in the patients included for 
assessment and those not included. However, there may have been selection bias with 
regard to ease of symptom control; perhaps nurses only selected those who were more 
settled and appeared to require less intervention. It was not possible to assess this.
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For the items that were endorsed with some frequency, the distribution of responses was 
low, with the majority of assessments scoring ‘on movement’. This could indicate that 
the scale is not sensitive enough. An alternative interpretation is that the findings may 
be indicative of a high degree of symptom control, with patients exhibiting few 
observable signs of distress. It may be that if this scale had been used in a general, acute 
hospital setting, rather than in specialist palliative care, then the results may have been 
different. However, one may argue that patients referred to specialist palliative care 
units experience symptoms that are more difficult to control and, as such, one could 
expect such a sample to demonstrate greater distribution of responses. Further testing in 
different patient populations would enable investigation of these arguments.
An issue that confronts researchers and health care professionals is the extent to which 
proxies provide information on patient symptom experiences that is comparable to that 
of patients. The empirical studies referred to earlier indicate that perceptions of health­
care professionals’ and patients’ assessments of symptoms are often incongruent (e.g. 
Holmes and Ebum, 1989; Larson et al, 1993; Peruselli et al, 1993). With a different 
approach, Lobchuk and Kristjanson (1997) carried out a study to compare 
interpretations of family caregiver and patient interpretations of symptom distress. 
Thirty-seven patients with lung cancer and their family caregivers completed the 
McCorkle and Young Symptom Distress Scale (1978). Levels of agreement between 
patient and caregiver ratings were moderate for fatigue, appetite, pain frequency, cough, 
nausea frequency, insomnia and breathing but poor or no different from chance for the 
remaining six items. Despite finding a consistent discrepancy between symptom distress 
ratings (family care-givers rated patients symptoms as more distressing than did 
patients), the authors suggest that, as the mean difference between scores of patients and 
family care-givers was small, the discrepancy may be clinically insignificant and 
caregivers may provide a reasonably accurate source of information. Lobchuk and 
Kristjanson’s work (1997) is limited by the small sample size and the inherent bias 
present in the sample, which only includes patients who are not cognitively impaired. 
Thus the very patients for whom self-assessment is not possible cannot be assessed. 
However, the question of how much agreement is sufficient to allow for the valid use of 
proxies is posed. This question has not been adequately addressed in the literature and 
warrants further attention.
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This current study used behavioural and physiological signs of distress as a precursor to 
more global assessment of symptom distress, in an attempt to obtain data that are more 
reliable. It was hypothesised that these indicators would be less open to interpretation 
and therefore yield higher reliability coefficients. Indeed, twelve of the items of the 
NASD Scale demonstrated moderate to good inter-rater reliability (although the low 
item endorsement must be remembered when interpreting this), indicating that this 
approach has advantages.
Jones et al (1998) have recently developed an instrument to measure terminal 
restlessness in dying hospice patients. Possible causes of restlessness or agitation in the 
terminal phase of cancer patients’ lives include physical causes (such as constipation, 
full bladder, dyspnoea, cerebral metastases) and psychological causes (such a mental 
anguish). In the absence of a clear definition of the term terminal restlessness, it is 
suggested that many patients show what observers perceive as “distress” (Jones et al, 
1998). These researchers have developed an observer-rated scale for assessing terminal 
restlessness and the findings have relevance for the current study. The first version of 
the instrument yielded very low inter-rater reliability scores and the ten questions 
relating to clinical signs were very poorly recorded. This is an interesting finding as, in 
a similar manner to the current study, the items were derived from data arising from the 
hospice staff who then used the scales.
In the second version of the Jones et al (1998) scale, data was reported to be highly 
skewed. Unfortunately, the authors do not state item endorsement figures or the 
direction of the skew so, although this may resemble the skew towards the lower end of 
the scale seen in the current study, this cannot be confirmed. Again, inter-rater 
reliability was low. The construct being measured by the instrument is restlessness but 
“restlessness” is included as an item in the scale, suggesting some confusion in item 
development. Similarly, there appears to be confusion in the scoring system for the 
scale, which was tested in different formats to see which yielded the highest inter-rater 
reliability. The highest kappa coefficients were obtained when responses were scored: 
“not at all” = 0, “a little” = 0, “quite a lot” = 1, “a great deal” = 1. Whilst reducing the 
amount of discrimination required by observers may be a valid technique of improving 
inter-rater reliability, scoring the absence of an item with the same score as “a little”
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does not appear logical and the validity of the improved reliability coefficients may be 
questioned.
The kappa coefficients were reported on six items and ranged from 0.41 to 0.62, 
indicating moderate agreement and these are in a similar range to those reported in this 
study. However, some of the final items retained in the instrument (namely distress, 
agitation, and anxiety) are subject to individual interpretation; as such, the development 
of a scale using behavioural and physiological signs, as in the current study, may 
provide a more objective instrument.
At the start of the current study, no research had used a behavioural approach to assess 
symptom distress. As discussed previously, there has been work using behavioural 
approaches to assess pain, one of the symptoms often included in symptom distress 
scales (e.g. Chambers and Price, 1967; Teske et al, 1983). Recently, Lobchuk et al 
(1997) reported a study investigating behavioural measures and cues used by family 
caregivers of patients with lung cancer, to assess levels of distress arising from 
individual symptoms. Thirty-seven family-caregivers completed the Symptom Distress 
Scale (SDS) (McCorkel and Young, 1978; McCorkle and Benoliel, 1983) and an open- 
ended questionnaire designed to elicit cues the caregivers responded to when assessing 
the symptom distress scores. Content analysis of the written responses identified the 
categories of impaired functioning, verbal cues, and non-verbal cues as the most 
frequent indices of symptom distress. There was no significant improvement in 
perceptual accuracy by caregivers that used multiple cues compared with those who 
used single cues for individual SDS items. However, with the small sample size (n = 37) 
and the absence of information regarding the power of the statistical tests, it is difficult 
to ascertain if these results indicate a true lack of difference or if a type II error has 
occurred.
The exploratory study (Lobchuk et al, 1997) is important as it appears to be the first to 
provide data on cues used by caregivers when assessing symptom distress. However, 
direct comparison cannot be made with the current study, as the patients are at different 
stages of illness. Thus, although behavioural cues such as impaired functioning, 
avoidance of interpersonal relationships, and behaviours to reduce distress from the 
symptom appear to be significant for caregivers, they may only be relevant when the 
patient is at an earlier point in their disease trajectory. However, this supports the need
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for further investigation of cues used by caregivers (professional and non-professional) 
when assessing symptom distress at different stages of the illness trajectory. 
Additionally, comparisons of cues utilised by professionals and non-professionals 
would be beneficial, in order to ascertain the reliability and validity of different proxy 
assessors.
Although items included in the current study were developed from clinicians 
representative of those testing the instrument, they were not frequently observed. This 
may have been due to the sample selected but an alternative explanation may be that the 
nurses were not in fact using these items as a basis for their assessment of the patients’ 
conditions and were perhaps using other indices? Content validity of the scale was 
checked by including the option for nurses to note other indices which they had noticed 
and were informing their assessment of the patient; however, no other items were noted.
Coffman et al (1997) studied intensive care nurses’ assessment of pain behaviour in 
children. The most frequently selected indicators of pain were tachycardia, tachypnoea, 
irritable/fussy, verbalising pain, increased blood pressure and rigidity (highest 
frequency was tachycardia, selected in 64% of 112 observations recorded). Nurses with 
more experience, education, and personal experience of pain selected more indicators of 
pain. The authors suggest that having a defined list of assessment items may have a 
biasing effect on nurses’ assessments but a number of exploratory studies have already 
identified indicators of pain used by paediatric nurses. Lack of testing for inter-rater 
reliability of nurses’ assessments limits interpretation of results; however, the finding 
that nurses’ selected, on average, five pain indicators during each observation, suggests 
that behavioural cues are used by paediatric intensive care nurses. This may support the 
interpretation of the current findings, that they are due more to a biased sample than to 
nurses not using the indices for their assessments.
However, research indicates that decision making is a complex phenomenon. Two types 
of cognitive processes, analytical and intuitive, may be used in critical thinking that 
results in clinical nursing judgements (Corcoran-Perry and Bungart, 1992; Umiker, 
1989). Analytical thinking is defined as a conscious, cognitive and sequential thought 
process (Corcoran-Perry and Bungart, 1992) where parts of a situation are analysed and 
then logically combined to arrive at a judgement. Intuitive thinking, in contrast, has 
three defining attributes: knowledge is received as a whole, awareness of that
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knowledge is immediate and the knowledge acquired is independent of linear reasoning 
(Benner and Tanner, 1987). Research has revealed that people involved in critical 
thinking use both analytical and intuitive processes, either alone or together, to make 
judgements, depending on a number of factors (e.g. the task, prior experience and 
competency of the person making the judgement) ( Benner, 1984; Corcoran, 1988; 
Dreyfus and Dreyfus, 1980). Thus, it may that by asking nurses to describe how they 
thought they assessed dying patients an analytical response was provoked. However, it 
may be that in reality they were using intuitive skills and using more global assessments 
of the whole. Perhaps these experienced nurses, ‘experts’, were not using individual 
cues but gathering information in a more general manner, categorising related 
information together in a sophisticated way (Green and Gilhooley, 1992). Consequently, 
although nurses’ claimed to use the behavioural signs included in the instrument, it may 
be that they were using more global assessment strategies.
Due to the potential bias in patient selection, it is difficult to interpret the poor item 
endorsement seen in this study. This could result from characteristics of the patients 
assessed or suggest that the behavioural cues lack relevance in this setting. Studies using 
behavioural cues for assessing pain and discomfort in dementia (e.g. Keefe, et al, 1985; 
Hurley et al, 1992) indicate that they provide reliable and valid methods of assessment 
in other patient populations. Therefore, further investigation of this complex area of 
assessment of symptom distress is required.
7.5 Conclusions
This study aimed to develop a nursing assessment tool for the measurement of symptom 
distress in dying cancer patients who are not suitable for self-assessment. Qualitative 
work led to the development of an instrument using behavioural and physiological 
indicators of distress and included items that clinicians felt pertained to discomfort 
caused by dehydration (such as licking lips and sucking on mouth sponges). The aim 
was to examine the use of behavioural and physiological indicators of distress during 
nurses' assessment of dying patients and the relationship of these indicators to perceived 
cause and degree of distress. Such a scale could then be used in empirical investigations 
of symptom distress related to terminal dehydration.
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However, poor item endorsement made interpretation of inter-rater reliability tests 
difficult; despite moderate correlation coefficients, one cannot be confident that the 
scale is reliable as the sample on which it was tested demonstrated little sensitivity with 
respect to the majority of scale items. The discussion linked the findings to possible 
selection bias in the sample obtained and to the complex area of human judgement and 
decision making and suggests the need for an in-depth investigation of this area.
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8 Ethical issues raised during the course of this research
8.1 Introduction
Research must be ethical so as to minimise potential harm to those involved, to increase 
the quality of results obtained and to protect the interests of the research community in 
the long term (Homan, 1991). Poor quality research in which confidence cannot be 
placed in the reliability and validity of the findings is unethical, as the costs to the 
participants are greater than any benefit gained by the research. This is particularly 
pertinent to research in palliative care where, increasingly, there has been debate 
regarding the suitability of palliative care populations for research (e.g. de Raeve, 1994; 
Mount et al, 1995). All stages of this research were studied and approved by external 
Ethics Committees and were scrutinised by fellow researchers and clinicians in the 
palliative care field. However, although Ethics Committee approval was obtained, 
ethical issues were raised through the procedure of the research and will be discussed 
here. The importance of including this chapter is emphasised by May (1987) who 
suggests that if the research community neglects to communicate ethical decisions and 
actions it ultimately risks neglecting the rights of those who are studied.
8.2 Ethical considerations
8.2.1 Preliminary areas
The first areas for consideration concern the worthiness of the project and the 
competence of the researcher (Miles and Huberman, 1994). Before individual ethical 
concerns arising from a particular methodology selected for a study can be addressed, 
the aims of the study need to be considered in terms of its potential to contribute to the 
wider body of knowledge. This is essential if one is to be able to accurately debate a 
cost-harm benefit of involvement in the study. The studies carried out in this project 
were deemed necessary, and arguments justifying the conduct of the studies are detailed 
in earlier chapters.
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8.2.2 Vulnerable populations and the suitability of palliative care populations 
for research
The frequently seen physical and psychosocial symptoms in palliative care patients may 
have a significant impact on the ethics and methodology of research conducted in this 
population (Bruera, 1994). As such, palliative care patients may be termed a vulnerable 
population. A vulnerable population was defined by Lasagna (1969) as a group of 
captive individuals. However, the Oxford Dictionary (Fowler and Fowler, 1964) 
enlarges on this concept and defines someone as vulnerable if they are capable of being 
physically or emotionally wounded or injured. Copp (1986) argued for a continuum of 
vulnerability; more vulnerable persons include those who lack resources or autonomy, 
are stigmatised, weakened or institutionalised, cannot speak for themselves, or are 
involved in illegal acts (Miles and Huberman, 1994). It has been suggested that some 
vulnerable groups (e.g. the mentally incompetent or dying) should not be used except 
when research is related to their immediate medical problems (Lasagna, 1969; Ramsey, 
1970; Macintyre, 1982). However others caution against avoiding research in difficult 
groups: “My research, and research into vulnerable social groups generally, cautions 
against the arrogance of assuming that comfort and safety are more important to them 
than the desire to be heard, or their desire to contribute to our attempts to understand 
them” (Kellehear, 1989, p.66).
Studies in palliative care populations raise challenges; Cassileth (1988, p.5), like Bruera 
(1994), observes that “the fragility of patients and their physical or cognitive limitations 
severely curtail the types of studies that are possible and the research methods that can 
be applied”. The emotional and physical distress often seen in dying patients may also 
limit their ability to consider their choices to participate (see below) (Kristjanson et al,
1994).
Some writers have argued that no research is morally justifiable in this client group and 
that “research into the needs and experiences of such patients could be said to be an 
affront to the dignity of those people who are terminally ill and an expression of 
profound disrespect for the emotional and physical state of such patients” (de Raeve, 
1994 p. 301). However, to deny patients the opportunity to contribute to research has 
been dismissed as “paternalistic, devaluing and disrespectful” (Mount et al, 1995, 
p. 165). It has been argued that well-conducted research is ethically defensible as it is 
important to gain the perspective of the dying patient and their family; however, only
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research that will contribute to knowledge that will have a direct impact on palliative 
care patients should be proposed (Bruera, 1994).
This argument was accepted in the current work and so, since the palliative care 
population under study could be defined as vulnerable (patients and bereaved carers), 
particular ethical issues were examined.
8.2.3 Informed consent
Informed consent requires that it is possible for people to agree or to refuse to 
participate in research once they have received comprehensive information regarding 
the purpose and nature of the research, including the possible risks and benefits of being 
involved and the extent of that involvement (Homan, 1991).
It is commonly proposed that there are four elements of consent (Gillon, 1986; Homan, 
1991). The informed components concern that what will and what may happen are 
disclosed to the subject in an adequate and unbiased manner and that the subject can 
understand this information. The consent components concern the subject’s ability to 
make rational judgements and that the decision to take part is voluntary and free from 
persuasion or coercion (Homan, 1991).
The qualitative approach used in Chapter 5, using semi-structured interviews with 
patients and bereaved carers, raised issues concerning the ability of the researcher to 
inform fully subjects of all likely sequelae to involvement. It is argued by some (e.g. 
Eisner, 1991; Wax, 1982) that true informed consent is not possible in qualitative 
research because of its very nature. It is often not possible, at the outset, to fully inform 
the subject of the direction of the research and possible harm, as the researcher may 
react and respond to events in the field and major themes may alter during the research 
process (Deyhle et al, 1992; Raudonis, 1992).
This was addressed here by viewing consent as a process rather than as a “one-off’ 
event. Munhall (1988) suggests that informed consent is a static past tense concept, 
favouring the term “process consenting” to reflect the “ongoing dynamic nature of 
qualitative research” (p. 151). This is particularly important when using vulnerable 
patients whose rapidly changing condition may demand the renegotiation of consent or 
a decision to withdraw by the researcher. Thus, throughout the research procedure, the
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researcher was mindful of the need to check that the subject wanted to continue, 
particularly when they became distressed, and reminded them of their right to withdraw 
at any time. This process of consent was also applied to the more quantitative approach 
used in Chapter 6. It was important that patients were given the opportunity to withdraw 
from the study if the burden of the protocol was too much. It is of note that no subjects 
withdrew from either of the studies, even though some became distressed (reasons for 
this are explored further in section 8.2.5, p. 193).
8.2.3.1 Is consent voluntary?
Potential subjects were approached for consent by the researcher, independent of the 
staff caring for the patients (or bereaved carers). Although no attempts were made to 
persuade or coerce subjects to become involved, the question of voluntary consent was 
raised. Hewlett (1996) argues that fully voluntary consent is rarely achievable as all 
decisions are made “within the context and influence of people and circumstances”. 
This does not refer to possible coercion or persuasion but addresses potential influences 
on an individual such as their health status (e.g. if ill, the accompanying psychological 
response may decrease autonomy (Kristjanson et al, 1994 ). Although such influences 
may not be strong enough to be termed coercion or enforcement there are many factors 
that may affect an individual’s ability to make a totally voluntary decision and so 
Hewlett (1996) suggests that consent be considered partially voluntary.
Strategies employed to minimise or reduce potential influences in these studies 
(Chapters 5 and 6) involved the provision of written information and allowing subjects 
time to consider their participation and to discuss this with relatives and their 
professional carers if they desired. It may have been desirable to employ an advocate -  
someone trained and independent who could ‘translate’ and mediate and offer a more 
detached view for the subject - although, this may be more important if the health care 
professionals caring for the patient are involved in the research or consent process. 
There are concerns that, if professional carers approach a patient for consent, the 
individual may feel some external pressure to participate; they may fear the possibility 
of threats to their future treatment, an obligation in return for care or a misplaced trust in 
the research (May, 1979). However, although the researcher was not an employee of the 
palliative care units in which the studies were conducted, there was a question regarding 
how subjects perceived the researcher, the presence of whom on the wards may have
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indicated to patients and families that the work had the support of the units, so that the 
possibility of a reluctance to refuse consent for the reasons outlined above may still 
have persisted.
Additionally, when the investigator introduced herself to subjects it was both as a 
researcher and a nurse. May (1979, p.37) cautions that “if subjects frequently 
misperceive the nurse researcher role, then to whom has the research subject given 
consent -  the nurse or the researcher?”. It is suggested that this is important as traits that 
may commonly be attributed to nurses (e.g. compassion, nurturance) may not be 
congruent with the perceptions of a researcher (May, 1979) and thus may bias the 
process of informed consent. Munhall (1988) suggests that patients may identify with 
the nursing role and assume that decisions are being made in their best interests and not 
dictated by the research demands. Indeed, this was borne out in the studies, as some 
patients stated that they did not want to read the information sheet as they felt confident 
that they would not be asked to participate in anything that was detrimental. This places 
a significant responsibility on the researcher.
It was felt important to introduce the researcher as a palliative care nurse, in order to 
increase the subjects’ confidence in the ability of the researcher to handle the 
information obtained in a sensitive and appropriate manner; however, the role of 
researcher was emphasised. Informed consent involves the negotiation of trust. This 
trust is particularly important as people may tell researchers want they think the 
researcher wants to hear or only what they feel safe in disclosing. The ethical 
implications of this are important as weak consent, with hesitancy on the part of the 
subject, may reduce the quality of the data obtained; subjects may try to protect 
themselves if the relationship with the researcher is not founded on trust (Miles and 
Huberman, 1994). Thus the introduction of the researcher as a nurse may highlight 
concern regarding informed consent, but was deemed necessary to enhance trust and 
safety and, as such, was argued to be an ethical approach.
Bruera (1994) suggests that the high rate of cognitive failure (up to 75%) seen in 
patients approaching death indicates the need for screening (e.g. by the Mini-Mental 
State Questionnaire) in order to facilitate informed consent and to ensure that 
meaningful results are obtained. In these studies formal mental state assessment was not 
carried out as nurses were granting access to patients and “screening out” those who
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were confused. Although it could be argued that this was subjective and open to bias, 
the introduction of a further research tool was felt to be inappropriate; this would 
increase the research burden and present a further ethical dilemma. Routine mental 
status assessments were not carried out in any of the data collection sites. Thus in order 
to assess this, consent would have to be obtained for the assessment procedure (as it 
would have been an addition to routine practice) and then for the research process. If 
screening is usual practice in a unit this dilemma does not arise.
A further issue raised by this research was that of signed consent. Ethics Committees 
required that signed consent was obtained. For four patients and one bereaved carer this 
raised anxieties and they expressed concern about signing a form when they had already 
verbally consented (and in the instance of the bereaved carer, had invited the researcher 
into their home). When this was explored in more depth, it appeared to them that they 
were getting involved in more than an interview study and the form raised anxieties 
regarding legalities and perhaps invasive procedures. After further careful explanation 
of the purpose of the form the four patients agreed to sign, however the bereaved 
relative insisted that it was enough that they had invited the researcher into their home.
A different issue arose when one bereaved relative signed the consent form and then 
invited her children to take part in the interview. Although they willingly consented the 
consent form was not a valid representation of the situation. These observations made 
during the data collection for the study in Chapter 5 took place in 1993. Aranda (1995) 
cited personal communication with the researcher Kanitsaki (1994), who reported 
similar issues. Obtaining formal written consent is a procedure intended to protect the 
vulnerable and ensure adequate explanation and absence of persuasion/coercion in the 
consent process; however, this discussion highlights that this is a more complex area 
than it might at first appear and that studies exploring the meaning of signed consent for 
research participants would be beneficial.
Homan (1991) raises an important issue in stating that more educated and literate 
individuals know that they can refuse and know how to refuse but that the less educated 
often defer to and comply with researchers. He makes a strong challenge regarding 
informed consent, suggesting that it may be serve more as a protection for the 
researcher than the subject. It is suggested that the act of consent discharges 
responsibility from the researcher onto the subject and that often the motivation for
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informed consent is often to allay suspicions and encourage participation rather than to 
fully appraise individuals of their rights and the potential harm from their involvement 
(Homan, 1991). This latter view appears slightly cynical but the work included here has 
emphasised the investigator’s responsibility to ensure that vulnerable groups are not 
exploited and to make adequate provision to reduce threats to non-voluntary 
misinformed consent.
In these studies refusal rates were 35% and 20% (Chapter 5 and Chapter 6 respectively). 
This compares with other research studies in palliative care populations (e.g. Payne et al 
(1996) who cite a 31% refusal rate for an interview study and Bruera et al (1994) citing 
refusal rates of 10-20%) and indicates that subjects were able to decline involvement; 
this increased the confidence that could be placed in the consent procedure.
8.2.3.2 Contacting potential subjects
There were practical considerations arising in the research procedure that have ethical 
dimensions. The first includes issues of contact. Discussions took place regarding how 
the first point of contact with potential subjects should be made, who would be the 
appropriate person to make it, and whether this would have any possible effect on 
consent rates and/or the quality of data obtained. The first point of contact for 
recruitment into studies depends partially on the sample selected. The researcher 
directly contacted subjects recruited from hospital or hospice patients. As discussed 
above, it was considered that if the staff caring for the patient introduced the researcher 
(or the research project) then the potential for patients to feel pressure to consent might 
be higher.
The issue was more complicated in the sample of bereaved carers (Chapter 5). Options 
included an introductory letter, telephone call or personal visit at home. It was decided 
that the method would include the sending of an introductory letter, outlining the 
purpose of the research and indicating that they would receive a telephone call to 
discuss the research project in two weeks. Instructions were given to write or telephone 
to indicate if they did not want further contact. It was felt that this approach provided 
potential subjects with an opportunity to consider the research in private, without the 
potential subtle pressure of someone face-to-face. The use of an advocate or 
independent person may also help, as outlined above, but this raises the costs of the
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research and was not an option in this study. However, there are concerns that the “letter 
approach” is an invasion of privacy and may raise anxieties for an individual, which 
then cannot be addressed immediately.
There may also be an effect on uptake into the research. A study involving bereaved 
people undertaken by Cartwright and Seale (1990) obtained an 81% response rate when 
researchers ‘cold called’, without an introductory letter or telephone call. The work 
(discussed in Chapter 5) obtained only a 65% response rate. Whilst other factors may 
have affected the response rates (e.g. length of time after the bereavement or type of 
research), it could be that it is more difficult to refuse someone face-to-face, when the 
individual is unprepared, and raises concern that this may be a subtle form of 
coercion/persuasion. Of practical concern, Cartwright and Seale (1990) note that their 
researchers spent a considerable amount of time travelling to empty houses or receiving 
refusals; this increases research expenses.
Still concerning the issue of possible coercion is the important question of what 
information regarding the researcher should be given. If an institution or single body is 
carrying out a research project should this be identified to the subject or will it impose 
another influence on them? It may be considered that using the name of a particular 
institution/individual may give the study credibility, but it may also add a subtle 
dimension of power. In the situations where patients were interviewed in palliative care 
units or hospitals the name of the University was given. However, in the bereaved 
sample, the University name was given in addition to the name of the palliative care unit 
where the deceased relative had died, as this had been the source of the sample. There 
was concern that acknowledging the latter institution may have contributed to some 
pressure to consent due to feelings of gratitude towards the place where the deceased 
had been cared for. There was also concern that this may have affected the nature of the 
data collected, with participants feeling less able to be honest in their responses if they 
perceived these to be negative or imply criticism of care received. However, it was felt 
that it would be unethical to withhold the name of the institution that had provided the 
contact, but care was taken to explain that the research was not being conducted by 
them or on behalf of them and that the anonymity of respondents would be preserved.
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8.2.4 Gatekeeping
As identified in Chapter 6, nurses appeared to act as ‘gatekeepers’ to many patients who 
they felt were not well enough to be approached, or who were deemed to be too 
emotionally fragile. Homan (1991) defines gatekeepers as those who control access to 
data and to human subjects and describes four types: first, those who control access to 
the field (e.g. managers, hospital administrators, head teachers); secondly, those who 
hold raw data (such as official census data, archives of county records); thirdly, those 
who give consent on behalf of others who are not competent or entitled to do so (e.g. 
parents); and fourthly, those who are engaged by researchers to introduce the research to 
subjects (e.g. cultural interpreters). In this work, the nurses were controlling access to 
the subjects and held a position of power. Family members occasionally acted as 
gatekeepers, feeling that involvement in a research study would reduce the amount of 
time and energy available to spend with them or discouraging the patient’s involvement 
suggesting that “they had had enough”. Wilkie (1997) echoes this finding. It was 
important to encourage family members to see that the patients had a right to decide for 
themselves and reassure them that no pressure to participate would be applied. This was 
achieved through careful explanation and discussion with relatives about their concerns 
and feelings.
Gatekeeping raises both ethical and practical issues. In this situation, some of the health 
care professionals were acting in a paternalistic manner, denying the individual their 
right to make their own decisions and undermining the ethical principle of the right of 
self-determination (or autonomy). Additionally, this practice does not facilitate the 
expression of the needs of the vulnerable (Aranda, 1995). Raudonis (1992) believes 
that, if the patient is cognitively able, then they have the right to listen to the 
researcher’s explanation and judge for themselves if they wish to be involved. It was of 
note that on one day, a nurse would say that a patient was not suitable for approach as, 
for example, there were a lot of emotional issues for the family or that the patient was 
too symptomatic, but on the following day a different nurse would suggest that the same 
patient would be suitable as they may appreciate the opportunity to be involved and 
possibly distracted from other issues. This suggested that some nurses were 
uncomfortable with research in the palliative care setting and did not feel that patients 
were able to act in an autonomous manner. Nurses did not express overt resistance to 
the research; on the contrary, during teaching/briefing sessions, which were held prior to
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commencing data collection, nurses appeared to support this. However, by limiting 
access to potential subjects resistance was expressed.
The gatekeeping experienced in these studies is not unique. Davies et al (1995) 
described similar difficulties encountered in a qualitative study of dying patients and 
their families. They facilitated recruitment by the researcher directly reviewing all 
patients’ notes with the staff. Such strategies need to be developed if representative 
samples are to be obtained.
Aside from the ethical issue of denying patients the right to self-determination this 
raises another ethical issue as the gatekeeping actions reduce the representative nature 
of the sample and limit the interpretation of findings; it can be argued that it is unethical 
to use a methodology that produces less reliable findings.
8.2.5 Risk versus benefit
The concept of benefit and risk of harm when assessing research projects is well 
documented. Research should not injure or harm subjects even if their participation is 
voluntary. This encompasses the ethical principles of beneficence (to do good) and non­
maleficence (to do no harm). Harm may be physical or psychological and may come 
about through the actual taking part or through the analysis and reporting of data 
(Babbie, 1995). In both the qualitative interviews (Chapter 5) and the testing of the 
questionnaires (Chapter 6), the main areas for probable harm were thought to be fatigue 
(arising from the completion of questionnaires and interviews) and emotional distress 
(as a possible consequence of focusing on distressing symptoms and the meaning that 
they might have for the individual patient or bereaved relative). Risk of harm is often 
difficult to quantify in research and particularly in qualitative research. Wilkie (1997) 
suggests that most qualitative research involves minimal risk or no risk to the 
participant. However, this can be questioned. For example, is the risk of greater self- 
knowledge or the threat of emotional distress minimal? The experience of conducting 
these studies suggests that, although the cathartic release observed in many participants 
was usually commented on positively, the threat was far from minimal and without 
sensitive and professional handling could have had negative consequences for 
participants.
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The researcher had a responsibility to weigh potential risk of harm very carefully, with 
other members of the research and palliative care community and with the Ethics 
Committees, to consider if the balance was equitable (Miles and Huberman, 1994), and 
to inform participants of the risks of fatigue and emotional distress. The potential for 
harm was then weighed against the potential benefits. Kristjanson et al (1994) caution 
against the use of lengthy questionnaires or interviews in populations of dying patients, 
suggesting that the research burden may be too heavy. As discussed in Chapter 6, this 
meant that the methodological advantages of using multiple outcome measures to 
triangulate data could not be pursued in an ideal manner.
Unfortunately, research with the dying does not always involve direct gains for the 
individual participant. Results of these studies may benefit the future care of dying 
patients but not those directly involved. However, potential indirect benefits were 
thought to include personal gain for the individual in the form of being listened to, and 
having the opportunity to contribute to society at a time when social roles may be 
diminishing due to approaching death, by adding to the body of scientific knowledge for 
society or groups within society or by leaving a personal legacy (e.g. Amenta and 
Bohnet, 1986; Raudonis, 1992).
It could be argued that the emotional pain expressed during research with the dying 
and/or bereaved is not acceptable. However, Kellehear (1989) suggested that this should 
not necessarily be equated with harm and, indeed, may be of benefit. For example, 
although the majority of bereaved respondents (Chapter 5) expressed emotional distress 
during the interview, none accepted the offer to stop the interview completely, although 
some asked for a pause in the tape recording, and many stated afterwards how beneficial 
they had found being involved. The reasons for the perceived benefit were explored; 
recurrent explanations included the opportunity for the bereaved person’s painful 
experience, and that of their loved one, to benefit others and the opportunity to ‘tell their 
story’, to be heard at a time (6-8 months after bereavement) when the opportunities to 
talk to friends and relatives about the details of their loved one’s dying were often 
reduced. This has been echoed by other researchers who have used the dying and the 
bereaved as subjects (e.g. Raudonis, 1992; Parkes, 1995; Aranda, 1995; Davies et al,
1995).
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Similarly, patients often exhibited distressing behaviours such as crying and anger, in 
both the studies described (Chapters 5 and 6). As Aranda (1995) points out, these 
behaviours are often seen in palliative care as they are frequently associated with the 
experiences of loss, suffering and dying. The difficulty lies in the process of 
differentiating between the effects of the research process and the life experience of the 
subject. It may be that the therapeutic benefits of the research process are not often 
reported (Aranda, 1995). Field notes taken through stages of the research process 
indicated the researcher’s underlying feeling of sadness and concern regarding the 
emotional expression of distress by subjects but this was tempered with an acceptance 
that this was appropriate for the experiences that the subjects were living through, and 
their gratitude for having the opportunity to participate and to talk.
Attempts to maximise the benefits of the research include the issue of the responsibility 
of the researcher to disseminate the findings. Research findings that do not enter the 
professional debate have little meaning. Dying patients and bereaved relatives 
participating in these studies, as stated above, often expressed the desire to leave a 
legacy, help others in a similar situation and make sense of their own personal 
experience. Not to give a voice to the experiences of these individuals would betray 
their consent to involvement in the research.
8.2.6 Anonymity, confidentiality and privacy
Anonymity concerns ensuring that data lacks markers, such that identification of the 
responses of individual participants or organisations cannot be made (Sieber, 1992). As 
such, the interviews carried out in these studies could never be anonymous to the 
researcher. However, confidentiality (where the researcher was able to identify 
individual’s responses but gives assurances that this would not be publicly 
acknowledged) was maintained. It was important not to confuse these terms and to 
inform subjects what could be honoured.
Privacy concerns the preservation of boundaries against the giving or receiving of 
unwanted information by research participants (Westin, 1970; Sieber, 1992). The 
emphasis upon self-control supports the need for informed consent, in order that 
individuals understand the purpose of the research and thus can maintain privacy as they 
choose (Homan, 1991). It also underlines issues concerning the researcher role and the
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trust that may be placed in it (discussed in section 8.2.3.1). Sieber (1992) suggests that 
researchers often underestimate or misunderstand the subtle issues of privacy, indicating 
that they may only emerge when details are given beyond what the subject intended to 
say. For example, an unexpected hesitancy from a respondent may be met with 
overzealous probing on the part of the researcher, leading to the divulging of 
information that the person wanted to remain private. Less overtly, a friendly and 
relaxed presentation by the researcher may encourage relaxation of the subject and 
promote more disclosure. Whilst this technique is encouraged in order to maximise the 
quality and depth of data gained, it highlights the potential for the right to privacy to be 
invaded. The power differential between the researcher and most subjects was evident 
in the studies carried out here; the researcher’s training as a nurse equipped her with 
skills and techniques to encourage disclosure of sensitive information. One subject’s 
occupation had been as a clinical research psychologist and, in contrast to the majority 
of respondents, he possessed equal if not greater skills of negotiation, highlighting the 
power discrepancy between researcher and researched. This emphasised the 
responsibility for the judicious use of these skills.
An area emphasising this dilemma arose during the testing of the symptom distress 
scales (Chapter 6). The question regarding decreased sexual interest on the Rotterdam 
Symptom Checklist was unanswered by a substantial number of respondents. The 
subject’s right to privacy and non-disclosure of this intimate area conflicted with the 
methodological requirements to explore reasons for the missing data. This highlights the 
need for compromise; although in-depth data regarding this particular question could 
not be obtained, the approach taken (respecting the right to privacy) ensured that the 
interviews continued, thus maximising the data gained for the overall aims of the study.
Issues of confidentiality may arise in research where the subject discloses information, 
which if not acted upon may be harmful to that individual. An example of this was a 
subject who expressed suicidal ideation and intentions. This may cause a conflict 
between the researcher role, requiring the respecting of information given in confidence, 
and a professional responsibility and duty of care towards that individual (the 
therapeutic imperative versus the research imperative (Munhall, 1988 ) (see section 
^  8.2.7, p. 197). Discussion and preparation for dealing with such eventualities was carried
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out prior to the commencement of the study, and could be argued to be the moral 
obligation of the researcher.
8.2.7 Therapeutics, intervention and advocacy
Research is not therapy. However, Patton (1990) suggests that techniques such as 
interviews are not a dispassionate one way exchange of words but complex human 
interactions. He, therefore, states that all interviews are “interventions”. If psychological 
(or physical) distress is apparent there may be ethical obligations to set up appropriate 
referral (bearing in mind the issue of confidentiality as previously discussed). The need 
for sensitivity in planning research with vulnerable groups was highlighted and 
adequate routes of referral for support and interventions for bereaved carers or dying 
patients were put in place before commencing data collection.
The aim of the research interviews was not to produce catharsis, although Morse 
(1991b) recognised that catharsis may be stimulated during qualitative interviews. It is 
not morally justifiable to leave someone in emotional distress without adequate support 
and backup. It was necessary to build into the closure of interviews an assessment of the 
participants’ emotional state and leave the person with contact numbers of counselling 
services and their General Practitioners, in the case of the bereaved relatives sample, or 
the ward staff, in the case of patients. There was role conflict at times and the researcher 
was mindful that, as participants had volunteered their time and risked sharing their 
painful experiences with a stranger, there was some obligation to listen to other parts of 
the story (not directly related to the research focus), although within time boundaries.
There were other instances of role conflict where, for example, subjects asked 
clinically-related questions that were not directly related to the research. Munhall (1988) 
suggests that in such circumstances “the therapeutic imperative of nursing (advocacy) 
takes precedence over the research imperative (advancing knowledge) (p. 151). The 
researcher’s response to such conflict was to defer discussion until data collection was 
completed and then to return to the question and discuss who would be the most 
appropriate person to deal with this (with the patient or bereaved relative’s consent). 
Being aware of the researcher’s personal view on the nature of the research/therapeutic 
relationship prior to data collection and devising strategies to cope with role conflict 
facilitated the resolution of such ethical dilemmas. Smith (1992) suggests that it may be
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morally reprehensible to withhold information when subjects ask but recognises that the 
research role is not one of counsellor, educator or therapist. Thus the approach taken in 
these studies was to intervene at a minimum level if required.
Ending the research relationship was another issue requiring attention. There was a need 
for the researcher to be clear with herself, as well as with the subjects, where the 
research relationship ended. It became apparent early on in the interviews with bereaved 
subjects that a relationship was established with many due to the intense personal 
emotions they had shared during the course of the interview. Some subjects expressed a 
wish for further visits from the researcher. Clear explanations were given that the 
continuation of a professional relationship was not possible, alongside emphasising the 
importance of their valuable contribution to the study. In addition, contacts for 
bereavement services were given. If the person felt that they would not be able to self- 
refer, the offer to refer on their behalf was made.
These experiences emphasise the importance of researcher training and on-going 
support. In order to fulfil the ethical demands of sensitive research it is necessary to 
have researchers with comprehensive skills -  such as good communication and 
sensitivity. Training included formal role-play with difficult scenarios and the 
formulation of strategies to deal with difficult situations. Large demands are placed on 
researchers using techniques such as interviews with the dying and bereaved, 
necessitating adequate provision for on-going support and debriefing. Wilkie (1997) 
contends that training and supervision of the researcher is as important as rigour in the 
design of the research. This discussion confirms the need for supervision and space for 
reflection for the researcher, which was established at the beginning of the study. This 
helped to preserve the professional and personal integrity of the researcher and ensured 
that the emotional reaction to the data collection and data itself did not interfere with the 
analysis and interpretation of the results.
8.3 Conclusions
Methodological rigour cannot be considered in isolation of ethics and there is a 
requirement to consider the rights and wrongs of the actions of the researcher. Erickson 
(1986) states that “ethical responsibility and scientific adequacy go hand in hand”. 
Whilst this is a laudable statement it does not give any insight into the dilemmas and
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tensions that scientific and ethical demands may cause. There are often conflicts 
regarding issues such as reducing validity of findings in order to minimise or prevent 
harm from occurring; or help-giving versus confidentiality (e.g. suicide). Some 
researchers (e.g. Baumrind, 1971) assert that if methodological rigour conflicts with the 
fundamental rights of subjects then methodology must be compromised. However, this 
poses a problem, as the relaxation of methodological rigour may threaten the integrity of 
the research findings, which, in turn, threatens the ethical integrity of the research.
Ethical issues should not be seen in isolation of research procedure, to be dealt with at 
beginning of research project and confined to one line in the write up. The ethical 
considerations arising during this research have salient points that add to body of 
knowledge and debate in this area.
First, with respect to the question of whether the dying and bereaved should be used in 
research studies, the experiences described supported the use of these subjects. 
Although no direct benefit from the research findings could be applied to the 
participants, indirect benefits were gained by some (as indicated by their positive 
comments about involvement) and people were able to decline consent. Second, the 
issues explored regarding informed consent were complex and suggest that research into 
the meaning of consent for participants is required. The research process demonstrated a 
range of considerations and factors that may affect obtaining informed consent in this 
vulnerable population.
The difficult issue of gatekeeping was explored and has methodological implications 
such as the reduction in the representativeness of the sample and limiting the reliability 
and generalisability of the findings. Whilst this was a requirement for access greater 
discussion of the ethical dilemmas of this issue with managers of potential sites of data 
collection is required for future work.
At the start of the research, considering issues surrounding the vulnerability of the dying 
and bereaved heightened awareness of the need for methodologically sound proposals. 
Attention to understanding and establishing informed consent helped to increase the 
quality of data as weak consent diminishes trust on the part of the participant and may 
contribute to poorer data (Miles and Huberman, 1994). Likewise, addressing 
confidentiality and privacy, in the manner described, may also have increased trust and
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contributed to data of greater quality and validity. This increases the confidence that can 
be placed in the findings.
The design of the studies, influenced by the debate on the potential risks and benefits of 
the research procedures (for example, limiting the number of questionnaires used in 
Chapter 6), may have increased the quality of data obtained by increasing acceptability 
of the study thereby increasing accrual rates and co-operation of subjects. This 
acknowledges the reduction in data available and is an area where trade-off and 
compromise between depth of data and sample size and composition were deemed 
necessary.
The training and planning necessary to address the issues raised regarding role 
boundaries and therapeutics allowed the researcher to explore sensitive areas in the 
knowledge of appropriate support and follow-up for both participant and researcher. 
This reduced the risk of over-involvement with participants, which could reduce the 
objectivity of the researcher, or a reluctance to ask sometimes difficult questions in the 
face of overt distress, which could have resulted in a reduction in data collection.
Being explicit about the methodological and ethical components of this research has 
demonstrated their close interrelationship. It is argued that by addressing the ethical 
dilemmas arising from this work, and the manner in which they were addressed, the 
confidence in the conduct, analysis and validity and reporting of findings is increased.
The need for good design and execution of research in this vulnerable group has been 
emphasised. It is not ethically justifiable to fail to provide meaningful answers to 
research questions due to poor design, as the terminally ill have invested their limited 
time and energy (Bruera, 1994). Equally though, not carrying out research in dying 
patients, under the shelter of the argument that it is ethically indefensible or “too 
hazardous”, risks halting the quest for a knowledge base to advance best clinical 
practice.
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9 Discussion and conclusion 
Terminal dehydration and symptom distress in the dying 
cancer patient: drawing the threads together
9.1 Overview
In the light of the literature reviewed and the empirical studies detailed here, this thesis 
argues that patients dying of malignant disease may suffer distress, either from 
symptoms arising as a consequence of dehydration or from symptoms arising from its 
treatment with artificial hydration therapies (AHT). However, such symptom distress 
may not always be recognised because, as yet, there is no suitable method for assessing 
its impact. The lack of suitable measurement instruments has also impeded the conduct 
of clinical research to investigate both this condition and appropriate treatment 
modalities. Thus, it has been argued that research into suitable methods of assessment of 
symptom distress is urgently required, in order to address adequately the gaps in the 
knowledge base concerning best practice for this important clinical problem.
This thesis has described studies concerning health care workers attitudes towards 
terminal dehydration in dying cancer patients, the symptom experience of dying cancer 
patients (with particular reference to symptoms associated with terminal dehydration 
and/or its treatment with AHT), and the development of self-rated and nurse-rated 
instruments for the measurement of symptom distress in dying cancer patients.
The work comprised:
• A critical review of literature pertaining to the issue of terminal dehydration in dying 
cancer patients
• A study of health care professionals (doctors and nurses) attitudes towards terminal 
dehydration and distressing symptoms that may arise from the condition or its 
treatment with artificial hydration therapies
• A critical review of literature pertaining to the concept of symptom distress and 
methods of measuring symptom distress in cancer patients
• A study of the symptom experience of dying cancer patients and the development of a 
Physical Symptom Distress Scale (PSDS)
• A study to test the Physical Symptom Distress Scale
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• A study to develop a Nurse Assessment of Symptom Distress Scale, using behavioural 
indicators of symptom distress, for use by nurses caring for dying patients who are 
unable to complete self-assessment scales
• An examination of the ethical issues arising during the course of these studies and their 
implications for the research described
9.2 Terminal dehydration
There are many possible sources of suffering that the dying may experience (Cassell, 
1982) and physical symptoms have been demonstrated to contribute to such suffering 
(e.g. MacAdam and Smith, 1987; Kuuppelomaki and Lauri, 1998). Chapter 2 revealed a 
continuing debate regarding the provision of artificial hydration in the end stages of life. 
Ethical and emotional elements are interwoven with pathophysiological arguments 
regarding potential benefits and burdens of treatment or non-treatment.
The literature reviewed demonstrated that terminal dehydration may present as a 
significant clinical issue in the care of the dying. Distressing symptoms may arise from 
the condition or from its treatment with AHT. Evidence presented suggested that health 
care professionals (doctors and nurses) vary in their attitudes towards perceived benefits 
and burdens of treating terminal dehydration with artificial hydration at the end of life 
(e.g. Marin et al, 1989; Andrews and Levine, 1989; Collaud and Rapin, 1991). Prior to 
the Andrews and Levine (1989) research, attitudes towards the state of terminal 
dehydration had not been studied in any previously published report. Thus a 
questionnaire survey was carried out, replicating and extending work undertaken in the 
USA (Andrews and Levine, 1989), to explore attitudes towards terminal dehydration in 
a sample of health professionals in England.
Importantly, the survey was widened to include doctors as they are significant members 
of the multiprofessional team and, ultimately, they prescribe AHT, if it is indicated. 
Andrews and Levine (1989) had not reported data pertaining to the reliability and 
validity attributes of the questionnaire used to assess attitudes towards terminal 
dehydration. This work addressed these issues thus strengthening the confidence that 
can be placed in the findings and the interpretation of the results. The study described 
here supported the findings of the earlier research indicating that differences in 
perceptions towards terminal dehydration existed among doctors and nurses in England. 
These differing attitudes appeared to be related to the experience of observing terminal
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dehydration and the type of place in which practitioners worked (i.e. general hospitals 
compared with palliative care units). Working in a palliative care setting and experience 
of observing terminal dehydration appeared to be inter-related (with hospice staff 
significantly more likely to be experienced in observing terminal dehydration untreated 
with AHT). The questionnaire survey supported empirically the debate seen in the 
literature regarding what constitutes appropriate treatment of terminal dehydration in 
dying patients. For some practitioners, the state of terminal dehydration is felt to confer 
benefits including reduced symptom distress while AHT are felt to increase symptom 
distress. For other clinicians the reverse is felt to be true. This may mean that patient 
treatment varies according to the setting in which people die, resulting in inequity of 
care whereby some patients experience less than optimal care. However, because 
current research findings are equivocal, what constitutes optimal care remains unknown.
Recent studies of family/caregiver perspectives towards the use of AHT at the end of 
life have suggested that there may be cultural variation in ethical principles. Factors 
thought to influence family caregivers’ perceptions include symptom distress, ethical 
and emotional issues (Musgrave et al, 1996; Parkash and Burge, 1997). Further 
investigation is required to provide more information regarding those factors affecting 
perceptions of terminal dehydration and AHT in the dying and the effects that such 
perceptions and interventions may have on bereavement outcomes. It is recognised that 
this current work has not included the significant area of debate in the ethical issues 
surrounding terminal dehydration and its treatment. This was omitted, not because it 
was considered less important but because, until the physical consequences of terminal 
dehydration are more adequately understood, the ethical debate cannot advance. 
However, it is recognised that future work will be required for their integration.
The advantages and disadvantages of terminal dehydration and the treatment of this 
state with AHT, with respect to symptoms and electrolyte imbalance, remain unclear. 
The literature reviewed prior to the commencing of this research (pre 1992) lacked 
conclusive evidence; the seven empirical studies published since this time are also 
equivocal (see Chapter 2). This highlights the ongoing need for assessment of the 
proposed benefits and disadvantages of the use of AHT in the dying, in order to provide 
an evidence base to enable optimal care for dying patients to be given. One of the 
arguments for the lack of conclusive evidence has been the variation in outcomes
\
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measured in the studies thus supporting the call for rigorous assessment of the 
suitability of instruments for measuring symptom distress. The studies described in 
Chapters 5-7, to develop and test assessment instruments for symptom distress in the 
dying, address the prerequisite area of demonstrating reliable and valid outcome 
measures.
9.3 Symptom distress in the dying cancer patient
Symptom distress, quality of life and suffering were demonstrated to be interrelated 
concepts, complicated by a lack of conceptual clarity and sometimes overlapping 
boundaries. It was argued that no suitable method of assessing symptom distress in the 
dying cancer patient existed and work was undertaken to gather empirical data on the 
symptom experience of a population of patients close to death. Findings from the 
studies described in Chapter 5 and Chapter 6 add to the theoretical understanding of the 
symptom experience. For example, the demonstration of a relationship between length 
of time before death and symptom distress supports the conceptual framework proposed 
by Cowan et al (1992), which places the severity of disease as an antecedent variable 
influencing manifest symptom distress. Likewise, the significant correlations found 
between symptom distress scores and global quality of life assessment support their 
proposal that symptom distress is a mediating variable affecting perceived quality of 
life. This is also consistent with the work of Portenoy et al (1994) who found that 
symptom distress correlated with quality of life assessment.
The work here also lends support to the Theory of Unpleasant Symptoms propounded 
by Lenz et al (1995; 1997) as, in the sample studied, it was apparent that the presence of 
symptoms was not always indicative of the level (or even presence) of symptom 
distress, supporting the dissection of the symptom experience into distinct entities such 
as occurrence, intensity, quality and distress. It was not possible to test the Theory of 
Unpleasant Symptoms in terms of the proposed effect of the symptom experience on 
performance (comprising functional status, cognitive functioning and physical 
performance (Lenz et al, 1997 ), as this would have required additional rating scales and 
it was felt that this would have put an unacceptable research burden on subjects. Future 
work incorporating such hypothesis testing is required.
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The correlation matrices described in Chapter 6 showed many positive inter-item 
correlations, indicating that increasing distress in one symptom was associated with 
increasing distress in another. These interaction effects between the symptoms provide 
evidence to support the synergistic effects of multiple symptom occurrences proposed in 
the Theory of Unpleasant Symptoms (Lenz et al, 1997). Further longitudinal work may 
help to determine the direction of causality and facilitate the development of therapeutic 
strategies to ameliorate such effects.
The considerable numbers of patients unable to complete self-assessment questionnaires 
reduced the sample available for testing of the PSDS. Over fifty percent of the 
population studied were too ill or mentally impaired to be included (Chapter 6). This 
concurs with recent findings of other research in terminally ill populations (e.g. Bruera 
et al, 1992; Cohen et al 1995; Payne et al, 1996). Cohen et al (1995) argue that the fact 
that less than half of the palliative care population can complete questionnaires does not 
mean that they should not be used in those who can. However, caution is required to 
ensure that attention given to assessment of symptoms is not biased. Thus the 
importance of developing reliable and valid proxy-rated measures is underlined.
9.4 Terminal dehydration and symptom distress: common ground
The PSDS was specifically developed in and for a heterogeneous population of dying 
cancer patients. Its purpose is to measure the distress caused by symptoms rather than 
their occurrence or severity. Recent work by Samarel et al (1996) demonstrated the 
utility of adapting the existing McCorkle and Young Symptom Distress Scale (1978) to 
include separate assessment of symptom occurrence, severity and distress. Earlier 
versions measured occurrence and severity (e.g. McCorkle and Young, 1978). 
Similarly, Portenoy et al (1994) have developed and validated the Memorial Symptom 
Assessment Scale, a patient-rated instrument designed to provide multidimensional 
information about 32 common symptoms. Their findings suggested that, of the three 
dimensions of the symptom experience assessed, symptom distress (as opposed to 
frequency or intensity) provided the most information relating to the impact of 
symptoms on quality of life. It is suggested that concurrent assessment of symptom 
distress and another dimension should be considered if the goal of evaluation is to 
examine the interaction between symptoms and quality of life (Ingham and Portenoy, 
1998).
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It could be argued that the disadvantages of increasing the length of such assessment 
tools, by the addition of the distress dimension, would be counterbalanced by the gain in 
depth of data. However, it is contended that a simpler scale, such as the PSDS, is 
equally as useful but poses less of a burden to subjects, thus making it more suitable for 
use in very ill patients.
This argument is justified by considering the goals of palliative care at the end stages of 
life. Should the aim be to remove all symptoms or is it more appropriate to aim to 
relieve the distress caused by the individual symptoms? If the latter is accepted then it 
may be sufficient to measure which symptoms are causing distress and not to assess 
aspects such as severity and occurrence separately. Once it is known where symptom 
distress lies, one can focus on interventions to aid its relief.
This view emphasises the importance of the meaning-centred approach to understanding 
the symptom experience of the patient (see Chapter 4) since it is the meaning that the 
person attaches to their symptoms that contributes to the distress they cause (Kleinman, 
1988). Consequently, lengthy questionnaires assessing the severity and occurrence of 
symptoms may detract from time that could be used to elicit more qualitative data that 
could aid interpretation of the meaning of symptoms and thus help identify potential 
treatment strategies.
This is further underlined by the experience of Rees et al (1998) who examined the 
feasibility and usefulness of the Edmonton Symptom Assessment Scale (ESAS) (see 
Chapter 4) in a hospital-based palliative care ward in the United Kingdom. 
Significantly, the authors do not report assessment of the scale for attributes of 
reliability or validity, particularly aspects of inter-rater reliability given that nurses or 
family members made some assessments for patients. Nevertheless, they conclude that 
although the scale provided a clear display of symptoms over time, it was not practical 
for their patients with poor performance status. Particular problems were identified 
with a trend towards worsening symptom scores over time. These were not attributed to 
worsening symptom control but considered to be a representation of the general 
deteriorating condition of the patients who were entering the final days of their illness. 
They postulate that “as a patient’s condition deteriorates, the ESAS becomes an 
inappropriate means of assessing symptom control” (Rees, et al, 1998 p.78). It could be 
suggested that this attempt to assess symptoms using the ESAS, a measure of symptom
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intensity, at this stage in the disease trajectory is unsuitable as the focus of assessment is 
flawed. Perhaps by measuring the distress caused by symptoms, as opposed to their 
intensity, an improvement in outcome over the same time period could be demonstrated.
Similarly, Tierney et al (1998) investigated the relationship between symptom relief (as 
assessed using the ESAS), quality of life and satisfaction with hospice care. The scores 
on the ESAS were not found to correlate with satisfaction of care, one day after 
admission to a palliative care unit. The authors suggest that this may be due to patients’ 
not attributing their symptom control to the hospice immediately on admission whereas 
the correlation of symptoms with satisfaction that was seen after five days of hospice 
intervention could be due to patients’ then viewing symptom control as within the unit’s 
remit. However, surely it may be that, when trying to assess factors impacting on 
quality of life and satisfaction with care, this study measures the wrong component of 
the symptom experience again, namely symptom severity/intensity (as assessed by the 
ESAS) instead of symptom distress.
As argued previously, alleviation of all symptom occurrence may not be a realistic goal 
in the face of rapidly advancing disease and multi-organ failure, however, physical and 
psychosocial interventions aimed at ameliorating the distress they cause can provide a 
useful approach.
The biomedical model starts from the need for an explanation of the reasons for 
symptoms (Tishelman et al, 1991), emphasising the view that symptoms are reflecting 
the underlying pathology. This contrasts with the cultural hermeneutic model where the 
goal is understanding and interpreting the meaning of the symptoms for the patient 
(Good and Delvicchio Good, 1980). It can be seen that assessing symptom distress as 
opposed to symptom intensity or frequency, is more in line with the cultural 
hermeneutic approach, as the emphasis shifts to the effect of the symptom on the 
individual from the cause. Understanding the cause of a symptom may enable clinicians 
to target interventions at elimination but, if that is not effective, treatment may be 
considered unsuccessful.
Hence it is suggested that by using an instrument to begin assessing distress, 
interventions may be targeted in a different way. Using the PSDS provided a trigger for 
many patients to explore the meaning of the symptoms that they were describing even
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though this data was unsolicited. For example, some patients when responding to the 
questions on tiredness and weakness spontaneously reflected on the marked 
deterioration in their own condition that they had observed. They then related this to the 
knowledge that this was associated with their rapidly progressing disease and 
approaching death. They often talked about the limitations that their symptoms imposed 
on their ability to fulfil their social roles. Fieldwork notes revealed that the researcher 
attributed the source of distress as the meaning of these symptoms in terms of social 
function and impending death.
Another patient commented that dry mouth was a source of symptom distress as it was a 
constant reminder of the drugs that she was taking. Whilst recognising that the drugs 
were effective in relieving her pain and breathlessness, the unremitting dry mouth 
served to emphasise her dependence on external agents for her comfort, a condition that 
she struggled to accept. A third example is taken from the situation, again described by 
more than one patient, where symptoms were said to be distressing, not because of their 
effect on the individual experiencing them, but because of their impact on the family 
members. For example, patients described the functional limitations placed on them by 
their breathlessness or pain as contributing to their sense of burden and source of 
concern and worry for their family caregiver. The following extract illustrates this:
“Oh I have got used to the shortness of breath now... it doesn’t bother me at 
all. What does bother me though ....is that I can’t do very much for myself
 and he is getting so tired... looking after me. To someone outside....
my puffing must look terrible... but I am used to living with it... at least I 
am still breathing (laughs) .... But he worries about me so... ”
This is supported by findings of other work (e.g. Ferrell, 1991). Implementing 
therapeutic strategies aimed at relieving or improving such symptoms as weakness at 
the end stage of cancer may be ineffectual, whereas psychosocial interventions (e.g. 
managing changing roles) aimed at addressing the distress could be more realistic, 
achievable, and beneficial to the patient. Ongoing assessment and monitoring of the 
frequency of symptoms such as weakness and fatigue may show only worsening results 
and deterioration to the point of death. In contrast, assessment of symptom distress 
regarding the same symptoms may demonstrate a positive outcome for the patient if the 
psychosocial interventions have been effective.
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Greater understanding of the meaning of symptoms, in the wider cultural and social 
context of the patient, may thus provide greater scope for therapeutic interventions. 
Recent work by Axelsson and Sjoden (1998) found ‘meaningfulness’ was the item 
correlating most strongly with global quality of life assessments in patients with 
advanced cancer, also supporting the call for a meaning-centred approach to care. 
Assessing distress alongside symptom severity and occurrence (or in place of) changes 
the focus from disease to illness. Disease is what is happening to the body, whereas 
illness is what is happening to the person and the impact and manifestation of that 
disease on the body (Kleinman, 1988; Greisinger et al, 1997).
It can be seen that if such understanding can be gained through the unstructured use of 
an instrument such as the PSDS, much greater insights may be found if such a tool is 
seen as a starting point for meaning-centred assessment. The questions on the PSDS 
may provide an opening to explore the meaning of symptoms for patients in a more 
naturalistic manner. Thus it can combine the demand for more “hard” data often 
required by purchasers and policy makers, yet be useful enough to provide a clinical 
tool which may stimulate a more qualitative approach to symptom management.
The common ground between the arguments put forward here for the assessment of 
symptom distress (as opposed to symptom intensity, frequency, duration and 
prevalence) and the hypothesis put forward to help explain different attitudes towards 
terminal dehydration (Chapter 3) is that of the conceptualisation of the objectives of 
interventions. Both discussions centre on the possibility of viewing the management of 
the distress of symptoms as the goal of care rather than the complete removal of 
symptom occurrence. Considering the word palliation can illuminate further the 
important distinction between treating states and managing distress. The word derives 
from the latin pallium meaning to cloak. Hence it can be seen that the tenet of palliative 
care does not rest on a paradigm of eradication but one of “hiding” or “veiling”.
The palliative care philosophy has always recognised that symptoms should be treated 
even if the underlying cause cannot be corrected (Dunlop, 1993). However, recent 
research literature in palliative care does not always emphasise this. Research often still 
concentrates on assessing prevalence of symptoms in patients with advanced cancer. For 
example, Vainio and Auvinen (1996) demonstrated statistically significant differences 
in the prevalence of pain and other common symptoms according to primary site of
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malignancy, on admission to palliative care centres in Europe, Australia and the United 
States of America. This contrasts with the National Hospice Study (NHS) (Wachtel et 
al, 1988) which did not find significant variations in symptom patterns in different types 
of cancer or primary site of disease. Wachtel and colleagues (1988) suggested that there 
may be a common final pathway for symptoms in people dying of cancer, independent 
of age, gender and disease. The conflicting findings may be accounted for by the timing 
of the two studies. Interviews were conducted with patients at median time span of 35 
and eight days prior to death in the NHS work (Wachtel et al, 1988) whereas patients 
were interviewed at an earlier stage in the Vainio and Auvinen (1996) study. Therefore, 
the proposed terminal common pathway for symptom experience may not exist beyond 
the last few weeks of life. Vainio and Auvinen (1996) suggest that such data on 
symptom prevalence be considered when evaluating the need for resources and planning 
palliative care services and call for population-based studies to document the prevalence 
of symptoms through the course of the disease.
However, while not denying the importance of such knowledge, it appears that a vital 
element of the palliative care approach is missing in such work as this: that of attention 
to symptom distress. Basing service provision and development on prevalence and 
severity data (regardless of the symptom pattern for different types of cancer seen 
within particular palliative care populations or whether there is a final common 
symptom pathway irrespective of primary disease site) could lead to inadequate 
targeting of services. If the important area of symptom distress is not considered, 
interventions to reduce the most prevalent symptoms may still leave symptoms that 
cause significant distress unaddressed.
Donnelly and Walsh (1995) have demonstrated that patients with advanced cancer are 
often polysymptomatic, a finding that is supported in the data presented in Chapters 5 
and 6. In a later paper, Donnelly et al (1995) suggest that the extensive symptom 
prevalence data arising from their work be used as an aid to determining priorities for 
clinical practice, research and education. Again, the important dimension of symptom 
distress is missing from this work. Consequently, it is argued that, even within the 
palliative care community, the profile of assessment of symptom distress needs raising.
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Dunlop (1993) recognises that the biomedical model often associates certain symptoms 
with particular diseases. Indeed, the work of those such as Vainio and Auvinen (1996), 
described above, supports this notion. The PSDS has been developed and tested for use 
in patients dying of malignant disease. However, it may have applications in other end- 
stage diseases. Future work to assess the suitability of the PSDS for use in non- 
malignant disease would be relevant as symptoms may be overlooked if a biomedical 
framework is being used (Dunlop, 1993). The possibility of generalising theories of 
symptom distress and quality of life to populations beyond cancer is supported by the 
findings of a pilot study by Cowan et al (1992). Their work demonstrated that symptom 
distress impacted on quality of life in groups of patients experiencing myocardial 
infarction and cancer, thus supporting a model of quality of life that is valid for chronic 
illness. An assessment tool such as the PSDS that rated symptom distress, irrespective 
of the source, could enable targeting and evaluation of interventions.
It has been highlighted that symptoms may contribute to the suffering of a dying patient 
(Cassell, 1991; Chapman and Gavrin, 1993). This discussion has argued that the study 
findings support the distinction between symptom distress and symptom intensity or 
frequency. Cheryn et al (1994) suggest that potential management strategies are 
required to relieve symptoms and thus reduce suffering. However their definition and 
taxonomy of suffering (described in Chapter 4) fails to capture the sense in which 
alleviation of distress does not necessarily equate with relieving or removing symptoms. 
It is not recognised, nor made explicit, that giving attention to strategies to tackle the 
distress may be as useful as removing the actual source. This is particularly important as 
it may not be possible to eliminate all symptoms in the dying patient.
Frankl (1984) suggests that suffering is not confined to physical discomfort or 
deprivation but depends on personal loss of meaning and purpose. The use of the PSDS 
as a basis for further more in-depth assessment of the meaning attributed to symptoms 
and the distress experienced may thus provide an approach to suffering that 
encompasses this philosophy. It is suggested that the biomedical framework which 
views suffering as a problem to be managed is valid and may contribute to frequently 
effective interventions; however, this approach is also limited as it does not encompass 
the wide range of human experience (Byock, 1994). One of the fundamental goals of 
palliative care is the relief of suffering (e.g. Wanzer et al, 1989), but whether this is an
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appropriate aim is open to speculation. Byock (1994) suggests that the ultimate problem 
of human suffering may be insoluble within a modem western worldview. However, 
approaching suffering in a similar manner to that of symptom distress, as outlined 
above, may enable a solution to be found, in that a search for the meaning behind the 
distress may provide an approach that has greater benefit to the dying person. Perhaps 
“suffering is not so much a problem requiring an explanation as a mystery demanding a 
presence” (source unknown, cited by Lunn, 1993) and hearing the distress caused by 
symptoms may offer an alternative.
Ahmedzai (1997) reminds those concerned with evaluating palliative care services that 
it is not the outcome alone that requires measurement but the process by which the 
outcome is attained. It is suggested that assessment of symptom distress (e.g. by the 
PSDS) may be an approach that could be usefully incorporated into such evaluation.
9.5 Contributions of this work to research and clinicai practice
The contributions of this work comprise both new findings and a new research tool. 
Although symptom distress is often referred to in the cancer and palliative care 
literature it has been argued that there has been a lack of conceptual clarity and a lack of 
appropriately validated measuring tools. This has sometimes contributed to conflicting 
findings and a reduced ability to generalise findings and make comparisons across 
studies. This work has addressed this deficit and makes a contribution to knowledge by 
its exploration of symptom distress in the dying population and the development of an 
instrument to measure it (the PSDS). The measuring instrument can be applied to future 
investigations addressing terminal dehydration in the dying cancer patient. It may also 
provide a useful tool for clinical practice, in the ongoing assessment of symptom 
distress and evaluation of therapeutic strategies designed to reduce such distress.
Any further use in research could help evaluate further the clinimetric properties of the 
instrument. It must be remembered that properties such as reliability and validity are not 
exclusive attributes of a measuring instrument but are also properties of the population 
in which the measure is being used, thus requiring re-evaluation in future studies 
(Waltz, et al, 1991). Additionally, the evaluation of the Rotterdam Symptom Checklist 
for use in palliative care populations demonstrates areas where further validation is 
required and provides further evidence for its utility, thus increasing the confidence in
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findings of recent research that has used this scale in very ill patients (e.g. Fulton, 1997) 
and supporting its future development and use.
The survey in Chapter 3 supported earlier work, and demonstrated a link between 
attitudes to symptom distress and terminal dehydration and place of work and 
experience of observing untreated terminal dehydration. These findings were used to 
formulate a novel explanatory hypothesis suggesting that the differences may reflect 
different philosophical approaches. This adds to the body of research literature and 
knowledge in the area of terminal dehydration. The substantial difference, in relation to 
the existing literature, that this explanatory model brings is the explicit recognition that 
there may not be one right way to approach the clinical problem of terminal 
dehydration. Accepting that different paradigms may exist in relation to approaches to 
care, and attempting to understand the rationale for such arguments, allows the debate to 
move on from its polarised positions. In addition, recognition of the unifying dimension 
of relief of distressing symptoms produces a direction for future research.
The strength of findings in the scale development rest on the systematic and 
comprehensive approach to development and testing, and in using clinimetric theory as 
a framework. Items were derived for the PSDS from an empirical study using multiple 
data sources and results of published data available and strongly supported the validity 
of the tool. The scale achieved an internal consistency rating (Cronbach’s coefficient 
alpha = 0.77) which indicates a high degree of reliability. Additionally, the PSDS was 
shown to be sensitive to changes across groups (such as those closer to death and those 
of different ages).
Previous developments of measuring instruments in the cancer and palliative care fields 
have not emphasised the importance of clinimetrics as a theoretical framework for 
evaluation, relying on psychometric approaches instead. The implications of such an 
approach, for both researchers and clinicians in developing measuring instruments, lie 
in the strength of assessing the more qualitative components of the sensibility of a scale 
alongside the more quantitative elements of reliability and validity (usually assessed 
with statistical methods). This may enhance the acceptability of a measuring instrument 
by clinicians who may otherwise approach its use cautiously, particularly in such a 
vulnerable population.
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The study to develop a nurse-rated symptom assessment scale used an approach novel 
to palliative care. Although the use of behavioural indices for the rating of distress and 
pain in children and in people with Alzheimer’s disease has been investigated, such an 
approach had not previously been attempted in palliative care. Items for inclusion in the 
scale were developed from interviews with experienced palliative care nurses and 
checked by “expert” clinicians and, as such, could claim good content validity. 
However, interpretation of the results was difficult. It was not possible to state with 
confidence whether the lack of item endorsement seen in the completed assessments 
was due to an absence of distress in patients or whether nurses were using other more 
global assessment strategies. The poor item endorsement reduced the ability to interpret 
the inter-rater reliability testing in a meaningful manner. Although there were negative 
findings in this study, and a successful tool was not developed at this stage, the work 
provides a foundation for future work and indicates the complexity of the area.
The ethical and methodological challenges met during the course of this work, and 
discussed in Chapter 8, add to the body of discursive literature in the area of palliative 
care research. By acknowledging the ethical dilemmas faced and strategies used to 
address them other researchers can assess the integrity of the work presented. 
Transparent debate of real issues such as the suitability of very ill and dying patients for 
involvement in such research emphasises the responsibility of the palliative care 
research community to address these important concerns.
9.6 Limitations of the work
Limitations of the work have been discussed in individual chapters and their 
implications when interpreting the findings have been drawn out. A major factor has 
been the difficulty in obtaining random samples and the gatekeeping experienced. This 
has reduced the representative nature of the samples used and may have introduced a 
source of bias into the research. This has the effect of limiting the ability to generalise 
from the findings and supports the call for further work to confirm the results obtained 
here.
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The inability to use multiple outcome measures for cross-validation of the PSDS, due to 
the research burden on very ill samples, has reduced the ability to explore the concepts 
of symptom distress and related variables in more depth. This will be an ongoing 
challenge when developing research programmes using very ill populations.
9.7 Conclusions
Terminal dehydration, and/or its treatment with AHT, may contribute significantly to 
symptom distress in the dying cancer patient. It appears that health care workers from 
specialist palliative care and non-specialist palliative care backgrounds have differing 
attitudes to the perceived benefits and negative consequences of this condition. It has 
been argued that such attitudes may represent a philosophical difference in approach, 
whereby specialist palliative care clinicians support the belief that greater benefit (in 
terms of relief of symptom distress) for dying patients is gained by treating the 
symptoms of terminal dehydration. In contrast, it is suggested that non-palliative care 
clinicians perceive that there is more benefit from preventing or correcting terminal 
dehydration. It is clear that symptom distress may result from either the condition or its 
treatment but, as yet, it has not been possible to investigate this further as no suitable 
measurement instruments are currently available.
A method of assessing symptom distress, related to terminal dehydration, has been 
developed for use in dying cancer patients. Evaluation of this measuring instrument 
suggests that it has properties of reliability, validity and sensibility and may provide 
meaningful results. Such an instrument has clinical implications and may be used as a 
starting point for meaning-centred assessment of symptoms, thus contributing to more 
holistic patient care. Alongside this, the instrument has research implications and may 
be used in studies to evaluate what interventions comprise optimal care for dying 
patients (e.g. the benefits of AHT or dehydration) and to explore factors impacting on 
concepts of symptom distress and quality of life, in order to facilitate development of 
strategies to optimise patient management.
216
The studies demonstrated that a large population of dying cancer patients for whom 
self-assessment of symptom distress is not feasible. An attempt to develop a 
complementary assessment scale for use by nurses, utilising behavioural indices of 
distress, failed to yield a reliable and valid instrument but provides a useful foundation 
for further developmental work in this area. This is crucial if palliative care practice is 
to be developed through use of systematic evaluation and research, which depend on 
robust and well validated outcome measures.
9.8 Areas for future research
In response to the empirical findings and conclusions of this study, future work in the 
following areas is suggested:
1. Further testing and validation of the PSDS and RSCL in random samples of dying 
cancer patients to confirm the findings and increase confidence in the generalisability 
of the instruments.
2. Longitudinal studies to evaluate the performance of the PSDS over time, in order to 
assess its utility in longitudinal studies (see 3.)
3. Longitudinal studies to evaluate changes in symptom distress related to terminal 
dehydration.
4. Longitudinal studies to investigate nature and direction of relationships between 
symptom distress and moderating variables, in order to increase understanding and 
enhance the repertoire of therapeutic interventions.
5. Substantial research is required to elucidate the processes that clinicians use when 
assessing symptom distress in dying patients who cannot verbalise their distress for 
whatever reason. This can then be used to develop a robust measurement instrument 
for the assessment of symptom distress by proxy. This will enable research to continue 
to address problems that may affect the quality of patients’ dying.
6. The hypothesis put forward that differences in attitudes towards terminal dehydration 
can be attributed to differing philosophical approaches to care needs to be empirically 
tested.
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7. There is a need for investigations that would enable evaluation of different 
management strategies for treatment of symptom distress related to terminal 
dehydration and/or treatment with AHT.
8. The clinimetric evaluation of the use of the PSDS in patients dying of non-malignant 
diseases needs to be explored as issues of symptom distress in relation to terminal 
dehydration and other causes are equally as important in these populations.
9.9 Endnote
“We often discover what will do, by finding out what will not do; and 
probably he who never made a mistake never made a discovery.”
Samuel Smiles (1812-1904) British writer.
This thesis does not demonstrate a course of research following a straight path to the 
answer. The clinical problem identified at the start of the journey still has not been 
answered. However, through the application of rigour the altered focus of the work 
contributes to the knowledge base of measurement issues in palliative care. These 
findings can be built upon in further work and the methodological and ethical issues that 
have been discussed will inform future research endeavours.
This has been an important lesson. As a student of research, the progress through this 
course of work has been invaluable. However, as a nurse and specialist palliative care 
clinician, the frustration of the remaining unanswered questions has, at times, been 
difficult to live with. It is hoped that the research skills gained through this process, and 
the knowledge that has been added to the field, will provide a foundation for the 
continuing work that lies ahead.
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APPENDIX 1: Survey questionnaire (from Chapter 3)
THE EFFECTS OF DEHYDRATION IN THE TERMINAL PATIENT
Please respond to all questions.
SECTION 1- Circle or insert the correct answer, as appropriate.
1. Have you observed, in your hospital/hospice experience, any patient in whom no 
form of food or fluid was given or taken for at least 3 days before death?
a. Yes
b. No
2. Please approximate ( or “guess”timate) the number of patients who you have 
observed in this state:________( write only one number on the line).
SECTION II- Please consider the terminal patient whose death is imminent in 
responding to these statements about dehydration. READ EACH STATEMENT 
CAREFULLY and circle the number which most closely reflects your level of 
agreement. Please respond to all the statements.
1. As fluid intake is reduced there is a reduction in the bouts of vomiting
5 4 3 2 1
Definitely Probably agree Neither agree Probably don’t Definitely
agree nor disagree agree don’t agree
2. Dehydration causes apathy and depression
5 4 3 2 1
Definitely Probably agree Neither agree Probably don’t Definitely
agree nor disagree agree don’t agree
3. Dying patients who are dehydrated rarely complain of thirst.
5 4 3 2 1
Definitely Probably agree Neither agree Probably don’t Definitely
agree nor disagree agree don’t agree
4. There is relief from choking and drowning sensations when fluids are discontinued.
5 4 3 2 1
Definitely Probably agree Neither agree Probably don’t Definitely 
agree nor disagree agree don’t agree
5. Dehydration is painful. 
5 4
Definitely
agree
Probably agree Neither agree 
nor disagree
Probably don’t 
agree
1
Definitely 
don’t agree
Please turn over
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6. Dry mouth caused by lack of fluid intake necessitates the use of I. V.Is and/or tube 
feeding.
5 4 3 2 1
Definitely Probably agree Neither agree Probably don’t Definitely 
agree nor disagree agree don’t agree
7. Coughing and pulmonary congestion are decreased with dehydration.
5 4 3 2 1
Definitely Probably agree Neither agree Probably don’t Definitely
agree nor disagree agree don’t agree
8. Tracheal and nasogastric suctioning are unnecessary for patients who are not given
I.V. fluids when their spontaneous intake of food and fluids is decreased.
5 4 3 2 1
Definitely Probably agree Neither agree Probably don’t Definitely
agree nor disagree agree don’t agree
9. Patients who are dehydrated experience relief from distressing symptoms.
5 4 3 2 1
Definitely Probably agree Neither agree Probably don’t Definitely
agree nor disagree agree don’t agree
10. Dehydration can be beneficial for the dying patient.
5 4 3 2 1
Definitely Probably agree Neither agree Probably don’t Definitely
agree nor disagree agree don’t agree
SECTION III -  Please indicate professional status by circling appropriate categories 
below.
1. Doctor -  H.O./S.H.O./Reg./Sen.Reg./Cons./Other
2. Nurse -  S.E.N./R.G.N./Sister/Charge Nurse/Other
3. Present Speciality________________________
4. Previous Hospice Experience -  Yes (Duration )
No
Thank you for your time and co-operation.
All the information will of course be anonymous and treated as strictly 
confidential.
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APPENDIX 2: Summary of statistical tests used
1. Analysis of variance (ANOVA)
ANOVA is a test used to compare the means of three or more unrelated samples. It is 
based on the null hypothesis that all sample means are equal, that there is no 
relationship between the independent and the dependent variables.
It is calculated by estimating the between-groups variance and comparing this with an 
estimate of the within-groups variance. The statistic obtained by this is referred to as the 
F ratio:
Between - groups estimated variance (mean square)
F =-------------------------------------------------------------
Within - groups estimated variance (mean square)
The F ratio is then compared to tabled values of the sampling distribution for F that 
assumes the null hypothesis is true. If the F ratio calculated is non-significant then the 
null hypothesis cannot be rejected. (If there are only two groups and equal population 
variances are assumed the ANOVA and the t test yield equivalent results (Mattson, 
1981)).
The F test or ratio describes the presence (or absence) of a significant difference 
between one or more of the groups but does not indicate where this difference may be 
found. Post hoc tests are required in order to assess where the difference lies. These 
multiple comparison procedures compare pairs of means between the groups. This 
could be done by multiple t-tests but this is not recommended as this would increase the 
likelihood of Type 1 errors (i.e. falsely rejecting the null hypothesis) (Polit, 1996; 
Bryman and Cramer, 1997). The multiple comparison procedures make adjustments for 
the number of comparisons that are made. Thus the more comparisons made, the larger 
the difference in pairs of means must be for a multiple comparison procedure to give a 
significant result (Norusis, 1993). There are numerous post hoc tests to choose from, 
differing in how they adjust the observed significance level. Fisher’s least significant 
difference (LSD) test is one of the simplest methods (Polit, 1996) and is calculated from 
the following formula:
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Where: X2= means for Groups 1 and 2
MSW = mean square within from ANOVA 
ni, n2 = number o f cases for Groups 1 and 2
To find the critical value in the t tables the degrees o f freedom are computed as 
d f = N - k  = dfw (where k = number o f groups)
If variances in the groups are unequal an alternative multiple comparison procedure is 
required and, again, there are many of these to chose from. Tamahane’s multiple 
comparison test was used for this purpose when required (Norusis, 1994).
1.1. Levene’s test for homogeneity of variance
This test examines whether the variances of three or more samples, rather than the 
means, are significantly different. It is used to examine the appropriateness of the 
ANOVA procedure on a data set, since the ANOVA analysis is based on the assumption 
that variances within the groups do not differ too widely. If the observed significance of 
the Levene test is small (i.e • P < 0 .05) then the null hypothesis that all variances are 
equal can be rejected. If variances are found to be significantly different between groups 
then non-parametric tests to test for mean differences are recommended (Bryman and 
Cramer, 1997).
1.2. Two-way ANO VA
One-way ANOVA tests for the effect of a single independent variable on a dependent 
variable. Two-way ANOVA is used to test for the effect of two independent variables 
on the dependent variable. With two-way ANOVA there are three null hypotheses to be 
tested. The first states that there are equal means across groups with respect to the first 
independent variable. The second states that there are equal means across groups with 
respect to the second independent variable. The third tests for interaction, or joint 
effects, between the two independent variables (hence its name of an interaction 
hypothesis). This interaction concerns whether the effect of one independent variable is 
consistent for every level of the second independent variable (Polit, 1996). This test 
yields three F statistics that are then tested for statistical significance.
t = x,-x2
MS, 1 0 1-----
 ^n i n 2 j
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2. Kolmogorov-Smirnov (test for one sample)
This test is used to compare the observed frequencies of the values of a variable 
measured at the ordinal level, against a theoretical distribution. In this work, frequencies 
of variables were compared with the Normal distribution. The Kolmogorov-Smirnov Z 
statistic and its probability value are given. The null hypothesis is that there is no 
difference between the observed distribution and the theoretical distribution. If the Z 
statistic returns a p value less than 0.05 the null hypothesis can be rejected, indicating 
that the sample obtained does not compare with an expected Normal distribution.
3. The correlation coefficient
Correlation tests provide a measure of the strength and direction of relationships 
between two variables. Linear correlation can be measured when the variables are at an 
interval level or ranked correlation can be obtained using ordinal variables. The 
correlation coefficient most widely used is Pearson’s product-moment correlation 
coefficient (Pearson’s r).
It is calculated using the equation:
Where:
 .  rxy = correlation coefficient for variables X and Y
£ (X -X ) (Y -Y j  Z  = the sum o f
r  = ---------------------------------------------------  X = individual value for variable X
8 = mean for variable X
Y = individual value for variable Y
Y = mean for variable Y
The null hypothesis is that there is no relationship between the variable studied (r=0). 
The correlation coefficient returns a value between -1.00 and + 1.00. Values of r below 
zero indicate a negative relationship between the two variables and values above zero 
indicate a positive relationship. The absolute value of r (i.e. the numerical value without 
any sign) indicates the strength of the linear relationship and a significance test can be 
applied to gain a measure of the significance of the correlation coefficient. The test 
statistic is computed using the formula:
The t statistic is then entered in the t table a t n - 2  degrees of freedom.
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4. Non-parametric correlation coefficients
Kendall’s tau is a non-parametric test of association between variables (analogous to 
Pearson’s r). The null hypothesis tested is that there is no relationship between the 
variables. Similarly to Pearson’s r, the correlation coefficient returns a value between -  
1.00 and + 1.00. Values of r below zero indicate a negative relationship between the two 
variables and values above zero indicate a positive relationship. The coefficient is based 
on the ranking of the data and Kendall’s tau-b (a corrected calculation to take into 
account any tied X and Y observations) is calculated using the formula:
C - D
T b  =  — ----------------
V[«(h - 1 ) /2 ] - Tx V K » - l ) /2 ] - Ty
where
C = number of Y pairs in natural order
D = the number of Y pairs in reverse order
n  = the total number of paired (X, Y) observations
n {n  — l) /2 = total number of possible pairs of observations
tx =  number of X observations that are tied at a given rank 
t  =  number of Y observations that are tied at a given rank
This complex calculation (from Pett, 1997) yields a value for Kendall’s “tau-b”, which 
can be tested for statistical significance and if p  < 0.05 the null hypothesis can be 
rejected.
253
5. The kappa coefficient
This statistic is used to assess inter-observer agreement. An often-used approach is that 
of calculating percentage agreement by the equation:
percentage agreement = 100
where:
/
number of agreements 
number of agreements - number of disagreements
number of agreements = number of cases rated the same by two raters 
number of disagreements = number of cases rated differently by two raters
A limitation of simple percentage agreement is that it does not take into account the 
level of agreement that can be expected to occur by chance (Bakeman and Gottman, 
1986). Consequently Cohen’s kappa (Cohen, 1960) yields a test statistic that adjusts for 
chance agreement. It is calculated using the following formula:
 proportion of observed agreement - proportion of chance agreement
fc —  ■
1 - proportion of chance agreement
The proportion of observed agreement is calculated by summing the number of 
agreements appearing on the diagonal of the contingency table and dividing by the total 
number of paired observations. The proportion of chance agreement is determined by:
_ ^  (row marginalXcolumn marginal) 
c - 2 j  ^ 2
The kappa coefficient can then be assessed for its magnitude in two ways. Either criteria 
suggested by Fleiss (1971) can be used (see Chapter 5) or kappa can be divided by its 
standard error to produce a z statistic which can, in turn, be used to determine if the 
kappa is significantly greater than zero (Siegel and Castellan, 1988). If the z statistic 
yields a significance value of p < 0.05 one can conclude that the raters exhibit 
significant agreement.
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6. Cronbach’s coefficient alpha
Cronbach’s coefficient alpha (a) (Cronbach, 1951) is one of the most commonly used 
reliability coefficients and is based on the internal consistency of a test. The reliability 
of a measure is equal to the proportion of variance among its composite items that is 
due to the latent variable (i.e. what the measure is intended to be measuring) and thus 
that is shared or communal (DeVellis, 1991).
It is calculated using the following formula (Norusis, 1994):
&cov/var a  = _______ ______
l + (&-l)cov/var
where k  is the number of items comprising the scale and coy is the average covariance 
between items and var is the average variance of the items.
If the items are standardised to have a variance of 1 the formula is simplified to: 
kr
\ + ( k - \ ) r
where k is the number of items comprising the scale and r is the average 
correlation between items.
From this it can be seen that a  is dependent on both the length of the test (i.e. the 
number of items included) and the correlation of the items within the test. If all the 
variation in observed scores arises from error then the reliability coefficient will be zero. 
Conversely, if there is no measurement error present, the reliability coefficient will be 1.
A standardised item a  can be obtained if all the items were standardised to have a 
variance of 1. If scale items have widely differing variances the two alphas may 
substantially differ (Norusis, 1994). It is possible to calculate a  repeatedly, each time 
omitting one item. If a  significantly increases when a specific item is left out, this 
would indicate that the homogeneity, or internal consistency, would be increased if that 
item were excluded and reliability improved (Streiner and Norman, 1989).
Coefficient alpha is considered a conservative estimate of a measure’s reliability 
(Carmines and Zeller, 1979).
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7. Multiple regression analysis
Multiple regression analysis is a technique that can be used to express relationships 
between dependent and independent variables. It is an extension of simple linear 
regression that uses two or more independent variables to predict a dependent variable 
(in this work, total symptom distress scores).
Multiple regression analysis was carried out to analyse relationships between individual 
scale items and the total scale scores. As the scale totals are aggregate scores of 
individual scale items it was to be expected that they would account for the variance 
seen in the total scores. However, multiple regression is useful in scale development to 
detect possible redundant items; Barker Bausell (1986) suggests that three or four 
variables can often explain almost as much variation in the dependent variable as can be 
explained by a larger number of variables. Thus, in this work, MRA was used to 
determine which of the set of variables (individual symptoms) appeared to have the 
most influence on the dependent variable (total symptom distress score).
There are several possible methods available for the identification of explanatory or 
predictor variables (i.e. those contributing the most to the variance seen in the 
dependent variable). Hierarchical multiple regression enters the independent variables 
into the model in a series of steps controlled by the researcher, based on logical or 
theoretical considerations (Polit, 1996). In contrast, stepwise multiple regression allows 
entry to be determined by statistical criteria. In this model, independent variables are 
entered into the equation singly, in the order in which the increment to R (the multiple 
correlation coefficient) is greatest. Values for R indicate the size of the relationship 
between the dependent variable and the independent variables and the square of R 
shows the proportion of variance in the dependent variable that is accounted for by the 
predictors (Polit, 1996). Unlike Pearson’s r, the multiple correlation coefficient cannot 
give an indication of the direction of relationships between the dependent and 
independent variables.
The statistical significance of the overall equation and R can be calculated using a 
similar test to that used in ANOVA, yielding an F statistic that can be compared to 
tabled values for the F distribution. The significance of the multiple regression 
coefficient at each step of the analysis can also be established. The statistical package 
used to analyses the data, SPSS , generates a t statistic for each regression coefficient
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and this tests the contribution of each independent variable entered into the equation. A 
significant t statistic means that the null hypothesis (that the regression coefficient is no 
different from zero) can be rejected and that the independent variable is contributing 
significantly to the regression, once the other independent variable are accounted for.
8. Factor analysis using Principal Components Analysis (PCA)
Exploratory factor analysis is a data reduction technique that can be used to explain and
group characteristics in a given set of data which go together to constitute a factor 
(Bryman and Cramer, 1997). Such analysis can be used to assess the degree to which 
items on a rating scale are tapping into the same concept. A factor is a dimension 
representing a condensed statement of the relationships between a set of variables 
(Kline, 1994). In Chapter 6 factor analysis was used to determine what constructs or 
dimensions could account for the correlations seen between items on the symptom 
distress scales.
Principal components analysis (PCA) is a commonly used form of factor analysis. It 
determines the structure of a set of variables by analysing the intercorrelations between 
them. The correlation matrix is the starting point for PCA, therefore the assumptions 
that variables should be linearly correlated needs to be borne in mind. Polit (1996) 
suggests that, although a normal distribution of the variables may enhance the factor 
analytic solution, the solution may still be useful even if some variables’ distributions 
depart from normality.
A fundamental requirement is that the correlation matrix be factorable (i.e. that there are 
a number of sizeable correlations between the variables). Bartlett’s test of sphericity can 
be used to test the hypothesis that the correlation matrix is an identity matrix (i.e. all the 
diagonal terms are 1 and all off-diagonal terms are zero (Norusis, 1994), a situation 
where there is no inter-item correlations. If this test yields a statistic that has a 
significance value p < 0.05 the hypothesis that the matrices are an identity can be 
rejected. It is suggested that the use of factor analysis be reconsidered if it appears that 
the correlation matrix is close to identity, as the variables must be related to each other 
for the factor model to be appropriate (Norusis, 1994). The Kaiser-Meyer-Olkin (KMO) 
measure of sampling adequacy is another a priori factor analysis test (an index 
comparing the magnitude of the observed correlation coefficients and the partial
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correlation coefficients); small values for KMO indicate that factor analysis of variables 
may not be useful (Norusis, 1994).
PCA is a complex procedure. The first step entails analysing variance in the observed 
variables to determine the number of factors that need to be extracted in order to explain 
the variance observed. This produces an unrotated factor solution that is difficult to 
interpret. The next stage involves rotation of the extracted factors in order to aid 
interpretability of factors. Rotation is not used as a method to improve the quality of the 
mathematical solution obtained, as rotated solutions are equivalent mathematically to 
unrotated ones (Kline, 1994). The objective of the rotation is to improve the 
interpretability and therefore the utility of the factor solution (Polit, 1996).
Two types of rotation can be carried out, orthogonal and oblique. It is often suggested 
that orthogonal rotations produce the solutions with greater theoretical clarity (Polit, 
1996; Kline, 1994). Orthogonal rotation using a varimax procedure yielded the most 
clear factor structure. Interpretation of factor solutions is subjective, relying on 
theoretical interpretation of meaningful factors. The meaning of a factor is determined 
by the items that load most highly on it. Differing levels of factor loadings to be 
considered are suggested by different writers but, in general, cut-off loadings of 0.3 or 
0.4 are often taken, whereby items below this level are ignored (e.g. Bryman and 
Cramer, 1997). In addition, items that load highly only onto one factor are also 
important, as they are unique to those factors and aid theoretical interpretation. Such an 
approach may demonstrate a reduction in the dimensionality of the data, by elimination 
of items that do not load highly onto clearly meaningful factors.
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APPENDIX 3: Patient Information Sheet (Chapter 5)
SYMPTOM DISTRESS SCALE - INFORMATION SHEET
Dear Patient,
I am a nurse carrying out a study to find out what symptoms are important when people are 
ill so that I can develop a way to assess these symptoms. This will help us evaluate the 
care we give.
I should like to interview you and ask some questions about your symptoms and illness. 
The interview will take about 10 minutes and I will record the interview by tape recorder, 
or make some notes as we talk. The interview tape will be written up later and the tapes 
will then be rubbed out.
The information you give me will be in strict confidence and not related in any way to 
your name. If you become tired during the interview, or want to withdraw from the study 
for any reason, we will stop the interview.
If you decide you do not wish to take part, or that you wish to stop the interview, this 
decision will have no effect on your medical/nursing care.
Please feel free at any point to ask me any questions about the study.
Yours Sincerely,
Jayne Sutcliffe 
(Nurse Researcher)
(University of Surrey)
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APPENDIX 4: Professional Carer Information Sheet (Chapter 5)
Information sheet.
The development of a symptom distress scale for use in 
patients dying of malignant disease.
I am a nurse carrying out a study to find out what are the major symptoms affecting 
patients in the terminal stages of malignant disease (who are in the last few days of life) in 
order to develop a symptom distress scale for use in such patients. This scale will then be 
used in a study investigating artificial hydration therapies in dying patients.
I should like to interview you and ask some questions about symptoms of dying patients. 
The interview will take about 15-25 minutes and I will record the interview by tape 
recorder, and make some notes as we talk. The interview tape will be transcribed later and 
the tapes will then be erased.
The information you give me will be in strict confidence and not related in any way to 
your name. If you do not wish to answer certain questions or wish to terminate the 
interview at any stage we will stop .
You are under no obligation to agree to an interview but should you agree I should be very 
grateful for your time and comments.
Please feel free at any point to ask me any questions about the study.
Yours Sincerely,
Jayne Sutcliffe
(Nurse Researcher, University of Surrey)
Consent Form
DEVELOPMENT OF A SYMPTOM DISTRESS SCALE
I give my consent to undergo the research procedure described in the above Information 
sheet. The purpose and possible consequences of this procedure, summarised in the 
Information sheet have been explained by Jayne Sutcliffe and are acceptable to me. I 
understand that I am free to withdraw at any stage without having to give a reason.
Signed........................................................... Date...................................................
Name in block capitals please..................................................................................
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APPENDIX 5: Letter sent to bereaved relatives (Chapter 5)
Address o f Institution 
4 January 1993
Dear "name"
I was a Staff Nurse at X  for 3 years and now I am carrying out a research study. I am 
developing a scale to assess how comfortable people are when they are very ill and dying. 
This is to help us evaluate the care that we give so that we may improve any areas as 
necessary.
I hope that this letter does not cause you any more distress but I understand that your 
"deceased's relationship to subject", "deceased's name", died in the care of X  last year. I 
should like to ask you if you would be willing to talk to me about your "deceased's 
relationship to subject’s" illness. If you feel able to talk with me I should like to interview 
you at a place and time convenient to you. An interview would be completely confidential 
and would take about twenty minutes to half an hour.
I should like to give you some time to consider this matter and I will telephone you in a 
week's time. If you should wish to write to ask me not to contact you again, or to agree to 
talking with me then please write to the above address. If you prefer then please wait until I 
telephone you and give me your reply then.
Thank you for your consideration of this matter.
Yours sincerely,
Mrs. Jayne Sutcliffe 
Nurse Researcher 
University of Surrey
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APPENDIX 6: Bereaved relatives consent form (Chapter 5)
CONSENT FORM FOR SYMPTOM DISTRESS SCALE STUDY
Nurse Researcher: Jayne Sutcliffe
Mrs J. Sutcliffe is studying the symptoms that people experience when they are very ill and 
dying. She believes that this study will help nurses to evaluate the care that they give and 
so improve any areas as necessary.
I agree to take part in an interview. I understand that talking about the illness and dying of 
the person that I cared for may be upsetting and may be tiring.
I know that I can stop the interview at any time I want. I have been assured that any 
information I give will be completely confidential and that my name will not be related to 
anything that I have said.
If I have any questions about the study I know that I can contact Mrs. Sutcliffe through X  
I agree to take part in this study.
Signed......................Date..................
Name in capitals please.
262
APPENDIX 7: Categories for content analysis
CATEGORY DEFINITIONS
PAIN. References to discomfort, pain or hurt
NAUSEA: References to feeling sick or nauseous
VOMITING: References to being sick, vomiting, bringing up food or fluids, 
expulsion of gastric contents
CONSTIPATION: References to difficulty passing stools, hard or infrequent 
motions, constipation
DIARRHOEA: References to loose or watery stools or diarrhoea
BREATHING: All references to difficulty with breathing including shortness 
of breath, tightness of breathing and wheezing, breathless
ANOREXIA: References to decreased or lack of appetite or interest in food
MOUTH:
Sub-categories:
Dry:
Pain:
Infection
Taste:
References to discomfort of mouth.
References to lack of moisture, salivation, unrelieved by 
drinking
References to discomfort or soreness related only to mouth 
References of known infection with thrush 
References to changes in sensation of taste
THIRST: References to thirst or desire to drink
MOBILITY: References to decreased ability to move self, how far they can 
walk
WEAKNESS: References to weakness or loss of muscle power
DROWSINESS: References to drowsiness or increased daytime sleepiness
FATIGUE: References to weariness and tiredness or lack of energy
POOR SLEEP: References to poor quality of sleep or inability to sleep, or 
interrupted sleep
INCONTINENCE: References to inability to control/hold in urine or faeces
DYSPHAGIA: References to difficulty swallowing
CONCENTRATION: References to poor concentration or reduced ability to focus 
attention on things
CONFUSION: References to feeling confused, muddled or impaired cognition 
or thinking
DIZZINESS: References to giddiness or feeling dizzy
BLURRED VISION: References to blurred sight or inability to focus as desired
BODY IMAGE: References to altered perception of appearance of self, in a 
negative manner
ANXIETY: References to feeling anxious, apprehensive, worried or fearful
LOW MOOD: References to feeling low and depressed
UNINTERESTED: References to loss of interest in daily activities
PAIN OF DYING:
DISTRESS AT DYING 
EXPECTATION/DESIRE 
TO DIE
References to distress of impending death f 
References to wanting death to come soon
LONELINESS: References to loneliness, isolation and lack of companionship
263
APPENDIX 8: PHYSICAL SYMPTOM DISTRESS SCALE (PSDS)
Would you please, for all symptoms mentioned, say to what extent you have been 
bothered or distressed by them, by ticking the box which describes best how you 
feel.
Since yesterday have you been bothered by:
1 2 3 4 5
Not Yes but not Alitde Quite a bit Very
at all distressing distressing distressing distressing
PAIN □ □ □ □ □
TIREDNESS □ □ □ □ □
NAUSEA □ □ □ □ □
VOMITING □ □ □ □ □
SHORTNESS OF □ □ □ □ □
BREATH
LACK OF □ □ □ □ □
APPETITE
DROWSINESS □ □ □ □ □
WEAKNESS □ □ □ □ □
CONSTIPATION □ □ □ □ □
POOR □ □ □ □ □
CONCENTRATION
DRY MOUTH □ □ □ □ □
SORE MOUTH □ □ □ □ □
THIRST □ □ □ □ □
DRY SKIN □ □ □ □ □
ITCHY SKIN □ □ □ □ □
INCONTINENCE
OF BLADDER □ □ □ □ □
Other:
□ □ □ □ □
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APPENDIX 9: Rotterdam Symptom Checklist (Chapter 6)
R O TTERD AM  SYM PTOM  C H EC KLIST C O N FID EN TIAL
PATIENT NUMBER:______ DATE COMPLETION: 
TIME COMPLETION:
In this questionnaire you will be asked about your symptoms. Would you please, for all 
symptoms mentioned, indicate to what extent you have been bothered by it, by circling 
the answer most applicable to you. The questions are related to the last 2 days.
Have you, during the last 2 days, been bothered by
lack of appetite not at all a little quite a bit very much
irritability not at all a little quite a bit very much
tiredness not at all a little quite a bit very much
worrying not at all a little quite a bit Very much
sore muscles not at all a little quite a bit very much
depressed mood not at all a little quite a bit very much
lack of energy not at all a little quite a bit very much
low back pain not at all a little quite a bit very much
nervousness not at all a little quite a bit very much
nausea not at all a little quite a bit very much
desperate feelings about the future not at all a little quite a bit very much
difficulty sleeping not at all a little quite a bit very much
headaches not at all a little quite a bit very much
vomiting not at all a little quite a bit very much
dizziness not at all a little quite a bit very much
decreased sexual interest not at all a little quite a bit very much
tension not at all a little quite a bit very much
abdominal aches not at all a little quite a bit very much
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anxiety not at all a little quite a bit very much
constipation not at all a little quite a bit very much
diarrhoea not at all a little quite a bit very much
heartburn/belching not at all a little quite a bit very much
shivering not at all a little quite a bit very much
tingling hands or feet not at all a little quite a bit very much
difficulty concentrating not at all a little quite a bit very much
sore mouth/pain when swallowing not at all a little quite a bit very much
loss of hair not at all a little quite a bit very much
burning/sore eyes not at all a little quite a bit very much
shortness of breath not at all a little quite a bit very much
dry mouth not at all a little quite a bit very much
All things considered, how would you O excellent
describe your quality of life during the O good
past week? O moderately good
O neither good nor bad
O rather poor
O poor
O extremely poor
Would you please check whether you answered all questions? 
Thank you for your help
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APPENDIX 10: Patient Information Sheet (Chapter 6)
SYMPTOM DISTRESS STUDY - INFORMATION SHEET
Dear Patient,
I am a nurse carrying out a study to find out what symptoms affect people and cause them 
distress when they are ill. This will help us to find ways of monitoring the symptoms that 
people have and help us to evaluate the care.that we give.
The study asks you to complete 2 questionnaires which ask you about how you are feeling. 
One questionnaire takes about 3 minutes to complete and the other 5-8 minutes. There will 
be a space of about 10 minutes in between you completing the scales. I will ask you a few 
brief questions after you have filled them in.
The information you give will be in strict confidence. If you become tired or want to 
withdraw from the study for any reason, we will stop.
If you decide you do not wish to take part, or that you wish to withdraw, this decision will 
have no effect on your medical/nursing care.
Please feel free at any point to ask me any questions about the study.
Yours Sincerely,
Jayne Sutcliffe 
(Nurse Researcher)
(University of Surrey)
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